Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution
3015399	p-tfr	mg/l (mg/l)	58240	122307	0.02%
3015399	s-tfr	mg/l (mg/l)	30788	61339	0.00%
3015399	p-tfr	— (—)	26139	43090	100.00%	Distribution not available
3015399	s-tfr	— (—)	2257	3147	100.00%	Distribution not available
3015399	p-transferriinireseptori	mg/l (mg/l)	134	150	0.00%
3015399	transferriinireseptori,liukoinen	mg/l (mg/l)	132	176	0.00%
3015399	p-transferriinireseptori	— (—)	54	59	100.00%	Distribution not available
3015399	s-transferriinireseptori,liukoinen	mg/l (mg/l)	38	47	0.00%
3015399	transferriinireseptori,liukoinen(p-tfr)	mg/l (mg/l)	18	24	0.00%
3015399	s-transferriinireseptori,liukoinen(ko)	mg/l (mg/l)	18	20	0.00%
3015399	transferriinireseptori,liukoinen	— (—)	17	21	100.00%	Distribution not available
3015399	transferriinireseptori,liukoinen(tfr)	mg/l (mg/l)	13	17	0.00%
3015399	p-transferriinireseptori,liukoinen(pi)	mg/l (mg/l)	8	11	0.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Dermatitis

9255

63298

1.65

323.31

2.6

2.2

2.98

2.93

mg/l

1.04

8091

54064

Cerebrovascular diseases

11156

56242

1.59

322.83

2.5

2.2

3.14

3.00

mg/l

6.17

9543

47737

Glomerular diseases

3047

15769

2.54

321.84

3.2

2.2

3.12

2.95

mg/l

3.62

2734

13470

Statin medication

10287

39203

1.61

321.72

2.4

2.1

2.91

2.89

mg/l

0.37

8898

33480

Other specified/unspecified arthritis

4172

23531

2.13

321.38

2.6

2.1

3.07

2.90

mg/l

4.18

3651

19939

Myocardial infarction, without ST-elevation

6446

38031

1.87

319.67

2.7

2.3

3.26

3.09

mg/l

5.21

5558

31970

Specific personality disorders

3733

20408

2.22

319.04

2.4

2.1

2.78

2.74

mg/l

0.61

3181

17589

Dental caries 3, only avohilmo

13877

51193

1.52

317.29

2.3

2.2

2.92

2.98

mg/l

2.39

11833

43675

Bronchitis

16888

83100

1.44

316.46

2.5

2.2

3.06

2.88

mg/l

16.48

14528

70935

Dental operations, only avohilmo

11490

41081

1.58

315.48

2.3

2.2

2.95

3.05

mg/l

3.76

9760

34894

Benign neoplasm: Colon, unspecified

3799

21126

2.26

314.90

2.9

2.3

3.23

2.94

mg/l

8.28

3207

17864

Glomerular disorders in diseases classified elsewhere

2089

9546

3.17

312.72

3.4

2.2

3.10

2.95

mg/l

2.18

1872

8140

Biological medication for rheuma

2528

12268

2.67

309.43

3.5

2.1

2.95

2.78

mg/l

3.34

2337

10581

Other medical care

6328

39495

1.83

308.72

2.3

2.2

3.43

3.00

mg/l

27.22

5497

33310

Gout, unspecified

3344

18249

2.42

308.04

2.9

2.2

3.43

3.04

mg/l

11.03

2926

15358

Other noninfective gastroenteritis and colitis

4197

22208

2.39

307.65

3.3

2.1

3.00

2.93

mg/l

1.03

3739

18907

Non-rheumatic valve diseases

8580

30669

2.61

307.65

2.7

2.1

3.32

2.83

mg/l

49.53

7498

25644

Falls/tendency to fall

18288

66776

1.49

307.65

2.3

2.2

2.91

2.86

mg/l

1.64

15520

57558

Cardiomyopathy (excluding other)

2188

9649

3.11

307.65

2.9

2.0

3.03

2.83

mg/l

2.95

1957

8021

Condition for Implicit Sepsis (Organ dysfunction codes)

15835

63891

2.18

307.65

2.7

2.1

3.10

2.88

mg/l

18.97

13614

54333

Diseases of arteries, arterioles and capillaries (FINNGEN)

4377

11168

3.64

307.65

2.8

1.8

3.23

2.72

mg/l

25.82

3840

9252

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

1593

5067

5.92

307.65

4.6

2.1

2.69

2.81

mg/l

1.51

1503

4346

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

16591

62315

1.87

307.65

2.6

2.1

3.22

2.83

mg/l

65.42

14509

52907

Hyperlipidaemia, other/unspecified

6055

34815

1.97

307.65

2.5

2.2

3.27

3.07

mg/l

6.37

5189

29381

Certain infectious and parasitic diseases

17997

57741

1.75

307.65

2.5

2.1

2.99

2.80

mg/l

18.52

15581

49134

Autoimmune diseases excluding thyroid diseases, strict definition

20362

61231

2.22

307.65

2.8

2.0

2.96

2.86

mg/l

6.61

18097

51681

Factors influencing health status and contact with health services

5275

13685

2.18

307.65

2.2

1.9

2.96

2.85

mg/l

1.98

4504

11541

Coronary atherosclerosis

10868

43247

1.90

307.65

2.6

2.2

3.12

2.97

mg/l

6.98

9488

36317

Substance abuse

8770

54921

1.73

307.65

2.4

2.2

3.00

2.89

mg/l

3.93

7457

47037

Asthma, unspecified (mode)

9382

41054

2.16

307.65

2.6

2.1

3.09

2.84

mg/l

15.36

8160

34813

Tramadol

15328

50592

2.38

307.65

2.6

2.1

3.06

2.85

mg/l

16.62

13254

42985

Ulcerative colitis (strict definition, require KELA)

3556

13720

3.94

307.65

3.9

2.1

2.81

2.82

mg/l

0.15

3237

11805

Persons encountering health services for other counselling and medical advice, not elsewhere classified

19841

72561

1.78

307.65

2.5

2.2

2.87

2.90

mg/l

0.74

17443

61684

Viral Sepsis

3533

17138

2.82

307.65

3.0

2.2

3.25

2.95

mg/l

8.88

3144

14477

Adjustment and management of implanted device

3286

17316

2.54

307.65

2.8

2.3

2.83

3.08

mg/l

6.78

2809

14505

Other diseases of urinary system

17597

68641

1.61

307.65

2.4

2.2

2.91

2.89

mg/l

0.62

15003

58724

Presence of cardiac and vascular implants and grafts

8457

33966

2.43

307.65

2.8

2.2

3.20

3.01

mg/l

8.82

7397

28523

Other special examinations and investigations of persons without complaint or reported diagnosis

12144

35707

1.96

307.65

2.4

2.0

2.90

2.88

mg/l

0.27

10668

30243

Low back pain

12579

60446

1.84

307.65

2.5

2.2

2.93

2.90

mg/l

0.55

10904

51399

Diseases of liver

5623

30855

2.28

307.65

2.9

2.2

3.30

2.93

mg/l

18.33

4993

26344

Explicit Sepsis

8105

40592

2.48

307.65

3.0

2.2

3.40

2.94

mg/l

39.56

7116

34299

Medical observation and evaluation for suspected diseases and conditions

12791

35693

2.14

307.65

2.5

2.0

2.96

2.88

mg/l

2.70

10803

30233

Persons encountering health services in other circumstances

6055

36399

1.95

307.65

2.5

2.1

3.18

2.87

mg/l

16.83

5224

30937

Calcific aortic valvular stenosis, operated

5103

29964

2.11

307.65

2.9

2.3

3.33

3.12

mg/l

6.59

4465

25058

Benign neoplasms

16318

64493

1.55

307.65

2.4

2.1

2.97

2.83

mg/l

10.71

14078

55111

Coxarthrosis

7685

33296

1.78

307.65

2.4

2.1

3.12

2.97

mg/l

5.03

6616

28034

Unspecified kidney failure

1952

8299

3.71

307.65

3.4

2.2

3.29

3.07

mg/l

2.91

1744

6937

General examination and investigation of persons without complaint and reported diagnosis

11528

35580

1.97

307.65

2.5

2.0

3.04

2.88

mg/l

8.98

10107

30144

Chronic gastritis

5120

26109

2.59

307.65

3.0

2.1

3.16

3.01

mg/l

3.35

4359

22002

Diseases of arteries, arterioles and capillaries

11281

52394

1.91

307.65

2.8

2.2

3.31

2.98

mg/l

26.34

9791

44278

Gonarthrosis [arthrosis of knee](FG)

11718

46484

1.65

307.65

2.4

2.1

3.09

2.91

mg/l

10.59

10113

39331

Malaise and fatigue

10386

39771

2.91

307.65

2.7

2.1

2.99

2.93

mg/l

1.78

8901

33574

Care involving dialysis

1627

5769

4.88

307.65

3.9

2.2

2.99

2.92

mg/l

0.56

1492

4881

Disorders of the thyroid gland

16024

73355

1.59

307.65

2.4

2.2

2.94

2.90

mg/l

1.13

13756

62580

Dental caries 3

13817

49949

1.55

307.65

2.4

2.2

2.92

2.98

mg/l

1.84

11795

42587

Crohn disease (strict definition, require KELA, min 2 HDR)

1510

4625

6.47

307.65

4.7

2.1

2.68

2.79

mg/l

1.37

1426

3968

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

3793

14898

3.81

307.65

3.8

2.1

2.79

2.82

mg/l

0.40

3458

12821

Pneumonia, organism unspecified

16055

69942

1.94

307.65

2.6

2.2

3.20

2.85

mg/l

50.08

13975

59642

Gastric ulcer

3274

15937

2.78

307.65

3.2

2.1

3.68

3.05

mg/l

22.97

2879

13373

Diseases of pulp and periapical tissues

5497

31116

2.10

307.65

2.6

2.2

3.06

2.93

mg/l

2.82

4722

26683

Exposure to unspecified factor

15228

85830

1.51

307.65

2.5

2.2

2.90

mg/l

0.02

12768

73760

Asthma (only as main-diagnosis)

12057

44902

1.84

307.65

2.5

2.1

3.00

2.82

mg/l

11.32

10580

38150

Bacterial Sepsis

8923

39029

2.74

307.65

3.0

2.2

3.33

2.98

mg/l

25.58

7758

32892

Persons encountering health services for specific procedures and health care

20023

74406

1.94

307.65

2.5

2.2

2.92

2.89

mg/l

1.23

17448

63333

18654

73368

1.46

307.65

2.5

2.2

3.03

2.88

mg/l

13.72

16031

62471

Iron deficiency anaemia secondary to blood loss (chronic)

3638

13848

4.45

307.65

4.4

2.0

4.18

2.88

mg/l

83.26

3295

11603

Dental pulpitis 2, only avohilmo

12232

43140

1.61

307.65

2.3

2.2

2.94

3.01

mg/l

2.08

10388

36748

Inflammatory bowel disease

6950

28317

3.59

307.65

3.9

2.1

2.85

mg/l

0.05

6350

24241

Hypothyroidism and >3 levothyroxin purchases

4962

9291

3.83

307.65

2.3

1.8

2.73

2.41

mg/l

20.72

4259

7920

Intestinal stricture

4925

29378

2.05

307.65

3.1

2.3

3.25

3.03

mg/l

6.10

4337

24884

Other diseases of anus and rectum

4908

26932

2.24

307.65

2.8

2.1

3.19

2.97

mg/l

6.17

4184

22766

Disorders of gallbladder, biliary tract and pancreas

15939

72214

1.58

307.65

2.6

2.2

3.10

2.91

mg/l

16.02

13867

61519

GI-bleeding

6143

31667

2.59

307.65

3.3

2.2

3.54

3.02

mg/l

32.93

5450

26666

AV-block

3015

13413

2.66

307.65

2.7

2.0

3.22

2.87

mg/l

10.95

2584

11000

Mood disorders

18460

75160

1.86

307.65

2.4

2.2

2.86

2.90

mg/l

1.44

15765

64466

9068

54832

1.66

307.65

2.4

2.2

3.03

2.90

mg/l

5.36

7763

46907

Presence of other functional implants

9095

40941

1.83

307.65

2.5

2.2

3.28

3.00

mg/l

18.07

7576

34367

Hypothyroidism, strict autoimmune, 3 medication purchases required

13884

67157

1.57

307.65

2.4

2.2

2.96

2.90

mg/l

1.99

11891

57336

Type 2 diabetes

17032

63016

1.84

307.65

2.6

2.1

3.19

2.83

mg/l

58.62

14898

53445

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

17384

70378

1.97

307.65

2.6

2.1

3.08

2.85

mg/l

26.42

15123

59982

Other disorders of fluid, electrolyte and acid-base balance

6007

26516

3.09

307.65

2.9

2.2

3.19

3.08

mg/l

2.30

5191

22416

Persons encountering health services for examination and investigation

11459

35708

1.79

307.65

2.4

2.0

2.95

2.88

mg/l

1.97

9880

30243

Constipation

15784

67996

1.97

307.65

2.5

2.2

2.92

2.97

mg/l

1.72

13389

58178

Reimbursement for rheumatic diseases

9275

59698

1.79

307.65

2.6

2.2

3.14

2.91

mg/l

15.92

8280

50821

Other and unspecified iron deficiency

10325

30276

8.57

307.65

4.2

2.0

4.05

2.83

mg/l

221.73

9341

25504

Diseases of oral cavity, salivary glands and jaws

15254

55947

1.53

307.65

2.4

2.2

2.90

2.97

mg/l

3.31

13012

47867

Septicaemia

7746

38127

2.56

307.65

3.0

2.2

3.42

2.95

mg/l

40.82

6796

32129

Other and unspecified anaemias

12053

38576

6.24

307.65

3.6

2.1

3.48

2.98

mg/l

53.35

10742

32331

Dental caries 1

13191

46821

1.59

307.65

2.4

2.2

2.93

3.00

mg/l

2.11

11242

39901

L04AD Calcineurin inhibitors

2052

7858

4.11

307.65

3.5

2.2

3.04

2.85

mg/l

3.22

1887

6782

Gastrointestinal diseases

11190

29291

2.21

307.65

2.5

1.8

2.87

2.70

mg/l

11.47

9743

24566

Implicit viral Sepsis

3526

17105

2.82

307.65

3.1

2.2

3.25

2.95

mg/l

8.90

3138

14450

Dental caries, including avohilmo

13181

46784

1.59

307.65

2.4

2.2

2.93

3.00

mg/l

2.03

11233

39865

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

1713

4645

3.49

307.65

2.6

1.9

3.25

2.94

mg/l

4.33

1512

3864

ILD medications: prednisolone, methylprednisolone, prednisone

22282

68447

2.22

307.65

2.8

2.0

3.08

2.83

mg/l

37.50

19583

57926

Dental caries 3 and operation codes

14936

55035

1.52

307.65

2.4

2.2

2.88

2.98

mg/l

5.14

12754

46892

Diseases of the musculoskeletal system and connective tissue

9351

30333

1.70

307.65

2.3

2.1

2.84

2.82

mg/l

0.36

8066

25694

Benign neoplasm of colon, rectum, anus and anal canal

10260

36561

2.58

307.65

2.8

2.2

3.27

2.89

mg/l

35.32

8909

31043

Dental caries

4497

21647

2.63

307.65

3.0

2.2

3.10

2.91

mg/l

4.80

3923

18581

Asthma, hospital admission 2, infections

9540

60689

1.78

307.65

2.7

2.2

3.10

2.92

mg/l

9.77

8396

51516

Bacterial infection, other or unspecified

10363

46420

2.67

307.65

2.8

2.2

3.39

2.92

mg/l

50.36

9037

39096

Used for control exclusion in common control thyroid runs

20577

59302

2.06

307.65

2.6

2.0

2.91

2.86

mg/l

2.33

18009

50057

Hypertensive diseases

13123

42766

2.00

307.65

2.5

2.1

2.99

2.83

mg/l

9.99

11560

36383

Infections, IBD-co-morbidities

3169

7277

4.31

307.65

3.0

1.9

3.08

2.86

mg/l

4.47

2792

6113

Other nutritional deficiencies

11935

62368

2.33

307.65

2.7

2.1

3.18

2.80

mg/l

49.96

10572

53309

Other systemic involvement of connective tissue (FG)

4448

23457

2.38

307.65

2.7

2.1

3.01

2.94

mg/l

1.10

3853

19702

Examination and observation for other reasons

11982

35151

2.55

307.65

2.9

2.0

3.02

2.88

mg/l

6.70

10472

29799

Sleep apnoea, including avohilmo

15179

67912

1.62

307.65

2.4

2.2

3.07

2.90

mg/l

12.62

13104

58142

Depression medications

5469

9801

3.37

307.65

2.2

1.8

2.77

2.41

mg/l

25.17

4720

8379

Acute renal failure

4227

18154

3.60

307.65

3.2

2.2

3.33

3.04

mg/l

9.12

3751

15260

Hypo-osmolality and hyponatraemia

3267

14737

3.20

307.65

2.8

2.2

3.08

3.13

mg/l

0.42

2804

12431

Malignant neoplasm of colon, excluding all cancers (controls excluding all cancers)

3295

16996

2.60

307.65

2.4

2.3

3.94

2.99

mg/l

40.20

2895

14308

Diseases of the skin and subcutaneous tissue

17750

61371

1.60

307.65

2.4

2.1

2.93

2.90

mg/l

0.80

15272

52303

Implicit Sepsis

14409

58210

2.44

307.65

2.8

2.1

3.17

2.91

mg/l

24.36

12437

49309

Iron deficiency anaemia

12503

39561

6.66

307.65

4.0

2.0

4.02

2.84

mg/l

254.19

11291

33311

Crohn disease

2994

10239

4.96

307.65

4.4

2.0

2.83

2.85

mg/l

0.19

2789

8771

Implicit bacterial Sepsis

7869

34875

2.84

307.65

3.0

2.2

3.33

3.00

mg/l

20.20

6855

29362

Asthma

13722

44902

1.86

307.65

2.5

2.1

2.97

2.82

mg/l

9.90

12029

38150

Peripheral artery disease

7272

37211

1.88

307.65

2.9

2.2

3.41

3.04

mg/l

22.38

6286

31250

Benzodiazepine use

17546

80562

1.77

307.65

2.4

2.2

2.97

2.91

mg/l

2.77

14743

69150

Other cataract

6713

31567

1.93

307.65

2.5

2.2

3.11

2.99

mg/l

2.79

5741

26775

Diabetes, varying definitions

17762

66976

1.81

307.65

2.6

2.1

3.16

2.81

mg/l

60.12

15546

56912

Recurrent or chronic depression

7267

24097

2.66

307.65

2.3

2.1

2.77

2.85

mg/l

1.99

6232

20997

Personality disorders

4336

23563

2.23

307.65

2.4

2.1

2.76

2.75

mg/l

0.20

3703

20332

Systemic connective tissue disorders

5910

35216

2.05

307.65

2.7

2.2

3.04

2.99

mg/l

1.06

5148

29941

Sleep disorders (combined)

16285

71492

1.68

307.65

2.4

2.2

3.03

2.89

mg/l

10.52

14030

61244

Spondylopathies

13455

51699

1.81

307.65

2.5

2.2

3.01

2.98

mg/l

0.65

11660

43864

Dentinal caries

3990

18900

2.72

307.65

3.0

2.2

3.14

2.92

mg/l

5.44

3470

16231

COPD/asthma related infections

17793

62277

1.58

307.65

2.5

2.1

2.99

2.83

mg/l

14.28

15358

53058

Major coronary heart disease event

10838

48990

1.68

307.65

2.6

2.2

3.19

2.99

mg/l

11.84

9458

41319

Aplastic and other anaemias

12882

41175

5.90

307.65

3.6

2.1

3.47

2.97

mg/l

57.72

11477

34554

Abnormalities of breathing

17063

57558

2.06

307.65

2.6

2.1

3.02

2.85

mg/l

13.93

14896

49018

Other specific joint derangements/joint disorders

11860

51944

1.72

307.65

2.4

2.1

2.81

2.80

mg/l

0.08

10274

44240

Codeine or tramadol medication

21210

73265

1.85

307.65

2.5

2.1

2.99

2.88

mg/l

7.62

18253

62466

Symptoms and signs involving the circulatory and respiratory systems

18341

57740

1.80

307.65

2.4

2.1

2.89

2.85

mg/l

1.44

15888

49181

Fever of other and unknown origin

10281

49164

2.40

307.65

2.8

2.1

3.27

2.88

mg/l

39.25

9100

41639

Obesity due to excess calories

8278

43243

2.42

307.65

2.7

2.2

3.22

2.79

mg/l

48.30

7370

37047

Asthma, excluding more controls

13237

41205

1.96

307.65

2.4

2.0

2.96

2.76

mg/l

15.34

11623

34921

Haemorrhage from respiratory passages

5945

29679

2.30

307.65

2.8

2.1

3.28

2.99

mg/l

11.50

5137

24952

Intestinal infectious diseases

15649

82901

1.65

307.65

2.7

2.2

2.99

2.89

mg/l

5.29

13638

70693

Abnormalities of heart beat

5694

32637

2.05

307.65

2.5

2.1

2.91

2.93

mg/l

0.21

4893

27628

Pain, not elsewhere classified

4449

23321

2.34

307.65

2.6

2.1

2.84

2.86

mg/l

0.27

3914

19880

Symptoms and signs involving the digestive system and abdomen

17898

58789

1.70

307.65

2.4

2.1

2.92

2.90

mg/l

0.29

15477

50011

General symptoms and signs

21012

60990

2.00

307.65

2.5

2.1

2.96

2.84

mg/l

8.84

18238

51837

Dialysis, with operation codes

2601

9933

4.29

307.65

3.8

2.2

3.07

2.93

mg/l

2.46

2378

8436

Pain in throat and chest

15073

54211

1.96

307.65

2.4

2.1

2.89

2.87

mg/l

0.28

12957

46165

Symptoms and signs involving the urinary system

12732

63628

1.78

307.65

2.5

2.2

2.99

2.98

mg/l

0.35

10762

54298

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

6398

16340

2.22

307.65

2.2

1.9

2.85

2.80

mg/l

0.85

5525

13800

Dental caries 1 and operation codes

14292

52356

1.53

307.65

2.4

2.2

2.89

3.00

mg/l

6.14

12169

44600

ILD medications: azathioprine

3356

11440

4.71

307.65

3.9

2.0

3.02

2.77

mg/l

8.16

3083

9731

Anaemias

8557

8294

15.49

307.65

3.6

1.8

3.52

2.43

mg/l

155.61

7760

7066

ILD medications

23041

69741

2.17

307.65

2.7

2.0

3.04

2.82

mg/l

29.46

20281

59044

Nephropathy related operations

2429

9876

3.92

307.65

3.8

2.2

3.11

2.95

mg/l

2.59

2214

8423

Inflammatory bowel disease treatment related agents

23761

72446

2.27

307.65

2.8

2.0

3.05

2.83

mg/l

32.76

21042

61219

Crohn's disease of large intestine

1164

3618

5.93

307.65

4.7

2.0

2.78

2.85

mg/l

0.51

1083

3093

Insulin, fast-acting

6089

34908

2.13

307.65

2.8

2.2

3.35

2.88

mg/l

32.72

5383

29717

Excluding asthma or asthma-COPD overlap

13592

45303

1.66

307.65

2.4

2.1

2.91

2.82

mg/l

4.28

11779

38494

Vocal cord dysfunction

1941

7105

3.11

307.65

2.4

1.7

2.90

2.64

mg/l

4.77

1646

5935

Ulcer of lower limb, not elsewhere classified

2721

12053

3.49

307.65

3.2

2.2

3.41

3.05

mg/l

8.19

2378

10184

Asthma, hospital admissions 3, pneumonia

5820

36051

1.91

307.65

2.8

2.3

3.24

3.00

mg/l

9.01

5140

30444

Insulin medication

10607

51257

2.14

307.65

2.8

2.2

3.36

2.87

mg/l

65.82

9330

43374

Angina pectoris

9063

40183

1.75

307.65

2.6

2.2

3.08

2.99

mg/l

2.79

7948

33680

Asthma (mode)

13400

45218

1.85

307.65

2.5

2.1

2.95

2.82

mg/l

7.48

11757

38415

Asthma (diagnoses ohter than nonallergic)

14271

83964

1.63

307.65

2.5

2.2

3.01

2.89

mg/l

5.94

12493

71502

Other arthritis (FG)

4764

27713

2.04

307.65

2.6

2.1

3.07

2.87

mg/l

6.31

4178

23449

Crohn disease (strict definition, all UC cases excluded)

1173

3585

6.39

307.65

4.5

2.0

2.69

2.85

mg/l

1.83

1109

3057

Dental caries 1, only avohilmo

13235

48176

1.54

307.65

2.3

2.2

2.93

3.00

mg/l

2.62

11289

41092

Selective serotonin reuptake inhibitors

17702

60863

1.71

307.65

2.3

2.2

2.88

2.93

mg/l

1.60

14938

52265

Biguanides

16073

63453

1.78

307.65

2.6

2.1

3.24

2.86

mg/l

60.04

13988

53858

Any reimbursement code in KELA

10350

26050

2.30

307.65

2.5

1.7

2.83

2.55

mg/l

26.15

9118

21708

Ulcerative colitis (strict definition, all Crohn cases excluded)

2884

11474

3.71

307.65

3.7

2.1

2.78

2.84

mg/l

0.71

2606

9835

Asthma-related pneumonia or sepsis

5820

36051

1.91

307.65

2.8

2.3

3.24

3.00

mg/l

9.01

5140

30444

Depression

17165

71106

1.93

307.65

2.4

2.2

2.85

2.89

mg/l

1.32

14670

61096

Non-selective monoamine reuptake inhibitors

6110

34983

2.00

307.65

2.5

2.2

3.04

3.03

mg/l

0.14

5216

29991

Other gastritis (incl. Duodenitis)

3875

20108

2.47

307.65

3.1

2.1

3.28

2.96

mg/l

10.45

3438

17006

Diseases of the digestive system

8974

46681

2.51

307.65

3.2

2.2

3.31

2.97

mg/l

24.36

7940

39490

Crohn disease (strict definition, require KELA)

1526

4711

6.35

307.65

4.7

2.1

2.68

2.79

mg/l

1.34

1441

4038

Dental pulpitis 2

12047

42189

1.62

307.65

2.3

2.2

2.94

3.00

mg/l

1.77

10225

35927

Abnormal findings on examination of blood, without diagnosis

7399

43957

1.86

307.65

2.6

2.2

3.00

mg/l

0.01

6563

37243

Other Crohn's disease

1643

4904

6.39

307.65

4.5

2.0

2.74

2.84

mg/l

1.09

1553

4198

Mood disorders, excluding more controls

17273

61759

1.99

307.65

2.4

2.2

2.88

2.91

mg/l

0.84

14744

53191

Gout, idiopatic and unspecified

4042

22747

2.30

307.65

2.9

2.2

3.40

3.04

mg/l

11.23

3548

19182

Insulin, intermediate and long-acting

9747

55322

2.12

307.65

2.8

2.2

3.35

2.93

mg/l

46.96

8574

46982

Codes for special purposes

7229

45374

1.87

307.65

2.7

2.2

2.91

2.86

mg/l

1.11

6324

38861

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

4379

22555

2.33

307.65

2.4

2.1

2.87

2.74

mg/l

3.40

3750

19591

Calcific aortic valvular stenosis, diagnosis (helper)

5094

29914

2.11

307.65

2.9

2.3

3.33

3.12

mg/l

6.66

4458

25015

5-aminosalicylic acid

4754

17139

4.20

307.65

3.9

2.0

2.78

2.76

mg/l

0.16

4341

14542

Insulin, fast-acting or short human

6119

36476

2.01

307.65

2.8

2.2

3.34

2.91

mg/l

28.70

5408

31081

Provisional assignment of new diseases of uncertain etiology

7214

45315

1.86

307.65

2.7

2.2

2.91

2.86

mg/l

1.12

6314

38811

Heart failure, not strict

15968

48082

3.17

307.65

2.9

2.1

3.31

2.83

mg/l

82.20

14179

40387

Dental operations

11081

38104

1.66

307.65

2.3

2.2

2.97

3.05

mg/l

2.43

9420

32226

Complications of medical and surgical care

12694

73941

1.93

307.65

2.7

2.2

3.09

2.93

mg/l

10.04

11059

62971

ILD medications: immunosuppressive drugs

12508

56424

2.76

307.65

3.0

2.0

3.06

2.81

mg/l

26.26

11282

47908

Major coronary heart disease event excluding revascularizations

9869

46343

1.67

307.65

2.6

2.2

3.21

3.00

mg/l

11.98

8526

39051

6858

43525

1.79

307.65

2.6

2.2

3.06

2.88

mg/l

6.96

6032

37156

Autoimmune diseases excluding thyroid diseases

20920

62933

2.21

307.65

2.8

2.0

2.97

2.86

mg/l

7.68

18596

53135

Neurological diseases, wide definition

5480

13475

2.35

307.65

2.3

2.0

2.83

2.69

mg/l

3.72

4733

11443

Autoimmune diseases related-to ILD

16343

80218

2.17

307.65

3.0

2.1

2.94

2.90

mg/l

1.20

14495

68126

Valvular operations

2428

11365

2.85

307.65

2.8

2.1

3.34

2.85

mg/l

19.23

2147

9405

Hernia of abdominal wall, postoperative

3029

12374

3.26

307.65

2.8

1.9

3.23

2.66

mg/l

24.57

2659

10410

Hypothyroidism, levothyroxine purchases

4962

9291

3.83

307.65

2.3

1.8

2.73

2.41

mg/l

20.72

4259

7920

Obesity, other/unspecified

6033

29912

2.60

307.65

2.8

2.1

3.19

2.79

mg/l

27.00

5384

25651

Dermatitis and eczema

17384

83678

1.49

307.65

2.5

2.2

2.88

2.91

mg/l

0.96

14937

71582

Hypertension

13103

42733

2.00

307.65

2.5

2.1

2.99

2.83

mg/l

10.01

11540

36355

Asthma (only as main-diagnosis), excluding more controls

11712

41205

1.93

307.65

2.5

2.0

2.99

2.76

mg/l

16.86

10293

34921

Alcohol use disorder, Swedish definition

8303

50258

1.74

307.65

2.4

2.2

3.04

2.91

mg/l

4.89

7123

42989

Diabetes, insulin treatment (Kela reimbursement)

17399

67146

1.81

307.65

2.6

2.2

3.23

2.85

mg/l

65.19

15200

57075

Type 2 diabetes, definitions combined

15879

60320

1.79

307.65

2.6

2.1

3.23

2.84

mg/l

60.56

13856

51116

Hypothyroidism, other/unspecified

15121

69081

1.62

307.65

2.4

2.2

2.94

2.89

mg/l

1.24

12996

58920

Cardiovascular diseases

10290

31337

2.04

307.65

2.4

2.0

2.80

2.60

mg/l

15.33

9033

26710

Other diseases of intestines

20356

67380

2.07

307.65

2.6

2.1

2.99

2.83

mg/l

14.84

17674

57466

Valvular heart disease excluding rheumatic fever

8639

30904

2.61

307.65

2.7

2.1

3.32

2.83

mg/l

49.80

7556

25860

Cardiovascular diseases (excluding rheumatic etc)

10764

34563

2.06

307.65

2.4

2.0

2.89

2.61

mg/l

26.20

9475

29441

Asthma, including avohilmo

19161

81865

1.48

307.65

2.4

2.2

2.96

2.89

mg/l

3.01

16702

69729

Insulin, combination of fast acting with intermediate-acting or long-acting

10629

59946

1.94

307.65

2.8

2.2

3.36

2.93

mg/l

53.12

9348

50894

Noninfective enteritis and colitis

9727

45099

2.91

307.65

3.6

2.1

2.90

2.91

mg/l

0.12

8785

38411

Other arrhythmias

10181

46810

1.92

307.65

2.4

2.1

2.88

2.78

mg/l

3.68

8775

39626

Other antidepressants

20004

60535

2.02

307.65

2.4

2.2

2.88

2.93

mg/l

1.82

17080

51969

Myocardial infarction

7749

35539

1.82

307.65

2.6

2.2

3.19

2.99

mg/l

9.10

6685

29794

Other heart diseases, wide

15900

58142

1.96

307.65

2.5

2.1

3.02

2.75

mg/l

31.15

13883

49528

All pneumoniae

17706

76231

1.85

307.65

2.6

2.2

3.12

2.84

mg/l

37.93

15439

65066

Spinal stenosis

8290

39901

1.92

307.65

2.6

2.2

3.05

3.06

mg/l

0.17

7172

33567

Other external causes of accidental injury

14109

50583

1.52

307.65

2.3

2.2

2.90

2.87

mg/l

0.68

11944

43707

Transplanted organ and tissue status

1874

6773

4.43

307.65

3.5

2.2

3.10

2.87

mg/l

3.96

1726

5814

Spondylosis

7968

44677

1.74

307.65

2.4

2.2

2.97

3.01

mg/l

0.65

6903

37870

Hernia

14888

69800

1.61

307.65

2.6

2.2

3.13

2.91

mg/l

18.08

12895

59519

Atrial fibrillation and flutter

5410

14148

3.13

307.65

2.6

1.9

3.23

2.70

mg/l

32.78

4749

11811

Anxiety disorders

15147

67819

1.81

307.65

2.4

2.2

2.80

2.87

mg/l

3.55

13011

58310

Disorders of lens

10416

41764

1.80

307.65

2.5

2.2

3.08

2.95

mg/l

5.39

8920

35635

Arthrosis

11179

42106

1.61

307.65

2.3

2.1

3.00

2.91

mg/l

3.19

9667

35711

Ulcerative colitis

5161

21221

3.51

307.65

3.8

2.1

2.87

2.86

mg/l

0.14

4694

18127

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

3465

13212

4.04

307.65

3.9

2.1

2.81

2.82

mg/l

0.07

3159

11373

Chronic periapical parodontitis

3253

16919

2.40

307.65

2.8

2.1

3.08

2.95

mg/l

2.16

2819

14529

Hypothyroidism (congenital or acquired)

5008

9334

3.85

307.65

2.3

1.8

2.74

2.41

mg/l

22.20

4298

7957

Paralytic ileus and intestinal obstruction

4144

22487

2.28

307.65

2.9

2.1

3.23

3.00

mg/l

5.45

3624

18961

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

10276

63740

1.90

307.65

2.7

2.2

3.08

2.94

mg/l

6.53

8949

54235

Symptoms and signs involving cognition, perception, emotional state and behaviour

16819

75061

1.80

307.65

2.4

2.2

2.89

2.93

mg/l

1.64

14404

64174

Other symptoms and signs involving cognitive functions and awareness

6992

41853

1.83

307.65

2.5

2.2

2.91

3.05

mg/l

4.71

5863

35447

Polyarthropathies

13049

46771

2.25

307.65

2.7

2.1

3.19

2.87

mg/l

33.47

11497

39685

Influenza and pneumonia

18477

76961

1.81

307.65

2.6

2.2

3.12

2.82

mg/l

42.29

16115

65689

Benign neoplasms

12387

47724

1.61

307.65

2.4

2.1

2.92

2.72

mg/l

16.59

10720

40829

Genitourinary diseases

9649

31064

1.71

307.65

2.4

2.1

2.87

2.83

mg/l

0.87

8324

26663

Colorectal cancer, excluding all cancers (controls excluding all cancers)

4502

24713

2.21

307.65

2.3

3.77

2.97

mg/l

41.50

3914

20895

Crohn's disease NAS

1445

4739

5.43

307.65

4.9

2.0

2.84

2.86

mg/l

0.12

1342

4031

Hard cardiovascular diseases

12193

50660

1.77

307.65

2.6

2.2

3.16

2.93

mg/l

16.82

10644

42954

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

9461

59846

1.86

307.65

2.7

2.2

3.08

2.95

mg/l

5.59

8242

50935

Hypertensive heart and/or renal disease

4239

16981

2.41

307.65

2.8

2.1

3.48

3.00

mg/l

21.77

3684

14040

Non-ischemic cardiomyopathy

5568

21926

2.85

307.65

2.9

2.1

3.59

2.90

mg/l

44.05

4899

18163

Benign neoplasm: Colon

9056

34425

2.63

307.65

2.9

2.2

3.29

2.91

mg/l

32.03

7885

29157

Any mental disorder

20262

64301

1.79

307.65

2.4

2.2

2.91

mg/l

0.07

17207

55353

Ischemic heart diseases

12209

48715

1.80

307.65

2.5

2.2

3.10

2.95

mg/l

7.71

10692

41113

Bleeding

14721

62823

2.04

307.65

2.9

2.2

3.29

2.91

mg/l

45.45

12863

53276

Other dorsopathies, not elsewhere classified

17542

63089

1.63

307.65

2.3

2.2

2.85

2.89

mg/l

1.70

15177

53638

Other functional intestinal disorders

7809

41200

2.20

307.65

2.6

2.1

2.90

2.93

mg/l

0.41

6736

34891

Fall on same level

19288

75760

1.57

307.65

2.4

2.2

2.98

2.86

mg/l

7.85

16351

65190

Oral corticosteroids

21473

70024

2.26

307.65

2.8

2.1

3.13

2.84

mg/l

47.83

18959

59146

Other intervertebral disc disorders

13197

56304

1.58

307.65

2.4

2.2

2.85

2.94

mg/l

4.46

11486

47859

All anxiety disorders

10483

48111

2.06

307.65

2.4

2.1

2.73

2.80

mg/l

2.81

8975

41600

Disorders of thyroid, IBD co-morbidities

2958

9475

2.74

307.65

2.4

1.9

2.79

2.75

mg/l

0.32

2559

7988

Non-invasive ventilation

3612

13288

3.28

307.65

2.5

1.9

2.30

2.70

mg/l

18.25

3390

11185

Continuous positive airway pressure

3132

10218

3.43

307.65

2.7

1.9

3.47

2.77

mg/l

29.95

2589

8510

Codeine

18065

56629

2.05

307.65

2.5

2.0

2.98

2.81

mg/l

15.46

15532

48158

Malignant neoplasm of digestive organs, excluding all cancers (controls excluding all cancers)

7209

33151

2.06

307.65

2.4

2.3

3.60

2.97

mg/l

47.80

6323

28035

Nerve, nerve root and plexus disorders

16971

76834

1.53

307.65

2.4

2.2

2.93

mg/l

0.02

14807

65379

Substance abuse, excluding more controls

8770

45736

1.94

307.65

2.4

2.2

3.00

2.90

mg/l

3.19

7457

39319

Diverticular disease of intestine

12951

46033

2.29

307.65

2.7

2.1

3.14

2.95

mg/l

11.84

11168

39013

Operations 2 for CAVS

5094

29914

2.11

307.65

2.9

2.3

3.33

3.12

mg/l

6.66

4458

25015

Ulcerative colitis, NAS

2935

11233

4.03

307.65

4.1

2.1

2.91

2.86

mg/l

0.50

2676

9624

Irritable bowel syndrome

4442

24135

2.24

307.65

2.4

2.0

2.69

2.85

mg/l

4.93

3761

20627

Cardiomyopathy

2967

13682

2.88

307.65

2.8

2.0

3.03

2.83

mg/l

3.84

2623

11404

Follow-up examination after treatment for conditions other than malignant neoplasms

7057

28791

1.81

307.65

2.4

2.0

2.88

mg/l

0.01

6042

24376

Calcific aortic valvular stenosis, including rheumatic fever

5105

30026

2.10

307.65

2.9

2.3

3.33

3.12

mg/l

6.74

4469

25111

Care involving use of rehabilitation procedures

10223

61757

1.80

307.65

2.5

2.2

2.73

2.93

mg/l

14.71

9063

52514

Parasetamol

15252

40834

2.22

307.65

2.4

2.0

2.94

2.73

mg/l

20.16

13226

34589

Sulfasalazine

4725

25432

2.26

307.65

2.8

2.1

3.14

2.84

mg/l

14.35

4239

21497

Hypothyreosis and Thyroxine purchase for inclusion criteria

15538

71646

1.60

307.65

2.4

2.2

2.94

2.90

mg/l

1.33

13353

61135

Type 2 diabetes, definitions combined, including avohilmo

15797

60331

1.76

307.65

2.5

2.1

3.22

2.83

mg/l

59.00

13761

51180

Rheumatoid arthritis

5368

27402

2.15

307.65

2.6

2.1

3.31

2.95

mg/l

19.55

4781

23109

Azathioprine

3356

11598

4.64

307.65

3.9

2.0

3.02

2.79

mg/l

7.25

3083

9847

Calcific aortic valvular stenosis

5103

29964

2.11

307.65

2.9

2.3

3.33

3.12

mg/l

6.59

4465

25058

Obesity

10952

60284

2.20

307.65

2.6

2.2

3.21

2.80

mg/l

53.26

9689

51595

Gastroduodenal ulcer

4673

24524

2.44

307.65

3.1

2.1

3.62

3.03

mg/l

29.14

4092

20596

Colectomy operation

3240

15121

3.16

307.65

3.0

2.3

3.69

2.98

mg/l

25.74

2893

12817

Finngen Rheumatological endpoints

16815

62182

1.73

307.65

2.5

2.1

2.98

2.82

mg/l

13.86

14707

52793

Heart failure and bmi 25plus

6551

21771

2.84

307.65

3.0

2.2

3.67

3.06

mg/l

42.65

5784

18096

First line medication for Crohn's disease

22680

67289

2.21

307.65

2.7

2.0

3.03

2.82

mg/l

27.84

20001

56868

Benign neoplasm: Colon

9248

51637

2.22

307.65

2.9

2.2

3.29

3.01

mg/l

18.94

8051

43653

Any gastric operation

15936

41605

2.25

307.65

2.5

1.9

2.99

2.63

mg/l

55.58

13813

35127

Other anxiety disorders

7704

37690

2.16

307.65

2.4

2.1

2.70

2.76

mg/l

1.41

6579

32585

Intracranial trauma

9300

42189

1.87

307.65

2.4

2.1

3.00

2.83

mg/l

7.44

7935

36080

8687

53124

1.69

307.65

2.4

2.2

3.04

2.90

mg/l

5.53

7436

45423

IBD patients in KELA-register

5389

19105

4.48

307.65

4.0

2.0

2.77

2.82

mg/l

0.80

4961

16377

Sleep apnoea

14309

65999

1.65

307.65

2.5

2.2

3.10

2.91

mg/l

15.47

12332

56517

All-cause Heart Failure

11501

40968

2.76

307.65

3.0

2.1

3.55

2.92

mg/l

83.31

10217

34212

Heart failure,strict

10829

34602

3.20

307.65

3.0

2.0

3.52

2.86

mg/l

87.52

9662

28757

Gonarthrosis

10035

38663

1.65

307.65

2.4

2.1

3.09

2.94

mg/l

6.77

8658

32742

Hypertension, essential

13179

41315

2.13

307.65

2.5

2.0

2.99

2.83

mg/l

9.91

11573

35104

Heart failure and coronary heart disease

5758

25568

2.12

307.65

3.0

2.2

3.63

3.05

mg/l

38.20

5083

21282

L04AA Selective immunosuppressants

3805

18360

2.78

307.65

3.2

2.2

3.13

2.88

mg/l

8.87

3494

15751

L04AX Other immunosuppressants

9920

53926

2.29

307.65

3.0

2.2

3.08

2.87

mg/l

15.25

8919

46052

Budesonide

2994

10460

4.67

307.65

3.9

2.0

2.74

2.82

mg/l

1.16

2730

8846

Pain in limb

14283

60856

2.00

307.65

2.5

2.2

2.94

2.91

mg/l

0.52

12379

51750

Use of hypnotics and sedatives

17596

70373

1.61

307.65

2.4

2.2

2.94

2.92

mg/l

0.73

15003

60375

Other bacterial diseases

18492

67378

2.35

307.65

2.7

2.1

3.27

2.85

mg/l

74.63

16148

57269

Sciatica+with lumbago

7672

46693

1.78

307.65

2.4

2.2

2.88

2.93

mg/l

0.95

6764

39796

Oxycodone

6481

30978

2.63

307.65

2.7

2.1

3.54

2.95

mg/l

50.13

5626

26060

Coxarthrosis [arthrosis of hip](FG)

8264

38865

1.75

307.65

2.4

2.1

3.13

2.95

mg/l

7.50

7117

32626

Migraine

7408

40545

1.75

307.65

2.4

2.1

2.69

2.76

mg/l

1.73

6434

34819

Mucosal proctocolitis

2810

9696

4.73

307.65

3.7

2.0

2.84

2.82

mg/l

0.11

2549

8310

GASTRO-related operations

15936

41605

2.25

307.65

2.5

1.9

2.99

2.63

mg/l

55.58

13813

35127

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

17239

75371

1.86

307.65

2.6

2.2

3.14

2.85

mg/l

39.26

15025

64334

Atrial fibrillation and flutter with reimbursement

4673

11141

3.53

307.65

2.6

1.8

3.22

2.74

mg/l

24.39

4106

9187

Concussion

7744

41001

1.85

307.65

2.4

2.1

2.97

2.84

mg/l

4.66

6601

35059

Erysipelas

9363

48705

2.12

307.65

2.7

2.2

3.31

2.92

mg/l

35.36

8168

41100

Autoimmune diseases

21860

63391

2.07

307.65

2.7

2.0

2.93

2.86

mg/l

3.89

19172

53523

Pain (limb, back, neck, head abdominally)

12886

41112

1.75

307.65

2.4

2.1

2.90

2.92

mg/l

0.35

11126

34697

Diseases of the eye and adnexa

13288

46627

1.55

307.65

2.3

2.1

2.79

2.83

mg/l

1.05

11513

40137

Pacemaker

5884

33092

2.23

307.65

2.8

2.3

3.21

3.11

mg/l

2.32

5136

27744

Secondary hypertension

1378

4640

4.19

307.65

3.0

1.9

3.08

2.69

mg/l

6.48

1238

3835

Asthma, unspecified (mode), excluding more controls

9113

37594

2.29

307.65

2.6

2.0

3.08

2.78

mg/l

20.95

7937

31790

Gout

4832

22408

2.56

307.65

2.9

2.2

3.43

3.04

mg/l

15.34

4241

18731

Diarrhoea and gastroenteritis of presumed infectious origin

11634

69532

1.72

307.65

2.7

2.2

3.02

2.89

mg/l

6.68

10125

59272

Lower back pain or/and sciatica

17246

81858

1.64

307.65

2.4

2.2

2.92

2.91

mg/l

0.17

14986

69770

Mental and behavioural disorders due to psychoactive substance use

9018

56158

1.71

307.65

2.4

2.2

3.00

2.89

mg/l

3.90

7661

48115

Chronic kidney disease

6576

28059

3.65

307.65

3.3

2.2

3.25

3.07

mg/l

6.70

5855

23481

16317

62166

1.91

307.65

2.6

2.1

3.12

2.83

mg/l

36.89

14243

52961

Anxiety (asthma-related co-morbidities)

10298

43996

2.19

307.65

2.4

2.1

2.73

2.80

mg/l

2.32

8819

38122

COPD differential diagnosis

13490

45233

1.65

307.65

2.4

2.1

2.92

2.82

mg/l

4.55

11700

38429

Hypertensive Heart Disease

3704

16026

2.33

307.65

2.8

2.1

3.53

3.00

mg/l

21.99

3197

13240

Hypothyroidism, drug reimbursement

2265

5445

3.66

307.65

2.4

1.7

2.80

2.45

mg/l

11.18

1953

4610

Disorders of lipoprotein metabolism and other lipidaemias

14033

52036

1.99

307.65

2.4

2.2

2.94

2.99

mg/l

1.23

12059

44210

Other reaction to severe stress, and adjustment disorders

5477

32803

1.93

307.65

2.5

2.1

2.90

2.77

mg/l

3.74

4731

28350

Episodal and paroxysmal disorders

19751

68048

1.66

307.65

2.4

2.2

2.91

2.88

mg/l

0.86

17031

58010

Other anaemias

12143

38881

6.19

307.65

3.6

2.1

3.48

2.98

mg/l

53.91

10822

32597

Asthma-related infections

9540

60689

1.78

307.65

2.7

2.2

3.10

2.92

mg/l

9.77

8396

51516

Other retinal disorders

10001

53700

1.72

307.65

2.6

2.2

3.13

3.01

mg/l

4.10

8484

45529

Asthma-related pneumonia

5813

35969

1.92

307.65

2.8

2.3

3.24

3.00

mg/l

9.02

5134

30373

Metabolic disorders

17618

61322

2.13

307.65

2.6

2.2

2.99

2.94

mg/l

1.81

15260

52252

Cerebrovascular diseases (FINNGEN)

4818

15878

2.61

307.65

2.5

1.9

3.05

2.69

mg/l

17.72

4203

13312

Other pulmonary diagnosis

13661

45303

1.67

307.65

2.4

2.1

2.92

2.82

mg/l

5.12

11838

38494

Other CVD (FINNGEN)

2152

5683

4.45

307.65

2.7

1.8

3.09

2.74

mg/l

7.08

1831

4643

Diseases of oesophagus, stomach and duodenum

21104

70162

2.21

307.65

2.7

2.1

3.08

2.86

mg/l

25.18

18316

59805

Other disorders of skin and subcutaneous tissue

11300

66474

1.81

307.65

2.7

2.2

3.11

2.96

mg/l

7.16

9789

56548

Disorders of adult personality and behaviour

4512

25055

2.16

307.65

2.4

2.1

2.78

2.74

mg/l

0.52

3841

21641

Depression or dysthymia

12711

40103

2.07

307.65

2.4

2.2

2.89

2.96

mg/l

1.84

10782

34652

Psychiatric diseases

19880

62326

1.82

307.65

2.4

2.2

2.91

2.90

mg/l

0.09

16947

53627

Soft tissue disorders

17794

64382

1.58

307.65

2.4

2.2

2.86

2.90

mg/l

1.65

15391

54755

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

6633

23637

2.02

307.65

2.5

1.9

3.10

2.66

mg/l

33.37

5881

20053

Cardiac arrhythmias

10177

36335

2.16

307.65

2.5

2.0

2.97

2.66

mg/l

25.99

8909

30824

Chronic lower respiratory diseases

19611

78694

1.46

307.65

2.4

2.2

2.99

2.87

mg/l

8.87

17090

67057

STROKE

8835

36267

1.96

307.65

2.5

2.1

3.06

2.85

mg/l

10.64

7687

30525

Other diseases of the digestive system

6169

31494

2.63

307.65

3.3

2.2

3.53

3.02

mg/l

32.49

5461

26506

Obesity related asthma

5434

29995

2.25

307.65

2.7

2.2

3.26

2.90

mg/l

18.14

4843

25663

Cystitis

14396

62060

1.58

307.65

2.4

2.2

2.93

2.89

mg/l

0.96

12313

52994

Neurological diseases

15212

50534

1.68

307.65

2.3

2.2

2.87

2.85

mg/l

0.34

13092

43188

Gout, FINNGEN

4832

27585

2.21

307.65

2.9

2.2

3.43

3.02

mg/l

16.93

4241

23080

Conduction disorders

4911

21376

2.38

307.65

2.6

2.1

3.18

2.83

mg/l

16.85

4199

17776

Personality disorders, excluding more controls

4336

19920

2.73

307.65

2.4

2.0

2.76

2.72

mg/l

0.62

3703

17304

Heart failure and antihypertensive medication

5568

10287

5.52

307.65

3.1

1.9

3.41

2.83

mg/l

32.27

5016

8529

Obesity and other hyperalimentation

10996

60557

2.20

307.65

2.6

2.2

3.21

2.80

mg/l

53.14

9725

51835

Syncope and collapse

7554

38392

2.08

307.65

2.5

2.1

2.97

2.94

mg/l

0.44

6389

32324

Senile cataract

9520

37919

1.78

307.65

2.5

2.2

3.09

2.98

mg/l

3.79

8100

32252

Glucagon-like peptide-1 (GLP-1) analogues

10259

44163

2.48

307.65

2.7

2.2

3.40

2.95

mg/l

51.07

8910

37216

Abdominal and pelvic pain

17687

58776

1.68

307.65

2.4

2.1

2.91

2.90

mg/l

0.10

15281

49998

Dorsalgia

17576

62857

1.70

307.65

2.4

2.2

2.90

mg/l

0.00

15214

53441

Renal failure

9826

39475

3.44

307.65

3.2

2.2

3.27

3.04

mg/l

14.02

8701

33178

Opioids

18473

57699

1.93

307.65

2.4

2.0

2.98

2.80

mg/l

15.59

15922

49066

ILD differential diagnosis

13480

45218

1.65

307.65

2.4

2.1

2.92

2.82

mg/l

4.45

11694

38415

Benign neoplasm of colon, rectum, anus and anal canal

11076

56238

2.23

307.65

2.8

2.2

3.27

3.00

mg/l

20.81

9619

47596

Cardiomyopathies, Primary/intrinsic

2145

9195

3.24

307.65

2.9

2.0

3.03

2.83

mg/l

2.76

1919

7642

Persons encountering health services in other circumstances, wide

21957

73327

1.76

307.65

2.5

2.2

2.94

2.90

mg/l

1.44

19170

62259

Headache

10910

54325

1.94

307.65

2.4

2.1

2.84

2.82

mg/l

0.37

9535

46229

Infections of the skin and subcutaneous tissue

8598

57153

1.69

307.65

2.7

2.2

3.01

2.87

mg/l

5.78

7546

48940

Pneumonias (Asthma/COPD co-morbidities)

17629

75978

1.86

307.65

2.6

2.2

3.12

2.84

mg/l

37.96

15378

64838

Paroxysmal tachycardia

3439

14025

2.51

307.65

2.6

1.9

3.04

2.67

mg/l

13.81

2979

11741

Neurotic, stress-related and somatoform disorders

15011

67091

1.82

307.65

2.4

2.2

2.80

2.87

mg/l

3.40

12898

57706

Dizziness and giddiness

12420

65311

1.77

307.65

2.5

2.2

2.91

2.97

mg/l

1.83

10686

55652

Heart failure, strict

11722

41475

2.78

307.65

3.0

2.1

3.54

2.92

mg/l

84.34

10417

34643

Other heart diseases

8476

25417

2.68

307.65

2.6

2.0

3.05

2.65

mg/l

33.40

7456

21604

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

26646

67777

4.38

307.65

3.3

1.9

3.48

2.69

mg/l

294.26

23691

57116

Other (not insulin) diabetes medications

16276

62845

1.78

307.65

2.6

2.1

3.22

2.85

mg/l

57.20

14196

53316

Pain in joint

10041

37944

2.03

307.65

2.5

2.1

2.78

2.90

mg/l

5.11

8649

32149

Arthropathies

15100

54476

1.54

307.65

2.4

2.1

2.88

2.82

mg/l

2.45

13081

46308

Anxiety disorders, excluding more controls

14210

55926

1.95

307.65

2.4

2.2

2.81

2.88

mg/l

2.74

12201

48309

Diabetes mellitus

17854

67260

1.81

307.65

2.6

2.1

3.16

2.80

mg/l

61.51

15624

57161

Nutritional anaemias

14138

46622

5.70

307.65

3.9

2.0

3.90

2.84

mg/l

242.97

12716

39158

Nausea and vomiting

4766

24425

2.42

307.65

2.9

2.2

3.04

2.98

mg/l

0.82

4176

20697

Dyspnoea

16796

73591

2.11

307.65

2.7

2.2

3.20

2.88

mg/l

41.37

14699

62501

Complications of surgical and medical care, not elsewhere classified

18032

77426

1.97

307.65

2.6

2.2

3.12

2.89

mg/l

25.67

15738

65881

Antihypertensive medication - note that there are other indications

10237

32002

1.98

307.65

2.3

2.0

2.83

2.63

mg/l

13.18

8916

27275

Pure hypercholesterolaemia

12298

48553

2.01

307.65

2.4

2.2

2.86

3.01

mg/l

9.01

10541

41169

Dorsopathies

17323

63440

1.52

307.65

2.3

2.2

2.85

2.89

mg/l

1.34

14969

53964

Mood [affective] disorders

18432

75026

1.87

307.65

2.4

2.2

2.86

2.90

mg/l

1.47

15739

64365

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

16317

62166

1.91

307.65

2.6

2.1

3.12

2.83

mg/l

36.89

14243

52961

Type 2 diabetes, wide definition

14965

51621

2.34

307.65

2.7

2.1

3.27

2.88

mg/l

55.15

13104

43581

Other disorders of urethra and urinary system

11731

58391

1.71

307.65

2.5

2.2

3.00

2.91

mg/l

3.43

10043

49799

Second line medication for Crohn's disease

10449

55240

2.38

307.65

3.0

2.2

3.06

2.87

mg/l

13.03

9405

47138

Other joint disorders

14300

54347

1.52

307.65

2.3

2.1

2.83

2.82

mg/l

0.40

12314

46187

COPD/asthma/ILD related infections

17793

62277

1.58

307.65

2.5

2.1

2.99

2.83

mg/l

14.28

15358

53058

Complications of procedures, not elsewhere classified

13994

74507

1.90

307.65

2.6

2.2

3.11

2.89

mg/l

18.58

12246

63381

Diaphragmatic hernia

6508

34545

2.46

307.65

3.0

2.2

3.29

3.00

mg/l

12.23

5686

29207

Disorders of choroid and retina

12534

62835

1.63

307.65

2.5

2.2

3.07

2.99

mg/l

2.92

10643

53478

Hypertensive diseases (excluding secondary)

8852

24965

2.44

307.65

2.6

1.9

2.95

2.67

mg/l

22.05

7849

21230

Endocrine, nutritional and metabolic diseases

15041

42282

2.09

307.65

2.4

2.0

2.89

2.74

mg/l

11.36

13038

35850

Injuries to the head

17706

83612

1.51

307.65

2.4

2.2

2.98

2.89

mg/l

4.92

14970

71745

Other septicaemia

6927

34714

2.57

307.65

3.0

2.2

3.44

2.96

mg/l

36.78

6096

29218

Diabetes medication

17774

69088

1.78

307.65

2.6

2.1

3.16

2.82

mg/l

57.45

15533

58758

Other soft tissue disorders, not elsewhere classified

17218

63369

1.96

307.65

2.5

2.2

2.91

2.90

mg/l

0.02

14945

53898

Type 2 diabetes, strict (exclude DM1)

15926

60636

1.79

307.65

2.6

2.1

3.23

2.84

mg/l

60.10

13896

51399

Renal tubulo-interstitial diseases

17548

71101

2.38

307.65

2.8

2.1

3.15

2.88

mg/l

35.41

15283

60343

Gastro-oesophageal reflux disease

11770

59937

2.08

307.65

2.6

2.1

3.01

2.89

mg/l

5.88

10042

51049

Inflammatory bowel disease, strict (require KELA)

5389

19513

4.37

307.65

4.0

2.1

2.77

2.82

mg/l

0.97

4961

16740

Hypothyroidism, strict autoimmune

12823

52805

1.84

307.65

2.4

2.0

2.94

2.86

mg/l

2.76

11015

44477

Oedema, not elsewhere classified

5507

27642

2.54

307.65

2.8

2.1

3.20

2.96

mg/l

8.68

4784

23374

Covid-19 confirmed case

4858

27357

2.23

307.65

2.8

2.2

2.90

2.92

mg/l

0.29

4273

23349

Acute tubulo-interstitial nephritis

10721

58609

1.91

307.65

2.6

2.1

3.14

2.89

mg/l

18.99

9212

49549

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

9760

62115

1.65

307.65

2.6

2.2

3.18

2.99

mg/l

9.68

8471

52718

Ischaemic heart disease, wide definition

12052

47888

1.81

307.65

2.5

2.2

3.09

2.95

mg/l

6.36

10524

40402

Osteopathies and chondropathies

8852

52885

1.86

307.65

2.7

2.2

3.09

2.96

mg/l

4.91

7647

45014

Crohn's disease of small intestine

1574

4960

5.88

307.65

4.6

2.0

2.83

mg/l

0.03

1477

4234

Neoplasms

12090

45740

1.54

307.02

2.3

2.1

2.91

2.70

mg/l

17.15

10494

39108

Other arthrosis

7678

36005

1.71

306.46

2.4

2.1

2.94

mg/l

0.07

6606

30516

Accidents

13947

50583

1.50

305.35

2.3

2.2

2.90

2.87

mg/l

0.82

11810

43707

Osteoporosis

4178

23196

2.17

305.19

2.9

2.3

3.30

3.12

mg/l

4.24

3578

19604

Gingivitis and periodontal diseases

14602

55209

1.48

303.96

2.3

2.2

2.84

2.97

mg/l

8.56

12378

47278

Mental and behavioural disorders due to alcohol, excluding acute intoxication

6527

41867

1.78

303.64

2.4

2.2

3.01

2.91

mg/l

2.19

5588

35804

Dysphagia

3847

21779

2.16

299.05

2.5

2.2

2.92

3.02

mg/l

1.71

3289

18395

Symptoms and signs concerning food and fluid intake

1849

8082

3.21

298.39

2.6

2.2

2.86

2.91

mg/l

0.40

1589

6872

Cough

6101

37084

1.80

297.68

2.5

2.1

2.99

2.91

mg/l

1.52

5263

31506

Seropositive rheumatoid arthritis

3997

22797

2.11

297.42

2.6

2.1

3.38

2.94

mg/l

22.58

3570

19140

Other headache syndromes

6360

40777

1.78

297.14

2.4

2.2

2.76

2.86

mg/l

3.34

5509

34861

Atherosclerosis, excluding cerebral and coronary sclerosis

6703

35002

1.81

295.93

2.9

2.2

3.43

3.05

mg/l

20.93

5773

29344

Other systemic involvement of connective tissue

4527

27096

2.05

295.22

2.7

2.2

3.01

2.98

mg/l

0.26

3920

23026

Other and unspecified dermatitis

7667

51465

1.69

294.92

2.6

2.2

2.98

2.93

mg/l

1.19

6715

43956

Disorders of other endocrine glands

6785

43740

1.76

294.27

2.7

2.3

3.10

2.92

mg/l

7.24

5891

37332

Ulcerative rectosigmoiditis

1528

6171

3.63

294.06

3.7

2.0

2.80

2.86

mg/l

0.45

1397

5264

Dental pulpitis 4

17679

69687

1.42

293.28

2.4

2.2

2.90

mg/l

0.03

15047

59669

6-mercaptopurine

722

1893

7.80

293.04

3.9

1.9

2.66

2.71

mg/l

0.25

664

1597

Vitamin B12 deficiency anaemia

1998

9179

3.09

292.78

3.2

2.0

3.22

2.93

mg/l

5.14

1765

7637

Alcohol use disorder, ICD-based

6046

38487

1.80

292.62

2.4

2.2

3.01

2.91

mg/l

2.52

5168

32953

Diseases of pulp and periapical tissues, including avohilmo

17657

69634

1.42

292.03

2.4

2.2

2.90

mg/l

0.01

15025

59620

Other disorders of teeth and supporting structures

3319

18048

2.26

291.44

2.7

2.2

3.17

2.97

mg/l

3.98

2897

15453

Dental pulpitis 1

17668

69716

1.42

291.38

2.4

2.2

2.90

mg/l

0.02

15035

59695

Disorders of eyelid, lacrimal system and orbit

12930

74490

1.50

291.03

2.4

2.2

2.89

2.96

mg/l

3.10

11088

63578

Coronary revascularization (ANGIO or CABG)

7063

32358

1.76

290.77

2.6

2.2

3.26

2.99

mg/l

12.73

6179

27091

Other neurological diseases

10945

63050

1.55

290.48

2.5

2.2

3.05

3.00

mg/l

1.16

9506

53431

Mental and behavioural disorders due to alcohol

7459

48385

1.69

290.04

2.4

2.2

3.00

2.90

mg/l

2.62

6361

41379

Gout, strict definition

2953

15837

2.51

289.05

3.0

2.2

3.46

3.04

mg/l

10.61

2597

13330

Myocardial infarction, strict

7049

33850

1.75

287.58

2.6

2.2

3.18

2.99

mg/l

7.44

6090

28369

Other diseases of intestine

2038

9444

2.94

286.46

3.3

2.1

3.12

2.95

mg/l

1.77

1802

8009

Other/unspecified dorsalgia

5759

36320

1.81

283.82

2.5

2.2

2.95

2.96

mg/l

0.16

4998

30816

Other or unspecified ileus, impaction or obstruction

2923

15441

2.38

282.59

3.0

2.1

3.24

3.01

mg/l

4.69

2562

13016

Shoulder lesions

11665

51324

1.52

282.57

2.4

2.2

2.89

2.98

mg/l

3.59

10141

43610

Unspecified haematuria

6392

35647

1.78

281.91

2.5

2.2

3.10

3.02

mg/l

1.59

5402

30325

Other diseases of hard tissues of teeth

9477

49197

1.58

281.60

2.4

2.2

2.77

2.92

mg/l

7.65

8105

42329

Behavioural syndromes associated with physiological disturbances and physical factors

4945

30376

1.90

280.04

2.5

2.2

2.74

2.76

mg/l

0.17

4249

26142

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

2352

11700

2.72

279.80

3.2

2.2

3.80

2.96

mg/l

30.94

2120

9968

Vascular disorders of the intestines

1306

5097

4.13

277.84

4.6

2.1

3.76

3.07

mg/l

15.08

1201

4273

Asthma/COPD (KELA code 203)

14810

78409

1.44

277.17

2.4

2.2

3.01

2.86

mg/l

8.96

12950

66812

Asthma, hospital admissions , main diagnosis only

12649

83686

1.48

275.91

2.5

2.2

3.01

2.89

mg/l

5.61

11098

71347

Benign neoplasm of other and ill-defined parts of digestive system

2787

14757

2.45

274.77

3.1

2.3

3.36

2.92

mg/l

13.31

2441

12540

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

3390

18841

2.17

274.57

2.7

2.1

3.39

2.81

mg/l

34.15

3007

16128

Symptoms and signs involving the nervous and musculoskeletal systems

8683

60627

1.61

273.92

2.4

2.3

2.83

2.95

mg/l

5.29

7636

51625

Schizophrenia or delusion, excluding more controls

4181

24280

1.96

272.63

2.2

2.1

2.84

mg/l

0.05

3585

21026

Hypokalaemia

1976

9260

2.93

272.34

2.9

2.2

3.25

3.04

mg/l

2.80

1716

7878

Diseases of the respiratory system

10736

38035

1.54

268.63

2.4

2.1

2.91

2.84

mg/l

2.52

9278

32206

Polyarthrosis

3056

15917

2.28

268.62

2.6

2.2

3.15

3.03

mg/l

1.92

2643

13338

Poisoning by drugs, medicaments and biological substances

3630

20733

2.09

267.57

2.4

2.2

2.94

2.78

mg/l

3.91

3099

17878

Gonarthrosis,primary

13184

61635

1.47

264.92

2.4

2.2

3.10

2.99

mg/l

5.07

11345

52428

Nonorganic sleeping disorders, excluding more controls

2681

13927

2.34

263.91

2.5

2.1

2.68

2.79

mg/l

1.68

2299

12075

External causes of morbidity and mortality

11162

39917

1.52

263.59

2.3

2.1

2.91

2.83

mg/l

2.80

9520

34366

Tumor necrosis factor alpha inhibitors

2237

11011

2.61

263.41

3.3

2.1

2.93

2.79

mg/l

2.15

2064

9511

Retention of urine

5310

28576

1.85

260.43

2.5

2.2

3.09

3.04

mg/l

0.85

4504

24212

Use of pramipexole

3483

20147

2.18

260.39

2.6

2.3

2.98

3.03

mg/l

0.66

2926

17193

Excessive, frequent and irregular menstruation

6598

23962

1.74

259.99

2.4

2.1

2.95

2.83

mg/l

3.44

5664

20482

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

14445

71059

1.43

258.64

2.5

2.2

3.14

2.91

mg/l

19.87

12451

60658

Other bacterial intestinal infections

2963

16282

2.30

258.57

3.1

2.2

3.18

3.00

mg/l

3.05

2607

13764

Intracranial injury

8668

58983

1.58

256.03

2.4

2.2

3.06

2.93

mg/l

4.16

7338

50394

COPD (mode)

4682

22872

1.90

254.94

2.5

2.1

3.43

2.95

mg/l

21.34

3987

19207

Noninfectious colitis NAS

2268

11442

2.59

254.92

3.4

2.1

2.98

2.92

mg/l

0.52

2034

9755

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

4379

26719

1.91

252.76

2.4

2.1

2.87

2.74

mg/l

3.18

3750

23064

Rheumatoid arthritis, including avohilmo

5822

38322

1.76

250.90

2.6

2.2

3.27

2.97

mg/l

15.87

5172

32482

Cholelithiasis, broad definition with cholecystitis

13174

67875

1.45

248.26

2.5

2.2

3.13

2.93

mg/l

15.16

11386

57739

Poisoning by medicine

3272

18544

2.11

247.96

2.4

2.2

2.94

2.77

mg/l

3.57

2795

16014

Other CVD

3199

18400

2.24

247.85

2.7

2.3

3.13

3.11

mg/l

0.20

2717

15507

All influenza

3799

22566

2.00

245.97

2.8

2.2

3.24

2.90

mg/l

10.68

3313

19198

Other ulcerative colitis

1090

4086

4.12

245.00

4.2

2.0

3.13

2.87

mg/l

3.13

1009

3487

Bipolar affective disorders

2805

15165

2.22

244.85

2.3

2.1

2.80

2.76

mg/l

0.41

2407

13142

Myalgia

3446

19937

2.06

243.70

2.5

2.1

2.83

2.89

mg/l

0.81

2947

16998

Hypotension

2804

15646

2.37

242.82

2.7

2.3

3.15

3.12

mg/l

0.18

2367

13157

Venous thromboembolism

8070

55227

1.60

242.77

2.6

2.3

3.33

3.00

mg/l

19.98

6970

46791

Convulsions, not elsewhere classified

3441

19528

2.02

242.33

2.4

2.1

2.95

2.83

mg/l

1.83

2913

16631

Symptoms and signs involving the skin and subcutaneous tissue

10114

73595

1.51

242.14

2.4

2.2

2.91

2.92

mg/l

0.29

8702

62953

Persistent mood disorders

3011

16821

2.17

241.30

2.4

2.2

2.88

2.89

mg/l

0.08

2571

14436

Type 1 diabetes, wide definition, subgroup 1

3131

17604

2.10

240.13

2.7

2.1

2.97

2.73

mg/l

6.43

2756

15049

Artrosis, including avohilmo

12704

51910

1.45

239.08

2.3

2.2

3.00

2.92

mg/l

3.01

10947

44324

Generalized anxiety disorder

2391

12398

2.37

239.03

2.3

2.1

2.69

2.71

mg/l

0.19

2036

10674

Type 1 diabetes

3752

22274

1.95

236.61

2.8

2.2

2.96

2.78

mg/l

4.91

3308

18988

Other diseases of liver

2677

14607

2.29

236.23

2.9

2.2

3.15

2.91

mg/l

4.93

2371

12525

Benign neoplasm: Colon, unspecified

3799

23128

2.02

235.88

2.9

2.3

3.23

3.04

mg/l

3.84

3207

19614

Emergency coronary revascularization (for ACS)

8306

42311

1.60

235.75

2.5

2.3

3.28

3.06

mg/l

10.39

7256

35593

Menorrhagia

5659

20188

1.77

235.46

2.5

2.2

3.05

2.90

mg/l

4.13

4844

17274

2109

10611

2.52

233.57

2.8

2.1

2.68

2.84

mg/l

2.80

1816

9049

Injuries to the abdomen, lower back, lumbar spine and pelvis

5902

39222

1.71

232.98

2.5

2.3

3.11

2.98

mg/l

2.88

4979

33373

Dental pulpitis 4, only avohilmo

17538

71622

1.37

232.60

2.3

2.2

2.88

2.91

mg/l

0.90

14949

61337

Injuries to the hip and thigh

7051

44653

1.63

232.31

2.5

2.3

3.15

3.02

mg/l

3.84

5996

37912

Extracorporeal dialysis

1131

4527

4.10

231.95

4.1

2.2

3.11

2.98

mg/l

1.04

1039

3861

Laparoscopic right hemicolectomy

1112

4525

4.58

231.74

2.5

2.2

4.20

3.06

mg/l

16.91

985

3816

Cholelithiasis

12646

67013

1.44

231.02

2.5

2.2

3.12

2.93

mg/l

12.99

10912

56980

Volume depletion

1624

7537

3.00

230.55

3.1

2.2

3.42

3.12

mg/l

3.95

1417

6373

Bacterial intestinal infections, IBD co-morbidities

2951

16824

2.19

229.32

3.1

2.2

3.17

3.01

mg/l

3.02

2596

14272

Polyneuropathies and other disorders of the peripheral nervous system

3328

19704

2.09

227.52

2.7

2.3

3.03

3.01

mg/l

0.12

2889

16727

Lumbar disc prolapse

9023

51512

1.52

227.36

2.4

2.2

2.85

2.93

mg/l

2.93

7890

43926

KRA_PSY_EATING, excluding more controls

1482

6515

2.99

227.33

2.6

2.0

2.66

2.54

mg/l

1.59

1263

5637

Dental pulpitis 1, only avohilmo

17535

71859

1.36

226.50

2.3

2.2

2.88

2.91

mg/l

0.74

14937

61545

Open wound of head

7454

51434

1.58

226.27

2.4

2.3

3.05

2.97

mg/l

1.64

6213

44021

Ulcerative ileocolitis

827

2794

4.96

226.21

4.4

1.9

2.88

2.87

mg/l

0.04

766

2396

Fibromyalgia

1464

6489

3.06

225.88

2.4

2.1

2.74

2.83

mg/l

0.91

1302

5515

Kidney transplant status

953

3506

4.40

224.93

3.4

2.2

2.99

2.93

mg/l

0.34

876

2999

Functional dyspepsia

3836

23370

1.92

224.43

2.6

2.1

2.72

2.89

mg/l

5.06

3312

19927

Benign neoplasm: Sigmoid colon

2696

15079

2.25

223.12

2.8

2.3

3.35

2.94

mg/l

11.98

2379

12755

Combinations of oral blood glucose lowering drugs

3945

24338

1.91

222.91

2.7

2.1

3.37

2.91

mg/l

23.69

3520

20678

Benign neoplasm of other and ill-defined parts of digestive system

2787

15819

2.24

222.91

3.1

2.2

3.36

2.99

mg/l

9.56

2441

13464

Emotionally unstable personality disorder

1991

9979

2.53

222.28

2.4

2.1

2.78

2.69

mg/l

0.94

1688

8625

Acute upper respiratory infections of multiple and unspecified sites

11107

61991

1.45

221.58

2.5

2.2

2.99

2.87

mg/l

5.14

9598

53092

Other diseases of blood and blood-forming organs, wide

3306

19649

2.05

219.85

2.7

2.3

3.44

2.93

mg/l

14.24

2884

16783

Injury, poisoning and certain other consequences of external causes

9110

32456

1.52

219.59

2.3

2.1

2.89

2.82

mg/l

2.02

7818

27842

Peripheral arterial reconstruction

2815

16195

2.25

219.35

3.0

2.3

3.47

3.12

mg/l

8.21

2437

13601

Chronic pancreatitis

1921

9652

2.62

219.06

2.8

2.2

2.99

2.93

mg/l

0.38

1710

8197

Polycystic ovarian syndrome, consortium definition

10815

48408

1.47

218.65

2.4

2.2

2.98

2.83

mg/l

7.60

9291

41418

Rotator cuff syndrome

8745

46712

1.52

218.59

2.4

2.2

2.91

2.99

mg/l

2.49

7621

39671

Fibrosis and cirrhosis of liver

1315

5793

3.44

217.73

3.5

2.2

3.73

2.99

mg/l

14.72

1206

4916

Other disorders of ear

13471

68867

1.40

216.83

2.4

2.3

3.02

2.93

mg/l

3.31

11418

58899

Other and unspecified polyneuropathies, also in other diseases

2946

17137

2.16

216.17

2.8

2.3

3.00

3.03

mg/l

0.26

2559

14531

Temporomandibular joint disorders

2333

12335

2.24

214.95

2.4

2.1

2.80

2.87

mg/l

0.96

2054

10496

Stroke, excluding SAH

8732

47125

1.53

213.25

2.5

2.3

3.22

3.04

mg/l

7.66

7425

39839

Hyperkalaemia

1024

4049

4.03

212.37

3.6

2.2

3.50

3.15

mg/l

3.08

918

3429

Coagulation defects, purpura and other haemorrhagic conditions

2964

17279

2.11

211.46

2.9

2.2

3.26

2.90

mg/l

9.43

2637

14780

Stroke, including SAH

9119

49400

1.51

211.12

2.5

2.3

3.22

3.02

mg/l

8.73

7774

41791

Visual disturbances and blindness

7368

52396

1.57

211.10

2.5

2.3

2.87

2.96

mg/l

2.33

6277

44761

Iron deficiency

554

1581

8.94

210.74

3.6

2.0

2.73

2.65

mg/l

0.29

505

1350

Complications of internal orthopaedic prosthetic devices, implants and grafts

3427

20853

2.00

210.71

2.7

2.2

3.23

3.04

mg/l

4.19

2967

17572

Chronic periodontitis

2199

11674

2.35

209.37

2.7

2.2

2.99

3.00

mg/l

0.07

1907

10025

Unspecified fall

7107

49857

1.58

208.34

2.4

2.3

2.99

2.97

mg/l

0.39

5950

42598

Sequelae of external causes of morbidity and mortality

3738

23257

1.92

207.88

2.7

2.2

3.11

2.97

mg/l

2.70

3327

19842

Ischaemic Stroke, excluding all haemorrhages

8261

45194

1.54

207.66

2.5

2.3

3.22

3.05

mg/l

6.38

7012

38154

Any operation in hilmo

676

827

4.75

207.28

2.0

1.4

2.90

2.43

mg/l

3.88

574

709

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

4793

20048

1.77

206.69

2.2

2.0

2.52

2.61

mg/l

2.87

4170

17316

Pulmonary heart disease, diseases of pulmonary circulation

4744

31241

1.77

205.89

2.8

2.3

3.52

3.03

mg/l

21.99

4177

26380

Adalimumab

1426

6512

2.93

205.00

3.7

2.1

2.94

2.80

mg/l

1.41

1314

5604

Cutaneous abscess, furuncle and carbuncle

3616

22210

1.90

204.68

2.8

2.2

3.03

2.85

mg/l

4.01

3169

19039

Benign neoplasm: Stomach

1578

7622

2.87

204.27

3.4

2.3

3.47

2.94

mg/l

11.25

1373

6454

Other obstetric conditions, not elsewhere classified

4862

20499

1.75

202.89

2.2

2.0

2.52

2.61

mg/l

2.88

4232

17729

Colon adenocarcinoma, excluding all cancers (controls excluding all cancers)

1910

9924

2.58

202.69

2.4

2.3

4.31

3.02

mg/l

38.14

1677

8328

Primary_lymphoid and hematopoietic malignant neoplasms

3467

21270

1.95

202.46

2.4

2.3

3.25

2.93

mg/l

9.54

3018

18004

DVT of lower extremities and pulmonary embolism

6114

42342

1.64

201.49

2.6

2.3

3.40

3.02

mg/l

18.79

5305

35882

Panic disorder

2231

11953

2.25

201.13

2.3

2.1

2.68

2.73

mg/l

0.45

1902

10287

Suicide or other Intentional self-harm

3479

21235

1.90

200.00

2.4

2.2

2.95

2.80

mg/l

3.76

2963

18318

Substance use, excluding alcohol

2697

15328

2.07

199.74

2.4

2.1

3.01

2.80

mg/l

4.35

2248

13222

Gonarthrosis, primary, with knee surgery

8029

47654

1.54

199.53

2.5

2.3

3.26

3.04

mg/l

11.11

6942

40271

Unspecified mental disorder

5714

38936

1.63

199.45

2.3

2.2

2.84

2.85

mg/l

0.11

4933

33476

Abnormal findings on diagnostic imaging of lung

6849

47356

1.59

199.39

2.6

2.3

3.26

3.02

mg/l

9.73

5911

40035

Preparatory care for dialysis

837

3134

4.81

199.02

4.2

2.2

2.91

3.01

mg/l

0.66

767

2686

Other extrapyramidal and movement disorders in other diseases

3360

20691

1.97

197.02

2.4

2.3

2.84

3.00

mg/l

3.82

2829

17661

Hyperkinetic disorders, excluding more controls

1445

6399

2.68

196.89

2.2

2.52

2.53

mg/l

0.12

1225

5603

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

2438

13566

2.16

196.63

2.4

2.1

2.94

2.74

mg/l

4.08

2089

11721

Conductive and sensorineural hearing loss

11395

60093

1.42

196.57

2.4

2.3

3.12

2.98

mg/l

7.36

9645

51196

Sensorineural hearing loss

10834

57432

1.43

195.34

2.4

2.3

3.14

2.99

mg/l

7.15

9151

48880

Type 1 diabetes, wide definition

3206

19224

1.93

195.03

2.7

2.2

2.98

2.76

mg/l

5.58

2823

16432

Other disorders of lacrimal gland

4835

32281

1.72

194.03

2.5

2.2

2.94

2.96

mg/l

0.23

4161

27581

Primary gonarthrosis, bilateral

7182

45065

1.56

193.96

2.5

2.3

3.19

3.03

mg/l

5.51

6171

38102

Colorectal adenocarcinoma, excluding all cancers (controls excluding all cancers)

2914

17346

2.06

193.95

2.3

4.01

2.99

mg/l

40.88

2518

14608

Pain and other conditions associated with female genital organs and menstrual cycle

3026

17181

1.97

193.65

2.3

2.1

2.59

2.70

mg/l

2.12

2534

14824

Diseases of the ear and mastoid process

18027

73064

1.32

192.93

2.3

2.2

2.90

2.88

mg/l

0.28

15460

62605

Coronary angioplasty

5528

28972

1.67

192.76

2.5

2.2

3.29

3.00

mg/l

11.31

4847

24181

Other diseases of pleura

6609

41532

1.59

192.73

2.7

2.3

3.49

3.02

mg/l

31.21

5662

35134

Malignant neoplasm of digestive organs

5615

38209

1.66

192.15

2.4

2.3

3.76

3.02

mg/l

50.27

4884

32215

Other acute lower respiratory infections

7838

54400

1.51

191.83

2.7

2.3

3.14

2.93

mg/l

10.22

6745

46357

Malignant neoplasm of colon

2382

13557

2.26

191.16

2.4

2.3

4.23

3.03

mg/l

43.71

2085

11429

Transient ischemic attack

7577

45556

1.54

190.29

2.5

2.3

3.06

3.05

mg/l

0.19

6567

38440

Extrapyramidal and movement disorders

5351

36724

1.67

190.00

2.4

2.3

2.90

3.03

mg/l

3.97

4495

31227

Degeneration of macula and posterior pole

6857

40488

1.58

189.13

2.5

2.3

3.19

3.09

mg/l

2.19

5732

34098

Disorders of mineral metabolism

1320

6092

2.98

188.73

3.0

2.2

3.11

3.00

mg/l

0.69

1163

5213

Other disorders of skin and subcutaneous tissue, not elsewhere classified

2243

12497

2.27

188.21

3.0

2.2

3.44

2.98

mg/l

11.27

1946

10645

Malignant neoplasm, excluding all cancers (controls excluding all cancers)

12624

57594

1.39

188.16

2.2

2.3

3.09

2.84

mg/l

20.41

10966

49342

Malignant neoplasm, wide definition for exclusion

12626

57604

1.39

188.12

2.2

2.3

3.09

2.84

mg/l

20.42

10968

49350

Sequelae with surgical and medical care as external cause

2989

18089

2.02

188.08

2.8

2.3

3.16

2.97

mg/l

3.54

2659

15422

Malignant neoplasm, wide definition for exclusion, excluding all cancers (controls excluding all cancers)

12624

57596

1.39

188.01

2.2

2.3

3.09

2.84

mg/l

20.30

10966

49344

Ulcerative proctitis

1066

4487

3.40

187.95

3.3

2.0

2.60

2.85

mg/l

3.16

964

3841

Injuries to the thorax

6294

44413

1.58

186.85

2.4

2.3

3.10

2.98

mg/l

2.75

5349

37853

Irregular menses

6714

38609

1.56

185.98

2.4

2.1

2.84

2.74

mg/l

3.31

5829

33228

Parodontitis or operation codes

12693

72832

1.38

185.68

2.3

2.2

2.87

2.96

mg/l

4.05

10728

62508

Restless leg syndrome

1912

10227

2.45

185.44

2.5

2.2

2.76

2.99

mg/l

5.25

1627

8726

Cirrhosis of liver, NAS

924

3758

4.09

185.37

3.6

2.2

3.99

3.02

mg/l

15.70

851

3188

Cardiomyopathy, other and unspecified

1242

5590

2.99

185.17

2.8

2.0

2.95

2.82

mg/l

1.02

1098

4660

Cardiodefibrillation

5271

36324

1.68

184.63

2.7

2.3

3.31

3.04

mg/l

10.34

4578

30686

Parodontitis

12670

72824

1.38

184.06

2.3

2.2

2.87

2.96

mg/l

4.04

10709

62500

Benign neoplasm: Ascending colon

1938

10432

2.42

183.92

2.9

2.3

3.28

2.93

mg/l

7.55

1724

8817

Benign neoplasm: Rectum, anus and anal canal

2821

16858

2.03

183.68

2.7

2.3

3.21

2.94

mg/l

5.89

2432

14270

Viral hepatitis, IBD co-morbidity

761

2607

3.69

183.48

2.4

1.9

2.97

2.67

mg/l

2.28

656

2218

Chronic periodontitis, including avohilmo

12608

72737

1.38

183.33

2.3

2.2

2.87

2.96

mg/l

4.17

10651

62435

Collagenous colitis

1454

7097

2.81

182.83

3.4

2.1

3.05

2.97

mg/l

0.57

1290

6032

Diabetic nephropathy, excluding more controls

2397

11540

2.27

182.49

3.3

2.4

3.13

3.11

mg/l

0.09

2155

9899

Secondary uncertain malignant neoplasm, excluding all cancers (controls excluding all cancers)

5690

34698

1.62

182.33

2.0

2.3

3.50

2.95

mg/l

35.94

4970

29392

Bacterial pneumoniae

5941

36772

1.60

181.90

2.6

2.2

2.92

mg/l

0.06

5231

31130

Visual disturbances

6672

47861

1.55

181.58

2.5

2.3

2.81

2.94

mg/l

4.69

5733

40900

Organic, including symptomatic, mental disorders

7249

37963

1.55

181.54

2.4

2.3

3.13

3.09

mg/l

0.61

5992

32163

Colorectal cancer

3509

22322

1.89

181.20

2.4

2.3

3.95

3.04

mg/l

41.70

3036

18810

Sulfonylureas

5446

29992

1.65

180.99

2.8

2.2

3.44

3.01

mg/l

24.90

4676

25050

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

3897

25295

1.81

180.88

2.6

2.3

3.39

2.97

mg/l

19.77

3486

21478

Acute upper respiratory infections

15813

79207

1.33

180.39

2.4

2.2

2.96

2.91

mg/l

2.05

13602

67556

Methotrexate

2193

12166

2.19

180.23

2.8

2.1

3.42

2.86

mg/l

19.92

1971

10263

Undetermined asthma, excluding more controls

1861

9737

2.32

180.10

2.5

2.0

3.01

2.83

mg/l

2.34

1616

8235

Kela-code for severe mental illness

5070

34441

1.64

180.06

2.3

2.2

2.88

2.86

mg/l

0.22

4378

29584

Seropositive rheumatoid arthritis, wide

3994

26104

1.79

179.39

2.6

2.3

3.39

2.97

mg/l

19.61

3568

22160

Coronary artery bypass grafting

4218

21096

1.78

179.16

2.6

2.2

3.29

3.02

mg/l

8.95

3696

17443

Disorders of lacrimal system

5875

41353

1.60

178.72

2.5

2.3

2.93

2.99

mg/l

0.89

5059

35265

Rheumatism, unspecified

2076

11370

2.24

178.68

2.6

2.2

2.89

2.98

mg/l

1.07

1852

9622

Other/unspecified seropositive rheumatoid arthritis

3947

25789

1.79

177.53

2.6

2.3

3.39

2.98

mg/l

19.51

3525

21893

Anaemia in chronic diseases classified elsewhere

530

1635

7.10

177.10

3.9

2.0

3.14

2.96

mg/l

1.04

488

1378

Haemorrhoids and perianal venous thrombosis

4096

26781

1.74

176.93

2.5

2.1

3.13

2.98

mg/l

3.32

3565

22574

Benign neoplasm: Rectum

2496

14597

2.10

176.64

2.7

2.3

3.24

2.93

mg/l

7.01

2168

12361

Hernia of abdominal wall

6287

44851

1.56

176.57

2.6

2.2

3.19

2.96

mg/l

9.47

5511

38224

Carpal tunnel syndrome

8405

56495

1.46

175.65

2.4

2.2

2.97

2.96

mg/l

0.10

7383

48151

Deforming dorsopathies

3910

25362

1.75

174.53

2.6

2.2

2.87

2.92

mg/l

0.67

3404

21605

Parodontitis and operation codes

11823

71635

1.38

173.76

2.3

2.2

2.86

2.96

mg/l

4.53

10001

61513

Alcohol dependence

3663

23434

1.79

173.75

2.5

2.2

3.10

2.93

mg/l

3.67

3134

20044

Dentofacial anomalies [including malocclusion]

3725

23565

1.76

173.25

2.5

2.1

2.76

2.81

mg/l

0.73

3284

20398

Pulmonary embolism

4235

28246

1.74

172.74

2.7

2.3

3.47

3.02

mg/l

17.90

3713

23865

Coxibs

4715

16545

1.68

171.52

2.3

2.91

2.97

mg/l

0.96

3986

14107

Benign neoplasm: Sigmoid colon

2696

16310

2.04

171.32

2.8

2.3

3.35

3.02

mg/l

8.14

2379

13847

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS), excluding all cancers (controls excluding all cancers)

1349

6601

2.87

171.16

2.7

2.3

3.05

2.99

mg/l

0.34

1169

5553

Dialysis

735

2730

4.35

170.95

4.0

2.2

2.87

2.96

mg/l

0.62

681

2322

Pulmonary heart disease

4235

28315

1.73

170.81

2.7

2.3

3.47

3.03

mg/l

17.22

3713

23936

Benign neoplasm: Caecum

1553

7987

2.63

170.41

2.9

2.3

3.29

2.95

mg/l

5.74

1386

6725

Sleep disorders

3033

18725

1.89

168.91

2.5

2.2

2.74

2.83

mg/l

1.38

2606

16119

Bacterial pneumonia, not elsewhere classified

5614

34886

1.59

168.14

2.6

2.2

2.91

2.93

mg/l

0.14

4953

29520

Acute bronchitis

6004

41923

1.56

167.95

2.7

2.3

3.20

2.96

mg/l

9.96

5143

35586

Fracture of lumbar spine and pelvis

3262

20714

1.88

167.94

2.6

2.3

3.20

3.07

mg/l

1.64

2745

17502

Benign neoplasm: Stomach

1578

8240

2.60

167.01

3.4

2.2

3.47

3.05

mg/l

7.23

1373

6996

Oesophageal varices

763

2964

4.31

166.47

3.8

2.1

4.30

2.93

mg/l

24.42

704

2512

Oter anti-inflammatory and antirheumatic agents, non-steroids

3697

12965

1.80

165.60

2.4

2.3

3.12

3.11

mg/l

0.11

3142

11019

Enterocolitis due to Clostridium difficile

1747

9452

2.41

163.58

3.2

2.2

3.23

3.07

mg/l

1.85

1545

7990

Colon adenocarcinoma

1910

10703

2.34

162.81

2.4

2.3

4.31

3.05

mg/l

36.69

1677

9025

Ascites

1157

5389

2.96

162.41

3.2

2.2

3.59

3.04

mg/l

7.96

1037

4533

Cellulitis

3020

18845

1.87

162.07

2.9

2.2

3.09

2.91

mg/l

3.73

2647

16108

Acute sinusitis

7147

48891

1.48

161.51

2.5

2.2

2.90

2.83

mg/l

2.03

6169

41996

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

1371

6932

2.75

160.01

3.1

2.2

3.14

3.07

mg/l

0.53

1227

5821

Undetermined asthma

1861

10139

2.21

159.96

2.5

2.1

3.01

2.85

mg/l

1.94

1616

8628

Migraine with aura

3327

21197

1.78

159.29

2.3

2.1

2.65

2.74

mg/l

1.65

2882

18216

Malignant neoplasm

12533

58604

1.35

158.95

2.2

2.3

3.13

2.86

mg/l

23.69

10849

50207

Post-traumatic stress disorder

1275

6118

2.65

158.78

2.5

2.0

2.59

2.67

mg/l

0.76

1110

5277

Primary_lymphoid and hematopoietic malignant neoplasms

3467

22620

1.80

158.24

2.4

2.3

3.25

3.02

mg/l

5.35

3018

19168

Streptococcal septicaemia

1335

6630

2.68

158.17

2.9

2.1

3.42

2.91

mg/l

9.56

1156

5577

Early onset COPD, excluding more controls

2716

16479

1.90

158.03

2.6

2.1

3.27

2.87

mg/l

9.97

2351

13939

Somatoform disorder

2321

13609

2.03

157.48

2.6

2.1

2.76

2.86

mg/l

1.26

1996

11704

Fracture of femur

3989

24415

1.73

157.33

2.6

2.3

3.24

3.14

mg/l

1.55

3347

20499

Seronegative rheumatoid arthritis

1756

9513

2.29

157.24

2.6

2.1

3.26

2.93

mg/l

6.37

1569

7985

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

2719

14976

1.89

157.07

2.3

2.2

2.65

2.58

mg/l

0.96

2345

12950

Benign neoplasm: Transverse colon

1502

7846

2.55

156.78

3.0

2.3

3.47

2.92

mg/l

12.15

1347

6641

Paracetamol of NSAID medication

2986

8935

1.85

156.50

2.2

2.94

2.78

mg/l

2.19

2551

7610

Disorders of skin appendages

6479

47222

1.50

156.08

2.5

2.2

2.83

2.84

mg/l

0.14

5670

40523

Mycoses

3660

24130

1.75

155.98

2.8

2.2

3.17

2.91

mg/l

6.57

3166

20623

Nonorganic sleeping disorders

2681

16383

1.92

155.96

2.5

2.2

2.68

2.82

mg/l

2.81

2299

14109

Unstable angina pectoris

5554

32837

1.58

155.86

2.6

2.2

3.21

3.02

mg/l

5.92

4858

27490

Other (seronegative) rheumatoid arthritis, wide

2825

17637

1.91

155.67

2.7

2.3

3.29

2.99

mg/l

7.58

2513

15004

Explicit bacterial Sepsis

1575

8291

2.41

155.65

2.9

2.1

3.39

2.92

mg/l

9.50

1370

7015

Direct fill therapy

1952

10982

2.18

155.41

2.8

2.3

2.82

2.86

mg/l

0.35

1714

9474

Phobic anxiety disorders

1860

10173

2.16

155.32

2.3

2.1

2.77

2.70

mg/l

0.78

1596

8811

Exclusions for E4_PCOS_CONSORTIUM

10514

51160

1.38

154.04

2.4

2.2

3.01

2.83

mg/l

9.20

8962

44023

Polyuria

3217

20743

1.82

153.98

2.5

2.2

2.77

2.99

mg/l

6.96

2690

17684

Other symptoms and signs involving the digestive system and abdomen

2343

13849

2.00

153.78

2.7

2.2

3.23

2.97

mg/l

5.57

2007

11811

Exposure to other specified factors

10099

73686

1.38

152.65

2.4

2.2

2.90

2.87

mg/l

0.63

8548

63361

Weight loss

1552

8298

2.49

152.47

2.5

2.3

2.75

2.98

mg/l

3.32

1318

7054

Deposits [accretions] on teeth

1117

5028

2.85

152.37

3.6

2.4

3.07

2.88

mg/l

1.25

1003

4327

Alcohol abuse, main dg, excluding more controls

1923

10686

2.11

152.09

2.4

2.1

2.91

2.82

mg/l

1.00

1663

9233

Chronic ulcer of skin, not elsewhere classified

1139

5465

2.94

151.71

3.5

2.2

3.52

3.05

mg/l

6.28

1029

4625

Enlarged lymph nodes

2181

12647

2.02

151.40

2.5

2.1

3.09

2.87

mg/l

3.75

1903

10774

Persons encountering health services for specific procedures, not carried out

1187

5693

2.73

151.15

3.0

2.1

3.04

2.85

mg/l

1.43

1002

4845

Spondyloarthritis

2576

15656

1.91

151.07

2.7

2.1

3.02

2.92

mg/l

1.39

2268

13319

Coxarthrosis, primary

8228

54389

1.44

151.06

2.4

2.3

3.15

3.05

mg/l

2.68

7082

45944

Other symptoms and signs involving the nervous and musculoskeletal systems

5774

41643

1.53

150.84

2.4

2.2

2.80

2.93

mg/l

4.31

5159

35570

Intestinal adhesions without obstruction

1271

6286

2.65

150.69

3.2

2.1

3.27

2.96

mg/l

3.01

1109

5316

Missing teeth due to accident, extraction or parodontitis

1668

9039

2.30

150.00

2.8

2.2

3.08

3.01

mg/l

0.54

1479

7756

Colorectal adenocarcinoma

2914

18587

1.89

149.44

2.3

4.01

3.05

mg/l

36.57

2518

15654

Nonalcoholic fatty liver disease

1333

6709

2.55

149.30

2.9

2.2

3.05

2.91

mg/l

1.17

1200

5746

Schizophrenia or delusion

4181

28357

1.64

149.18

2.2

2.84

mg/l

0.04

3585

24400

Amputation

1583

8553

2.42

148.91

3.2

2.2

3.48

3.05

mg/l

8.07

1379

7171

Diabetic retinopathy, excluding more controls

3913

14795

1.77

147.87

2.9

2.4

3.14

3.11

mg/l

0.35

3433

12751

Disturbances of skin sensation

3712

24725

1.70

147.86

2.3

2.2

2.71

2.83

mg/l

2.63

3203

21316

Other degenerative diseases of the nervous system

3866

19489

1.69

147.80

2.3

2.1

3.00

2.98

mg/l

0.26

3167

16479

COPD

6290

38032

1.51

147.50

2.6

2.2

3.39

3.00

mg/l

21.00

5351

32016

Schizophrenia, schizotypal and delusional disorders

4194

28528

1.63

147.49

2.2

2.84

2.85

mg/l

0.06

3595

24546

Total colectomy operation

749

3038

3.79

146.54

4.2

2.1

3.33

2.91

mg/l

4.15

698

2593

Total colectomy

749

3038

3.79

146.54

4.2

2.1

3.33

2.91

mg/l

4.15

698

2593

Purpura and other haemorrhagic conditions

1995

11562

2.13

146.28

2.9

2.3

3.34

2.92

mg/l

8.27

1799

9874

Ventral hernia

3331

21845

1.76

145.55

2.7

2.2

3.27

2.97

mg/l

8.08

2925

18527

Other dialysis

577

2082

4.91

145.17

4.2

2.2

2.79

2.98

mg/l

1.56

537

1781

Artificial opening status

888

3934

3.32

143.45

3.2

2.2

3.41

2.98

mg/l

3.43

791

3334

Other diseases of stomach and duodenum

1018

4737

2.94

142.73

3.4

2.1

3.27

2.99

mg/l

3.03

922

3967

Acute pancreatitis

2716

17060

1.86

142.55

2.6

2.2

3.04

2.98

mg/l

0.70

2347

14412

Disorders of synovium and tendon

7118

47901

1.44

142.44

2.4

2.1

2.84

2.92

mg/l

2.04

6226

40795

Eating disorder

1484

7885

2.38

142.35

2.6

2.1

2.66

2.60

mg/l

0.52

1264

6793

Ulcerative enterocolitis

600

2198

4.33

142.03

4.1

2.0

3.09

2.91

mg/l

0.92

540

1882

Peripheral artery operations in Hilmo

1971

11474

2.12

141.93

3.1

2.2

3.44

3.04

mg/l

7.99

1728

9551

Soft tissue disorders related to use, overuse and pressure

3513

23294

1.70

141.93

2.5

2.2

2.88

2.99

mg/l

1.96

3051

19728

Injuries to the shoulder and upper arm

11477

76640

1.34

141.76

2.4

2.3

2.95

mg/l

0.04

9752

65547

Benign neoplasm: Ascending colon

1938

11341

2.17

141.68

2.9

2.3

3.28

3.02

mg/l

4.43

1724

9636

Fissure and fistula of anal and rectal regions

3185

20635

1.74

141.56

2.6

2.0

2.81

2.88

mg/l

0.87

2726

17588

Other blood glucose lowering drugs, excl. Insulins

2392

14652

1.95

141.09

2.8

2.2

3.38

2.97

mg/l

10.16

2098

12335

Chronic sinusitis

5793

42122

1.50

140.98

2.4

2.2

2.76

2.93

mg/l

6.27

4980

36087

Coeliac disease

1832

10437

2.16

140.94

2.6

2.2

2.74

2.85

mg/l

1.45

1627

8925

Exclusions for E4_PCOS_BROAD

2390

14583

1.94

140.82

2.7

2.3

3.00

2.87

mg/l

1.99

2120

12554

Nonischemic cardiomyopathy

891

3946

3.14

140.11

2.7

2.1

2.75

2.92

mg/l

1.17

794

3324

Superficial injury of head

3171

20688

1.76

140.02

2.4

2.3

2.98

2.95

mg/l

0.27

2664

17688

Spondylopathies (FG)

1902

10838

2.06

139.95

2.6

2.1

2.94

2.79

mg/l

2.13

1675

9240

Migraine without aura

2718

17028

1.81

139.12

2.3

2.1

2.69

2.70

mg/l

0.18

2375

14656

Other diseases of upper respiratory tract

16959

72969

1.28

139.01

2.3

2.2

2.84

2.96

mg/l

7.81

14486

62285

Artificial joint operation, meniscal resection

12546

67102

1.32

139.00

2.4

2.2

3.11

2.97

mg/l

7.36

10830

57139

Osteoporosis with pathological fracture (FG)

1088

5306

2.86

138.81

3.0

2.2

3.49

3.13

mg/l

3.04

937

4393

4352

27061

1.64

138.70

2.6

2.3

3.32

3.14

mg/l

3.49

3632

22677

Monoclonal gammopathy of undetermined significance (MGUS), excluding all cancers (controls excluding all cancers)

832

3682

3.49

137.92

3.0

2.3

3.07

3.00

mg/l

0.28

728

3105

Other postsurgical states

1004

4725

2.91

137.19

3.1

2.2

3.65

2.91

mg/l

12.29

917

4018

Dipeptidyl peptidase 4 (DPP-4) inhibitors

1695

9557

2.23

137.07

2.7

2.1

3.41

2.93

mg/l

11.55

1470

8057

Viral pneumonia

1805

10287

2.13

136.90

2.8

2.1

3.13

2.90

mg/l

3.07

1584

8775

Benign neoplasm: Rectum, anus and anal canal

2821

18192

1.84

136.88

2.7

2.3

3.21

3.02

mg/l

3.15

2432

15437

Fracture of rib(s), sternum and thoracic spine

4015

27690

1.64

136.82

2.5

2.2

3.09

3.01

mg/l

1.24

3384

23563

Abnormal weight loss

1394

7469

2.49

136.44

2.5

2.3

2.75

2.99

mg/l

3.40

1178

6338

Endocarditis

611

2300

4.06

136.21

3.2

2.0

3.35

2.90

mg/l

2.74

550

1900

Other chronic obstructive pulmonary disease

6039

37071

1.50

135.79

2.6

2.2

3.41

3.00

mg/l

21.52

5127

31201

Other chronic obstructive pulmonary disease, including avohilmo

7339

46392

1.44

135.72

2.5

2.3

3.33

3.01

mg/l

18.09

6239

39312

Benign neoplasm: Caecum

1553

8661

2.37

135.16

2.9

2.3

3.29

3.03

mg/l

3.47

1386

7338

Cholecystectomy

9879

68950

1.36

134.89

2.5

2.2

3.05

2.96

mg/l

2.77

8578

58693

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

4474

31519

1.59

134.86

2.4

2.3

2.94

2.91

mg/l

0.38

3888

27012

Oxicams

3789

14345

1.67

134.62

2.3

3.08

3.05

mg/l

0.26

3280

12193

Mixed and other personality disorders

1168

5777

2.54

134.60

2.6

2.1

2.76

2.78

mg/l

0.08

998

4998

Heartburn

1477

7934

2.28

134.35

2.6

2.1

2.70

2.95

mg/l

3.74

1258

6749

Viral infections characterized by skin and mucous membrane lesions

5539

40378

1.51

134.19

2.6

2.3

3.02

2.90

mg/l

2.90

4832

34608

Problems related to lifestyle

1454

7747

2.27

133.83

2.4

2.0

3.03

2.79

mg/l

3.51

1259

6593

Insomnia

2209

13376

1.95

133.54

2.4

2.2

2.69

2.84

mg/l

2.67

1906

11482

Special screening examination for infectious and parasitic diseases

3130

14970

1.70

132.86

2.0

1.9

2.48

2.67

mg/l

5.22

2447

12872

Other diseases of lip and oral mucosa

2182

13183

1.95

132.68

2.6

2.2

2.96

3.00

mg/l

0.31

1937

11310

Eating disorders

1696

9599

2.16

132.09

2.6

2.1

2.69

2.68

mg/l

0.11

1456

8236

Bacterial pneumonia (organism specified)

6306

42900

1.47

130.96

2.6

2.2

2.94

3.00

mg/l

1.13

5547

36215

Allergic asthma (mode), excluding more controls

3174

20368

1.69

130.92

2.4

2.0

2.73

2.72

mg/l

0.13

2806

17366

Benign neoplasm: Rectum

2496

15849

1.89

130.25

2.7

2.3

3.24

3.02

mg/l

4.05

2168

13456

Haemolytic anaemias

647

2619

4.02

130.09

3.5

2.2

4.12

3.01

mg/l

12.00

577

2236

Any event in cancer register

13043

62701

1.30

129.82

2.2

3.12

2.82

mg/l

29.34

11240

53781

Alcoholic liver disease

1406

7604

2.34

128.84

2.8

2.2

3.69

2.96

mg/l

14.40

1242

6480

Polymyalgia rheumatica

2014

12230

2.06

128.73

2.7

2.3

3.17

3.13

mg/l

0.26

1702

10309

Fitting and adjustment of other devices

4878

32722

1.55

128.45

2.4

2.2

3.24

3.06

mg/l

5.08

4165

27430

Other disorders of veins

5186

37752

1.52

128.10

2.5

2.2

3.06

2.92

mg/l

2.94

4328

32225

Supplementary factors related to causes of morbidity and mortality classified elsewhere

4094

28636

1.60

127.44

2.5

2.3

3.20

2.89

mg/l

11.35

3564

24547

Disorders resulting from impaired renal tubular function

631

2553

3.98

126.54

3.2

2.2

3.02

mg/l

0.02

592

2177

Amputation of toe

1130

5798

2.68

126.43

3.2

2.2

3.34

3.06

mg/l

2.93

989

4891

Psoriatic and enteropathic arthropathies

1574

8766

2.14

126.02

2.9

2.1

3.05

2.84

mg/l

2.45

1406

7434

Other disorders of kidney and ureter

1823

10763

2.09

125.90

2.9

2.2

3.11

2.97

mg/l

1.59

1646

9176

Cervicalgia

2775

17966

1.76

125.61

2.4

2.2

2.95

2.98

mg/l

0.27

2409

15250

Other specified and unspecified personality disorders

1323

7020

2.33

125.29

2.5

2.1

2.87

2.82

mg/l

0.34

1134

6041

Disorders of sclera, cornea, iris and ciliary body

7193

55094

1.41

124.95

2.4

2.2

2.92

mg/l

0.01

6283

47110

Acute pancreatitis (for exclusion)

2716

17673

1.78

123.13

2.6

2.2

3.04

3.00

mg/l

0.47

2347

15036

Temporomandibular joint disorders, including avohilmo

5553

40976

1.48

123.12

2.3

2.2

2.64

2.78

mg/l

6.01

4808

35231

Benign neoplasm: Transverse colon

1502

8526

2.29

122.69

3.0

2.2

3.47

3.00

mg/l

8.95

1347

7246

Non-allergic asthma (mode), excluding more controls

2590

16355

1.77

122.38

2.5

2.1

2.97

2.82

mg/l

2.78

2306

13777

Disorder of lipoprotein metabolism, unspecified

1916

11559

2.00

120.21

2.6

2.2

3.22

3.08

mg/l

1.49

1625

9770

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

6753

50386

1.41

119.77

2.3

2.2

2.82

2.93

mg/l

3.46

5781

43200

Enteropathic arthropathies

440

1499

4.82

118.48

4.2

1.9

2.88

2.80

mg/l

0.32

407

1254

Injuries to the ankle and foot

9110

65708

1.34

118.35

2.4

2.2

2.83

mg/l

0.01

7786

56653

Cholangitis (primary sclerosing, PSC)

975

4817

2.73

118.34

3.4

2.2

3.23

2.96

mg/l

2.15

870

4060

Chronic rhinitis, nasopharyngitis and pharyngitis

4129

29238

1.56

118.32

2.4

2.2

2.66

2.90

mg/l

8.54

3487

25126

Atopic dermatitis

7318

48011

1.39

118.20

2.3

2.2

2.65

2.79

mg/l

6.28

6166

41442

Delirium, not induced by alcohol and other psychoactive substances

1666

9772

2.11

117.71

2.5

2.3

3.23

3.16

mg/l

0.45

1418

8252

Allergic asthma (mode)

3174

20877

1.64

117.01

2.4

2.0

2.73

2.74

mg/l

0.07

2806

17854

Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)

6580

34269

1.43

116.96

2.4

2.3

3.11

2.98

mg/l

3.62

5550

28942

Amiodarone users

1484

8515

2.24

116.20

3.0

2.3

3.18

3.03

mg/l

1.32

1310

7235

Meniscus derangement

7317

38411

1.39

116.17

2.3

2.1

2.95

2.92

mg/l

0.58

6288

32587

Certain disorders involving the immune mechanism

2536

16456

1.78

115.73

2.9

2.3

3.16

2.93

mg/l

4.99

2293

14127

Fungal Sepsis

647

2754

3.61

115.73

3.4

2.0

3.39

2.95

mg/l

3.18

575

2327

Subjective visual disturbances

3267

22387

1.66

115.38

2.4

2.2

2.69

2.93

mg/l

8.03

2804

19165

Pain in thoracic spine

2005

12260

1.89

114.73

2.3

2.2

2.85

2.92

mg/l

0.60

1768

10458

Sequelae of cerebrovascular disease

4915

31782

1.51

114.15

2.6

2.3

3.21

3.07

mg/l

2.60

4117

26825

Osteomyelitis

988

4976

2.66

113.99

3.4

2.2

3.28

2.98

mg/l

2.92

875

4221

Myeloproliferative diseases

1278

7049

2.36

113.67

2.7

2.2

4.85

3.02

mg/l

21.97

1101

5961

Injuries to the elbow and forearm

9355

67577

1.33

113.35

2.4

2.3

2.97

2.91

mg/l

1.59

7911

57879

COPD related to multimorbidity

5433

34274

1.48

113.14

2.7

2.3

3.49

3.02

mg/l

24.31

4616

28942

Noninflammatory disorders of female genital tract

6502

24647

1.43

113.01

2.3

2.1

2.83

2.82

mg/l

0.11

5534

21075

Later onset COPD, excluding more controls

3037

16042

1.71

112.82

2.6

2.2

3.50

3.02

mg/l

14.81

2564

13400

5675

40454

1.47

112.54

2.4

2.3

3.00

3.12

mg/l

2.70

4808

34059

Disturbance of activity and attention

1385

7558

2.14

112.49

2.2

2.3

2.51

2.59

mg/l

0.77

1169

6563

Barrett oesophagus

745

3381

3.11

112.41

2.9

2.1

3.17

2.95

mg/l

1.31

654

2840

Injuries to the knee and lower leg

17215

83192

1.24

112.18

2.3

2.2

2.95

2.89

mg/l

2.23

14716

71209

Acetic acid derivatives and related substances

4441

16383

1.53

111.48

2.3

2.95

2.97

mg/l

0.25

3746

13971

Disorders of parathyroid gland

2911

19457

1.71

111.42

2.9

2.3

3.33

3.10

mg/l

4.32

2507

16470

Idiopathic gout

1320

7412

2.29

110.55

2.9

2.2

3.25

3.00

mg/l

2.62

1156

6258

Traumatic subdural haemorrhage

1802

10694

1.96

110.53

2.4

2.2

3.22

3.07

mg/l

1.38

1517

9017

Cervical disc disorders

4627

33777

1.49

110.13

2.4

2.2

2.93

2.98

mg/l

0.74

4006

28709

In situ neoplasms

4729

33199

1.50

109.91

2.5

2.3

3.04

2.91

mg/l

2.52

4008

28122

Misadventures to patients during surgical and medical care

1942

12037

1.92

109.43

2.8

2.2

3.20

2.91

mg/l

6.06

1719

10287

Decubitus ulcer and pressure area

925

4642

2.73

109.13

3.1

2.2

3.36

3.10

mg/l

1.76

782

3882

Hyperkinetic disorders

1458

8159

2.08

109.03

2.2

2.4

2.52

2.60

mg/l

0.97

1235

7110

Diabetic nephropathy

2417

15902

1.86

108.64

3.3

2.5

3.12

3.23

mg/l

1.42

2171

13674

Ovarian cyst

5273

22515

1.47

107.98

2.3

2.1

2.82

2.83

mg/l

0.19

4522

19266

Basal cell carcinoma, excluding all cancers (controls excluding all cancers)

6328

33371

1.42

107.69

2.4

2.3

3.10

2.98

mg/l

2.88

5297

28180

Type of accident

3724

26415

1.57

107.46

2.5

2.3

3.19

2.89

mg/l

9.53

3237

22632

Malignant neoplasm of skin, excluding all cancers (controls excluding all cancers)

7130

37779

1.39

107.40

2.4

2.3

3.11

2.95

mg/l

4.95

6044

32017

Implicit fungal Sepsis

592

2510

3.65

107.05

3.3

2.0

3.32

2.96

mg/l

2.21

525

2121

Other disorders of glucose regulation and pancreatic internal secretion

1246

6880

2.26

106.80

3.0

2.2

2.97

2.93

mg/l

0.21

1108

5850

Elevated blood glucose level

1206

6612

2.30

106.53

2.9

2.2

3.38

2.95

mg/l

5.99

1057

5609

Congenital malformations, deformations and chromosomal abnormalities

7728

58264

1.35

106.27

2.5

2.2

2.92

2.80

mg/l

3.77

6706

50166

Basal cell carcinoma, including avohilmo, excluding all cancers (controls excluding all cancers)

6402

33786

1.41

106.12

2.4

2.3

3.09

2.98

mg/l

2.67

5354

28540

Other necrotizing vasculopathies (FG)

905

4514

2.65

105.98

2.9

2.1

3.18

3.01

mg/l

1.21

790

3780

Other eating disorders

873

4290

2.69

105.91

2.6

2.1

2.73

2.59

mg/l

1.27

756

3694

Acute posthaemorrhagic anaemia

605

2583

3.44

105.53

4.0

2.0

3.74

2.98

mg/l

7.09

535

2136

Disorders of calcium metabolism

921

4634

2.62

105.28

2.7

2.1

3.35

3.06

mg/l

2.10

804

3957

Cervicobrachial syndrome

2789

18752

1.66

104.29

2.4

2.1

2.82

2.93

mg/l

2.01

2495

15998

Skin changes due to chronic exposure to nonionizing radiation

5333

38378

1.46

103.62

2.4

2.3

3.00

3.13

mg/l

3.31

4513

32270

Candidiasis

1855

11528

1.91

103.58

3.0

2.2

3.23

2.89

mg/l

5.39

1594

9873

Migraine with aura and triptan purchases

2044

12930

1.82

102.62

2.3

2.1

2.64

2.73

mg/l

1.16

1749

11184

Internal derangement of knee

4749

35031

1.46

102.28

2.3

2.1

2.95

2.87

mg/l

1.33

4032

29787

Other and unspecified nonorganic psychotic disorders

2379

15507

1.71

101.91

2.2

2.1

2.74

2.78

mg/l

0.31

2023

13389

Actinic keratosis

5201

37534

1.47

101.88

2.4

2.3

3.00

3.14

mg/l

3.22

4401

31555

Acquired haemolytic anaemia

460

1790

4.48

101.85

3.6

2.1

4.08

3.10

mg/l

7.18

419

1534

Myeloproliferative diseases (CML excluded)

1156

6404

2.35

101.72

2.6

2.2

5.07

3.02

mg/l

22.90

989

5415

Other abnormal uterine and vaginal bleeding

3201

15774

1.62

101.50

2.5

2.2

3.19

2.99

mg/l

4.55

2682

13392

Extreme obesity with alveolar hypoventilation

644

2878

3.22

101.38

3.0

2.1

4.27

2.96

mg/l

15.51

549

2454

Epilepsy

4039

29144

1.51

101.35

2.3

2.2

2.93

2.92

mg/l

0.10

3411

24817

Inflammatory diseases of female pelvic organs

8296

49867

1.34

101.33

2.3

2.2

2.84

2.85

mg/l

0.05

7068

42794

Disorders of conjunctiva

11105

76503

1.28

101.27

2.3

2.2

2.80

2.89

mg/l

3.70

9509

65661

Fracture of shoulder and upper arm

4645

34467

1.47

101.17

2.5

2.3

2.95

2.99

mg/l

0.58

3921

29389

L04AC Interleukin inhibitors

712

3271

2.87

100.77

3.7

2.0

3.02

2.82

mg/l

1.63

664

2825

Hallux valgus (acquired)

4345

22875

1.50

100.71

2.3

2.1

2.89

2.94

mg/l

0.52

3633

19369

Abnormalities of gait and mobility

1693

10442

1.98

100.41

2.5

2.3

2.89

3.02

mg/l

1.22

1448

8838

Urticaria and erythema

4732

35252

1.46

100.18

2.5

2.2

2.90

2.85

mg/l

0.80

4081

30349

3061

20298

1.65

100.11

2.6

2.3

3.32

3.18

mg/l

1.97

2530

17022

Thrombocytopenia, unspecified

1051

5657

2.42

100.08

2.8

2.2

3.43

2.97

mg/l

4.83

940

4796

Non-allergic asthma (mode)

2590

17129

1.67

99.94

2.5

2.1

2.97

2.88

mg/l

1.23

2306

14510

Hyperplasia of prostate

4726

19800

1.48

99.70

2.3

2.2

2.96

3.02

mg/l

1.02

3986

16843

Postprocedural disorders of digestive system, not elsewhere classified

560

2394

3.58

99.23

4.4

2.1

3.24

2.94

mg/l

1.47

497

2029

Diseases of the myoneural junction and muscle

1664

10203

1.96

98.89

2.6

2.3

3.12

3.00

mg/l

1.26

1382

8693

Fracture of lower leg, including ankle

7115

55859

1.36

98.35

2.4

2.2

2.97

2.94

mg/l

0.44

6111

47794

Benign neoplasm: Descending colon

948

4959

2.52

98.35

2.8

2.3

3.44

2.93

mg/l

5.96

864

4196

Adrenocortical insufficiency

589

2571

3.36

98.25

3.4

2.2

3.22

2.98

mg/l

1.68

544

2180

Spondylolisthesis/Spondylolysis

2295

15047

1.73

98.08

2.5

2.2

2.88

2.98

mg/l

1.42

2000

12784

Sub-endpoint used in defining T1D endpoints

4024

28802

1.50

97.97

2.8

2.3

3.02

2.94

mg/l

1.39

3543

24515

Hypertensive Renal Disease

578

2474

3.26

97.86

3.1

2.0

3.25

3.05

mg/l

1.18

519

2033

Papulosquamous disorders

4965

37447

1.44

97.22

2.5

2.2

3.01

2.94

mg/l

1.09

4310

32040

Other diseases of pericardium

649

2925

3.00

97.05

2.7

2.0

3.31

2.85

mg/l

5.08

578

2420

Chronic periodontitis, complicated

1280

7355

2.15

96.68

2.6

2.2

3.02

2.97

mg/l

0.27

1111

6278

COPD, hospital admissions

6091

40077

1.40

96.17

2.6

2.3

3.40

3.01

mg/l

20.03

5175

33903

Psychotic depression

836

4109

2.49

96.02

2.4

2.1

3.01

2.89

mg/l

0.81

726

3541

Alzheimer disease, excluding more controls

2472

10950

1.72

95.90

2.3

2.2

3.03

3.10

mg/l

0.62

1971

9205

Duodenal ulcer

1527

9179

1.98

95.89

3.0

2.1

3.58

3.04

mg/l

7.71

1327

7675

Hydronephrosis

1540

9295

1.98

95.87

2.5

2.1

3.17

2.95

mg/l

2.54

1337

7862

Umbilical hernia

3332

23646

1.56

95.38

2.5

2.2

3.13

2.90

mg/l

4.92

2919

20263

Monoamine oxidase A inhibitors

1534

9187

1.94

95.29

2.4

2.2

2.81

2.95

mg/l

1.51

1301

7936

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

1257

7205

2.15

95.22

2.8

2.1

3.16

2.91

mg/l

2.37

1118

6150

Myelodysplastic syndrome, excluding all cancers (controls excluding all cancers)

511

2146

3.77

95.20

3.2

2.2

3.19

3.02

mg/l

0.78

451

1797

Cholangitis (primary sclerosing, PSC), with reimbursement 202

344

1168

5.02

94.38

4.2

2.2

3.05

3.01

mg/l

0.10

321

1002

Vitamin deficiency, wide

762

3736

2.75

94.35

3.0

2.1

3.22

2.93

mg/l

2.56

673

3161

Vitamin deficiency

762

3736

2.75

94.35

3.0

2.1

3.22

2.93

mg/l

2.56

673

3161

Symptoms and signs involving speech and voice

4294

31933

1.48

94.26

2.4

2.3

2.87

2.98

mg/l

1.79

3618

27266

UC patients in KELA-register (code 208), prior to 1994

685

3220

2.90

94.05

3.9

2.1

3.02

mg/l

0.00

621

2734

Other complications of surgical and medical care, not elsewhere classified

1340

7830

2.07

93.93

2.8

2.1

3.12

2.90

mg/l

2.37

1206

6687

Obsessive-compulsive disorder

899

4588

2.38

93.53

2.5

2.1

2.71

2.67

mg/l

0.24

770

3949

Zoster [herpes zoster]

2399

16199

1.71

93.12

2.7

2.3

3.21

3.01

mg/l

2.94

2066

13746

COPD, early/later onset

6112

40298

1.39

93.10

2.6

2.3

3.41

3.01

mg/l

21.01

5185

34098

Other/unspecified rheumatoid arthritis

1795

11409

1.88

92.94

2.8

2.3

3.41

3.06

mg/l

6.00

1597

9664

Social phobias

1087

5903

2.17

92.85

2.2

2.1

2.74

2.67

mg/l

0.41

916

5090

Diseases of male genital organs

6333

24593

1.38

92.76

2.3

2.91

2.96

mg/l

0.95

5446

21114

Haemorrhage, not elsewhere classified

603

2720

3.15

92.66

3.4

2.1

3.72

3.06

mg/l

4.29

532

2288

Pruritus

1521

9249

1.97

92.39

2.8

2.2

2.87

2.91

mg/l

0.26

1321

7885

Malignant neoplasm of skin

8379

51029

1.32

92.36

2.4

2.3

3.13

3.07

mg/l

1.35

7053

43139

Mental and behavioural disorders due to sedatives or hypnotics

917

4769

2.37

91.94

2.5

2.1

2.95

2.87

mg/l

0.44

773

4106

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

3722

26753

1.51

91.87

2.4

2.2

2.83

2.72

mg/l

2.21

3201

23153

Intestinal malabsorption

695

3314

2.83

91.84

3.4

2.1

2.82

2.90

mg/l

0.33

610

2798

Ulcer of oesophagus

1011

5499

2.33

91.55

3.1

2.1

3.46

2.97

mg/l

5.36

886

4626

Familial hypercholesterolemia

2141

14148

1.75

91.44

2.5

2.2

3.21

3.08

mg/l

1.71

1843

11910

Pleural effusion

2141

14209

1.77

91.30

2.8

2.3

3.43

3.04

mg/l

9.41

1865

11933

Alcohol-induced chronic pancreatitis

876

4526

2.45

91.21

2.6

2.1

2.98

2.95

mg/l

0.11

762

3875

Acute gastritis

1081

5979

2.23

91.17

3.0

2.1

3.35

2.99

mg/l

4.19

957

5044

Endometriosis

4843

21570

1.44

91.00

2.2

2.1

2.79

2.85

mg/l

0.90

4114

18465

Other disorders of eyelid

5850

44090

1.39

90.95

2.4

2.3

2.91

3.08

mg/l

5.58

4970

37297

Transport accidents

5957

40900

1.37

90.94

2.3

2.1

2.87

2.84

mg/l

0.38

5090

35415

Other enthesopathies

3640

26329

1.50

90.94

2.3

2.1

2.83

2.94

mg/l

1.90

3144

22465

Ankylosing spondylitis

1191

6733

2.10

90.91

2.6

2.1

3.03

2.90

mg/l

1.33

1041

5781

Coxarthrosis, primary, with hip surgery

6158

45910

1.38

90.60

2.4

2.3

3.19

3.07

mg/l

3.21

5298

38747

Colitis, primary sclerosing

268

795

6.04

90.60

4.8

2.1

3.20

2.96

mg/l

0.70

246

687

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

2106

13364

1.74

90.45

2.7

2.3

3.07

2.82

mg/l

4.04

1872

11533

Basal cell carcinoma, including avohilmo

7718

48926

1.34

90.00

2.4

2.3

3.11

3.08

mg/l

0.38

6473

41311

Diabetic retinopathy

4842

23385

1.48

89.73

2.8

2.5

3.20

3.22

mg/l

0.20

4211

20315

Essential (haemorrhagic) thrombocythaemia

599

2748

3.14

89.40

2.7

2.2

3.59

2.96

mg/l

3.47

517

2328

Arthropathies in other diseases classified elsewhere

561

2471

3.14

89.34

3.3

2.0

3.19

2.91

mg/l

2.03

500

2085

Other hammer toe(s) (acquired)

2232

13933

1.71

89.17

2.4

2.2

2.99

3.05

mg/l

0.48

1867

11657

Left ventricular outflow tract obstruction (LVOTO), broad definition

1244

7182

2.06

89.15

2.6

2.3

3.15

2.84

mg/l

4.59

1107

6217

Seropositive rheumatoid arthritis, strict definition

2017

13234

1.77

88.96

2.5

2.2

3.38

2.94

mg/l

11.15

1814

11285

Cardiac arrest

818

3479

2.41

88.90

2.8

1.8

3.21

2.74

mg/l

6.28

709

2823

Basal cell carcinoma

7535

48294

1.34

88.69

2.4

2.3

3.12

3.08

mg/l

0.48

6322

40761

Triptan medication for migraine, single purchase ok

9928

55175

1.28

88.46

2.2

2.70

2.82

mg/l

6.65

8544

47537

Migraine, single triptan purchase ok & required. ICD-code if available is included

9928

55175

1.28

88.46

2.2

2.70

2.82

mg/l

6.65

8544

47537

Acute myeloid leukaemia and myelodysplastic syndromes, excluding all cancers (controls excluding all cancers)

598

2767

3.13

87.90

3.1

2.2

3.13

3.01

mg/l

0.58

521

2323

Other malignant neoplasms of skin (=non-melanoma skin cancer)

7400

46947

1.34

87.76

2.4

2.3

3.15

3.08

mg/l

1.28

6219

39616

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1343

8056

2.04

87.65

2.7

2.2

3.11

2.95

mg/l

1.52

1188

6860

Myocarditis

578

2516

2.78

87.21

2.5

1.8

3.08

2.69

mg/l

2.63

506

2085

Malignant neoplasm of stomach, excluding all cancers (controls excluding all cancers)

881

4655

2.41

86.93

2.6

2.2

3.44

2.99

mg/l

4.56

793

3891

Migraine without aura and triptan purchases

2086

13742

1.71

86.92

2.4

2.1

2.65

2.73

mg/l

0.94

1804

11897

Alcohol abuse, main dg

1923

12464

1.75

86.51

2.4

2.2

2.91

2.84

mg/l

0.63

1663

10732

Other diseases of oesophagus

1310

7775

2.02

86.46

2.7

2.1

3.11

2.98

mg/l

1.05

1128

6566

Other disorders of adrenal gland

698

3430

2.76

86.38

3.3

2.2

3.14

2.93

mg/l

1.78

643

2905

ICD-8 DM (Sub-endpoint used for defining DM endpoints)

535

2301

3.01

86.33

2.7

2.1

2.59

2.83

mg/l

2.35

476

2011

Other and unspecified myopathies

1203

7039

2.12

86.28

2.5

2.2

3.14

3.03

mg/l

0.79

986

5954

Aortic valve malfunction, age under 60 years

1141

6505

2.09

85.43

2.6

2.2

3.18

2.85

mg/l

4.87

1014

5629

Trochanteric bursitis

1752

11201

1.81

85.15

2.6

2.2

2.85

3.03

mg/l

2.73

1511

9480

Glomerulonephritis

1353

8157

1.99

85.00

2.9

2.2

3.12

2.94

mg/l

1.82

1221

6962

Hypoglycaemia, other or unspecified

973

5350

2.27

84.56

3.1

2.2

2.98

2.90

mg/l

0.41

869

4549

Charcot foot

302

1006

4.95

84.48

3.4

1.9

3.19

2.95

mg/l

0.95

270

842

Glucosamine medication

6698

42703

1.35

84.41

2.4

2.3

3.07

3.09

mg/l

0.32

5589

36117

Open wound of lower leg

1935

12704

1.75

84.25

2.7

2.2

3.33

2.94

mg/l

6.57

1659

10889

Sicca syndrome [Sjögren]

1208

7109

2.09

84.23

2.6

2.2

3.03

3.01

mg/l

0.11

1049

6061

Emotional disorders starting during childhood or adolecense, excluding more controls

666

3089

2.60

83.85

2.5

2.4

2.72

2.46

mg/l

2.76

575

2681

Other metabolic disorders

1649

10415

1.82

83.47

2.5

2.1

2.97

2.89

mg/l

0.74

1430

8938

Thyroiditis, ILD-related definition

1531

9528

1.88

83.43

2.5

2.1

2.76

2.87

mg/l

1.12

1327

8099

Special screening examination for other diseases and disorders

1121

6367

2.05

82.72

2.7

1.9

2.16

2.84

mg/l

28.75

1001

5391

Asthma and allergy, excluding more controls

1647

10184

1.78

82.42

2.4

2.0

2.58

2.66

mg/l

0.91

1451

8709

Other diseases of pancreas

1031

5843

2.20

82.16

2.6

2.2

3.05

2.97

mg/l

0.45

888

4939

Dental caries 2 and operation codes

9682

63659

1.27

81.81

2.3

2.2

2.69

2.84

mg/l

10.26

8204

55020

Conjunctivitis

9775

70713

1.27

81.57

2.3

2.2

2.76

2.87

mg/l

5.47

8343

60765

Leisure time condition

2307

15808

1.65

81.39

2.5

2.3

3.14

2.92

mg/l

4.20

1970

13557

Thoracic aortic aneurysm

1757

11437

1.80

81.37

2.4

2.1

3.17

2.94

mg/l

2.79

1507

9648

Speech and linguistic disorders, excluding more controls

996

5131

2.11

81.30

2.5

2.3

2.85

2.66

mg/l

1.24

869

4472

ILD, hospital admission 2, with pulmonary infections

1297

7846

2.00

81.27

2.8

2.2

3.27

3.02

mg/l

2.87

1146

6616

Aortic aneurysm

3036

21517

1.55

81.19

2.4

2.2

3.30

2.99

mg/l

7.64

2598

18046

Abnormal serum enzyme levels

3840

28397

1.48

81.18

2.4

2.2

2.79

3.02

mg/l

7.96

3406

24022

Insulin, fast-acting (human)

1876

12247

1.73

81.08

2.7

2.1

2.81

mg/l

0.01

1656

10459

Psoriasis

3476

25526

1.49

81.03

2.5

2.2

3.08

2.91

mg/l

3.18

3026

21879

Use of disulfiram, acamprosate or naltrexone

1046

5886

2.10

80.66

2.3

2.1

2.83

2.86

mg/l

0.18

894

5102

Need for other prophylactic measures

792

4163

2.45

79.99

2.5

2.2

2.59

2.96

mg/l

4.02

691

3553

Fall on same level involving ice and snow

7256

58778

1.31

79.77

2.3

2.84

2.94

mg/l

3.52

6176

50275

Dementia, including avohilmo

6070

33285

1.37

79.73

2.3

3.15

3.12

mg/l

0.26

4920

28126

Other diseases of blood and blood-forming organs

949

5295

2.25

79.60

2.8

2.2

4.06

2.98

mg/l

9.38

808

4489

Faecal incontinence

1210

7212

2.02

79.43

2.5

2.2

2.91

3.08

mg/l

1.46

1002

6123

Iridocyclitis

2853

20389

1.55

79.12

2.5

2.2

3.00

2.92

mg/l

0.89

2524

17445

Vasomotor and allergic rhinitis

4779

36201

1.39

79.07

2.3

2.2

2.76

2.83

mg/l

1.26

4130

31180

Urticaria

3748

27939

1.46

79.03

2.4

2.2

2.85

2.82

mg/l

0.35

3243

24088

Superficial injury of lower leg

3131

22720

1.51

78.65

2.5

2.2

3.04

2.88

mg/l

2.79

2645

19483

IBD (strict) with PSC

193

499

7.16

78.60

4.8

1.9

2.99

3.00

mg/l

0.02

181

432

Secondary malignant neoplasm of other and unspecified sites, excluding all cancers (controls excluding all cancers)

2808

20105

1.56

78.59

1.9

2.3

3.56

2.93

mg/l

25.45

2458

17060

Abscess of anal and rectal regions

1030

5802

2.08

78.53

2.9

2.0

2.99

2.79

mg/l

1.60

905

4979

COPD, hospital admission 2, with asthma infections

4284

27891

1.44

78.17

2.7

2.3

3.48

3.02

mg/l

19.59

3651

23517

Hyperparathyroidism

2462

17075

1.62

78.03

2.9

2.3

3.28

3.11

mg/l

2.32

2120

14443

Acute alcohol intoxication, ICD10

2367

16343

1.61

78.01

2.4

2.2

2.97

2.85

mg/l

1.52

2030

14059

SLE (Finngen)

516

2312

2.99

77.94

2.9

2.0

3.02

2.91

mg/l

0.45

468

1949

All influenza (not pneumonia)

1878

12371

1.71

77.84

2.7

2.2

3.28

2.87

mg/l

7.01

1637

10601

Colitis, primary sclerosing, strict definition

211

591

6.62

77.70

4.5

2.0

3.27

2.97

mg/l

0.70

192

511

Other necrotizing vasculopathies

1020

5888

2.19

77.63

2.9

2.2

3.18

3.07

mg/l

0.71

893

4985

Colonic or urogenital fistula

3387

24990

1.49

77.34

2.6

2.2

2.83

2.93

mg/l

1.90

2900

21428

Parkinson's disease, excluding more controls

1714

10833

1.76

77.24

2.3

2.2

3.00

3.06

mg/l

0.47

1415

9128

Asthma and allergy

1647

10348

1.74

77.23

2.4

2.0

2.58

2.68

mg/l

1.19

1451

8860

Superficial injury of hip and thigh

1977

13300

1.70

77.11

2.6

2.3

3.16

3.02

mg/l

1.52

1696

11269

Other and unspecified drugs and medicaments

1158

6909

2.05

76.98

2.8

2.2

3.18

2.95

mg/l

1.88

1037

5875

Other and unspecified effects of external causes

3396

25028

1.48

76.89

2.5

2.2

2.77

2.82

mg/l

0.76

2931

21529

Benign neoplasm of other and unspecified endocrine glands

1561

9962

1.82

76.88

2.6

2.2

3.05

2.85

mg/l

2.49

1385

8487

Secondary right heart disease

668

3409

2.72

76.66

3.9

2.2

3.99

3.04

mg/l

7.19

615

2852

Diseases of salivary glands

2356

16330

1.60

76.02

2.4

2.2

2.93

2.95

mg/l

0.13

2055

14037

Other benign neoplasms of skin

4548

34392

1.40

75.93

2.4

2.3

3.01

2.92

mg/l

1.52

3868

29183

Dental caries 2

9810

64324

1.25

75.85

2.3

2.2

2.69

2.84

mg/l

10.25

8299

55586

Other and unspecified mood [affective] disorders

926

5112

2.14

75.75

2.3

2.0

2.76

2.71

mg/l

0.29

796

4407

Atopic dermatitis, strict definition with reimbursement

3772

27376

1.44

75.31

2.4

2.2

2.62

2.71

mg/l

1.72

3220

23671

Left bundle-branch block

923

5151

2.17

75.00

2.4

2.0

2.92

2.86

mg/l

0.30

778

4295

Hepatic failure, not elsewhere classified

558

2666

2.92

74.94

3.2

2.1

3.67

3.03

mg/l

4.49

503

2250

Other mental disorders due to brain damage and dysfunction and to physical disease

1547

10005

1.84

74.91

2.7

2.3

3.15

3.11

mg/l

0.22

1308

8510

Other problems related to primary support group, including family circumstances

1522

9433

1.81

74.80

2.8

2.3

2.92

2.72

mg/l

2.96

1346

8212

Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)

1686

11042

1.77

74.73

2.2

2.3

3.36

2.95

mg/l

7.14

1473

9326

Recurring oral aphthae, including avohilmo

1796

11942

1.74

74.70

2.6

2.3

2.98

2.92

mg/l

0.45

1547

10221

Benign neoplasm: Small intestine

593

2910

2.82

74.56

3.3

2.2

3.64

2.95

mg/l

5.41

531

2441

Unspecified privation

1442

9130

1.86

74.52

2.7

2.2

2.87

2.92

mg/l

0.28

1227

7802

Other pulmonary heart/vessel disease

724

3831

2.55

74.45

3.9

2.3

3.94

3.04

mg/l

7.30

667

3206

Agranulocytosis

1435

9085

1.86

74.45

2.5

2.3

3.16

2.94

mg/l

2.16

1274

7748

Thyrotoxicosis, other and/or unspecified

2465

17350

1.58

74.29

2.5

2.2

2.93

2.91

mg/l

0.09

2145

14839

Other symptoms and signs involving the circulatory and respiratory systems

872

4793

2.20

74.01

2.4

2.1

3.10

2.87

mg/l

1.73

756

4076

Other diseases of arteries and capillaries

1236

7559

1.96

73.99

3.7

2.2

3.44

2.96

mg/l

6.49

1103

6394

Benign neoplasm: Descending colon

948

5456

2.23

73.96

2.8

2.2

3.44

3.05

mg/l

3.69

864

4617

Anosmia

262

803

4.02

73.87

2.4

1.5

2.86

2.54

mg/l

1.56

226

642

Infliximab

169

421

8.37

73.68

3.3

1.9

2.50

2.95

mg/l

1.66

161

361

Schizophrenia

1894

12630

1.67

73.48

2.3

2.2

2.84

2.85

mg/l

0.04

1648

10917

Injuries to the neck

2814

20289

1.53

73.36

2.4

2.2

2.81

2.83

mg/l

0.14

2419

17472

Other local infections of skin and subcutaneous tissue

1313

8145

1.90

73.34

3.0

2.2

3.05

2.92

mg/l

1.21

1159

6932

Other and unspecified local infections of skin and subcutaneous tissue

1246

7646

1.93

72.94

3.0

2.2

3.05

2.92

mg/l

1.21

1106

6511

Other skin changes

2198

15309

1.64

72.88

2.6

2.3

3.05

2.99

mg/l

0.56

1906

13034

Abnormal results of function studies

1129

6757

2.00

72.71

2.9

2.1

3.08

2.88

mg/l

1.76

982

5769

Alcohol withdrawal state with delirium

893

4999

2.18

72.41

2.5

2.2

2.99

2.95

mg/l

0.16

750

4279

Postprocedural endocrine and metabolic disorders, not elsewhere classified

1500

9586

1.79

72.33

2.4

2.1

2.92

2.89

mg/l

0.19

1300

8233

Other coagulation defects

1012

5913

2.10

72.24

3.2

2.2

3.08

2.88

mg/l

1.48

886

5074

Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)

1652

10920

1.78

72.11

2.6

2.3

3.19

3.06

mg/l

1.13

1425

9087

Pain associated with micturition

1535

9932

1.80

72.04

2.5

2.2

2.88

2.96

mg/l

0.60

1318

8488

Failure and rejection of transplanted organs and tissues

239

765

5.39

72.01

3.1

2.2

3.25

2.96

mg/l

1.05

215

670

Abnormal involuntary movements

1716

11382

1.74

71.91

2.5

2.2

2.84

2.94

mg/l

1.04

1463

9696

Diseases of peritoneum

1366

8622

1.87

71.87

3.2

2.3

3.26

2.99

mg/l

3.14

1220

7327

Immunodeficiencies

701

3675

2.47

71.70

3.6

2.2

3.17

2.92

mg/l

2.07

651

3126

Hypopituitarism

876

4870

2.17

71.57

2.6

2.3

3.06

2.84

mg/l

1.74

785

4205

Triptan medication for migraine, min. 3 purchases

6865

43924

1.30

71.07

2.2

2.1

2.67

2.75

mg/l

3.00

5934

37958

Stomatitis and related lesions

1065

6269

1.99

70.97

2.7

2.2

2.87

2.92

mg/l

0.27

909

5385

Mouth breathing

4758

37147

1.37

70.89

2.4

2.3

2.64

2.91

mg/l

16.52

4142

32033

Postmenopausal bleeding

3432

13912

1.48

70.81

2.4

2.3

3.14

3.08

mg/l

0.51

2868

11835

Presence of other devices

3010

22153

1.50

70.65

2.3

2.2

2.90

3.04

mg/l

2.63

2694

18589

Disorders of psychological development

1459

8568

1.78

70.44

2.5

2.4

2.80

2.69

mg/l

0.86

1262

7434

Acute peritonitis

888

5038

2.19

70.41

3.5

2.2

3.37

3.03

mg/l

3.22

814

4261

Familial hypercholesterolemia, with ischemic heart disease

1309

8262

1.91

70.39

2.7

2.2

3.23

3.05

mg/l

1.92

1118

6858

Non-follicular lymphoma, hilmo, excluding all cancers

1209

7447

1.94

70.37

2.2

2.3

3.36

2.93

mg/l

5.31

1048

6284

Early onset COPD

2716

19660

1.53

70.16

2.6

2.2

3.27

2.94

mg/l

7.18

2351

16776

Parkinson's disease, strict definition, excluding more controls

1587

10146

1.75

70.16

2.3

2.2

2.98

3.06

mg/l

0.72

1308

8556

Other hearing loss

3683

27557

1.44

69.36

2.4

2.3

2.99

3.07

mg/l

1.25

3054

23276

Secondary malignant neoplasm of respiratory and digestive organs, excluding all cancers (controls excluding all cancers)

2131

14873

1.62

68.86

1.9

2.3

3.63

2.94

mg/l

19.33

1872

12610

Excessive attrition of teeth

5333

22797

1.36

68.80

2.3

2.2

2.74

2.85

mg/l

3.11

4528

19820

Osteonecrosis

788

4347

2.29

68.78

2.8

2.1

2.89

2.99

mg/l

0.62

709

3670

Acute alcohol intoxication

3086

22793

1.47

68.67

2.4

2.2

3.01

2.92

mg/l

1.16

2641

19437

Disorders of vestibular function (Vertigo)

5918

47491

1.33

68.35

2.4

2.3

2.92

3.02

mg/l

2.69

5037

40421

Other sleep disorders

1382

8794

1.80

67.99

2.5

2.1

3.05

2.87

mg/l

1.72

1228

7537

Mental and behavioural disorders due to opioids

494

2274

2.73

67.72

2.7

2.1

3.14

2.72

mg/l

3.04

419

1984

Phlebitis and thrombophlebitis (not including DVT)

2798

20484

1.51

67.62

2.5

2.2

3.21

2.93

mg/l

6.27

2396

17454

Voice disturbances

3299

24799

1.46

67.47

2.3

2.77

2.95

mg/l

3.77

2816

21256

DVT of lower extremities

2433

17443

1.56

67.33

2.6

2.2

3.28

2.98

mg/l

5.42

2080

14788

Fentanyl

1311

8264

1.83

67.13

2.5

2.1

3.57

3.06

mg/l

8.15

1105

6875

Neuromuscular dysfunction of bladder

1181

7300

1.91

67.08

2.6

2.2

2.72

2.98

mg/l

3.43

1020

6241

Fall on and from stairs and steps

3153

23545

1.47

67.06

2.4

2.3

2.93

2.95

mg/l

0.25

2672

20121

Diagnoses used for exclusion with ILD

3241

24305

1.46

67.03

2.6

2.3

3.30

3.01

mg/l

7.03

2815

20654

Glaucoma

7288

52840

1.29

66.94

2.4

2.3

3.03

3.06

mg/l

0.43

6196

44687

Drug-induced adrenocortical insufficiency

310

1214

4.22

66.89

3.8

2.1

3.53

3.01

mg/l

3.30

286

1042

Dementia

5645

31370

1.35

66.51

2.3

3.14

3.13

mg/l

0.17

4568

26491

Multiple myeloma, excluding all cancers (controls excluding all cancers)

664

3524

2.47

66.42

2.3

2.96

mg/l

0.01

570

2969

Other general symptoms and signs

694

3639

2.32

65.98

2.7

2.2

2.82

2.87

mg/l

0.26

609

3119

Arthropathy in ulcerative colitis

243

834

5.01

65.94

4.0

2.1

2.90

2.98

mg/l

0.21

219

717

Right hemicolectomy

866

5019

2.20

65.87

2.9

2.2

3.79

3.06

mg/l

8.27

767

4232

Alzheimer’s disease, wide definition, excluding more controls

2132

10073

1.61

65.84

2.2

3.01

3.11

mg/l

1.08

1704

8476

Assault

1458

9386

1.73

65.70

2.2

2.1

2.83

2.75

mg/l

0.67

1229

8129

Artificial joint re-operation

958

5725

2.11

65.54

2.7

2.3

3.27

3.08

mg/l

1.43

840

4831

Acute and subacute iridocyclitis

2356

16830

1.55

65.49

2.5

2.2

3.02

2.92

mg/l

1.15

2093

14435

Ankylosing spondylitis, ICD10

1134

6959

1.90

65.33

2.7

2.1

3.04

2.87

mg/l

1.84

992

5970

Primary coxarthrosis, bilateral

3656

28110

1.43

65.26

2.4

2.3

3.18

3.08

mg/l

1.49

3137

23717

Other and unspecified nerve root and plexus disorders, also in other diseases

2178

15326

1.57

65.12

2.3

2.2

2.61

2.89

mg/l

7.58

1909

13127

Anterior Iridocyclitis

2501

18076

1.53

65.08

2.5

2.2

3.00

2.91

mg/l

1.11

2219

15495

ILD, hospital admissions 3, with pneumonia sepsis

1112

6873

1.96

64.99

2.7

2.2

3.36

3.06

mg/l

3.17

988

5750

Propionic acid derivatives

4524

17556

1.37

64.49

2.2

2.4

2.88

2.95

mg/l

1.10

3868

15020

Multiple myeloma and malignant plasma cell neoplasms

656

3507

2.45

64.24

2.3

2.97

2.96

mg/l

0.05

563

2952

In situ neoplasms

4729

37589

1.36

64.14

2.5

2.3

3.04

2.99

mg/l

0.51

4008

31889

malignant neoplasm of male genital organs, excluding all cancers (controls excluding all cancers)

3763

17479

1.42

64.09

2.1

2.2

2.99

2.90

mg/l

1.22

3187

14781

Chronic hepatitis, not elsewhere classified

503

2438

2.77

64.08

2.9

2.1

3.09

2.96

mg/l

0.52

452

2077

Varicose veins

8243

52055

1.26

64.05

2.4

2.2

3.11

2.97

mg/l

5.06

7139

44183

Other pleural conditions

1389

9075

1.80

63.93

2.9

2.2

3.48

3.03

mg/l

6.46

1199

7632

Cytomegalovirus infection, IBD co-morbidity

347

1446

3.53

63.79

3.5

2.1

3.11

3.07

mg/l

0.13

323

1230

Unspecified urinary incontinence

1201

7593

1.89

63.73

2.6

2.3

3.15

3.06

mg/l

0.65

952

6454

Disorders of iron metabolism

247

866

4.63

63.70

3.6

2.0

2.45

3.18

mg/l

5.99

221

766

Fracture of skull and facial bones

2475

17841

1.51

63.70

2.4

2.2

2.87

2.90

mg/l

0.22

2088

15379

Oesophagitis

734

4038

2.25

63.50

2.8

2.1

3.11

2.96

mg/l

0.75

643

3390

Maternal care for other conditions predominantly related to pregnancy

2510

17914

1.51

63.35

2.2

2.1

2.67

2.66

mg/l

0.06

2151

15488

Any dementia, excluding more controls

4685

25753

1.37

63.35

2.4

2.3

3.13

3.14

mg/l

0.08

3785

21818

Other symptoms and signs involving the urinary system

1329

8574

1.81

63.31

2.3

2.2

3.01

2.97

mg/l

0.25

1190

7290

Diseases of external ear

4152

32454

1.38

63.14

2.5

2.3

2.93

mg/l

0.05

3399

27829

Other embolism and thrombosis

1660

11229

1.69

63.01

2.7

2.2

3.25

2.95

mg/l

4.46

1445

9547

L01XX Other antineoplastic agents

803

4624

2.24

62.86

2.6

2.2

5.28

3.05

mg/l

17.45

702

3902

Benign neoplasm: Duodenum

399

1801

3.29

62.82

3.3

2.3

3.80

3.01

mg/l

4.03

354

1524

Ulcerative colitis (strict) with PSC

152

387

7.06

62.78

4.7

1.9

3.21

3.04

mg/l

0.28

141

332

Other respiratory disorders and diseases

2642

19465

1.51

62.73

2.8

2.3

3.80

3.05

mg/l

24.71

2271

16403

Other diseases of the respiratory system

2642

19465

1.51

62.73

2.8

2.3

3.80

3.05

mg/l

24.71

2271

16403

Keratitis

4252

33291

1.37

62.71

2.4

2.2

2.89

2.91

mg/l

0.29

3702

28487

Disorders of ocular muscles, binocular movement, accommodation and refraction

5808

46719

1.30

62.53

2.3

2.2

2.84

mg/l

0.04

4972

40187

Disorders of vitreous body and globe

6068

48368

1.30

62.52

2.5

2.3

2.94

3.02

mg/l

1.68

5164

41166

Other specified/unspecified bacterial intestinal infections

891

5251

2.08

62.09

3.0

2.2

3.00

mg/l

0.00

781

4447

Thyrotoxicosis

3128

23608

1.45

62.02

2.5

2.2

2.96

2.94

mg/l

0.19

2707

20174

Lesion of ulnar nerve

1654

11167

1.66

61.87

2.5

2.2

3.06

2.89

mg/l

1.79

1436

9595

Other/unspecified cytomegaloviral diseases

304

1211

3.84

61.82

3.3

2.1

3.14

3.03

mg/l

0.29

286

1037

Persons with potential health hazards related to communicable diseases

4631

36322

1.34

61.75

2.5

2.2

2.80

2.72

mg/l

1.76

4045

31362

Other viral diseases

3505

26694

1.41

61.69

2.6

2.2

2.87

2.79

mg/l

1.22

3103

23055

Acidosis

322

1323

3.70

61.67

3.1

2.1

3.48

3.15

mg/l

1.31

282

1125

Erosion of teeth, including avohilmo

2485

17441

1.51

61.58

2.4

2.2

2.67

2.81

mg/l

2.48

2076

15199

Other bursopathies

1600

10753

1.68

61.50

2.6

2.2

2.96

2.99

mg/l

0.19

1374

9100

Alzheimer’s disease (Late onset), excluding more controls

2026

9432

1.61

61.46

2.3

2.2

3.01

3.12

mg/l

1.21

1629

7931

Fracture of forearm

6873

53210

1.28

61.28

2.3

2.96

2.94

mg/l

0.25

5817

45460

Viral and other specified intestinal infections

2611

18611

1.48

61.25

2.7

2.2

2.87

2.74

mg/l

2.03

2328

15834

Psoriatic arthropathies

1184

7418

1.81

61.10

2.4

2.1

3.11

2.85

mg/l

2.38

1048

6331

Diabetes mellitus in pregnancy

4045

20283

1.38

61.03

2.2

2.1

2.70

2.63

mg/l

1.62

3532

17561

TMD related operations

1947

13597

1.59

60.92

2.3

2.2

2.76

2.83

mg/l

0.67

1726

11740

Fracture of foot, except ankle

2817

20902

1.46

60.89

2.4

2.2

2.85

2.83

mg/l

0.22

2409

17996

Other viral hepatitis

750

4168

2.12

60.32

2.3

2.1

2.91

2.79

mg/l

0.66

649

3628

Disorders of vitreous body

5871

47004

1.30

60.15

2.5

2.3

2.93

3.02

mg/l

2.00

4993

40002

Lichen simplex chronicus and prurigo

840

4896

2.09

60.13

2.7

2.2

3.03

2.95

mg/l

0.42

724

4154

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

799

4511

2.05

59.95

2.4

2.1

2.99

2.75

mg/l

1.88

666

3919

Scoliosis

1133

7103

1.85

59.87

2.6

2.2

2.83

2.84

mg/l

0.05

975

6033

Impingement syndrome of shoulder

2790

20715

1.46

59.68

2.4

2.1

2.86

2.97

mg/l

1.65

2407

17599

Flat foot [pes planus] (acquired)

1108

6899

1.84

59.19

2.4

2.1

2.88

2.89

mg/l

0.06

945

5834

Abnormal findings on diagnostic imaging of other body structures

1591

10832

1.68

59.08

2.5

2.2

3.06

2.96

mg/l

0.67

1415

9244

Radiculopathy

2066

14688

1.56

59.08

2.6

2.2

2.98

3.05

mg/l

0.76

1780

12379

Other respiratory diseases principally affecting the interstitium

2290

16701

1.54

58.83

2.6

2.3

3.23

3.07

mg/l

2.43

2019

14079

Anti-inflammatory and antirheumatic products, non-steroids

4477

17561

1.35

58.79

2.2

2.4

2.88

2.95

mg/l

1.14

3801

15025

Cytomegaloviral disease

352

1531

3.29

58.74

3.4

2.1

3.12

3.04

mg/l

0.22

328

1307

Benign neoplasm: Small intestine

593

3185

2.51

58.71

3.3

2.2

3.64

3.11

mg/l

3.47

531

2681

Dental caries 2, only avohilmo

9465

63513

1.22

58.71

2.3

2.2

2.69

2.84

mg/l

9.51

8004

54902

Immunodeficiency with predominantly antibody defects

402

1851

3.02

58.68

3.5

2.2

3.29

2.96

mg/l

1.88

381

1593

Carcinoma in situ of skin of other and unspecified parts of face

1063

6707

1.94

58.66

2.7

2.3

3.16

3.08

mg/l

0.40

897

5607

Invasive ventilation

963

5879

1.98

58.65

2.7

2.2

3.29

2.96

mg/l

2.57

823

5000

Other disorders of the musculoskeletal system and connective tissue

1781

12392

1.62

58.63

2.5

2.2

2.81

2.98

mg/l

2.33

1536

10572

Endometriosis of pelvic peritoneum

1908

13140

1.57

58.62

2.2

2.1

2.65

2.76

mg/l

1.54

1621

11374

Laparoscopic left hemicolectomy

299

1239

3.97

58.31

2.0

2.1

3.10

3.06

mg/l

0.07

249

1063

malignant neoplasm of male genital organs

5173

26434

1.33

58.30

2.2

2.3

3.02

3.04

mg/l

0.29

4337

22377

COPD, hospital admissions 3, with asthma pneumonia sepsis

3586

23703

1.41

57.61

2.7

2.3

3.50

3.04

mg/l

17.52

3053

19906

Other disorders of eye and adnexa

1719

11909

1.62

57.34

2.3

2.2

2.64

2.90

mg/l

4.56

1471

10237

Disorders of oesophagus in diseases classified elsewhere

332

1436

3.46

57.28

3.6

2.1

3.52

3.13

mg/l

1.55

299

1191

Superficial injury of abdomen, lower back and pelvis

1867

13110

1.58

57.23

2.5

2.2

2.98

2.88

mg/l

0.96

1576

11244

Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)

3672

16985

1.40

56.87

2.1

2.3

2.98

2.91

mg/l

0.88

3103

14355

Other and unspecified coagulation defects

663

3670

2.25

56.83

3.3

2.1

3.06

2.87

mg/l

0.85

584

3142

Other inflammatory liver diseases

857

5101

2.02

56.77

3.1

2.1

3.10

2.90

mg/l

1.51

765

4334

Other specified/unspecified systemic involvement of connective tissue

793

4634

2.09

56.65

2.9

2.1

2.94

2.97

mg/l

0.15

706

3951

Other follicular disorders

888

5308

1.97

56.60

2.8

2.1

3.01

2.77

mg/l

1.92

787

4559

Chronic viral hepatitis

631

3389

2.21

56.49

2.3

2.1

2.98

2.77

mg/l

1.13

543

2955

Other diseases of biliary tract

1119

7152

1.85

56.39

3.0

2.2

3.33

3.03

mg/l

2.74

1006

6035

Primary biliary cholangitis (PBC)

326

1388

3.29

56.27

3.3

2.1

3.19

3.05

mg/l

0.36

299

1160

Malnutrition

341

1521

3.42

55.87

3.1

2.5

3.39

3.04

mg/l

1.14

313

1289

Trigger finger

1638

11245

1.62

55.76

2.5

2.1

2.86

2.94

mg/l

0.76

1426

9566

Vitreous haemorrhage

1261

8287

1.77

55.73

2.9

2.2

3.02

3.00

mg/l

0.10

1093

7062

Arthropathy in Crohn disease

194

644

5.26

55.72

4.7

2.0

2.81

2.84

mg/l

0.07

185

558

Adverse effects, not elsewhere classified

2384

17529

1.49

55.67

2.5

2.2

2.72

2.85

mg/l

2.31

2069

15046

Anorexia (incl.atypical)

876

5266

1.98

55.36

2.7

2.1

2.62

2.72

mg/l

0.66

752

4511

Other disorders of bladder

1505

10266

1.67

55.31

2.5

2.2

2.89

3.00

mg/l

1.19

1229

8724

Sequelae of injuries, of poisoning and of other consequences of external causes

2680

20031

1.45

55.21

2.3

2.2

2.80

2.88

mg/l

1.03

2297

17277

Drug-induced osteoporosis with pathological fracture

273

1116

4.14

55.20

3.7

2.3

3.97

3.29

mg/l

3.23

248

954

Chronic laryngitis and laryngotracheitis

1722

12018

1.61

55.12

2.7

2.2

3.11

2.98

mg/l

1.29

1433

10256

Mixed connective tissue disease

865

5220

2.01

55.09

2.9

2.2

2.99

2.95

mg/l

0.17

768

4458

Cervicocranial syndrome

1311

8639

1.72

55.07

2.3

2.2

2.76

2.96

mg/l

2.55

1155

7329

Other autoimmune haemolytic anaemias

233

885

4.86

55.07

2.6

2.1

4.24

3.12

mg/l

6.06

211

761

Other maternal disorders predominantly related to pregnancy

6979

36475

1.26

55.05

2.2

2.1

2.73

2.77

mg/l

0.71

6060

31324

Lung transplant status

154

453

7.25

54.99

3.7

2.1

3.34

3.19

mg/l

0.25

148

393

Pyogenic arthritis

839

4973

1.98

54.92

2.7

2.1

3.38

2.93

mg/l

4.74

743

4196

Benign neoplasm of other and unspecified endocrine glands

1561

10738

1.65

54.85

2.6

2.2

3.05

2.95

mg/l

0.82

1385

9170

Lung transplantation

154

455

7.17

54.60

3.7

2.1

3.34

3.19

mg/l

0.25

148

393

Folate deficiency anaemia

171

540

6.25

54.54

3.5

1.9

3.03

2.89

mg/l

0.33

156

466

Other disorders starting during childhood or adolecense, excluding more controls

591

3008

2.22

54.44

2.3

2.5

2.81

2.51

mg/l

3.30

524

2634

Diseases of inner ear

6761

55396

1.26

54.35

2.4

2.3

2.92

3.01

mg/l

2.59

5753

47166

Amenorrhoea

925

5629

1.90

54.32

2.6

2.1

2.73

2.62

mg/l

0.88

820

4867

Golimumab

440

2132

2.62

54.15

2.8

2.0

2.93

2.83

mg/l

0.39

403

1830

ILD, hospital admissions

1886

13522

1.58

54.10

2.6

2.3

3.24

3.05

mg/l

2.46

1661

11414

Postmenopausal osteoporosis with pathological fracture

849

5203

2.08

54.04

2.8

2.4

3.37

3.23

mg/l

0.55

720

4366

Redundant prepuce, phimosis and paraphimosis

2023

14333

1.51

54.03

2.5

2.2

2.96

2.92

mg/l

0.24

1758

12374

Other shoulder lesions

1113

7100

1.78

53.83

2.6

2.1

2.81

2.90

mg/l

0.61

933

6041

Paralytic ileus

519

2693

2.44

53.77

3.1

2.1

3.16

2.96

mg/l

0.82

460

2264

Viral hepatitis

856

5114

1.94

53.69

2.4

2.1

2.98

2.82

mg/l

0.96

738

4412

Malignant neoplasm of prostate

5079

26002

1.32

53.69

2.2

2.3

3.02

3.05

mg/l

0.28

4253

22008

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

869

5248

1.95

53.64

2.5

2.1

2.93

2.85

mg/l

0.44

750

4490

Wet age-related macular degeneration

2339

17130

1.52

53.47

2.6

2.3

3.30

3.20

mg/l

0.82

1952

14371

Secondary and unspecified malignant neoplasm of lymph nodes, excluding all cancers (controls excluding all cancers)

1750

12333

1.59

53.44

2.0

2.3

3.36

2.91

mg/l

7.94

1535

10490

Emotional disorders and disorders of social functioning with onset specific to childhood

718

4048

2.08

53.33

2.6

2.5

2.74

2.56

mg/l

1.64

623

3502

Disorders of continuity of bone

1139

7347

1.78

53.31

2.6

2.1

2.98

2.88

mg/l

0.58

985

6298

Dissociative [conversion] disorders

541

2846

2.36

53.20

2.5

2.0

2.79

2.72

mg/l

0.29

465

2454

Reactive arthropathies

1059

6697

1.80

52.99

2.4

2.1

2.88

2.87

mg/l

0.06

924

5711

Atopic dermatitis, strict definition

3554

27184

1.37

52.95

2.4

2.2

2.59

2.71

mg/l

2.60

3043

23490

Bulimia nervosa (incl. atypical)

530

2792

2.41

52.93

2.3

2.0

2.74

2.59

mg/l

1.04

438

2405

Systemic lupus erythematosus

516

2710

2.46

52.62

2.9

2.1

3.02

2.92

mg/l

0.39

468

2309

Other disorders of white blood cells

740

4348

2.09

52.34

3.0

2.2

3.19

2.94

mg/l

1.69

640

3702

Superficial injury of thorax

1796

12744

1.57

52.16

2.4

2.2

3.16

2.94

mg/l

2.53

1537

10895

Unspecified acute lower respiratory infection

1769

12497

1.57

52.12

2.7

2.2

3.11

2.89

mg/l

3.35

1556

10746

Mixed hyperlipidaemia

549

2938

2.35

52.09

2.8

2.1

3.34

3.07

mg/l

1.83

480

2495

Other disorders involving the immune mechanism, not elsewhere classified

432

2131

2.66

52.09

3.1

2.3

3.09

2.93

mg/l

0.62

397

1827

False labour

3685

18054

1.37

51.98

2.0

2.1

2.53

2.67

mg/l

3.98

3215

15596

Other viral diseases, not elsewhere classified

2201

16094

1.49

51.77

2.7

2.3

2.90

2.84

mg/l

0.48

1963

13880

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

2074

15105

1.51

51.68

2.4

2.1

2.73

2.77

mg/l

0.35

1784

12924

Benign neoplasm: Duodenum

399

1961

2.95

51.64

3.3

2.2

3.80

3.14

mg/l

2.95

354

1670

Dermatophytosis

1559

10840

1.62

51.57

2.6

2.2

3.10

2.95

mg/l

1.56

1355

9273

Unspecified/other endometriosis

1151

7464

1.74

51.56

2.2

2.1

2.63

2.69

mg/l

0.42

983

6450

Other and unspecified diseases of blood and blood-forming organs

381

1819

2.91

51.47

3.0

2.1

3.51

3.02

mg/l

1.22

326

1543

Interstitial lung disease endpoints

1901

13764

1.56

51.40

2.6

2.3

3.26

3.05

mg/l

2.80

1673

11619

Interstitial lung disease

1901

13764

1.56

51.40

2.6

2.3

3.26

3.05

mg/l

2.80

1673

11619

Other interstitial pulmonary diseases

1901

13767

1.56

51.33

2.6

2.3

3.26

3.06

mg/l

2.74

1673

11620

Covid-19 suspected case

2504

18745

1.45

51.33

2.5

2.2

2.96

2.78

mg/l

3.53

2169

16116

SLE, strict definition

497

2605

2.48

51.22

2.8

2.1

3.01

2.93

mg/l

0.34

450

2221

SLE, ICD10

497

2605

2.48

51.22

2.8

2.1

3.01

2.93

mg/l

0.34

450

2221

Visual impairment including blindness (binocular or monocular)

921

5759

1.91

51.22

2.7

2.3

3.57

3.05

mg/l

5.92

727

4841

Congenital malformations of heart and great arteries

1528

10215

1.62

51.15

2.6

2.4

3.14

2.81

mg/l

4.59

1365

8834

Localized swelling, mass and lump of skin and subcutaneous tissue

3755

29744

1.35

51.00

2.4

2.2

3.02

2.93

mg/l

1.05

3230

25442

Inflammatory disease of uterus

1750

12412

1.57

50.96

2.4

2.1

2.77

mg/l

0.01

1496

10684

Reactive arthropathies, FINNGEN

853

5175

1.90

50.67

2.5

2.1

2.74

2.84

mg/l

0.80

748

4354

Other and unspecified disorders of skin and subcutaneous tissue

856

5263

1.95

50.62

2.6

2.2

3.45

2.99

mg/l

5.96

688

4476

Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)

1494

10339

1.63

50.61

2.2

2.3

3.34

2.96

mg/l

4.94

1270

8728

Cerebral palsy and other paralytic syndromes

1407

9608

1.65

50.58

2.6

2.3

3.07

2.93

mg/l

1.10

1193

8207

Congenital malformations of the circulatory system

1686

11512

1.58

50.51

2.7

2.4

3.11

2.81

mg/l

4.04

1501

9943

Psoriasis vulgaris

2170

15966

1.49

50.43

2.5

2.2

3.04

2.91

mg/l

1.56

1891

13685

severe traumatic brain injury, does not include concussion

2733

20875

1.43

50.40

2.4

2.3

3.23

3.05

mg/l

2.24

2307

17644

COPD-related respiratory insufficiency

1514

10569

1.64

50.27

2.8

2.3

3.85

3.02

mg/l

16.72

1289

8851

Fibroblastic disorders

2832

21661

1.41

50.24

2.4

2.2

2.84

3.04

mg/l

4.89

2435

18255

Squamous cell neoplasms and carcinomas of the skin

1652

11762

1.62

50.23

2.6

2.3

3.19

3.15

mg/l

0.26

1425

9847

Benign neoplasm: Adrenal gland

869

5361

1.92

50.18

2.7

2.2

3.21

2.88

mg/l

3.41

772

4551

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

401

1955

2.70

49.86

3.1

2.2

3.05

2.95

mg/l

0.32

366

1675

Deficiency of other B group vitamins

346

1616

3.04

49.72

3.0

2.1

3.05

mg/l

0.01

300

1375

Hypermobility syndrome

712

4166

2.05

49.68

2.5

2.1

2.70

2.72

mg/l

0.11

638

3586

Diabetic retinopathy, strict definition

2380

15842

1.50

49.62

2.9

2.5

3.06

3.21

mg/l

2.04

2057

13761

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

6667

55077

1.24

49.62

2.3

2.2

2.67

2.85

mg/l

9.02

5640

47342

Childhood asthma (age<16), excluding more controls

1569

8523

1.57

49.61

2.3

2.0

2.58

2.53

mg/l

0.44

1367

7288

Allergic rhinitis

3656

28584

1.34

49.51

2.3

2.2

2.68

2.76

mg/l

1.63

3157

24716

Other and unspecified injuries of head

797

4829

1.97

49.47

2.6

2.2

2.69

2.93

mg/l

2.62

674

4097

Diabetic neuropathy

1548

10967

1.66

49.10

3.0

2.5

3.17

3.22

mg/l

0.35

1377

9467

Other juvenile arthritis

561

3057

2.22

49.09

3.3

2.2

3.09

2.65

mg/l

5.11

511

2620

Conjunctivitis (acute, non atopic)

3264

25414

1.37

49.03

2.4

2.2

2.91

2.85

mg/l

0.86

2830

21894

Enthesopathies of lower limb, excluding foot

2448

18343

1.43

49.03

2.4

2.2

2.85

2.92

mg/l

0.69

2095

15684

Unspecified misadventure during surgical and medical care

715

4247

2.08

49.02

2.8

2.1

3.24

2.98

mg/l

1.95

628

3612

Diseases of spleen

280

1205

3.46

48.83

3.2

2.1

3.95

3.04

mg/l

4.15

243

1034

Non-follicular lymphoma

1209

8131

1.73

48.81

2.2

2.3

3.36

3.03

mg/l

3.44

1048

6902

Infections with a predominantly sexual mode of transmission

3570

28151

1.35

48.70

2.2

2.1

2.75

2.73

mg/l

0.18

2987

24341

Benign paroxysmal vertigo

3483

27585

1.36

48.65

2.4

2.3

2.88

3.01

mg/l

2.35

2959

23522

Maternal care for other known or suspected fetal problems

3014

14840

1.40

48.58

2.1

2.58

2.63

mg/l

0.84

2626

12817

Unspecific neurodegenerative disorder

5361

30603

1.30

48.55

2.3

2.4

3.07

3.17

mg/l

2.06

4340

25818

Hypoparathyroidism

516

2807

2.40

48.40

3.1

2.2

3.73

3.09

mg/l

3.74

443

2374

Multiple myeloma and malignant plasma cell neoplasms

656

3848

2.17

48.28

2.3

2.2

2.97

3.10

mg/l

0.57

563

3240

Retinal vascular occlusion

1532

10810

1.62

48.15

2.6

2.3

3.12

3.09

mg/l

0.15

1312

9091

Postprocedural musculoskeletal disorders, not elsewhere classified

885

5578

1.90

48.00

2.7

2.2

2.84

3.04

mg/l

1.96

782

4733

Schizoaffective disorder

905

5653

1.84

48.00

2.2

2.1

2.92

2.82

mg/l

0.70

793

4854

Malignant neoplasm of stomach

703

4178

2.06

47.86

2.7

2.2

3.54

3.09

mg/l

3.58

637

3500

Childhood asthma (age<16)

1569

8592

1.56

47.76

2.3

2.0

2.58

2.53

mg/l

0.43

1367

7352

Unknown and unspecified causes of morbidity

896

5581

1.83

47.68

2.6

2.0

2.98

2.89

mg/l

0.57

849

4721

Disorders of magnesium metabolism

142

437

6.84

47.68

3.7

1.9

3.04

3.24

mg/l

0.34

130

388

Open wound of forearm

1139

7548

1.72

47.53

2.7

2.2

3.15

2.92

mg/l

2.29

962

6432

Adhesive capsulitis of shoulder

1936

14100

1.50

47.51

2.4

2.2

2.95

2.98

mg/l

0.28

1645

11976

Other specified/unspecified inflammatory spondylopathies

594

3313

2.12

47.46

2.6

2.0

2.90

2.86

mg/l

0.17

523

2837

Juvenile arthritis (FINNGEN)

622

3532

2.09

47.37

3.3

2.2

3.07

2.70

mg/l

4.17

565

3024

Presbycusis

1886

13747

1.53

47.31

2.4

2.3

2.97

3.19

mg/l

3.58

1502

11530

Personal history of other diseases and conditions

1375

9402

1.63

47.31

2.5

2.3

2.71

mg/l

0.01

1153

8109

Allergic conjunctivitis

6943

57889

1.23

47.20

2.3

2.2

2.68

2.85

mg/l

8.99

5882

49818

Convalescence

689

4060

2.03

46.98

2.5

2.1

3.03

2.94

mg/l

0.48

576

3429

Polyp of the female genital tract

3926

18166

1.34

46.94

2.3

2.2

3.01

2.94

mg/l

0.84

3355

15544

Systemic lupus erythematosus, unspecified

437

2263

2.54

46.91

2.8

2.1

3.00

2.95

mg/l

0.18

395

1924

Retinal vascular disorders

1552

11022

1.60

46.87

2.6

2.3

3.12

3.10

mg/l

0.16

1329

9265

Nephrotic syndrome

443

2301

2.50

46.74

3.2

2.3

2.99

3.00

mg/l

0.02

395

1963

Respiratory insufficiency

1016

6589

1.77

46.41

2.9

2.2

4.51

3.00

mg/l

24.25

869

5521

Amputation of foot

384

1933

2.80

46.34

3.5

2.2

3.53

3.09

mg/l

2.49

340

1638

Pericarditis

451

2330

2.38

46.28

2.7

2.0

3.12

2.81

mg/l

1.99

390

1944

Malignant neoplasm of small intestine, excluding all cancers (controls excluding all cancers)

419

2150

2.57

46.18

2.8

2.2

3.40

2.96

mg/l

2.38

379

1806

Fenamates

2090

10329

1.48

46.14

2.3

2.88

2.98

mg/l

0.89

1782

8856

Alcohol-induced acute pancreatitis

457

2392

2.40

46.08

2.5

2.1

2.82

2.96

mg/l

0.51

387

2046

Bronchiectasis

1034

6818

1.79

46.05

2.6

2.2

3.17

2.99

mg/l

1.38

888

5756

Other and unspecified urticaria

2319

17481

1.44

45.87

2.5

2.2

2.91

2.84

mg/l

0.67

2006

15040

Other symptoms and signs involving general sensations and perceptions

541

3017

2.25

45.81

2.5

2.2

3.13

3.07

mg/l

0.23

457

2547

Open wound of ankle and foot

1209

8166

1.67

45.71

2.7

2.2

2.92

2.88

mg/l

0.22

1048

6998

Carcinoma in situ of other and unspecified digestive organs

362

1782

2.83

45.69

2.8

2.2

3.42

2.94

mg/l

1.59

317

1508

Memory loss

1197

8161

1.71

45.69

2.4

2.3

2.53

3.12

mg/l

14.98

979

6941

Mental and behavioural disorders due to tobacco

989

6412

1.77

45.68

2.4

2.1

3.17

2.87

mg/l

3.51

812

5499

ILD, hospital admissions 1, main diag only

1660

11998

1.57

45.66

2.6

2.3

3.24

3.05

mg/l

2.35

1458

10133

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

4267

34539

1.30

45.57

2.4

2.2

2.78

2.76

mg/l

0.22

3631

29873

Other and unspecified immunodeficiencies with predominantly antibody defects

209

806

4.03

45.48

3.2

2.1

2.91

3.04

mg/l

0.33

198

689

Wide developmental disorders, excluding more controls

343

1570

2.59

45.27

2.1

2.7

2.62

2.57

mg/l

0.17

287

1394

Correction of physiology of bite - demanding therapy visit

860

5410

1.85

45.25

2.4

2.1

2.93

2.83

mg/l

0.74

769

4658

IgA nephropathy (IgA glomerulonephritis)

334

1578

2.82

45.13

3.1

2.0

3.04

2.97

mg/l

0.19

304

1346

Disorders of muscles

1175

7896

1.67

44.90

2.5

2.1

2.89

2.92

mg/l

0.17

1033

6686

Other and unspecified disorders of white blood cells

553

3130

2.22

44.86

2.9

2.2

3.28

2.98

mg/l

1.64

477

2631

Sequelae of other external causes

677

4026

2.01

44.85

2.7

2.1

3.01

2.97

mg/l

0.13

609

3396

Other enthesopathy of foot (+metatarsalgia)

1165

7817

1.67

44.80

2.4

2.1

2.69

2.92

mg/l

3.34

989

6635

Metatarsalgia

1093

7246

1.70

44.66

2.4

2.1

2.65

2.93

mg/l

4.28

927

6138

Other diseases of jaws

829

5166

1.85

44.63

2.6

2.1

2.97

2.90

mg/l

0.43

709

4411

Drug-induced cataract

343

1659

2.82

44.58

3.3

2.1

3.58

3.07

mg/l

2.85

305

1417

Suppurative and necrotic conditions of lower respiratory tract

691

4161

2.01

44.37

2.7

2.2

3.12

3.01

mg/l

0.55

601

3539

Vascular diseases of the intestine

532

2992

2.26

44.34

3.7

2.1

3.51

3.06

mg/l

3.37

477

2495

Hypertension, Pulmonary Arterial

163

561

4.98

44.20

5.5

2.2

3.43

3.10

mg/l

0.69

156

470

Smoking dependency

989

6462

1.76

44.19

2.4

2.1

3.17

2.87

mg/l

3.45

812

5534

Discitis, unspecified

260

1132

3.38

44.14

2.8

2.1

3.38

3.13

mg/l

0.82

231

948

Infective dermatitis

1379

9629

1.60

44.13

2.5

2.2

3.07

2.90

mg/l

1.56

1204

8249

Malignant neoplasm of urinary organs, excluding all cancers (controls excluding all cancers)

1393

9772

1.60

44.00

2.4

2.3

3.26

2.96

mg/l

4.19

1191

8237

Cardiac murmurs and other cardiac sounds

1133

7487

1.67

43.99

2.7

2.3

2.91

2.81

mg/l

0.82

1008

6419

Prurigo nodularis

362

1800

2.73

43.98

2.9

2.1

2.96

3.11

mg/l

0.61

308

1524

Heart failure and hypertrophic cardiomyopathy

281

1281

3.30

43.90

3.8

2.2

3.48

3.15

mg/l

1.01

248

1087

Other abnormal findings of blood chemistry

572

3284

2.15

43.85

2.6

2.1

3.28

2.97

mg/l

1.81

519

2784

Oesophageal obstruction

482

2627

2.32

43.84

2.7

2.1

3.11

3.03

mg/l

0.31

413

2186

Emotional disorders starting during childhood or adolescence

671

3957

1.98

43.78

2.5

2.4

2.72

2.57

mg/l

1.09

580

3427

Cholecystitis

1741

12708

1.52

43.54

2.7

2.2

3.34

3.05

mg/l

4.37

1503

10666

Ankylosing spondylitis, strict definition

523

2887

2.15

43.41

2.6

2.1

2.94

2.80

mg/l

0.81

462

2499

Cystic kidney disease

443

2359

2.40

43.34

3.0

2.2

2.80

2.97

mg/l

1.03

393

2021

Crystal arthropathies, rheuma endpoint

286

1309

3.14

43.27

2.9

2.0

3.81

3.18

mg/l

2.36

242

1081

Benign neoplasm: Rectosigmoid junction

523

2949

2.23

42.97

2.7

2.2

3.36

2.93

mg/l

2.42

453

2487

Inguinal hernia

7257

41719

1.22

42.95

2.3

2.2

3.00

2.93

mg/l

1.43

6218

35485

Corns and callosities

850

5418

1.83

42.94

2.9

2.2

3.11

3.00

mg/l

0.71

739

4593

Diseases of tongue

783

4883

1.88

42.92

2.4

2.2

2.91

3.02

mg/l

0.54

664

4191

Nail disorders

976

6392

1.74

42.86

2.8

2.2

2.84

2.90

mg/l

0.42

863

5465

Injuries to unspecified part of trunk, limb or body region

1211

8329

1.65

42.73

2.7

2.2

3.08

2.93

mg/l

0.87

1039

7095

D07AA Corticosteroids, weak (group I)

1873

13807

1.48

42.60

2.6

2.2

2.74

2.82

mg/l

0.76

1645

11857

Female infertility

3620

17793

1.33

42.58

2.2

2.1

2.67

2.71

mg/l

0.53

3118

15319

Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)

1467

10421

1.57

42.54

2.4

2.3

3.10

3.00

mg/l

0.80

1240

8694

Spontaneous rupture of synovium and tendon

957

6254

1.75

42.43

2.7

2.2

3.11

3.01

mg/l

0.55

839

5262

Retinal detachments and breaks

4188

34330

1.30

42.34

2.4

2.2

2.99

3.02

mg/l

0.47

3564

29145

Speech and linguistic disorders

1024

6474

1.70

42.34

2.5

2.85

2.71

mg/l

0.85

891

5625

Any event in hilmo or specialist outpatient

6.94

42.11

1.9

1.4

2.70

2.63

mg/l

0.07

Striking against or struck by other objects

3603

28932

1.31

42.11

2.4

2.2

2.89

2.83

mg/l

0.66

3055

24941

Speech therapy

3237

25844

1.35

41.92

2.5

2.3

2.78

2.99

mg/l

4.94

2899

22049

Carcinoma in situ of skin of other and unspecified parts of face

1063

7253

1.75

41.89

2.7

2.3

3.16

3.17

mg/l

0.04

897

6102

Erosion of teeth

246

1055

3.24

41.87

3.4

2.4

2.87

2.68

mg/l

0.55

220

918

Agoraphobia

401

2050

2.37

41.87

2.3

2.0

2.71

2.67

mg/l

0.12

351

1772

Other noninflammatory disorders of uterus, except cervix

2639

13905

1.39

41.69

2.4

2.3

3.16

3.06

mg/l

1.10

2263

11797

Opening and dilatation of root channel of tooth

763

4750

1.86

41.67

2.5

2.1

2.68

2.83

mg/l

1.04

642

4075

Other crystal arthropathies

286

1334

3.07

41.47

2.9

2.1

3.81

3.10

mg/l

3.02

242

1112

Blepharochalasis

3449

27801

1.33

41.44

2.4

2.3

2.84

3.08

mg/l

7.57

2916

23576

Injuries to the wrist and hand

12960

83697

1.16

41.41

2.3

2.2

2.82

2.89

mg/l

2.74

11061

71800

Seborrhoeic dermatitis

1133

7724

1.66

41.27

2.6

2.2

2.92

2.91

mg/l

0.06

979

6590

Sacroiliitis, not elsewhere classified

580

3348

2.02

41.23

2.4

2.0

2.73

2.79

mg/l

0.34

528

2878

Follow-up examination after treatment for malignant neoplasms

1205

8283

1.62

41.20

2.3

2.1

3.38

3.03

mg/l

3.25

1031

6909

Infection of intervertebral disc (pyogenic)

210

859

3.80

41.19

3.3

2.1

3.12

3.15

mg/l

0.05

183

729

Other and unspecified acquired haemolytic anaemias

172

642

4.64

41.19

4.8

2.1

4.49

3.11

mg/l

3.81

160

552

Disorders of refraction and accommodation

3029

23862

1.35

41.15

2.3

2.79

2.81

mg/l

0.26

2554

20607

Procreative management

3412

22940

1.32

41.09

2.4

2.3

2.66

2.81

mg/l

3.26

2989

19873

Any dementia

4960

29196

1.28

41.06

2.4

3.13

3.15

mg/l

0.23

3999

24646

Carcinoma in situ of skin

975

6521

1.76

40.93

2.6

2.3

3.14

2.99

mg/l

1.06

835

5504

Other disorders of patella

1885

13939

1.45

40.86

2.3

2.0

2.85

2.79

mg/l

0.51

1611

11955

Female infertility, cervigal, vaginal, other or unspecified origin

3241

17156

1.34

40.84

2.2

2.1

2.66

2.71

mg/l

0.60

2789

14784

Use of memantine

3313

23250

1.35

40.82

2.3

2.4

3.11

3.22

mg/l

1.73

2637

19505

Use of other anti-dementia drugs

3313

23250

1.35

40.82

2.3

2.4

3.11

3.22

mg/l

1.73

2637

19505

Diplopia

1543

11166

1.54

40.79

2.5

2.2

2.95

2.96

mg/l

0.04

1344

9546

Etanercept

739

4590

1.87

40.76

2.7

2.1

3.00

2.83

mg/l

1.24

669

3953

Ocular pain

973

6463

1.72

40.54

2.4

2.2

2.62

2.87

mg/l

3.93

843

5529

Lymphoid leukaemia

693

4278

1.94

40.50

2.6

2.4

3.67

2.91

mg/l

7.86

616

3609

Deviated nasal septum

3735

30261

1.30

40.46

2.2

2.72

2.95

mg/l

7.84

3200

25979

Other benign neoplasms of skin

4548

37758

1.28

40.34

2.4

2.3

3.01

2.99

mg/l

0.16

3868

32109

Giant cell arteritis

570

3388

2.14

40.31

2.7

2.2

3.17

3.15

mg/l

0.04

494

2826

Carcinoma in situ of colon

219

932

3.70

40.11

2.9

2.2

3.81

3.03

mg/l

1.79

189

790

Viral pneumonia (unknown virus, not influenza)

784

4959

1.82

40.08

2.7

2.1

3.00

2.84

mg/l

0.90

688

4225

Otitis externa

2521

19635

1.38

39.39

2.5

2.2

2.89

2.87

mg/l

0.19

2110

16875

Other disorders of nervous system

789

5057

1.82

38.98

2.5

2.2

3.08

3.01

mg/l

0.29

671

4280

Other disorders of gingiva or/and edentulous alveolar ridge

619

3731

1.96

38.86

2.9

2.3

2.84

2.92

mg/l

0.37

539

3180

Tubulo-interstitial nephritis, not specified as acute or chronic

897

5912

1.74

38.81

2.7

2.1

3.40

2.99

mg/l

3.93

776

4959

Other and unspecified aplastic anaemias

184

721

3.91

38.80

3.2

2.0

3.17

2.96

mg/l

0.46

156

618

Preparation and fitting of bite rail to mouth

1508

10911

1.51

38.72

2.3

2.1

2.69

2.83

mg/l

1.46

1344

9418

Other inflammation of eyelid

1521

11071

1.52

38.66

2.4

2.2

2.65

2.96

mg/l

6.35

1292

9457

Other infectious diseases

993

6714

1.70

38.61

3.0

2.2

3.29

3.00

mg/l

2.64

872

5691

Congenital iodine-deficiency syndrome/hypothyroidism

440

2442

2.31

38.52

2.4

2.3

3.24

3.07

mg/l

0.51

389

2072

Other disorders of bone

2235

17153

1.40

38.46

2.5

2.2

2.85

mg/l

0.06

1909

14760

TMD related pain

462

2585

2.21

38.34

2.5

2.1

2.89

2.85

mg/l

0.18

404

2220

Drug-induced osteoporosis

194

792

3.80

38.21

3.4

2.1

3.43

3.25

mg/l

0.45

176

676

Moderate visual impairment, binocular

447

2507

2.29

38.11

2.8

2.3

3.99

3.18

mg/l

6.09

334

2105

Nonhereditary hypogammaglobulinemia

174

668

3.99

38.07

3.5

2.0

3.32

2.96

mg/l

1.29

169

575

Progressive vascular leukoencephalopathy

499

2934

2.25

37.92

2.7

2.3

2.81

3.21

mg/l

3.35

428

2451

Nonalcoholic steatohepatitis

135

453

5.01

37.91

2.7

2.0

3.12

3.06

mg/l

0.09

118

387

Other/unspecified synovitis and tenosynovitis

1329

9443

1.55

37.86

2.4

2.1

2.92

2.95

mg/l

0.21

1145

7996

Temporal arteritis

512

3011

2.18

37.85

2.7

2.2

3.15

3.18

mg/l

0.10

442

2507

Dislocation, sprain and strain of joints and ligaments at neck level

1715

12708

1.47

37.83

2.2

2.1

2.68

2.78

mg/l

1.21

1454

10937

Pneumonitis due to solids and liquids

1001

6796

1.68

37.83

2.7

2.2

3.44

3.11

mg/l

2.43

836

5718

Malignant neoplasm of bronchus and lung

1352

17467

0.67

37.80

2.1

2.3

3.51

3.10

mg/l

4.78

1140

14601

Carcinoma in situ of other and unspecified digestive organs

362

1922

2.57

37.52

2.8

2.2

3.42

3.09

mg/l

0.89

317

1631

Attention to artificial openings

494

2840

2.13

37.48

2.9

2.2

3.51

3.00

mg/l

3.91

431

2393

Chronic nephritic syndrome

508

2944

2.10

37.36

3.0

2.2

3.17

3.00

mg/l

0.76

462

2489

Vitamin D deficiency

258

1186

2.92

37.35

2.8

2.1

3.38

2.90

mg/l

1.93

228

1018

Synovial cyst of popliteal space [Baker]

877

5793

1.73

37.34

2.6

2.1

2.95

3.04

mg/l

0.56

755

4849

Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)

1196

8426

1.59

36.99

2.3

3.29

2.96

mg/l

4.29

1028

7113

Bullous disorders

741

4774

1.85

36.87

2.6

2.2

2.96

3.05

mg/l

0.38

637

4034

Gestational diabetes (for exclusion)

4307

25216

1.27

36.69

2.2

2.1

2.75

2.62

mg/l

3.88

3715

21859

Systemic sclerosis (FG)

316

1577

2.57

36.68

3.5

1.9

3.08

3.01

mg/l

0.18

284

1301

Alzheimer’s disease (Atypical or mixed), excluding more controls

988

5793

1.68

36.57

2.4

2.2

3.31

3.16

mg/l

0.95

786

4850

Female genital prolapse

3541

16533

1.31

36.45

2.3

2.2

2.96

3.00

mg/l

0.39

3038

14098

Chronic myeloproliferative disease

225

1018

3.45

36.43

2.8

2.1

5.39

3.17

mg/l

6.01

203

858

Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)

378

2039

2.40

36.20

2.7

2.2

4.06

2.96

mg/l

6.18

332

1696

Chronic lymphocytic leukaemia, helper endpoint

378

2039

2.40

36.20

2.7

2.2

4.06

2.96

mg/l

6.18

332

1696

Giant cell arteritis with polymyalgia rheumatica

512

3052

2.15

36.16

2.7

2.2

3.15

3.16

mg/l

0.02

442

2542

Benign neoplasm: Skin of eyelid, including canthus

1712

12825

1.46

36.09

2.5

2.3

3.09

2.92

mg/l

1.80

1464

10906

Assault by bodily force

800

5165

1.72

36.08

2.2

2.1

2.77

mg/l

0.00

665

4487

Congenital malformations of the urinary system

714

4551

1.83

36.06

2.9

2.3

2.90

2.88

mg/l

0.06

629

3906

Mental disorders, not otherwise specified

956

6451

1.66

35.94

2.3

2.1

2.63

2.74

mg/l

0.84

821

5551

Focal epilepsy

2464

19378

1.37

35.74

2.3

2.94

2.93

mg/l

0.06

2083

16621

therapeutic use

408

2276

2.31

35.45

2.8

2.1

3.55

3.06

mg/l

3.04

335

1914

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum, excluding all cancers (controls excluding all cancers)

1146

8083

1.59

35.25

2.2

2.3

3.42

2.97

mg/l

5.15

970

6802

Benign neoplasm: Adrenal gland

869

5843

1.72

35.09

2.7

2.2

3.21

3.00

mg/l

1.62

772

4967

Abnormal findings on examination of urine, without diagnosis

567

3455

1.98

35.05

2.8

2.2

3.27

2.96

mg/l

2.18

517

2929

Carcinoma in situ of skin of trunk

405

2271

2.33

35.05

2.6

2.3

3.24

2.97

mg/l

1.19

344

1885

Idiopathic thrombocytopenic purpura

415

2328

2.25

34.95

2.8

2.2

3.30

2.95

mg/l

1.49

378

1964

Suppurative and unspecified otitis media

4293

31683

1.26

34.88

2.4

2.2

2.77

2.73

mg/l

0.47

3700

27293

Adenomyosis (Endometriosis of uterus)

1541

11400

1.48

34.83

2.3

2.2

2.87

2.96

mg/l

0.83

1315

9741

Abnormal findings on antenatal screening of mother

1023

7051

1.62

34.82

2.0

2.37

2.54

mg/l

2.31

927

6049

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

953

6535

1.67

34.77

2.8

2.2

3.21

2.97

mg/l

2.42

844

5565

Acne

1169

8220

1.56

34.76

2.5

2.2

2.67

2.63

mg/l

0.27

1026

7085

Arthropathic psoriasis

1252

8966

1.54

34.64

2.4

2.2

3.12

2.89

mg/l

2.15

1108

7697

Autism spe, excluding more controls

254

1163

2.62

34.60

2.2

2.4

2.70

2.53

mg/l

0.89

210

1020

Pyothorax

526

3156

2.02

34.51

2.6

2.2

3.17

3.05

mg/l

0.59

459

2689

Neuralgia and neuritis, unspecified

601

3697

1.89

34.50

2.5

2.1

2.75

2.94

mg/l

1.56

526

3127

Acute suppurative otitis media

3014

22633

1.31

34.47

2.4

2.2

2.77

2.68

mg/l

1.44

2612

19479

Late syphilis

201

868

3.33

34.44

3.3

2.0

3.41

3.07

mg/l

0.93

176

767

Excessive vomiting in pregnancy

970

6640

1.63

34.28

2.2

2.1

2.70

2.73

mg/l

0.16

816

5694

Polycythaemia vera

450

2597

2.15

34.26

2.4

2.2

8.06

2.94

mg/l

26.83

385

2167

Carcinoma in situ of colon

219

1006

3.35

34.20

2.9

2.2

3.81

3.20

mg/l

1.24

189

864

Speech disturbances, not elsewhere classified

1053

7381

1.62

34.09

2.6

2.2

3.23

3.06

mg/l

1.00

854

6251

Adenocarcinoma and papilloma adenocarcinoma of rectum, excluding all cancers (controls excluding all cancers)

1110

7836

1.59

34.01

2.2

2.3

3.46

2.97

mg/l

5.64

935

6586

Fracture at wrist and hand level

3722

30674

1.27

33.96

2.3

2.2

2.81

2.87

mg/l

0.90

3232

26434

Acute and transient psychotic disorders

1276

9164

1.52

33.96

2.2

2.1

2.85

2.86

mg/l

0.07

1104

7897

Fall involving bed

428

2467

2.24

33.91

2.8

2.3

3.40

3.19

mg/l

0.76

360

2079

Hyperhidrosis

380

2059

2.22

33.85

2.3

2.0

2.74

2.88

mg/l

0.63

317

1762

Small fibre neuropathy

365

1994

2.37

33.82

2.7

2.2

2.77

3.09

mg/l

2.00

306

1701

Gingival hyperplasia

410

2293

2.18

33.81

3.1

2.3

2.74

2.90

mg/l

0.83

355

1952

Malignant neoplasm of respiratory system and intrathoracic organs

1647

19982

0.71

33.74

2.1

2.3

3.44

3.08

mg/l

4.83

1388

16741

Endometriosis of ovary

1929

14733

1.40

33.70

2.3

2.2

2.82

2.84

mg/l

0.15

1639

12661

Arterial embolism and thrombosis

740

4837

1.78

33.65

2.9

2.2

3.67

3.06

mg/l

6.29

651

4045

Autoimmune hyperthyroidism

675

4276

1.78

33.59

2.4

2.0

2.81

2.90

mg/l

0.45

597

3630

Brachial plexus disorders

1024

7093

1.60

33.52

2.3

2.1

2.66

2.78

mg/l

1.39

919

6107

Anankastic personality disorder

455

2615

2.06

33.52

2.4

2.0

2.51

2.76

mg/l

2.26

400

2252

Lung diseases due to external agents

1666

12582

1.45

33.51

2.6

2.3

3.43

3.07

mg/l

5.16

1412

10560

Pyoderma gangrenosum

131

470

4.75

33.38

3.5

2.0

3.11

3.06

mg/l

0.08

121

402

Asthma and opportunity respiratory infection

598

3762

1.93

33.29

2.8

2.2

3.14

3.04

mg/l

0.43

536

3159

Diseases of middle ear and mastoid

7112

50714

1.19

33.27

2.3

2.2

2.76

2.82

mg/l

1.32

6121

43554

Sarcoidosis

1489

11051

1.47

33.21

2.5

2.2

3.18

2.96

mg/l

2.59

1327

9468

Carbimazole or st.post thyroidectomy, condition for graves disease

2342

18482

1.36

33.19

2.3

2.2

2.83

2.90

mg/l

0.68

2023

15851

Gout due to impairment of renal function

176

747

3.81

32.89

3.4

2.0

3.42

3.12

mg/l

0.87

162

648

Superficial injury of wrist and hand

2179

17015

1.37

32.83

2.4

2.2

2.82

2.81

mg/l

0.12

1851

14673

Other abnormalities of plasma proteins

228

1074

3.04

32.56

2.7

2.0

3.30

3.17

mg/l

0.34

200

916

Chronic Coagulation defects

332

1767

2.38

32.50

3.5

2.2

2.85

2.86

mg/l

0.04

289

1518

Pollen allergy

2087

16045

1.37

32.42

2.4

2.2

2.61

2.71

mg/l

1.57

1775

13890

Dependent personality disorder

280

1406

2.57

32.27

2.4

2.0

3.02

2.98

mg/l

0.10

250

1213

Other epidermal thickening

552

3412

1.93

32.25

3.1

2.2

3.19

2.97

mg/l

1.11

492

2891

Thyrotoxicosis with diffuse goitre

1552

11618

1.45

32.18

2.3

2.2

2.82

2.87

mg/l

0.33

1348

9981

Parodontitis or/and operation codes

8363

43833

1.18

32.15

2.4

2.3

2.84

2.87

mg/l

0.74

7109

37933

Other female pelvic inflammatory diseases

1862

14342

1.40

32.07

2.4

2.2

2.86

2.89

mg/l

0.20

1565

12319

Hepatomegaly and splenomegaly, not elsewhere classified

154

604

3.76

32.04

3.5

1.9

3.93

2.84

mg/l

4.31

149

524

Polyarthritis, unspecified

451

2630

2.04

31.94

2.7

2.0

3.09

2.90

mg/l

0.92

405

2207

Rash and other nonspecific skin eruption

1155

8304

1.55

31.82

2.6

2.3

2.93

2.94

mg/l

0.05

986

7081

Other endocrine disorders

666

4132

1.80

31.81

2.8

2.5

3.08

2.76

mg/l

3.17

590

3578

Acute pharyngitis

1571

11664

1.43

31.80

2.4

2.1

2.72

2.69

mg/l

0.23

1357

10013

Vasculitis limited to skin, not elsewhere classified

346

1889

2.34

31.79

3.1

2.2

3.37

3.07

mg/l

1.17

312

1581

Hidradenitis suppurativa

432

2492

2.05

31.52

3.0

2.0

2.99

2.74

mg/l

1.25

389

2154

conjunctival haemorrhage

883

6087

1.66

31.51

2.7

2.3

3.19

3.02

mg/l

1.22

781

5167

Diffuse large B-cell lymphoma, helper endpoint

525

3227

1.95

31.44

2.1

2.3

3.53

2.97

mg/l

3.56

450

2703

Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)

525

3227

1.95

31.44

2.1

2.3

3.53

2.97

mg/l

3.56

450

2703

Herpesviral [herpes simplex] infections

1330

9791

1.49

31.42

2.6

2.2

3.00

2.89

mg/l

0.97

1173

8382

Chronic diseases of tonsils and adenoids

9880

55652

1.15

31.32

2.2

2.70

2.87

mg/l

10.27

8536

47854

Psoriatic arthropathies, ICD10

1151

8271

1.54

31.30

2.5

2.2

3.10

2.91

mg/l

1.43

1019

7086

Hallux rigidus

1501

11233

1.45

31.14

2.3

2.1

2.92

2.98

mg/l

0.44

1208

9468

Right bundle-branch block

432

2507

2.05

31.10

2.8

2.0

3.29

2.88

mg/l

2.00

361

2081

Chronic tubulo-interstitial nephritis

485

2910

1.97

31.09

3.0

2.1

3.19

3.06

mg/l

0.62

433

2426

Atrophic disorders of skin

1596

12095

1.44

31.03

2.4

2.2

2.91

2.95

mg/l

0.29

1386

10326

Female infertility, associated with anovulation

922

6340

1.60

31.02

2.2

2.0

2.77

2.53

mg/l

3.27

811

5489

Pneumonia due to other infectious organisms, not elsewhere classified

401

2291

2.13

30.99

2.8

2.0

3.27

2.93

mg/l

2.04

363

1943

Seborrhoeic keratosis

2545

20496

1.33

30.94

2.4

2.2

2.92

3.05

mg/l

1.84

2201

17385

Benign neoplasm: Rectosigmoid junction

523

3249

1.97

30.86

2.7

2.2

3.36

3.10

mg/l

1.11

453

2741

Lateral epicondylitis

1357

9981

1.46

30.76

2.3

2.1

2.88

2.89

mg/l

0.08

1180

8547

Manic episode

362

1990

2.17

30.72

2.1

2.0

2.74

2.85

mg/l

0.32

315

1708

Leiomyoma of uterus

5630

27215

1.21

30.69

2.3

2.2

3.08

2.82

mg/l

9.89

4767

23484

Hypertrophy of breast in women and men

2131

16764

1.36

30.62

2.3

2.2

2.76

2.87

mg/l

1.78

1855

14444

Injury of unspecified body region

896

6214

1.64

30.56

2.7

2.2

3.06

2.92

mg/l

0.73

768

5272

Secondary parkinsonism, excluding more controls

310

1631

2.32

30.45

2.5

2.1

2.98

2.95

mg/l

0.08

261

1368

Supervision of high-risk pregnancy

2420

11574

1.34

30.45

2.1

2.74

2.70

mg/l

0.40

2117

10036

Other psoriatic arthropathies

1116

8015

1.54

30.45

2.4

2.2

3.11

2.91

mg/l

1.63

988

6859

Disorders of tooth development and eruption

573

3470

1.81

30.34

3.6

2.3

2.73

2.72

mg/l

0.05

502

3026

Cluster headache, strict

412

2366

2.04

30.12

2.7

2.0

2.64

2.82

mg/l

1.04

359

2019

Other disorders of conjunctiva

1615

12343

1.43

30.11

2.5

2.3

3.08

2.99

mg/l

0.82

1415

10538

Other and unspecified follicular disorders

462

2761

1.98

30.08

2.6

2.0

3.03

2.81

mg/l

0.90

406

2348

Benign lipomatous neoplasm

3139

25823

1.28

30.02

2.3

2.92

2.88

mg/l

0.36

2664

22007

Viral warts

1128

8140

1.53

29.98

2.8

2.2

2.89

2.84

mg/l

0.27

1009

6967

Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence

643

4073

1.75

29.97

2.4

2.6

2.80

2.62

mg/l

1.58

570

3552

Focal epilepsy, strict definition

2244

17842

1.35

29.94

2.3

2.95

2.94

mg/l

0.09

1891

15299

Macular pucker

1698

13128

1.43

29.93

2.4

2.3

2.92

3.05

mg/l

1.25

1419

11116

Cardiomyopathy, Hypertrophic obstructive

242

1179

2.63

29.91

3.5

2.0

3.32

2.95

mg/l

1.10

213

977

Malignant neoplasm of small intestine

299

1601

2.48

29.90

2.9

2.2

3.50

3.14

mg/l

1.33

269

1350

Other or ill-defined heart diseases

555

3444

1.81

29.67

2.9

2.0

2.99

2.83

mg/l

0.84

482

2888

Cluster headache, wide

440

2587

1.97

29.57

2.7

2.0

2.70

2.85

mg/l

0.81

385

2205

Car occupant injured in other and unspecified transport accidents

2106

16605

1.35

29.57

2.3

2.2

2.89

2.83

mg/l

0.62

1824

14254

Ingrowing nail

613

3932

1.78

29.56

2.8

2.1

2.92

2.89

mg/l

0.14

535

3362

Melanocytic naevi

3169

26128

1.28

29.55

2.4

2.2

2.72

2.79

mg/l

1.17

2773

22385

Amputation of ankle bones

299

1597

2.42

29.54

3.9

2.1

3.57

3.11

mg/l

2.23

266

1351

Other and unspecified vasculitis limited to skin

314

1704

2.36

29.43

3.1

2.2

3.41

3.07

mg/l

1.24

281

1435

Orchitis and epididymitis

949

6636

1.57

29.37

2.4

2.2

2.96

2.99

mg/l

0.14

827

5698

Impotence

589

3757

1.81

29.37

2.3

2.1

2.73

2.93

mg/l

1.28

522

3225

Malignant neoplasm of oesophagus, excluding all cancers (controls excluding all cancers)

429

2536

2.03

29.33

2.2

3.56

2.91

mg/l

3.80

384

2115

Other noninflammatory disorders of vulva and perineum

1042

7442

1.54

29.12

2.4

2.1

2.71

2.85

mg/l

1.37

902

6381

Pneumocystosis

229

1129

2.82

29.07

2.9

2.2

3.28

3.11

mg/l

0.50

212

958

Urethral stricture

677

4482

1.73

28.95

2.3

2.2

2.95

3.01

mg/l

0.24

558

3811

Left ventricular outflow tract obstruction, narrow definition

552

3481

1.83

28.90

2.5

2.4

3.16

2.85

mg/l

2.01

503

2990

Hypertrophic cardiomyopathy

501

3117

1.93

28.89

3.3

2.2

3.23

3.02

mg/l

0.93

440

2640

Isolated proteinuria

370

2120

2.15

28.69

3.0

2.1

3.32

2.94

mg/l

2.47

336

1801

Lymphoid leukaemia

693

4652

1.74

28.67

2.6

2.3

3.67

3.04

mg/l

5.50

616

3940

Carcinoma in situ of skin

975

7007

1.60

28.61

2.6

2.3

3.14

3.12

mg/l

0.05

835

5901

Tongue abnormality

725

4905

1.71

28.56

2.4

2.2

2.92

3.03

mg/l

0.50

617

4129

Drug-induced hypoglycaemia without coma

236

1174

2.68

28.53

2.6

2.1

2.99

3.06

mg/l

0.16

202

1001

Other/unspecified reactive arthropathies

758

5142

1.67

28.53

2.5

2.1

2.71

2.88

mg/l

1.59

666

4379

Other nutritional anaemias

157

657

3.40

28.49

2.9

1.9

3.27

3.13

mg/l

0.22

130

553

Nummular dermatitis

928

6557

1.58

28.36

2.5

2.2

2.74

2.93

mg/l

1.73

807

5558

Volvulus

334

1857

2.20

28.23

2.9

2.1

3.40

3.02

mg/l

0.92

289

1561

TMD muscular pain linked with fibromyalgia

146

597

3.61

28.21

2.6

2.1

2.51

2.87

mg/l

1.67

134

514

Viral pneumonia (known virus, not influenza)

318

1762

2.31

28.19

3.4

2.2

3.13

2.99

mg/l

0.36

288

1493

Other disorders of penis

957

6754

1.55

28.19

2.5

2.2

2.82

2.93

mg/l

0.84

806

5838

Use of biperiden

595

3840

1.77

28.12

2.3

2.1

2.86

2.99

mg/l

0.81

514

3274

Other and unspecified visual disturbances

1077

7825

1.53

28.08

2.7

2.2

2.68

2.94

mg/l

3.83

928

6689

Tinnitus

2563

20825

1.31

28.07

2.3

2.2

2.76

2.93

mg/l

3.03

2173

17846

Explicit fungal Sepsis

115

424

4.59

28.05

4.3

1.9

3.70

3.11

mg/l

1.07

104

364

Waldenstrom macroglobulinemia, lymphoplasmacytic lymphoma, excluding all cancers (controls excluding all cancers)

129

509

4.27

28.03

2.9

2.2

3.07

3.11

mg/l

0.05

113

428

Autoimmune hepatitis

123

462

4.00

27.88

3.6

1.8

3.02

3.05

mg/l

0.06

114

387

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

3129

25901

1.27

27.87

2.3

2.2

2.95

2.92

mg/l

0.33

2679

22256

Corneal ulcer

1959

15436

1.35

27.75

2.3

2.2

2.82

2.90

mg/l

0.71

1696

13263

Open wound of wrist and hand

4798

40789

1.21

27.65

2.3

2.2

2.84

2.86

mg/l

0.21

4077

35093

Acne vulgaris

887

6194

1.57

27.54

2.4

2.1

2.66

2.63

mg/l

0.19

779

5344

Atypical facial pain

600

3913

1.77

27.51

2.6

2.1

2.85

2.95

mg/l

0.53

510

3326

Dermatitis due to substances taken internally

658

4373

1.72

27.49

2.7

2.2

3.18

2.91

mg/l

1.99

555

3715

Mental and behavioural disorders due to use of other stimulants, including caffeine

298

1582

2.19

27.44

2.1

2.95

2.69

mg/l

0.88

242

1386

Other and unspecified tonsillitis

3679

26139

1.24

27.41

2.3

2.1

2.73

2.67

mg/l

0.85

3236

22556

Other and unspecified abdominal hernia

499

3135

1.89

27.39

2.9

2.1

3.20

3.03

mg/l

0.74

429

2640

Malignant immunoproliferative diseases

155

671

3.55

27.38

2.8

2.1

3.20

3.05

mg/l

0.29

137

562

COPD, hospital admissions 1, only main diagnosis

4258

30972

1.23

27.36

2.6

2.3

3.47

3.03

mg/l

17.56

3603

26123

Type 1 diabetes, definitions combined

1040

7438

1.50

27.33

2.3

2.2

2.65

2.63

mg/l

0.18

909

6452

Erythema intertrigo

307

1694

2.29

27.30

3.0

2.1

3.34

3.09

mg/l

1.11

281

1418

Sleep disorders, other/unspecified

398

2342

2.00

27.22

2.4

2.1

2.59

2.79

mg/l

0.94

324

2016

Intentional self-harm by unspecified means

171

753

3.03

27.18

2.3

2.0

2.84

2.79

mg/l

0.11

155

645

Other aneurysm

654

4369

1.73

27.18

2.7

2.1

3.55

2.98

mg/l

4.16

568

3663

Benign neoplasm of mouth and pharynx

1166

8597

1.48

27.15

2.5

2.2

2.90

2.88

mg/l

0.08

977

7316

Other peripheral vascular diseases

925

6584

1.57

27.09

2.8

2.1

2.94

2.90

mg/l

0.13

813

5583

Type 1 diabetes, strict (exclude DM2)

1033

7397

1.50

26.99

2.3

2.65

2.63

mg/l

0.17

902

6418

Renal tubulo-interstitial disorders in diseases classified elsewhere

151

642

3.43

26.97

2.6

2.0

3.33

3.12

mg/l

0.37

134

545

Unspecified jaundice

590

3844

1.76

26.86

2.8

2.2

3.43

3.05

mg/l

1.94

515

3234

Anxious personality disorder

240

1207

2.45

26.78

2.4

2.0

2.55

2.73

mg/l

0.79

207

1031

Haemorrhage in early pregnancy

3056

24722

1.27

26.78

2.1

2.72

2.77

mg/l

0.60

2646

21296

Olecranon bursitis

652

4329

1.69

26.75

2.6

2.1

3.00

2.96

mg/l

0.17

557

3653

Recurring oral aphthae

567

3690

1.80

26.72

3.1

2.2

2.96

mg/l

0.00

491

3122

Pregnancy examination and test

1968

9650

1.36

26.70

2.0

2.1

2.54

2.65

mg/l

1.66

1669

8341

Carcinoma in situ of skin of scalp and neck

314

1782

2.33

26.67

2.9

2.3

3.15

3.01

mg/l

0.38

274

1500

Systemic sclerosis

316

1769

2.23

26.61

3.5

2.1

3.08

3.04

mg/l

0.10

284

1496

Otalgia

906

6452

1.57

26.58

2.6

2.3

2.72

2.87

mg/l

1.28

769

5543

Dysplasia of cervi uteri

2675

16868

1.29

26.53

2.2

2.1

2.71

2.74

mg/l

0.25

2286

14569

Gastrojejunal ulcer

178

812

2.96

26.48

3.3

2.0

3.70

3.17

mg/l

1.61

157

686

380

6293

0.55

26.43

2.3

2.2

4.17

3.03

mg/l

7.72

322

5329

Chronic lymphocytic leukaemia

378

2258

2.11

26.30

2.7

2.2

4.06

3.14

mg/l

4.51

332

1901

Xerosis cutis

217

1088

2.74

26.29

3.2

2.2

3.24

3.15

mg/l

0.18

190

931

Other condition

1488

11415

1.41

26.26

2.6

2.2

3.29

2.88

mg/l

6.51

1340

9788

Ptosis of eyelid

1237

9310

1.47

26.15

2.5

2.2

2.70

3.05

mg/l

5.50

1074

7913

Other congenital malformations

973

7006

1.53

26.11

2.5

2.3

2.81

2.79

mg/l

0.07

845

6078

Filling of root of tooth

366

2139

2.05

26.08

2.5

2.0

2.48

2.96

mg/l

3.98

318

1819

Anorexia

217

1079

2.64

26.06

2.6

2.2

2.72

2.98

mg/l

0.93

193

913

Other and unspecified vascular occlusions

1119

8314

1.50

26.05

2.5

2.3

3.08

3.11

mg/l

0.13

955

6998

Inflammatory diseases of prostate (prostatitis)

1332

10063

1.43

26.03

2.2

2.91

2.99

mg/l

0.68

1152

8610

Superficial injury of shoulder and upper arm

1243

9318

1.45

25.94

2.3

2.2

2.98

2.93

mg/l

0.22

1021

7978

Traumatic subarachnoid haemorrhage

402

2401

1.95

25.92

2.3

2.1

3.36

2.97

mg/l

1.49

346

2030

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

3039

25252

1.26

25.87

2.3

2.2

2.79

2.81

mg/l

0.15

2610

21793

Other specified/unspecified soft tissue disorders

601

3971

1.73

25.83

2.6

2.1

3.17

3.06

mg/l

0.47

547

3305

Special screening examination for neoplasms

506

3200

1.80

25.79

2.8

2.0

2.92

2.90

mg/l

0.06

423

2695

Clear cell adenocarcinoma of kidney, excluding all cancers (controls excluding all cancers)

504

3221

1.84

25.66

2.3

2.2

3.19

2.93

mg/l

1.34

434

2714

Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers

474

2982

1.86

25.56

2.4

2.2

3.51

2.96

mg/l

3.70

412

2496

Systemic sclerosis, icd10

313

1771

2.20

25.55

3.6

2.1

3.09

3.04

mg/l

0.11

282

1507

Colitis due to radiation

169

786

3.22

25.54

2.9

2.0

3.14

3.08

mg/l

0.12

155

673

Appendectomy

7698

66099

1.15

25.39

2.2

2.84

2.86

mg/l

0.32

6656

56806

Myeloid leukaemia

319

1815

2.16

25.30

2.5

2.1

3.02

2.99

mg/l

0.08

274

1522

Ganglion

2267

18331

1.30

25.22

2.3

2.1

2.78

2.86

mg/l

0.99

1978

15648

Acquired absence of limb

141

598

3.39

25.20

3.8

2.1

3.26

3.09

mg/l

0.33

128

516

Hypertrophy of breast

1830

14483

1.35

25.19

2.3

2.2

2.73

2.85

mg/l

1.91

1589

12474

Hypertension, portal

188

8.11

25.17

3.7

2.0

3.80

3.27

mg/l

0.60

167

Suggestive for eosinophilic asthma

1003

7321

1.51

25.13

2.4

2.2

2.95

2.94

mg/l

0.07

857

6238

Orthopaedic devices associated with adverse incidents

247

1326

2.54

25.11

2.7

2.2

3.78

3.15

mg/l

3.35

193

1121

Strabismus

2987

24857

1.26

25.09

2.4

2.3

2.90

2.85

mg/l

0.53

2592

21406

Ovarian dysfunction

892

6384

1.55

25.08

2.3

2.1

2.64

2.63

mg/l

0.07

790

5491

Other and unspecified rosacea

933

6740

1.53

25.06

2.5

2.2

3.11

2.92

mg/l

0.95

827

5777

Congenital malformations of cardiac chambers and connections

106

392

4.20

25.03

4.0

3.6

3.56

2.59

mg/l

1.19

347

Cramp and spasm

536

3485

1.78

25.03

2.7

2.2

2.89

2.93

mg/l

0.13

454

2964

Other and unspecified psoriasis

737

5110

1.62

25.01

2.5

2.2

3.20

2.95

mg/l

1.36

645

4344

Polycystic ovarian syndrome

683

4665

1.65

24.95

2.3

2.0

2.60

2.56

mg/l

0.22

612

4007

Rosacea

1244

9399

1.44

24.89

2.4

2.2

3.02

2.89

mg/l

0.77

1083

8065

Focal brain injury

691

4691

1.62

24.84

2.3

2.1

3.07

2.93

mg/l

0.64

581

3995

Secondary and unspecified malignant neoplasm of lymph nodes

956

6970

1.53

24.75

2.1

2.2

3.41

3.02

mg/l

3.62

829

5899

Need for immunization against other single viral diseases

245

1287

2.38

24.74

4.6

2.0

2.40

3.04

mg/l

4.86

217

1111

Hydrocele

1280

9689

1.42

24.63

2.5

2.2

2.99

3.03

mg/l

0.20

1101

8235

Other specified congenital malformation syndromes affecting multiple systems

225

1153

2.49

24.62

2.7

2.9

3.10

2.73

mg/l

0.88

200

1026

Tonsillectomy and adenotomy

6596

40522

1.17

24.60

2.2

2.59

2.75

mg/l

8.81

5767

35089

Amyloidosis

271

1487

2.31

24.59

2.6

2.1

3.08

3.26

mg/l

0.64

242

1258

Pre-eclampsia or poor fetal growth

3391

28560

1.24

24.52

2.3

2.1

2.83

2.72

mg/l

2.31

2974

24618

Other predominantly sexually transmitted diseases, not elsewhere classified

1861

14781

1.34

24.52

2.2

2.1

2.72

mg/l

0.01

1588

12780

Dental pulpitis 3

1554

8638

1.38

24.45

2.2

2.3

2.66

2.50

mg/l

2.39

1323

7422

Complications of cardiac and vascular prosthetic devices, implants and grafts

277

1542

2.30

24.34

3.4

2.2

3.60

3.00

mg/l

2.80

242

1309

Congenital malformations of cardiac septa

766

5190

1.59

24.32

2.7

2.4

3.22

2.78

mg/l

3.30

680

4490

Syphilis

298

1669

2.15

24.31

2.9

2.0

3.22

3.01

mg/l

0.76

260

1437

Cyst of kidney

788

5592

1.60

24.31

2.6

2.2

3.07

3.05

mg/l

0.07

698

4731

Dermatographic urticaria

751

5244

1.60

24.29

2.3

2.1

2.77

2.83

mg/l

0.36

646

4491

Other noninfective disorders of lymphatic vessels and lymph nodes

417

2573

1.91

24.29

2.8

2.1

3.08

2.91

mg/l

0.55

367

2156

Protein-energy malnutrition of moderate and mild degree

143

636

3.54

24.29

3.3

2.5

3.44

3.04

mg/l

0.79

128

542

L01XE Protein kinase inhibitors

658

4524

1.68

24.16

2.2

3.63

3.02

mg/l

4.10

586

3840

Other disorders starting during childhood or adolescence

594

3918

1.68

24.13

2.4

2.6

2.81

2.60

mg/l

1.83

527

3422

Any prescribed medicine buy

4.81

24.12

1.7

2.8

2.92

2.84

mg/l

0.08

Kyphosis

182

872

2.77

24.10

2.8

2.2

3.07

3.15

mg/l

0.10

162

749

Focal epilepsy, mode (most common among epilepsy diagnosis)

2085

16856

1.32

24.09

2.2

2.3

2.97

2.92

mg/l

0.40

1759

14459

Primary open-angle glaucoma

3865

32341

1.23

24.00

2.3

3.13

3.14

mg/l

0.04

3221

27256

Lesion of lateral popliteal nerve

555

3663

1.73

24.00

2.7

2.1

3.00

2.95

mg/l

0.21

489

3107

Hypotension due to drugs

205

1046

2.70

23.91

2.5

2.2

3.00

3.20

mg/l

0.55

175

889

Lichen ruber planus, wide definition including periferal and oral lichen planus

2253

18401

1.30

23.86

2.3

2.85

2.98

mg/l

1.73

1908

15760

Carcinoma in situ of skin of trunk

405

2545

2.00

23.82

2.6

2.2

3.24

3.15

mg/l

0.29

344

2143

Malignant immunoproliferative diseases

155

717

3.26

23.80

2.8

2.1

3.20

3.12

mg/l

0.16

137

617

Open wound of abdomen, lower back and pelvis

353

2087

1.99

23.77

2.5

2.1

3.09

2.86

mg/l

0.88

310

1801

Pregnancy hypertension

4643

36287

1.20

23.64

2.3

2.1

2.94

2.74

mg/l

8.62

4133

31214

Congenital malformations of aortic and mitral valves

452

2854

1.83

23.63

2.5

2.4

3.21

2.85

mg/l

1.91

416

2454

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

5164

39466

1.19

23.57

2.3

2.1

2.94

2.75

mg/l

7.63

4615

33861

Bruxism

242

1291

2.33

23.38

2.5

2.0

2.77

2.86

mg/l

0.15

217

1109

Other neurotic disorders

565

3760

1.70

23.37

2.4

2.1

2.88

2.98

mg/l

0.42

479

3172

Event of undetermined intent

663

4544

1.62

23.36

2.4

2.2

2.97

2.84

mg/l

0.59

574

3898

Persistent delusional disorders

830

5939

1.54

23.35

2.3

2.2

2.83

2.98

mg/l

1.02

714

5032

Palmar fascial fibromatosis [Dupuytren]

1774

14144

1.34

23.31

2.4

2.2

2.85

3.09

mg/l

4.19

1512

11850

Superficial injury of forearm

1056

7848

1.46

23.29

2.4

2.2

2.97

2.84

mg/l

1.04

883

6726

Algoneurodystrophy

377

2285

1.93

23.20

2.7

2.0

3.01

2.88

mg/l

0.48

323

1971

Portal vein thrombosis

197

987

2.58

23.08

4.0

2.0

4.06

3.04

mg/l

3.92

176

842

Other and unspecified disorders of vitreous body

4465

38610

1.20

22.98

2.3

2.87

3.01

mg/l

3.65

3771

32892

Acquired pure red cell aplasia [erythroblastopenia]

279

5.03

22.87

3.3

2.0

3.21

2.89

mg/l

0.41

231

Other/unspecified enthesopathies of lower limb, excluding foot

746

5238

1.56

22.82

2.4

2.1

2.85

2.90

mg/l

0.18

643

4451

Glaucoma suspect

4140

35845

1.21

22.78

2.4

2.3

2.94

3.06

mg/l

2.42

3587

30413

Allergic bronchopulmonary aspergillosis (ABPA)

123

6.38

22.77

2.4

1.6

3.44

2.88

mg/l

0.62

105

Postprocedural disorders of nervous system

792

5634

1.54

22.76

2.3

2.1

2.69

2.76

mg/l

0.41

708

4862

Amyloidosis, other/unspecified

225

1195

2.44

22.74

2.6

2.1

2.99

3.28

mg/l

1.03

200

1007

Acute laryngitis and tracheitis

1261

9443

1.40

22.64

2.7

2.2

2.71

2.67

mg/l

0.28

1092

8092

Gangrene, not elsewhere classified

119

493

3.57

22.60

2.9

2.0

3.53

3.04

mg/l

1.32

105

429

L02BX Other hormone antagonists and related agents

639

4461

1.68

22.57

2.0

2.2

3.10

2.98

mg/l

0.71

558

3783

Infarction of spleen

102

400

4.33

22.56

3.3

2.0

4.44

3.29

mg/l

1.87

342

Molar incisor enamel hypoplasia, with caries

128

553

3.52

22.55

3.8

2.91

2.45

mg/l

1.43

118

492

Pure hyperglyceridaemia

268

1492

2.18

22.53

2.6

2.1

3.05

3.14

mg/l

0.17

232

1272

Intentional self-harm by sharp object

308

1781

2.05

22.51

2.7

2.0

3.04

2.70

mg/l

2.00

270

1544

Mental and behavioural disorders due to cannabinoids

289

1613

2.03

22.49

2.0

2.64

mg/l

0.01

230

1410

Behavioural disorders, excluding more controls

218

1109

2.27

22.48

2.2

2.3

2.70

2.58

mg/l

0.34

194

955

Panniculitis affecting regions of neck and back

433

2732

1.81

22.47

2.5

2.1

2.95

mg/l

0.02

383

2303

Monoarthritis, not elsewhere classified

476

3069

1.76

22.43

2.5

2.0

3.04

2.86

mg/l

1.19

415

2582

Urolithiasis

3688

31655

1.22

22.42

2.4

2.2

3.07

2.98

mg/l

1.32

3162

26928

Nontoxic multinodular goitre

2225

18276

1.29

22.40

2.3

3.14

3.05

mg/l

0.80

1902

15507

Sequelae of injuries of neck and trunk

338

2011

1.98

22.37

2.4

2.1

2.82

2.94

mg/l

0.40

297

1711

Acute generalized exanthematous pustulosis

529

3523

1.73

22.36

2.8

2.2

3.12

2.95

mg/l

0.91

446

2983

Other chondrocalcinosis

180

904

2.84

22.34

2.9

2.2

3.78

3.31

mg/l

1.47

156

770

Allergic contact dermatitis

1470

11507

1.37

22.17

2.2

2.76

2.84

mg/l

0.71

1281

9887

Arterial embolism and thrombosis of lower extremity artery

435

2783

1.84

22.15

2.9

2.1

3.99

3.03

mg/l

6.80

374

2325

Microscopic polyangiitis

385

4.30

22.11

2.5

2.1

2.92

3.17

mg/l

0.50

334

Somnolence, stupor and coma

509

3355

1.73

22.10

2.7

2.1

2.97

3.00

mg/l

0.08

446

2841

Dronedarone medication

337

2022

2.00

22.10

2.6

2.0

3.43

2.85

mg/l

2.77

283

1664

Complications of other internal prosthetic devices, implants and grafts

462

2999

1.80

22.09

2.6

2.1

3.21

3.02

mg/l

0.61

402

2524

Other hereditary haemolytic anaemias

101

391

3.96

22.02

3.4

2.2

5.26

3.03

mg/l

2.94

332

Magnesium deficiency

180

7.33

22.01

3.2

1.8

3.04

3.45

mg/l

0.39

158

Maternal care for known or suspected abnormality of pelvic organs

2801

16130

1.25

21.98

2.1

2.64

2.71

mg/l

0.91

2429

13926

Pemphigoid

353

2177

2.01

21.91

2.7

2.2

3.24

3.20

mg/l

0.08

304

1830

Specific development disorders of scholastic skills

471

3001

1.74

21.89

2.4

2.5

2.67

2.58

mg/l

0.25

403

2618

Benign neoplasm: Skin of eyelid, including canthus

1712

13733

1.34

21.85

2.5

2.3

3.09

3.01

mg/l

0.55

1464

11713

Follicular cysts of skin and subcutaneous tissue

1922

15557

1.31

21.83

2.5

2.2

2.85

2.92

mg/l

0.69

1671

13339

Other renal tubulo-interstitial diseases

294

1699

2.07

21.81

2.5

2.0

3.17

3.05

mg/l

0.38

256

1432

Dislocation, sprain and strain of joint and ligaments of hip

436

2810

1.83

21.69

2.5

2.1

3.13

3.04

mg/l

0.37

384

2372

Oligomenorrhoea

428

2721

1.80

21.59

2.5

2.1

2.83

2.74

mg/l

0.39

377

2342

Polycystic ovarian syndrome, broad definition

1294

10015

1.39

21.59

2.2

2.0

2.74

2.57

mg/l

2.38

1147

8606

Tobacco use

566

3837

1.67

21.53

2.4

2.1

3.17

2.87

mg/l

2.29

494

3271

Conotruncal defects

186

937

2.56

21.51

3.3

3.39

2.67

mg/l

1.46

170

821

Visual field defects

968

7229

1.48

21.51

2.5

2.2

3.01

3.00

mg/l

0.03

824

6142

Other retinal artery occlusion

304

1803

2.09

21.51

2.7

2.2

3.11

3.12

mg/l

0.02

259

1518

Pneumonia derived septicemia

413

2627

1.84

21.51

2.7

2.2

3.21

2.94

mg/l

1.08

358

2230

Pneumonia due to Streptococcus pneumoniae

471

3064

1.74

21.50

2.6

2.1

3.05

2.90

mg/l

0.57

403

2594

Malignant neoplasm of rectosigmoid junction, excluding all cancers (controls excluding all cancers)

345

2102

1.96

21.49

2.2

3.50

2.94

mg/l

1.89

314

1756

Plantar fascial fibromatosis

995

7406

1.45

21.48

2.4

2.1

2.78

2.93

mg/l

1.45

861

6273

Necrotizing fasciitis

272

4.81

21.45

2.9

1.9

3.74

2.98

mg/l

1.63

231

Fluid overload

172

7.11

21.45

3.8

2.0

3.31

2.97

mg/l

0.65

148

Other secondary gonarthrosis

574

3911

1.66

21.44

2.5

2.2

2.77

3.02

mg/l

1.86

506

3297

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)

678

4771

1.59

21.30

2.6

2.3

3.54

2.97

mg/l

4.87

593

4003

Generalized skin eruption due to drugs and medicaments

468

3072

1.77

21.25

2.7

2.2

3.15

2.93

mg/l

1.24

396

2610

Oral lichen ruber planus wide, hypothyreosis or thyroxin

605

4194

1.65

21.21

2.2

2.88

3.06

mg/l

0.81

517

3571

Endometriosis ASRM stages 1,2

1948

15848

1.30

21.18

2.2

2.65

2.78

mg/l

2.07

1653

13684

Chronic iridocyclitis

564

3837

1.66

21.17

2.6

2.2

3.07

2.95

mg/l

0.50

500

3239

Juvenile rheumatoid arthirtis

275

1564

2.08

21.16

2.9

2.0

3.22

2.67

mg/l

3.21

252

1325

Mental retardation, excluding more controls

383

2324

1.82

21.12

2.3

2.6

3.01

2.76

mg/l

1.56

344

2037

Cluster headache, strict, including avohilmo

523

3496

1.68

21.02

2.6

2.1

2.69

2.84

mg/l

0.84

461

3005

Entropion and trichiasis of eyelid

1009

7630

1.47

20.98

2.5

2.3

3.04

3.13

mg/l

0.53

835

6434

Wide developmental disorders

343

2072

1.90

20.95

2.1

2.6

2.62

2.67

mg/l

0.20

287

1822

Myocardial infarction, with ST-elevation

2058

16906

1.30

20.95

2.5

2.3

3.22

3.10

mg/l

1.32

1754

14218

Calculus of kidney and ureter

3380

28973

1.22

20.94

2.4

2.2

3.04

2.97

mg/l

0.88

2905

24669

Lichen planus, including avohilmo

1931

15744

1.31

20.93

2.3

2.87

2.98

mg/l

1.15

1630

13472

Bell's palsy

1267

9821

1.39

20.91

2.4

2.2

3.08

2.93

mg/l

1.30

1076

8384

Von Willebrand disease

186

950

2.54

20.90

4.0

2.0

2.90

3.00

mg/l

0.20

166

810

Protozoal diseases

328

1991

1.99

20.89

2.8

2.2

3.19

3.07

mg/l

0.37

296

1686

Spinal instabilities

319

1898

1.95

20.86

2.7

2.0

3.26

3.01

mg/l

1.33

285

1602

Diffuse large B-cell lymphoma

525

3565

1.72

20.83

2.1

2.2

3.53

3.09

mg/l

2.39

450

2996

Cardiomyopathy in other diseases

317

4.39

20.80

2.7

2.0

3.26

3.00

mg/l

0.37

270

Foreign body in alimentary tract

622

4336

1.62

20.77

2.5

2.2

3.12

2.97

mg/l

0.80

518

3699

Eosinophilic disease (BM)

192

986

2.43

20.66

3.1

2.1

2.96

2.94

mg/l

0.04

168

822

Benign neoplasm: Pituitary gland, craniopharyngeal duct

551

3744

1.66

20.65

2.2

2.92

2.82

mg/l

0.54

486

3190

Other specified disorders of kidney and ureter

391

2481

1.85

20.64

2.7

2.1

3.27

3.02

mg/l

1.00

352

2101

Carcinoma in situ of skin of ear and external auricular canal

190

994

2.57

20.61

2.7

2.2

3.16

2.94

mg/l

0.59

161

840

Use of levodopa decarboxylase inhibitor

1542

12345

1.36

20.61

2.3

2.96

3.12

mg/l

1.74

1273

10405

Salpingitis and oophoritis

1848

14988

1.31

20.59

2.4

2.2

2.93

2.90

mg/l

0.16

1549

12883

Cluster headache, wide,, including avohilmo

551

3739

1.65

20.57

2.6

2.1

2.73

2.86

mg/l

0.69

487

3203

Cerebral cysts

625

4357

1.60

20.54

2.8

2.2

2.98

2.88

mg/l

0.41

560

3712

Unspecified nephritic syndrome

273

1578

2.10

20.49

3.0

2.1

3.20

3.05

mg/l

0.53

243

1348

Embolic stroke with flimmer

315

1891

1.98

20.44

2.7

2.1

3.07

2.95

mg/l

0.36

272

1578

Blood alcohol or alcohol intoxication level

279

1610

2.04

20.43

2.2

2.0

3.41

2.83

mg/l

2.09

239

1376

Hypoplasia of dental enamel, including avohilmo

137

641

3.15

20.38

4.3

3.8

2.93

2.51

mg/l

1.31

127

570

Disease of hard tissues of teeth, NOS

141

648

2.83

20.31

2.5

2.0

2.43

3.02

mg/l

1.98

119

552

Other noninflammatory disorders of vagina

859

6324

1.48

20.25

2.5

2.2

2.92

2.90

mg/l

0.07

729

5426

Certolizumab pegol

216

1166

2.29

20.23

2.4

1.9

3.06

2.80

mg/l

0.85

195

1004

Other keratitis

1170

9007

1.40

20.23

2.5

2.2

2.80

2.88

mg/l

0.63

1014

7704

Drug-induced neutropenia

766

5571

1.53

20.14

2.2

3.32

2.98

mg/l

2.75

692

4734

Other congenital malformations of the digestive system

516

3466

1.68

20.11

3.7

2.4

2.98

2.84

mg/l

0.80

467

3004

Other immunodeficiencies

155

751

2.74

20.10

4.7

2.3

2.86

3.06

mg/l

0.46

149

653

Cachexia

303

4.23

20.08

2.6

1.9

2.87

3.07

mg/l

0.37

258

ILD-related respiratory insufficiency

400

2595

1.86

20.04

3.1

2.2

3.68

3.10

mg/l

2.78

365

2195

Exclusion endpoint for clefts

250

1416

2.14

19.96

2.7

3.13

2.75

mg/l

1.01

223

1249

Lactose intolerance

362

2260

1.85

19.89

2.7

2.1

2.87

2.96

mg/l

0.32

314

1921

Sacrococcygeal disorders, not elsewhere classified

343

2108

1.87

19.85

2.3

2.1

2.58

2.95

mg/l

2.87

305

1797

Thalassaemia

237

5.16

19.85

2.8

2.0

3.92

2.80

mg/l

2.72

201

Drug-induced obesity

131

596

2.99

19.83

2.8

2.0

3.25

2.98

mg/l

0.49

114

513

Assault by unspecified means

219

1179

2.19

19.78

2.1

2.94

2.76

mg/l

0.41

190

1028

Alzheimer disease, including avohilmo

4323

27366

1.20

19.74

2.3

2.4

3.07

3.19

mg/l

2.38

3512

22984

Toxic liver disease

195

1030

2.40

19.74

3.1

2.1

2.60

3.12

mg/l

2.81

167

887

Hypersplenism

241

4.79

19.63

3.1

1.9

3.46

2.93

mg/l

1.04

210

Other obstructive and reflux uropathy

514

3484

1.66

19.59

2.5

2.0

3.30

2.86

mg/l

2.96

458

2926

Acquired absence of organs, not elsewhere classified

158

776

2.64

19.56

3.1

2.1

3.07

3.14

mg/l

0.13

135

666

Chondrocostal junction syndrome [Tietze]

436

2872

1.76

19.53

2.7

2.1

2.80

2.94

mg/l

0.66

370

2443

Other and unspecified glaucoma

816

6049

1.51

19.51

2.4

2.3

3.12

3.13

mg/l

0.06

688

5097

Degenerative macular diseases

1419

11318

1.36

19.51

2.6

2.3

3.10

mg/l

0.00

1180

9536

Superficial injury of ankle and foot

1234

9600

1.37

19.49

2.5

2.2

2.77

2.78

mg/l

0.08

1061

8283

Nasal polyp

2059

16986

1.28

19.48

2.3

2.2

2.85

2.97

mg/l

1.58

1754

14523

Bullous pemphigoid

283

1703

2.10

19.47

2.6

2.2

3.22

3.23

mg/l

0.01

239

1435

Shock, not elsewhere classified

130

591

2.93

19.47

3.2

1.9

2.84

3.14

mg/l

0.41

118

497

Other/unspecified enthesopathies, not elsewhere classified

939

7047

1.44

19.46

2.4

2.1

2.99

mg/l

0.02

815

5958

Fracture of neck

648

4613

1.58

19.44

2.7

2.2

3.08

3.01

mg/l

0.26

566

3921

Parkinson's disease, including avohilmo

1800

14738

1.31

19.41

2.3

3.01

3.11

mg/l

1.02

1493

12447

Other strabismus

2374

19792

1.25

19.38

2.4

2.3

2.81

2.82

mg/l

0.01

2053

17059

Carrier of infectious disease

289

1725

2.01

19.37

2.7

2.0

3.36

2.97

mg/l

1.18

258

1493

Vascular dementia

1036

7657

1.43

19.31

2.5

2.4

3.21

3.29

mg/l

0.31

835

6396

Carcinoma in situ of skin of upper limb, including shoulder

279

1673

2.09

19.30

2.6

2.3

2.90

3.00

mg/l

0.31

237

1397

Mixed disorders of conduct and emotions, excluding more controls

244

1360

2.04

19.26

2.3

2.4

2.90

2.45

mg/l

2.02

217

1191

Postviral fatigue syndrome

117

513

3.12

19.22

2.9

2.2

2.24

2.76

mg/l

3.33

101

446

Alcoholic gastritis

180

925

2.40

19.21

2.6

1.9

3.26

3.07

mg/l

0.46

152

792

Oral leukoplakia and related diseases, including avohilmo

940

7102

1.45

19.20

2.4

2.2

2.97

3.02

mg/l

0.17

805

6054

Dental pulpitis 3, only avohilmo

1413

8128

1.34

19.18

2.2

2.3

2.66

2.49

mg/l

2.37

1199

6974

Myeloid leukaemia

319

1970

1.95

19.13

2.5

2.2

3.02

3.13

mg/l

0.26

274

1661

Benign neoplasm: Oesophagus

160

800

2.63

19.13

2.9

2.1

3.06

3.13

mg/l

0.12

144

666

Autism

265

1530

2.01

19.11

2.2

2.4

2.71

2.61

mg/l

0.39

220

1332

Adenocarcinoma and papillary adenocarcinoma of stomach, excluding all cancers (controls excluding all cancers)

320

1960

1.91

19.10

2.6

2.2

3.38

3.03

mg/l

1.32

293

1626

Specific development disorders of speech and language

627

4246

1.56

19.08

2.6

2.5

2.89

2.79

mg/l

0.52

550

3691

Ethmoidectomy

1333

10519

1.35

19.03

2.5

2.2

2.84

2.87

mg/l

0.19

1155

9057

Emphysema

785

5780

1.50

18.99

2.5

2.2

3.40

2.97

mg/l

3.85

670

4844

Impacted cerumen

1099

8518

1.41

18.98

2.5

2.3

2.97

3.01

mg/l

0.20

816

7260

Inflammatory diseases of the central nervous system

885

6625

1.46

18.91

2.5

2.2

3.08

2.92

mg/l

0.92

762

5639

CR(E)ST syndrome

200

1088

2.34

18.81

3.9

2.1

3.13

mg/l

0.01

183

916

Schizoid personality disorder

197

1046

2.25

18.79

2.4

2.0

3.05

2.99

mg/l

0.13

177

893

Biomechanical lesions, not elsewhere classified

543

3770

1.64

18.76

2.3

2.2

2.67

3.01

mg/l

2.14

451

3196

Pneumococcal septicemia

389

2522

1.80

18.75

2.7

2.2

3.20

2.97

mg/l

0.79

336

2147

Other and specified injuries of hip and thigh

279

1673

2.03

18.73

2.6

2.2

2.98

3.13

mg/l

0.46

235

1422

Fibrosis of liver

101

425

3.53

18.73

3.7

2.0

3.60

3.04

mg/l

1.33

366

Testicular dysfunction

321

1954

1.85

18.73

2.4

2.1

3.16

2.89

mg/l

1.11

269

1697

Hyperfunction of pituitary gland

550

3808

1.61

18.71

2.5

2.1

2.71

2.80

mg/l

0.54

466

3282

Degenerative diseases of the nervous system

4148

27405

1.19

18.68

2.3

2.4

3.07

3.18

mg/l

2.03

3330

23038

Chronic hepatitis NAS

176

918

2.46

18.64

2.9

2.0

3.23

3.12

mg/l

0.20

158

777

Otitis externa, unspecified

1155

8989

1.38

18.60

2.6

2.2

2.86

2.85

mg/l

0.03

982

7753

Carcinoma in situ of skin of scalp and neck

314

1982

2.02

18.56

2.9

2.3

3.15

3.18

mg/l

0.05

274

1683

FESS (DNB20)

1280

10083

1.36

18.55

2.5

2.2

2.85

2.86

mg/l

0.10

1103

8684

Toxic effects of substances chiefly nonmedicinal as to source

1177

9172

1.37

18.53

2.3

2.2

2.81

2.85

mg/l

0.22

1013

7881

Operations for atrial fibrillation

201

1109

2.36

18.52

2.7

2.1

2.87

3.15

mg/l

0.88

176

944

Myositis

300

1825

1.93

18.51

2.4

2.1

3.06

2.98

mg/l

0.21

268

1524

Lichen planus

1356

10794

1.35

18.44

2.4

2.3

2.86

3.00

mg/l

1.24

1160

9201

Gastrointestinal stromal tumor and sarcoma, excluding all cancers (controls excluding all cancers)

151

757

2.70

18.35

2.3

2.1

3.36

3.17

mg/l

0.36

128

630

Complications following infusion, transfusion and therapeutic injection

192

1035

2.33

18.32

3.1

2.0

3.09

3.02

mg/l

0.16

164

882

Correction of physiology of bite - very demanding therapy visit

334

2097

1.86

18.29

2.7

2.1

3.04

2.87

mg/l

0.62

300

1800

Other disorders of electrolyte and fluid balance, not elsewhere classified

126

585

2.92

18.28

2.8

2.2

2.96

3.30

mg/l

1.06

116

485

Neuroendocrine tumor and carcinoma of small intestine, excluding all cancers (controls excluding all cancers)

175

922

2.47

18.26

2.7

2.1

3.17

3.06

mg/l

0.20

157

765

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS)

318

2002

1.94

18.13

2.1

2.2

2.83

3.18

mg/l

1.93

261

1660

Multiple myeloma

318

2002

1.94

18.13

2.1

2.2

2.83

3.18

mg/l

1.93

261

1660

Allergic urticaria

893

6737

1.44

18.08

2.4

2.2

2.82

2.84

mg/l

0.11

753

5758

Pathological/recurrent dislocation and subluxation of joint, not elsewhere classified

769

5633

1.46

18.02

2.3

2.1

2.82

2.79

mg/l

0.15

655

4826

Melanocytic naevi of trunk

1194

9365

1.36

17.95

2.4

2.2

2.73

2.78

mg/l

0.28

1044

7981

Endocrine disorders, other/unspecified

244

1420

2.07

17.90

2.8

2.1

3.58

3.05

mg/l

2.39

216

1209

Benign neoplasm: Anus and anal canal

325

2043

1.87

17.88

2.7

2.2

3.07

2.93

mg/l

0.49

280

1723

Unspecified protein-energy malnutrition

385

3.83

17.83

2.7

2.3

3.61

3.09

mg/l

0.53

326

Common variable immunodeficiency

395

3.46

17.81

4.0

2.0

2.97

3.30

mg/l

0.73

350

Other sideroblastic anaemias

240

4.64

17.78

4.3

1.8

3.99

3.03

mg/l

2.07

201

Other bursitis of hip

247

1449

2.06

17.77

2.6

2.0

2.74

3.06

mg/l

1.38

215

1200

Lactose intolerance, other/unspecified

315

1955

1.86

17.76

2.7

2.1

2.88

2.99

mg/l

0.36

276

1664

Heterophoria

867

6534

1.44

17.73

2.3

2.2

2.79

2.81

mg/l

0.14

754

5600

Other and unspecified injuries of lower leg

791

5877

1.47

17.72

2.5

2.2

2.92

2.85

mg/l

0.37

676

5032

Dental caries 3 and operation codes, only avohilmo

4287

18882

1.18

17.65

2.2

2.3

2.79

2.87

mg/l

1.50

3697

16349

Leiomyoma of uterus

7409

38171

1.13

17.62

2.3

2.2

3.11

2.92

mg/l

7.27

6256

32885

Lesion of radial nerve

410

2716

1.72

17.54

2.7

2.1

3.10

3.02

mg/l

0.22

352

2283

Ectropion of eyelid

494

3431

1.66

17.52

2.4

2.3

3.10

3.18

mg/l

0.29

417

2865

Personal history of risk-factors, not elsewhere classified

167

868

2.40

17.49

2.7

2.1

2.70

2.80

mg/l

0.24

153

734

Osteonecrosis due to drugs

168

893

2.51

17.48

2.7

2.1

2.92

3.27

mg/l

1.14

153

770

Glaucoma secondary to other eye disorders

474

3251

1.66

17.41

2.8

2.2

3.28

3.06

mg/l

1.06

423

2754

Carcinoma in situ of other and unspecified sites

388

2564

1.77

17.41

2.5

2.2

3.15

2.96

mg/l

0.80

328

2152

Scleritis and episcleritis

623

4469

1.53

17.36

2.4

2.1

2.84

2.92

mg/l

0.42

549

3814

Parkinson's disease

1714

14133

1.30

17.29

2.3

3.00

3.10

mg/l

0.95

1415

11930

Other arterial embolism and thrombosis

337

2152

1.82

17.29

3.0

2.1

3.17

3.04

mg/l

0.49

297

1800

Other or unspecified common variable immunodeficiency

206

5.02

17.26

2.9

2.0

3.13

3.16

mg/l

0.04

182

Psoriasis (vulgaris), strict definition

325

2042

1.81

17.24

2.5

2.1

3.33

2.91

mg/l

2.15

284

1758

Carcinoma in situ of rectum

116

540

3.06

17.22

2.3

2.1

2.68

2.94

mg/l

0.76

101

461

Respiratory disorders in diseases classified elsewhere

179

968

2.36

17.22

3.0

2.1

3.50

3.12

mg/l

0.95

167

832

Testicular hypofunction

282

1697

1.87

17.22

2.4

2.1

3.18

2.89

mg/l

1.06

238

1478

Bronchitis, not specified as acute or chronic

925

7048

1.41

17.22

2.7

2.1

3.19

2.90

mg/l

2.08

789

5960

Early lumbar disc prolapse, operated

873

6553

1.41

17.14

2.1

2.65

2.70

mg/l

0.33

769

5711

Follow-up care involving plastic surgery

423

2835

1.69

17.10

2.4

2.1

3.38

2.96

mg/l

2.74

331

2391

Benign neoplasm: Skin of other and unspecified parts of face

1152

9070

1.37

17.10

2.4

2.3

3.04

2.92

mg/l

0.78

968

7667

Congenital malformations and deformations of the musculoskeletal system

930

7065

1.41

17.08

2.7

2.3

2.68

2.75

mg/l

0.46

806

6134

Left hemicolectomy

297

1863

1.93

17.05

2.9

2.2

3.08

3.13

mg/l

0.09

270

1571

Other other unspecified disorders of the circulatory system

425

2872

1.70

17.03

2.9

2.2

3.01

3.07

mg/l

0.22

376

2437

274

1653

1.91

17.03

2.3

2.1

2.84

2.87

mg/l

0.08

237

1424

Glaucoma, exfoliation

1342

10823

1.34

16.98

2.3

3.16

3.21

mg/l

0.30

1128

9066

Secondary thrombocytopenia

157

815

2.49

16.96

2.8

2.0

3.33

3.01

mg/l

0.85

150

715

Primary open-angle glaucoma, strict

3066

26537

1.21

16.96

2.4

2.3

3.11

3.14

mg/l

0.22

2563

22386

Mixed conductive and sensorineural hearing loss

1342

10783

1.33

16.94

2.4

2.3

3.02

2.98

mg/l

0.19

1109

9188

Rare circulating lymphoid malignancy, excluding all cancers (controls excluding all cancers)

346

2235

1.80

16.91

2.2

2.5

3.07

2.87

mg/l

0.69

302

1900

Autism spe

254

1503

1.95

16.88

2.2

2.3

2.70

2.64

mg/l

0.24

210

1307

Maltreatment syndromes

521

3623

1.57

16.85

2.3

2.0

2.75

2.70

mg/l

0.18

436

3128

Hepatocellular carcinoma, excluding all cancers (controls excluding all cancers)

309

1945

1.86

16.84

2.8

2.3

3.69

2.98

mg/l

4.18

271

1628

N06DA Anticholinesterases

3969

28353

1.19

16.79

2.2

2.4

3.12

3.19

mg/l

0.83

3210

23809

Use of anticholinesterases

3969

28353

1.19

16.79

2.2

2.4

3.12

3.19

mg/l

0.83

3210

23809

Symptoms and signs involving emotional state

334

2132

1.79

16.79

2.4

2.1

2.51

2.86

mg/l

1.96

294

1821

Bicuspidal aortic valve syndrome

371

2425

1.74

16.77

2.4

2.3

3.23

2.91

mg/l

1.31

340

2082

Use of antiglaucoma preparations and miotics

966

7496

1.41

16.76

2.4

2.3

3.14

3.18

mg/l

0.15

815

6307

Bursitis of shoulder

277

1689

1.90

16.76

2.3

2.0

2.65

3.03

mg/l

2.33

249

1413

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum

1078

8472

1.38

16.75

2.2

3.41

3.04

mg/l

3.43

907

7175

Other prurigo

152

784

2.51

16.74

2.6

2.1

3.14

3.12

mg/l

0.02

131

666

Malignant neoplasm of head and neck, excluding all cancers (controls excluding all cancers)

1025

7963

1.38

16.72

2.2

2.3

2.79

2.94

mg/l

1.34

864

6729

Lichen simplex chronicus

374

2456

1.74

16.71

2.5

2.1

2.95

3.00

mg/l

0.13

332

2081

Childhood allergy (age < 16)

1670

11233

1.28

16.67

2.5

2.2

2.49

2.51

mg/l

0.17

1457

9648

Injury of muscle and tendon at shoulder and upper arm level

3755

32968

1.18

16.67

2.3

2.2

2.90

2.98

mg/l

1.42

3246

28237

Neovascular glaucoma

471

3256

1.64

16.67

2.8

2.2

3.28

3.04

mg/l

1.24

421

2746

Other overlap syndromes

231

1358

2.07

16.66

2.9

2.1

3.28

3.04

mg/l

0.74

202

1158

248

1472

1.97

16.62

2.4

1.9

2.77

2.66

mg/l

0.54

228

1258

Poisoning by narcotics and psychodysleptics [hallucinogens]

176

938

2.22

16.53

2.5

2.0

3.05

2.79

mg/l

0.73

147

805

Benign neoplasm: Oesophagus

160

846

2.45

16.53

2.9

2.0

3.06

3.19

mg/l

0.28

144

722

Hemiplegia

573

4095

1.55

16.52

2.6

2.2

3.14

2.99

mg/l

0.63

494

3463

Disorders of speech understanding and production

464

3133

1.63

16.44

2.6

2.5

2.94

2.82

mg/l

0.59

410

2729

Effects of foreign body entering through natural orifice

2449

20820

1.22

16.43

2.3

2.2

2.83

2.88

mg/l

0.47

2083

17977

Other and unspecified types of non-Hodgkin lymphoma, hilmo

474

3299

1.64

16.42

2.4

2.2

3.51

3.11

mg/l

2.10

412

2765

Carcinoma in situ, bladder

360

2375

1.78

16.41

2.6

2.2

3.11

2.98

mg/l

0.47

305

1993

Other and unspecified epidermal thickening

312

1982

1.84

16.41

3.1

2.2

3.42

2.96

mg/l

2.09

284

1688

Astigmatism

663

4856

1.50

16.40

2.3

2.80

2.83

mg/l

0.13

564

4190

Clear cell adenocarcinoma of kidney

504

3555

1.62

16.40

2.3

2.2

3.19

3.06

mg/l

0.49

434

3027

Abrasion of teeth

3053

19399

1.20

16.33

2.3

2.2

2.68

2.89

mg/l

6.31

2578

16854

Lichen sclerosus et atrophicus

1030

8051

1.38

16.31

2.4

2.2

2.95

3.02

mg/l

0.38

885

6868

Meralgia paraesthetica

363

2384

1.74

16.28

2.5

2.1

2.68

2.96

mg/l

1.92

316

2021

Septal defects

686

4955

1.49

16.24

2.7

2.5

3.17

2.80

mg/l

2.37

606

4290

Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere

771

5798

1.46

16.18

2.6

2.2

3.13

3.10

mg/l

0.10

657

4845

Neuroendocrine tumor and carcinoma of small intestine

175

963

2.34

16.16

2.7

2.1

3.17

3.24

mg/l

0.14

157

833

Other interventions on the root canals of the tooth

209

1195

2.09

16.15

2.5

2.1

2.79

2.94

mg/l

0.29

178

1028

Injuries involving multiple body regions

410

2765

1.67

16.11

2.6

2.1

2.85

2.93

mg/l

0.34

341

2351

Benign neoplasm of mouth and pharynx

1166

9269

1.35

16.10

2.5

2.2

2.90

2.99

mg/l

0.60

977

7928

Chronic myeloid leukaemia, excluding all cancers (controls excluding all cancers)

124

603

2.73

16.05

2.8

2.1

2.81

2.99

mg/l

0.36

114

510

Adenocarcinoma and papilloma adenocarcinoma of rectum

1035

8139

1.38

16.03

2.2

3.44

3.05

mg/l

3.66

867

6885

Dissection of aorta

370

2458

1.73

16.02

2.7

2.1

3.31

3.03

mg/l

1.18

310

2067

Sequelae of injuries of upper limb

961

7440

1.38

15.96

2.3

2.2

2.70

2.90

mg/l

2.00

831

6405

Melanocytic naevi

3169

27580

1.19

15.96

2.4

2.2

2.72

2.86

mg/l

3.19

2773

23678

Other disorders of optic [2nd] nerve and visual pathways

688

5110

1.48

15.95

2.4

2.2

3.18

2.92

mg/l

2.03

604

4352

Combined immunodeficiencies

146

754

2.48

15.94

3.4

2.2

3.05

3.09

mg/l

0.09

130

650

Benign neoplasm: Other and unspecified parts of small intestine

204

1178

2.16

15.91

3.3

2.1

3.47

3.03

mg/l

1.33

184

973

Paraplegia, diplegia of upper limbs

262

1610

1.93

15.88

2.8

2.1

3.23

3.02

mg/l

0.53

221

1374

Paranoid personality disorder

221

1291

2.03

15.87

2.2

2.0

2.76

2.88

mg/l

0.30

196

1106

Other abnormal immunological findings in serum

235

1403

2.00

15.86

2.6

2.1

2.75

2.93

mg/l

0.54

208

1199

Other acute viral hepatitis

146

748

2.41

15.83

2.4

2.1

2.79

2.96

mg/l

0.38

124

649

Other infective otitis externa

641

4706

1.50

15.82

2.5

2.2

2.93

2.91

mg/l

0.07

525

4016

Achilles tendinitis

1003

7806

1.37

15.81

2.4

2.1

2.94

mg/l

0.02

848

6651

Burns and corrosions

1378

11144

1.31

15.79

2.3

2.2

2.81

2.85

mg/l

0.31

1177

9634

Benign neoplasm: Skin of ear and external auricular canal

431

2956

1.65

15.79

2.3

2.2

3.32

2.94

mg/l

1.75

364

2492

Disorders of breast

5590

46694

1.14

15.75

2.3

2.2

2.79

2.91

mg/l

3.42

4797

40026

Sequelae of injuries of head

526

3725

1.55

15.74

2.3

2.1

2.90

mg/l

0.01

436

3192

Iridocyclitis in diseases classified elsewhere

222

1311

2.05

15.68

2.8

2.2

3.35

3.06

mg/l

0.82

190

1119

Parkinson's disease, strict definition

1587

13123

1.29

15.67

2.3

2.98

3.11

mg/l

1.33

1308

11081

Infections of genitourinary tract in pregnancy

1032

8095

1.37

15.66

2.3

2.1

3.02

2.78

mg/l

2.59

911

6903

Anomalies of dental arch relationship, including avohilmo

2017

15198

1.25

15.66

2.5

2.2

2.73

2.76

mg/l

0.24

1748

13107

Radial styloid tenosynovitis [de Quervain]

564

4041

1.52

15.61

2.3

2.0

2.72

2.86

mg/l

0.93

488

3437

Pre-eclampsia or eclampsia

2267

19259

1.23

15.55

2.4

2.2

2.98

2.75

mg/l

5.07

1989

16560

Vascular dementia (subcortical)

366

2459

1.75

15.51

2.4

2.3

3.20

3.27

mg/l

0.14

312

2075

248

1507

1.94

15.51

2.3

2.79

2.51

mg/l

1.45

215

1305

Impetigo

464

3222

1.59

15.48

3.1

2.2

2.87

2.78

mg/l

0.37

410

2795

Trigeminal neuralgia

628

4611

1.50

15.44

2.4

2.1

2.88

2.98

mg/l

0.41

545

3906

Overexertion and strenuous or repetitive movements

999

7815

1.37

15.39

2.3

2.2

2.62

2.86

mg/l

2.43

834

6721

Keratitis and keratoconjunctivitis in other diseases classified elsewhere

412

2823

1.66

15.34

2.6

2.1

3.06

3.08

mg/l

0.07

360

2377

Thyroiditis

766

5807

1.44

15.31

2.4

2.2

2.66

2.91

mg/l

2.28

656

4955

Syndrome of inappropriate secretion of antidiuretic hormone

367

3.55

15.30

2.7

2.0

2.76

3.21

mg/l

1.19

314

Disorders of myoneural junction and muscle in diseases classified elsewhere

111

530

2.86

15.27

3.1

2.1

3.53

3.15

mg/l

0.73

454

Hodgkin lymphoma

310

1992

1.78

15.27

2.3

2.1

3.29

2.82

mg/l

2.75

281

1703

Burns and corrosions of external body surface, specified by site

1093

8652

1.34

15.25

2.2

2.81

2.88

mg/l

0.61

938

7458

Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue

125

625

2.66

15.21

2.1

3.06

3.03

mg/l

0.06

108

532

Superficial injuries involving multiple body regions

296

1886

1.81

15.18

2.8

2.0

2.96

2.99

mg/l

0.06

245

1604

Intracranial and intraspinal abscess and granuloma

144

755

2.44

15.14

3.0

2.0

3.32

3.18

mg/l

0.22

125

653

Parodontitis, operation under 40 years and operation codes

896

6897

1.38

15.13

2.3

2.1

2.63

2.51

mg/l

0.89

761

5963

Schizotypal disorder

241

1447

1.90

15.11

2.1

2.0

2.88

2.78

mg/l

0.26

201

1255

Diffuse brain injury

368

2437

1.66

15.10

2.2

2.0

3.01

2.82

mg/l

0.55

304

2086

Type 1 diabetes, strict definition

778

5850

1.41

15.09

2.2

2.3

2.63

2.57

mg/l

0.46

676

5105

Personal history of certain other diseases

230

1381

1.97

15.05

2.3

2.0

3.45

2.58

mg/l

4.90

203

1175

Other and unspecified haemorrhagic conditions

197

1139

2.11

15.04

3.3

2.2

4.02

3.08

mg/l

2.95

174

987

Recurrent dislocation of patella

538

3844

1.52

14.99

2.2

2.0

2.86

2.66

mg/l

1.24

470

3286

Sudden idiopathic hearing loss

1063

8437

1.35

14.97

2.5

2.2

3.14

2.96

mg/l

1.34

899

7198

Benign neoplasm: Pituitary gland, craniopharyngeal duct

551

3988

1.53

14.95

2.2

2.92

mg/l

0.02

486

3398

Other diseases of spinal cord

333

2192

1.74

14.87

2.4

2.1

3.11

3.00

mg/l

0.30

298

1862

Parodontitis, under 40 years and operation codes

893

6889

1.37

14.85

2.3

2.1

2.63

2.51

mg/l

0.89

758

5957

!Aliquae complicationes praecoces traumatis

436

3024

1.61

14.84

2.7

2.2

3.37

2.98

mg/l

2.57

381

2589

Early complications of trauma

436

3024

1.61

14.84

2.7

2.2

3.37

2.98

mg/l

2.57

381

2589

Dermatopolymyositis (FG)

161

871

2.23

14.84

2.7

1.9

3.29

3.12

mg/l

0.34

144

723

Nonsuppurative otitis media

2600

19324

1.21

14.83

2.4

2.2

2.70

2.72

mg/l

0.12

2257

16524

Injury of other and unspecified intrathoracic organs

649

4818

1.47

14.82

2.3

2.2

2.98

mg/l

0.01

548

4094

Malignant neoplasm of urinary organs

1061

8447

1.36

14.81

2.3

3.31

3.05

mg/l

2.46

906

7158

Ehlers-Danlos syndrome

134

691

2.50

14.77

3.2

2.1

2.46

2.84

mg/l

1.56

113

596

Benign neoplasm of meninges

1009

7968

1.36

14.76

2.4

2.3

2.99

2.95

mg/l

0.24

850

6755

Personal history of medical treatment

122

608

2.61

14.75

3.0

2.0

3.26

2.99

mg/l

0.53

105

524

Carcinoma in situ of skin of ear and external auricular canal

190

1115

2.22

14.72

2.7

2.2

3.16

3.07

mg/l

0.19

161

951

Dental caries 1 and operation codes, only avohilmo

3667

16202

1.18

14.72

2.2

2.3

2.80

2.91

mg/l

2.25

3148

14067

Other bullous disorders

311

2030

1.78

14.67

2.2

2.83

3.04

mg/l

0.93

266

1747

Alkalosis

129

5.97

14.67

3.4

2.0

3.09

3.28

mg/l

0.22

110

Encephalitis

321

2103

1.75

14.66

2.4

2.2

3.10

2.95

mg/l

0.39

272

1788

Abscess of lung

180

1020

2.16

14.66

3.0

2.0

2.94

3.09

mg/l

0.38

157

874

Carcinoma in situ of rectum

116

579

2.80

14.64

2.3

2.1

2.68

3.10

mg/l

1.51

101

504

Atlantoaxial subluxation

445

2.99

14.62

2.6

2.1

3.70

3.17

mg/l

1.37

379

Somnolence

164

904

2.24

14.62

2.6

1.9

2.82

2.88

mg/l

0.14

148

780

Examination and encounter for administrative purposes

421

2897

1.60

14.60

2.4

2.0

3.12

2.91

mg/l

1.00

374

2444

Other specified/unspecified dorsopathies

381

2579

1.65

14.59

2.3

2.1

2.64

3.01

mg/l

2.39

329

2162

Type 1 diabetes, strict definition, subgroup 1

731

5483

1.41

14.46

2.2

2.3

2.61

2.56

mg/l

0.32

634

4777

Malignant neoplasm of kidney, except renal pelvis

973

7691

1.37

14.46

2.3

3.35

3.05

mg/l

2.87

833

6504

Pseudopolyposis of colon

165

4.84

14.45

2.6

1.9

2.90

3.38

mg/l

0.67

143

Pre-eclampsia

2095

17796

1.23

14.43

2.4

2.1

2.99

2.73

mg/l

5.54

1841

15311

Other encephalitis

304

1977

1.77

14.42

2.4

2.2

3.10

2.95

mg/l

0.36

257

1679

Status epilepticus

386

2631

1.64

14.38

2.4

2.2

3.04

2.92

mg/l

0.36

331

2239

Postpartum care and examination

1664

8788

1.27

14.36

2.1

2.63

2.64

mg/l

0.06

1446

7589

Campylobacter enteritis

293

1888

1.78

14.34

2.5

2.1

3.27

2.94

mg/l

1.02

251

1613

Other forms of systemic lupus erythematosus

117

582

2.65

14.34

3.1

2.0

3.15

3.03

mg/l

0.22

110

495

malignant neoplasm of female genital organs, excluding all cancers (controls excluding all cancers)

1919

15950

1.24

14.34

2.2

2.3

3.23

3.01

mg/l

2.92

1625

13547

Abdominal aortic aneurysm (AAA)

1187

9505

1.32

14.32

2.4

2.2

3.53

3.05

mg/l

6.83

1012

7873

Scabies

434

3017

1.58

14.32

2.5

2.1

2.99

2.83

mg/l

0.66

360

2600

Gastrointestinal stromal tumor and sarcoma

151

831

2.40

14.30

2.3

2.0

3.36

3.27

mg/l

0.15

128

708

Poisoning by and exposure to other and unspecified chemicals and noxious substances, undetermined intent

153

825

2.25

14.29

2.8

2.2

3.15

3.07

mg/l

0.16

138

703

Neuroendocrine tumor and carcinoma of stomach

314

3.61

14.28

3.2

2.0

3.50

3.42

mg/l

0.09

270

Other and unspecified iridocyclitis

446

3133

1.58

14.26

2.5

2.1

2.75

2.99

mg/l

1.65

396

2657

Right ventricular outflow tract obstruction

119

598

2.63

14.26

3.4

3.3

3.16

2.68

mg/l

0.73

109

521

Benign neoplasm of urinary organs

480

3428

1.56

14.16

2.4

2.2

2.83

2.93

mg/l

0.39

408

2893

Nosocomial condition (hospital)

417

3.14

14.15

2.8

2.0

3.14

3.32

mg/l

0.20

352

Female infertility, tubal origin

470

3310

1.54

14.08

2.3

2.1

2.72

2.73

mg/l

0.05

414

2890

Congenital malformations of the musculoskeletal system, not elsewhere classified

183

1057

2.11

14.03

3.6

2.1

2.50

2.81

mg/l

1.49

155

913

Endometriosis of rectovaginal septum and vagina

843

6544

1.39

14.02

2.3

2.2

2.96

2.91

mg/l

0.24

713

5616

L02BB Anti-androgens

1031

8255

1.36

14.00

2.0

2.3

3.08

3.06

mg/l

0.09

870

6929

Varicose veins of other sites

633

4709

1.45

13.98

2.9

2.2

3.24

2.94

mg/l

2.09

535

4014

Other salmonella infections

401

2771

1.62

13.98

2.5

2.0

3.00

mg/l

0.02

326

2319

Eosinophilia

193

1134

2.06

13.97

3.1

2.1

2.97

3.05

mg/l

0.21

169

976

Marginal zone B-cell lymphoma, excluding all cancers (controls excluding all cancers)

188

1100

2.10

13.96

2.4

2.2

3.12

3.03

mg/l

0.22

169

927

Exposure to other and unspecified inanimate mechanical forces

676

5085

1.44

13.96

2.7

2.2

2.71

2.85

mg/l

0.97

570

4347

Other disorders of cornea

955

7539

1.36

13.94

2.5

2.2

3.00

2.99

mg/l

0.04

834

6427

Neuroendocrine tumor and carcinoma of stomach, excluding all cancers (controls excluding all cancers)

318

3.56

13.93

3.2

2.0

3.50

3.27

mg/l

0.27

264

Other maltreatment syndromes

287

1832

1.73

13.88

2.2

2.1

2.68

2.82

mg/l

0.44

241

1607

Collapsed vertebra, not elsewhere classified

112

559

2.71

13.88

2.8

2.2

3.24

3.30

mg/l

0.07

464

Secondary parkinsonism

310

2052

1.75

13.83

2.5

2.2

2.98

3.16

mg/l

0.72

261

1742

Alcohol abuse counselling and surveillance

180

1028

2.06

13.81

2.2

2.0

3.19

2.97

mg/l

0.55

168

884

Open wound of neck

460

2.70

13.81

2.9

1.9

3.07

3.03

mg/l

0.07

401

Carcinoma in situ of skin of lower limb, including hip

238

1499

1.94

13.78

2.5

2.2

2.88

3.03

mg/l

0.48

205

1269

Small cell lung cancer, helper endpoint

1936

0.43

13.77

2.5

2.1

3.36

3.12

mg/l

0.53

1619

Small cell lung cancer

1936

0.43

13.77

2.5

2.1

3.36

3.12

mg/l

0.53

1619

Secondary uncertain malignant neoplasm

1363

11226

1.29

13.76

2.1

2.3

3.54

3.03

mg/l

7.82

1167

9533

Episcleritis

518

3752

1.51

13.71

2.3

2.1

2.84

2.90

mg/l

0.27

455

3206

Cerebral aneurysm, nonruptured

876

6862

1.37

13.67

2.4

2.2

3.18

2.95

mg/l

1.75

772

5849

Secondary parkinsonism+Parkinsonism in other disease

318

2122

1.73

13.66

2.5

2.2

3.00

3.13

mg/l

0.46

267

1801

Alcohol induced polyneuropathy

131

692

2.44

13.63

2.7

2.0

3.16

3.14

mg/l

0.02

117

602

Nontoxic goitre/thyroid nodule

3329

29440

1.17

13.62

2.3

3.07

3.02

mg/l

0.57

2848

25010

Benign lipomatous neoplasm

3139

27622

1.18

13.62

2.3

2.92

2.96

mg/l

0.48

2664

23656

Disorder of the sleep-wake schedule

202

1203

1.98

13.61

2.9

2.1

2.76

2.94

mg/l

0.54

172

1032

Recurrent dislocation and subluxation of joint

644

4803

1.43

13.56

2.3

2.0

2.77

mg/l

0.00

546

4105

Benign neoplasm: Other and unspecified parts of small intestine

204

1236

2.03

13.56

3.3

2.1

3.47

3.23

mg/l

0.56

184

1044

Myopia

1267

10328

1.29

13.54

2.3

2.2

2.70

2.78

mg/l

0.57

1065

8878

Parodontitis, under 40 years, or operation codes

930

7300

1.34

13.54

2.3

2.1

2.66

2.52

mg/l

1.13

789

6313

Peptic ulcer

130

683

2.40

13.50

3.6

2.0

3.49

3.27

mg/l

0.40

119

576

Dissocial personality disorder

154

837

2.12

13.48

2.1

2.0

3.17

2.91

mg/l

0.55

139

733

Cauda equina syndrome

156

870

2.21

13.47

2.5

2.0

2.89

3.03

mg/l

0.26

138

743

Systemic disorders of connective tissue in diseases classified elsewhere

228

3.83

13.40

4.0

1.9

2.95

3.15

mg/l

0.30

190

Chondropathies

1584

13224

1.26

13.40

2.5

2.2

2.81

2.86

mg/l

0.37

1353

11394

Other localized connective tissue disorders

225

1390

1.91

13.40

2.8

2.1

3.03

3.08

mg/l

0.10

198

1167

291

1925

1.79

13.37

2.8

2.2

3.42

3.07

mg/l

1.36

248

1629

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

6690

49995

1.12

13.34

2.2

2.75

2.83

mg/l

2.48

5783

42972

Parodontitis, under 40 years

927

7288

1.34

13.34

2.3

2.1

2.66

2.51

mg/l

1.14

786

6303

Anogenital herpesviral [herpes simplex] infection

646

4862

1.44

13.33

2.2

2.1

2.62

2.71

mg/l

0.52

521

4219

Benign neoplasm of middle ear and respiratory system

772

5960

1.39

13.32

2.4

2.2

3.06

2.87

mg/l

1.17

676

5053

Other specified/unspecified hearing loss

867

6813

1.37

13.31

2.3

2.2

2.93

3.01

mg/l

0.53

757

5785

Other specified/unspecified necrotizing vasculopathies

172

994

2.12

13.31

3.5

2.1

3.55

3.22

mg/l

0.54

150

846

Malignant neoplasm of rectum

1014

8136

1.34

13.30

2.2

3.35

3.05

mg/l

2.77

847

6885

Acute myeloid leukaemia and myelodysplastic syndromes

225

1402

1.93

13.28

2.6

2.2

3.01

3.26

mg/l

0.78

187

1196

Amputation of thigh

346

2369

1.69

13.27

3.1

2.2

4.07

3.17

mg/l

5.37

294

1986

Benign neoplasm: Cerebral meninges

906

7161

1.36

13.23

2.3

2.92

2.96

mg/l

0.19

760

6082

Problems related to social environment

327

2199

1.69

13.21

2.6

2.1

3.13

3.02

mg/l

0.40

294

1879

Other congenital malformations of upper alimentary tract

103

508

2.76

13.21

2.9

2.2

3.69

3.00

mg/l

2.13

445

Abnormal findings in nipple discharge synovial fluid wound secretions

183

1076

2.05

13.18

2.9

2.2

2.63

3.08

mg/l

1.44

158

924

Disorders of optic nerve and visual pathways

992

7923

1.34

13.18

2.4

2.2

3.11

2.85

mg/l

2.75

870

6801

Vulvovaginal ulceration/inflammation in other diseases

633

4770

1.44

13.16

2.4

2.1

2.81

2.76

mg/l

0.23

523

4096

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

1256

10270

1.29

13.14

2.2

2.3

2.86

2.85

mg/l

0.04

1086

8781

Pre-existing hypertension complicating pregnancy, childbirth and the puerperium

774

5984

1.39

13.13

2.5

2.1

3.01

2.66

mg/l

4.56

695

5188

Chronic myeloid leukaemia [CML], BCR/ABL-positive

122

638

2.48

13.12

2.8

2.0

2.83

3.10

mg/l

0.65

112

545

Pediculosis, acariasis and other infestations

562

4150

1.47

13.11

2.5

2.1

2.88

2.87

mg/l

0.03

472

3565

Oral lichen ruber planus

264

1707

1.81

13.11

2.5

2.1

2.97

3.09

mg/l

0.20

230

1451

Carcinoma in situ of skin of upper limb, including shoulder

279

1852

1.83

13.10

2.6

2.2

2.90

3.23

mg/l

1.50

237

1559

Other and unspecified nail disorders

226

1403

1.88

13.09

3.0

2.1

2.90

2.99

mg/l

0.26

208

1201

Senility

120

606

2.34

13.06

2.9

2.1

3.13

3.43

mg/l

0.63

102

503

Uterine polyps

934

7394

1.34

13.03

2.2

2.92

2.94

mg/l

0.04

794

6371

Dislocation of lens

177

1032

2.05

13.02

2.6

2.1

3.09

3.12

mg/l

0.03

140

847

Other specified/unspecified spondylopathies

292

1931

1.74

13.00

2.9

2.1

3.35

3.14

mg/l

0.74

265

1609

Infective bursitis

293

1927

1.72

12.98

2.8

2.1

3.03

3.04

mg/l

0.02

260

1626

Hereditary hypogammaglobulinemia

216

3.95

12.96

4.0

2.2

3.24

3.04

mg/l

0.25

190

Other fall from one level to another

2339

20217

1.20

12.95

2.3

2.82

2.86

mg/l

0.28

2001

17390

Abnormal blood-pressure reading, without diagnosis

438

3107

1.54

12.95

2.4

2.1

2.76

2.91

mg/l

0.45

366

2628

Dislocation, sprain and strain of joints and ligaments of thorax

345

2354

1.65

12.93

2.4

2.1

2.88

2.95

mg/l

0.26

305

1995

Granulomatous disorders of skin and subcutaneous tissue

293

1939

1.73

12.90

2.5

2.1

2.82

2.95

mg/l

0.44

266

1651

Background retinopathy and retinal vascular changes

238

1506

1.85

12.89

2.9

2.1

3.05

3.12

mg/l

0.16

211

1278

Isolated proteinuria with specified morphological lesion

141

775

2.27

12.88

3.0

2.0

3.03

3.13

mg/l

0.22

128

660

Other peripheral vertigo

976

7823

1.34

12.87

2.4

2.2

2.95

3.02

mg/l

0.45

820

6645

Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue

125

667

2.45

12.84

2.1

2.0

3.06

3.10

mg/l

0.07

108

566

Clefts and syndromes for tooth agenesis exclusion, including avohilmo

344

2341

1.64

12.83

2.7

2.5

2.99

2.71

mg/l

0.90

309

2053

Postzoster neuralgia

189

1141

2.05

12.82

2.6

2.1

3.38

3.22

mg/l

0.34

160

958

Other diseases of gallbladder

493

3602

1.52

12.82

2.6

2.2

3.04

3.03

mg/l

0.05

423

3009

Infection due to other mycobacteria

183

1084

2.02

12.80

2.8

2.1

3.27

3.16

mg/l

0.21

165

897

Acute lymphadenitis

611

4589

1.44

12.80

2.4

2.1

2.91

2.82

mg/l

0.44

543

3935

Atrial septal defect

414

2914

1.57

12.75

2.8

2.5

3.20

2.85

mg/l

1.55

370

2525

Sequelae of injuries of lower limb

919

7286

1.34

12.73

2.5

2.2

2.77

2.89

mg/l

0.79

785

6246

Degeneration of the brain due to alcohol

246

1574

1.82

12.72

2.4

2.1

3.26

3.03

mg/l

0.66

217

1343

Malignant neoplasm of endocrine gland, excluding all cancers (controls excluding all cancers)

830

6513

1.37

12.71

2.4

2.2

3.01

2.86

mg/l

0.97

717

5563

Benign neoplasm of other and unspecified intrathoracic organs

133

719

2.31

12.70

2.9

2.1

3.28

3.05

mg/l

0.44

116

605

Other secondary coxarthrosis

354

2440

1.63

12.69

2.8

2.1

3.31

3.06

mg/l

0.56

314

2065

Calcific tendinitis of shoulder

554

4098

1.46

12.68

2.4

2.1

2.88

2.93

mg/l

0.22

482

3486

Other abnormal products of conception

3499

20648

1.16

12.67

2.1

2.63

2.67

mg/l

0.52

3038

17974

Vascular dementia (mixed)

193

1171

2.00

12.67

2.7

2.2

2.78

3.22

mg/l

1.77

159

995

Hyperosmolality and hypernatraemia

162

934

2.12

12.63

2.6

2.1

3.12

3.44

mg/l

0.83

143

793

Myelodysplastic syndrome

124

667

2.47

12.62

2.8

2.2

3.26

3.20

mg/l

0.08

105

564

Other and unspecified erythematous conditions

334

2282

1.66

12.61

3.0

2.1

2.78

3.02

mg/l

1.08

291

1936

Disorders of phosphorus metabolism and phosphatases

291

3.35

12.60

3.9

2.5

3.41

3.21

mg/l

0.16

251

Drug-induced systemic lupus erythematosus

446

2.78

12.57

4.2

2.1

2.93

3.22

mg/l

0.48

379

Other misadventures during surgical and medical care

243

1559

1.83

12.57

2.9

2.1

3.27

3.07

mg/l

0.52

215

1345

Cystic fibrosis with pulmonary manifestations

8.60

12.51

4.0

1.8

3.04

2.70

mg/l

0.41

Other drug-induced secondary parkinsonism

115

598

2.47

12.48

2.5

2.1

3.17

3.37

mg/l

0.35

514

Defects in the complement system

460

2.72

12.47

5.5

2.4

2.90

2.88

mg/l

0.04

399

Cushing syndrome

138

759

2.24

12.46

2.8

2.0

2.96

3.09

mg/l

0.31

127

649

Acute appendicitis, no complications

6183

56462

1.12

12.46

2.2

2.79

2.85

mg/l

1.27

5399

48623

Additional codes for the location of defect, injury or illness

593

4479

1.45

12.38

2.3

2.1

2.72

2.95

mg/l

1.97

536

3795

Benign neoplasm: Pancreas

280

1862

1.75

12.37

2.8

2.2

3.42

2.95

mg/l

1.60

253

1566

Unspecified event, undetermined intent

265

1726

1.74

12.36

2.3

2.1

3.10

2.94

mg/l

0.31

228

1485

Other otitis externa (chronic)

671

5153

1.41

12.34

2.5

2.2

2.92

2.91

mg/l

0.05

551

4396

Evidence of alcohol involvement determined by level of intoxication

126

669

2.27

12.31

2.1

1.9

3.34

2.78

mg/l

1.34

109

572

Other puerperal infections

846

6689

1.35

12.27

2.1

2.61

2.59

mg/l

0.08

712

5763

Other specified and unspecified disorders of lens

125

680

2.41

12.23

2.4

2.1

2.99

3.22

mg/l

0.34

561

Complications peculiar to reattachment and amputation

423

2.77

12.20

3.4

2.0

3.58

3.34

mg/l

0.33

364

Nonpyogenic thrombosis of intracranial venous system

116

607

2.40

12.19

2.4

2.0

3.78

3.00

mg/l

1.07

523

Dystonia

560

4197

1.45

12.17

2.2

2.97

2.96

mg/l

0.02

474

3553

Open wound of shoulder and upper arm

209

1291

1.86

12.14

2.4

2.1

3.11

2.96

mg/l

0.38

174

1109

Toxic effect of other and unspecified substances

144

801

2.13

12.13

2.5

2.0

2.68

2.88

mg/l

0.53

124

699

Asthma mixed form (mode), excluding more controls

545

4043

1.45

12.12

2.3

2.0

3.06

2.85

mg/l

1.25

487

3392

Other and unspecified mononeuropathies, also in other diseases

328

2250

1.64

12.12

3.0

2.1

3.29

3.05

mg/l

0.74

281

1883

Medical abortion

8019

40319

1.10

12.08

2.2

2.85

2.86

mg/l

0.18

6757

34606

Benign neoplasm: Anus and anal canal

325

2239

1.67

12.07

2.7

2.2

3.07

3.14

mg/l

0.19

280

1887

Hypertrichosis

255

1663

1.77

12.07

2.1

2.0

2.74

2.65

mg/l

0.34

227

1412

Other disorders of the genitourinary system

1343

11201

1.27

12.06

2.5

2.3

3.02

mg/l

0.00

1145

9549

Other specified and unspecified disorders of eye and adnexa

416

2983

1.55

12.05

2.3

2.1

2.58

3.05

mg/l

3.25

339

2532

Other diseases of peritoneum

489

3606

1.50

12.05

2.8

2.2

3.03

2.99

mg/l

0.13

416

3071

Complications of genitourinary prosthetic devices, implants and grafts

284

1900

1.72

12.04

2.5

2.0

2.83

3.00

mg/l

0.64

244

1602

Aspergillosis

106

545

2.55

12.03

2.7

2.0

3.41

3.10

mg/l

0.58

470

Other erythematous conditions

368

2586

1.59

11.99

2.9

2.1

2.76

3.01

mg/l

1.28

322

2197

Previous suicide attempt

121

644

2.32

11.98

2.7

2.1

2.66

2.80

mg/l

0.28

111

549

Congenital malformations of gallbladder, bile ducts and liver

123

666

2.36

11.96

3.7

2.5

2.86

3.13

mg/l

0.74

104

575

Perforation of tympanic membrane

1048

8522

1.31

11.92

2.4

2.2

2.93

2.92

mg/l

0.09

889

7264

Other orthopaedic follow-up care

562

4218

1.44

11.92

2.4

2.1

2.94

2.93

mg/l

0.03

488

3552

Human immunodeficiency virus [HIV] disease resulting in other conditions

162

932

1.99

11.89

2.1

2.0

2.52

2.90

mg/l

1.07

140

822

Disturbances of smell and taste

424

3055

1.53

11.85

2.4

2.1

2.91

2.99

mg/l

0.37

366

2573

Mantle cell lymphoma, excluding all cancers (controls excluding all cancers)

168

998

2.04

11.84

2.1

3.01

2.92

mg/l

0.22

145

840

Hodgkin lymphoma, hilmo

310

2113

1.66

11.83

2.3

2.1

3.29

2.92

mg/l

1.80

281

1817

Evidence of alcohol involvement determined by blood alcohol level

165

965

2.01

11.82

2.2

2.0

3.37

2.96

mg/l

0.75

141

833

Oral leukoplakia and related diseases

585

4448

1.44

11.81

2.3

2.2

2.90

3.05

mg/l

0.60

508

3764

Causalgia

184

1109

1.93

11.81

2.4

2.0

2.41

2.88

mg/l

2.76

169

956

Urethritis and urethral syndrome

244

1577

1.76

11.80

2.5

2.0

2.80

3.02

mg/l

0.91

211

1329

Blindness, monocular

115

610

2.40

11.79

2.6

2.1

3.60

3.30

mg/l

0.48

532

Intussusception

225

1427

1.80

11.79

2.3

2.1

2.47

2.94

mg/l

3.57

205

1212

Achalasia of cardia

202

1254

1.88

11.73

2.7

2.0

3.03

3.11

mg/l

0.19

178

1059

Degeneration of nervous system due to alcohol

246

1606

1.78

11.73

2.4

2.1

3.26

3.01

mg/l

0.74

217

1369

Adenocarcinoma and papillary adenocarcinoma of stomach

320

2204

1.65

11.72

2.6

2.2

3.38

3.13

mg/l

0.79

293

1855

Retinal haemorrhage

271

1810

1.73

11.71

2.7

2.2

2.84

3.12

mg/l

1.23

235

1527

Erectile dysfunction

874

7012

1.35

11.71

3.0

2.3

2.93

2.99

mg/l

0.30

759

5965

Rare circulating lymphoid malignancy

346

2426

1.62

11.68

2.2

2.4

3.07

3.00

mg/l

0.17

302

2070

Hirsutism in women

226

1446

1.82

11.68

2.1

2.0

2.69

2.63

mg/l

0.19

202

1236

Other and unspecified medical devices associated with adverse incidents

359

3.11

11.67

2.6

2.0

3.10

3.30

mg/l

0.29

312

Recurrent and persistent haematuria

104

532

2.46

11.64

2.4

2.0

2.78

3.02

mg/l

0.57

450

Otitis media, unspecified

1195

9053

1.28

11.63

2.4

2.3

2.68

2.74

mg/l

0.47

1052

7757

Other/unspecified crystal arthropathies

455

2.81

11.59

2.9

2.1

3.69

3.26

mg/l

0.39

393

Mental and behavioural disorders due to hallucinogens

233

3.19

11.58

2.3

1.8

2.22

2.85

mg/l

1.41

204

Surgical ablation of atrial fibrillation

336

3.05

11.57

2.7

2.0

2.66

3.19

mg/l

1.21

296

Contact with and exposure to communicable diseases

3335

29589

1.15

11.54

2.3

2.2

2.87

2.68

mg/l

6.03

2907

25578

Thyroiditis, unspecified

175

1050

1.96

11.54

2.4

2.1

2.84

2.98

mg/l

0.36

150

895

Complications predominantly related to the puerperium

2700

23774

1.17

11.53

2.1

2.72

2.74

mg/l

0.14

2325

20487

Wegener granulomatosis

183

1119

1.94

11.48

2.8

2.1

3.01

3.10

mg/l

0.26

164

961

Lesion of plantar nerve

626

4811

1.41

11.48

2.4

2.2

2.83

3.03

mg/l

1.24

550

4093

Post-traumatic wound infection, not elsewhere classified

268

1783

1.70

11.45

2.7

2.1

3.26

2.99

mg/l

1.02

230

1533

Dermatopolymyositis

168

1003

1.98

11.38

2.7

2.0

3.28

3.16

mg/l

0.26

151

852

Systemic sclerosis,strict definition

114

609

2.35

11.36

3.7

2.1

3.58

3.06

mg/l

1.08

106

518

Benign neoplasm of major salivary glands

941

7597

1.32

11.35

2.3

2.2

3.06

2.90

mg/l

1.12

794

6428

Other and unspecified paralytic syndromes

161

951

2.01

11.35

2.4

2.1

2.96

3.14

mg/l

0.44

132

813

Hyperkinetic disorders (excl. ADHD)

188

1135

1.87

11.32

2.7

2.9

2.57

2.61

mg/l

0.12

167

995

Haemangioma and lymphangioma, any site

857

6846

1.33

11.29

2.8

2.3

2.99

2.83

mg/l

0.96

758

5844

Striae atrophicae

130

723

2.18

11.27

2.6

2.1

2.67

2.87

mg/l

0.66

117

614

Injury of eye and orbit

1340

11179

1.25

11.25

2.4

2.2

2.70

2.85

mg/l

1.92

1147

9657

Human immunodeficiency virus [HIV] disease

178

1070

1.88

11.21

2.1

2.59

2.91

mg/l

0.94

154

943

Inguinal or femoral hernia, bilateral

1091

8969

1.29

11.20

2.3

2.2

2.97

3.00

mg/l

0.16

927

7610

Dementia in other diseases classified elsewhere

493

3691

1.48

11.20

2.5

2.2

2.86

3.12

mg/l

1.33

376

3123

Paralytic strabismus

733

5777

1.37

11.20

2.4

2.2

3.17

3.00

mg/l

1.03

649

4884

Spinal osteochondrosis

122

660

2.18

11.17

2.5

2.0

2.72

3.01

mg/l

0.84

107

572

Hyperprolactinaemia

365

2586

1.56

11.17

2.4

2.0

2.64

2.74

mg/l

0.50

308

2249

Alzheimer disease

3626

24585

1.15

11.16

2.3

2.4

3.08

3.21

mg/l

2.26

2888

20652

Benign neoplasm: Liver/bile ducts

254

1681

1.72

11.15

2.5

2.1

2.75

2.80

mg/l

0.10

216

1428

Benign neoplasm: Parotid gland

754

5952

1.36

11.11

2.2

2.98

2.87

mg/l

0.61

629

5041

Hypersomnia

164

981

1.98

11.07

2.6

2.0

3.20

2.97

mg/l

0.36

151

845

Type 1 diabetes, wide definition, subgroup 2

1326

0.40

11.07

2.2

2.1

3.10

2.98

mg/l

0.17

1088

Restrictive cardiomyopathy

266

3.63

11.06

3.9

2.2

3.05

3.19

mg/l

0.22

232

Factitial dermatitis

342

2.93

11.03

2.7

2.1

3.69

2.95

mg/l

0.56

291

Fistulae involving female genital tract

178

1086

1.91

11.02

3.0

2.1

2.84

3.02

mg/l

0.53

154

923

Short Achilles tendon (acquired)

270

1805

1.67

11.01

2.4

2.0

1.86

2.91

mg/l

25.26

261

1523

Scar conditions and fibrosis of skin

413

3000

1.51

11.00

2.3

2.1

2.82

2.90

mg/l

0.21

367

2560

Open bite

532

4013

1.43

10.98

2.4

2.72

2.67

mg/l

0.19

464

3495

Alopecia areata

285

1939

1.66

10.97

2.4

2.1

2.60

2.86

mg/l

1.59

258

1658

Other injuries of upper limb, level unspecified

127

709

2.19

10.94

2.8

2.0

3.09

2.98

mg/l

0.13

112

609

Viral infections of the central nervous system

731

5758

1.36

10.93

2.3

2.1

2.97

2.89

mg/l

0.41

637

4915

Complex cardiac defects

417

2.70

10.92

4.1

3.3

3.76

2.82

mg/l

0.85

364

Contusion of other and unspecified parts of foot

491

3660

1.45

10.90

2.5

2.1

2.74

2.75

mg/l

0.04

426

3150

Gluteal tendinitis

359

2546

1.55

10.89

2.3

2.1

2.86

2.97

mg/l

0.46

310

2158

Waldenstrom macroglobulinemia, lymphoplasmacytic lymphoma

294

3.44

10.89

3.0

2.0

2.80

3.14

mg/l

0.52

260

Disorders of orbit

446

3286

1.49

10.87

2.5

2.1

2.75

2.99

mg/l

1.70

401

2777

Erythema nodosum

326

2284

1.60

10.86

2.8

2.1

3.35

2.98

mg/l

1.46

284

1933

Other congenital malformations of heart

443

2.58

10.84

3.2

3.0

3.08

3.04

mg/l

0.06

391

Benign neoplasm of other and unspecified intrathoracic organs

133

761

2.15

10.74

2.9

2.0

3.28

3.21

mg/l

0.11

116

654

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

746

5904

1.35

10.70

2.4

2.2

3.00

2.86

mg/l

0.73

620

5021

Abnormality of white blood cells, not elsewhere classified

103

545

2.40

10.67

2.9

2.1

2.62

3.16

mg/l

2.02

473

Non-small cell lung cancer, squamous, helper endpoint

284

4096

0.64

10.67

2.1

2.3

3.52

3.15

mg/l

1.12

244

3415

Non-small cell lung cancer, squamous

284

4096

0.64

10.67

2.1

2.3

3.52

3.15

mg/l

1.12

244

3415

Oral lichen ruber planus, hypothyreosis or thyroxin

178

1105

1.92

10.64

2.2

2.1

3.17

3.09

mg/l

0.10

148

942

Embolic stroke

530

4032

1.44

10.62

2.5

2.2

3.12

3.13

mg/l

0.03

460

3357

Other and unspecified acne

152

896

1.98

10.61

2.9

1.9

2.71

2.77

mg/l

0.16

135

769

Aneurysms, operations, SAH

1686

14471

1.22

10.58

2.4

2.3

3.22

3.01

mg/l

2.45

1476

12337

Unspecified behavioural syndromes associated with physiological disturbances and physical factors +Physiological and behavioural factors associated with disorders of diseases classified elsewhere

194

1226

1.84

10.56

3.3

2.5

2.89

2.83

mg/l

0.10

170

1057

Hordeolum and other deep inflammation of eyelid

549

4187

1.42

10.56

2.4

2.1

2.55

2.90

mg/l

3.96

471

3547

Leukaemia of unspecified cell type

105

559

2.34

10.56

1.9

2.2

3.22

2.93

mg/l

0.67

466

Dislocation, sprain and strain of joints and ligaments of knee

6597

56639

1.10

10.55

2.2

2.80

2.82

mg/l

0.32

5683

48839

Haemangioma, any site

795

6358

1.33

10.43

2.8

2.2

3.00

2.84

mg/l

0.89

699

5421

Other factor of the environment

146

862

2.03

10.42

3.6

2.0

3.14

3.08

mg/l

0.11

135

741

Thiamine deficiency

350

2.81

10.40

2.7

2.0

2.73

3.01

mg/l

0.49

309

Antepartum haemorrhage, not elsewhere classified

882

7134

1.31

10.39

2.0

2.1

2.64

2.66

mg/l

0.07

778

6211

Graves disease, strict definition

992

8134

1.29

10.37

2.2

2.71

2.85

mg/l

1.38

866

6992

Carcinoid syndrome

118

662

2.25

10.36

2.2

2.0

3.13

3.22

mg/l

0.13

576

Vascular syndromes of brain in cerebrovascular disorders

497

3772

1.45

10.36

2.6

2.2

3.25

3.12

mg/l

0.48

437

3207

Crushed, pushed or stepped on by crowd or human stampede

666

5202

1.36

10.35

2.6

2.2

2.56

2.78

mg/l

1.84

572

4482

Inguinal hernia, bilateral

1063

8791

1.28

10.33

2.3

2.2

2.98

3.00

mg/l

0.10

902

7465

Abnormal findings in secretions and smears from cervix uteri vagina vulva

5341

38496

1.11

10.32

2.2

2.63

2.79

mg/l

6.73

4654

33167

Alzheimer’s disease (Late onset)

2612

19872

1.17

10.30

2.3

2.4

3.06

3.25

mg/l

3.47

2089

16635

Allergic purpura

326

2303

1.57

10.30

2.9

2.1

2.98

2.92

mg/l

0.16

290

1970

Endometriosis ASRM stages 3,4

2515

22252

1.17

10.27

2.3

2.2

2.85

2.87

mg/l

0.19

2135

19171

Conduct disorder

218

1409

1.72

10.27

2.2

2.69

2.60

mg/l

0.23

194

1205

Postmenopausal atrophic vaginitis

2581

13686

1.17

10.26

2.2

2.3

2.88

3.03

mg/l

2.55

2234

11691

Otorrhagia

442

2.58

10.25

2.7

2.2

2.74

3.20

mg/l

1.16

381

Residual foreign body in soft tissue

467

3484

1.44

10.21

2.2

2.0

2.93

2.87

mg/l

0.22

390

2946

Melanocytic naevi of trunk

1194

9988

1.26

10.21

2.4

2.2

2.73

2.89

mg/l

1.24

1044

8558

Prepatellar bursitis

422

3103

1.47

10.21

2.4

2.1

3.03

2.92

mg/l

0.37

372

2630

Dependence on enabling machines and devices, not elsewhere classified

132

757

2.08

10.21

4.2

2.5

2.92

2.99

mg/l

0.14

121

654

Encephalopathy

120

677

2.20

10.20

3.1

2.0

3.62

3.16

mg/l

0.78

113

576

Malignant neoplasm of oral cavity, excluding all cancers (controls excluding all cancers)

438

3251

1.47

10.20

2.3

2.2

2.73

2.91

mg/l

1.10

379

2732

Later onset COPD

3459

24523

1.15

10.17

2.6

2.3

3.53

3.08

mg/l

14.71

2882

20537

Other and unspecified injuries of ankle and foot

421

3104

1.47

10.13

2.6

2.1

2.85

2.77

mg/l

0.33

363

2666

Tracheo-bronchomalasia

182

3.27

10.12

2.5

1.5

3.02

2.55

mg/l

0.84

145

Maternal care related to the fetus and amniotic cavity and possible delivery problems

4818

25860

1.12

10.09

2.0

2.1

2.64

2.75

mg/l

3.02

4187

22301

Congenital malformations of great arteries

236

1547

1.71

10.08

3.1

3.0

3.09

2.75

mg/l

1.45

212

1362

Pregnancy with abortive outcome

8411

41043

1.09

10.08

2.2

2.85

2.87

mg/l

0.34

7137

35199

Abnormality of red blood cells

314

2.87

10.07

2.6

2.0

3.03

3.15

mg/l

0.11

275

Benign neoplasm: Tongue

278

1916

1.63

10.06

2.7

2.2

2.73

2.95

mg/l

0.86

233

1615

Dementia due to Parkinsons disease, excluding more controls

236

1579

1.71

10.05

2.2

2.77

3.06

mg/l

1.48

169

1311

Cerebral palsy

178

1108

1.83

10.04

2.6

2.5

2.86

2.81

mg/l

0.08

152

969

Malignant neoplasm of breast, HER-positive

2858

31527

0.87

10.04

2.2

2.3

2.99

3.04

mg/l

0.44

2424

26884

Embedded and impacted teeth

2729

20576

1.16

10.02

2.1

2.63

mg/l

0.07

2419

17666

Inguinal hernia, unilateral

289

2014

1.62

10.00

2.3

2.1

3.05

3.02

mg/l

0.06

251

1684

Femoral hernia, unilateral

289

2014

1.62

10.00

2.3

2.1

3.05

3.02

mg/l

0.06

251

1684

Inguinal of femoral hernia, unilateral

289

2014

1.62

10.00

2.3

2.1

3.05

3.02

mg/l

0.06

251

1684

Open wound of hip and thigh

313

2198

1.56

9.98

2.3

2.2

2.99

2.87

mg/l

0.35

277

1874

Malignant neoplasm of anus and anal canal, excluding all cancers (controls excluding all cancers)

140

830

2.03

9.95

2.5

2.1

3.52

3.11

mg/l

0.73

115

696

Carcinoma in situ of skin of lower limb, including hip

238

1623

1.75

9.93

2.5

2.2

2.88

3.22

mg/l

1.55

205

1351

Congenital malformations of pulmonary and tricuspid valves

102

553

2.33

9.89

3.5

3.2

3.21

2.72

mg/l

0.63

480

Endometriosis diagnosis and infertility diagnosis occurring together

1076

8935

1.27

9.87

2.3

2.1

2.62

2.72

mg/l

0.92

926

7715

Other acute skin changes due to ultraviolet radiation

372

2713

1.52

9.87

2.6

2.1

2.97

3.03

mg/l

0.15

319

2281

Abnormal findings on diagnostic imaging of central nervous system

442

3304

1.46

9.84

2.3

2.1

2.91

2.88

mg/l

0.10

392

2812

Habit and impulse disorders

151

899

1.89

9.83

2.4

2.0

3.21

2.74

mg/l

1.41

124

782

Drug-induced headache, not elsewhere classified

358

2.71

9.83

2.6

1.9

2.89

2.87

mg/l

0.02

308

Acute appendicitis

8073

71155

1.09

9.83

2.2

2.83

2.88

mg/l

1.06

7034

61069

Idiopathic pulmonary fibrosis

822

6689

1.32

9.82

2.4

2.3

3.17

3.08

mg/l

0.44

721

5616

Benign lipomatous neoplasm of other sites/unspecified

868

7067

1.30

9.81

2.3

2.97

2.95

mg/l

0.07

738

5970

Symptoms and signs involving appearance and behaviour

105

572

2.25

9.79

2.6

1.9

3.18

2.89

mg/l

0.94

481

Toxic effect of carbon monoxide

189

1210

1.80

9.77

2.2

2.0

3.09

3.07

mg/l

0.03

170

1030

Carcinoma in situ of other and unspecified sites

388

2877

1.52

9.76

2.5

2.2

3.15

3.07

mg/l

0.28

328

2453

Oral lichen ruber planus, including avohilmo

568

4410

1.39

9.75

2.3

2.2

2.75

3.02

mg/l

1.46

481

3761

Disorder of external ear, unspecified

321

2287

1.56

9.74

2.5

2.1

3.03

mg/l

0.01

279

1952

Lack of expected normal physiological development

245

1428

1.65

9.73

2.8

2.69

2.51

mg/l

0.83

225

1252

Exfoliative dermatitis

127

736

2.08

9.73

2.6

2.0

2.91

3.22

mg/l

0.74

109

626

Leukaemia of unspecified cell type

105

576

2.26

9.71

1.9

2.2

3.22

3.03

mg/l

0.40

499

Malignant neoplasm of thyroid gland, excluding all cancers (controls excluding all cancers)

726

5801

1.33

9.70

2.4

2.2

3.00

2.86

mg/l

0.77

623

4944

Benign neoplasm: Liver

226

1506

1.70

9.70

2.4

2.1

2.71

2.80

mg/l

0.27

193

1281

Benign neoplasm: Larynx

306

2157

1.57

9.68

2.3

2.2

3.02

2.89

mg/l

0.37

273

1798

Poor fetal growth

1285

10863

1.24

9.66

2.2

2.1

2.57

2.59

mg/l

0.15

1126

9399

Malignant neoplasm of anus and anal canal

296

2.96

9.64

2.4

2.0

3.25

3.26

mg/l

0.00

251

Carcinoma in situ, bladder

360

2646

1.54

9.64

2.6

2.2

3.11

3.07

mg/l

0.11

305

2248

Viral meningitis

359

2601

1.51

9.63

2.3

2.1

2.81

2.82

mg/l

0.03

319

2232

Benign neoplasm: Liver/bile ducts

254

1739

1.65

9.59

2.5

2.0

2.75

2.90

mg/l

0.41

216

1489

Malignant neoplasm of other and unspecified parts of tongue, excluding all cancers (controls excluding all cancers)

220

1463

1.71

9.58

2.2

2.65

3.02

mg/l

1.88

194

1223

Autonomic disorders

232

1560

1.69

9.57

2.6

2.0

2.95

3.09

mg/l

0.39

206

1315

Other hyperalimentation

202

3.52

9.56

2.6

1.8

3.00

3.11

mg/l

0.11

178

Measles

110

603

2.10

9.55

2.4

2.1

2.97

2.88

mg/l

0.21

522

Pustular psoriasis

456

3444

1.44

9.53

2.3

2.1

3.16

3.01

mg/l

0.54

392

2932

Shoulder region

151

924

1.93

9.49

2.5

2.0

2.23

3.08

mg/l

6.84

135

794

Short stature, not elsewhere classified

259

1669

1.64

9.49

3.3

3.0

2.69

2.50

mg/l

1.03

235

1475

Alzheimer’s disease (Atypical or mixed)

1028

8562

1.28

9.49

2.4

3.38

3.30

mg/l

0.36

815

7159

Allergic colitis

245

1659

1.64

9.47

3.3

1.9

2.85

2.62

mg/l

1.07

218

1442

Other and unspecified trigeminal disorders

175

1109

1.83

9.47

2.5

2.1

2.75

2.96

mg/l

0.82

153

939

Assault by blunt object

134

782

1.95

9.47

1.9

2.0

2.53

2.81

mg/l

0.81

104

684

Behavioural disorders

218

1438

1.68

9.46

2.2

2.70

2.63

mg/l

0.18

194

1237

Vitamin A deficiency

304

2.86

9.43

3.5

1.9

3.55

3.05

mg/l

0.90

263

Central retinal artery occlusion

253

1750

1.66

9.43

2.8

2.2

3.26

3.16

mg/l

0.27

220

1476

Benign neoplasm: Skin of other and unspecified parts of face

1152

9697

1.25

9.41

2.4

2.3

3.04

3.01

mg/l

0.16

968

8220

Inflammatory disorders of male genital organs, not elsewhere classified

134

787

1.96

9.40

2.6

2.0

3.26

3.02

mg/l

0.51

123

675

Femoral hernia

465

3536

1.43

9.38

2.4

2.1

3.16

3.03

mg/l

0.50

400

2980

Acute epiglottitis

160

989

1.86

9.37

2.4

1.9

3.05

2.89

mg/l

0.27

132

839

Cysts of oral region, not elsewhere classified

411

3052

1.45

9.36

2.4

2.1

3.15

2.90

mg/l

0.87

357

2593

Gestational [pregnancy-induced] hypertension

2686

23917

1.15

9.33

2.3

2.1

2.88

2.70

mg/l

5.26

2404

20544

Retinal detachment with retinal break

1289

10953

1.24

9.33

2.3

2.2

3.02

3.01

mg/l

0.03

1088

9307

Macular hole

573

4506

1.39

9.31

2.5

2.2

3.05

3.09

mg/l

0.12

494

3794

Carcinoma in situ of skin, other sites/unspecified

150

934

1.98

9.30

2.5

2.3

3.45

3.08

mg/l

1.01

130

775

Hereditary deficiency of other clotting factors

109

613

2.17

9.28

3.3

2.0

2.63

2.84

mg/l

0.65

537

Asthma mixed form (mode)

545

4213

1.38

9.28

2.3

2.1

3.06

2.88

mg/l

1.01

487

3557

Other protozoal intestinal diseases

155

957

1.88

9.26

2.8

2.1

2.51

2.95

mg/l

1.67

137

814

Malignant neoplasm of thymus, excluding all cancers (controls excluding all cancers)

221

3.14

9.22

1.8

3.09

3.03

mg/l

0.06

183

Disorder of pancreatic internal secretion, other and/or unspecified

463

2.38

9.21

3.4

2.1

2.95

3.12

mg/l

0.23

402

Pustulosis palmaris et plantaris

411

3072

1.46

9.21

2.3

2.1

3.10

3.01

mg/l

0.27

351

2608

Small cell lung cancer, excluding all cancers (controls excluding all cancers)

1711

0.51

9.21

2.5

2.2

3.36

2.99

mg/l

0.95

1416

Malignant neoplasm of mesothelium and soft tissue, excluding all cancers (controls excluding all cancers)

663

5285

1.34

9.21

2.1

2.3

3.02

2.93

mg/l

0.49

564

4454

Corneal scars and opacities

276

1938

1.60

9.21

2.6

2.2

2.94

3.06

mg/l

0.38

231

1642

Certain conditions originating in the perinatal period

882

6392

1.28

9.19

2.6

2.4

2.69

2.66

mg/l

0.16

762

5532

Other and unspecified thalassaemias

5.46

9.18

2.8

2.1

4.62

2.75

mg/l

1.91

Other surgical follow-up care

339

2460

1.51

9.17

2.7

2.1

2.77

2.89

mg/l

0.51

288

2057

Papilloedema, unspecified

244

1676

1.65

9.15

2.6

2.1

3.20

2.95

mg/l

0.94

221

1447

Malignant neoplasm of tongue, excluding all cancers (controls excluding all cancers)

260

1803

1.61

9.15

2.2

2.69

2.96

mg/l

1.35

226

1512

Thyrotoxicosis with toxic multinodular goitre

620

4922

1.36

9.13

2.4

2.3

3.09

3.10

mg/l

0.06

535

4171

Other benign neoplasms of connective and other soft tissue

929

7663

1.28

9.13

2.5

2.2

2.89

2.83

mg/l

0.33

804

6516

Benign intracranial hypertension

117

675

2.09

9.12

2.5

2.0

3.32

2.67

mg/l

1.30

108

583

Other and unspecified bullous disorders

120

702

2.09

9.10

2.2

2.0

3.14

mg/l

0.00

106

604

Other and unspecified disorders of adult personality and behaviour

359

2.55

9.08

2.1

1.8

3.07

2.80

mg/l

0.46

310

Liver disorders in diseases classified elsewhere

163

3.66

9.08

2.3

1.9

2.53

2.95

mg/l

0.76

147

Other nonthrombocytopenic purpura

108

613

2.18

9.07

3.0

2.0

3.05

3.26

mg/l

0.46

515

Cystic fibrosis, other manifestations/unspecified

111

5.20

9.00

3.6

1.9

2.78

2.69

mg/l

0.13

Benign neoplasm: Skin of ear and external auricular canal

431

3274

1.45

8.98

2.3

2.2

3.32

3.07

mg/l

0.91

364

2775

Congenital malformations of the nervous system

233

1585

1.64

8.97

2.4

3.02

2.79

mg/l

0.67

201

1374

Morphin

179

1152

1.77

8.97

2.2

2.0

3.51

3.09

mg/l

1.31

150

950

Hypermetropia

710

5716

1.32

8.95

2.3

2.4

2.90

2.87

mg/l

0.09

602

4893

Hereditary factor VIII deficiency

146

3.76

8.94

5.3

2.1

2.91

2.88

mg/l

0.02

133

Medial epicondylitis

344

2500

1.49

8.92

2.3

2.1

2.76

2.91

mg/l

0.68

298

2126

Benign neoplasm: Liver

226

1535

1.66

8.91

2.4

2.0

2.71

2.90

mg/l

0.71

193

1320

Vertigo of central origin

180

1173

1.80

8.90

2.5

2.1

3.14

3.17

mg/l

0.05

144

997

Type1 diabetes, definitions combined, early onset

637

5023

1.33

8.89

2.3

2.4

2.57

2.60

mg/l

0.17

554

4393

Malignant melanoma, excluding all cancers (controls excluding all cancers)

1706

14864

1.19

8.88

2.3

2.99

2.95

mg/l

0.21

1451

12601

Drug- and heavy-metal-induced tubulo-interstitial and tubular conditions

166

3.66

8.86

3.0

2.0

3.49

3.13

mg/l

0.33

142

Benign neoplasm: Other and unspecified parts of mouth

333

2426

1.51

8.86

2.7

2.2

2.98

2.90

mg/l

0.26

287

2044

Appendicitis, broad definition

8640

74230

1.08

8.84

2.2

2.84

2.88

mg/l

0.89

7521

63638

Other haemoglobinopathies

122

4.57

8.83

2.6

1.9

4.80

2.94

mg/l

1.53

101

Failed induction of labour

597

4719

1.35

8.83

2.1

2.74

2.54

mg/l

2.00

520

4081

Benign leiomyoma with endometriosis

1577

13671

1.20

8.82

2.3

3.06

2.95

mg/l

0.98

1297

11685

Disorders of purine and pyrimidine metabolism

375

2.57

8.79

3.1

2.0

4.07

3.28

mg/l

1.35

330

Other abnormal findings in urine

180

1177

1.79

8.79

2.5

2.1

3.24

3.04

mg/l

0.42

165

988

Mental retardation

383

2846

1.46

8.79

2.3

2.6

3.01

2.78

mg/l

1.34

344

2504

Secondary polycythaemia

229

1561

1.64

8.78

2.7

2.1

5.34

3.07

mg/l

6.88

198

1330

Diseases of appendix

8716

74666

1.08

8.78

2.3

2.2

2.85

2.88

mg/l

0.78

7587

64000

Injury of muscle and tendon at hip and thigh level

887

7315

1.28

8.78

2.3

2.2

2.91

mg/l

0.01

762

6277

Unspecified visual impairment (binocular)

168

1078

1.82

8.77

3.0

2.2

2.67

3.07

mg/l

1.47

145

922

Tic and related disorders

128

755

1.93

8.76

3.0

2.7

2.73

2.69

mg/l

0.08

113

660

Other/unspecified disorders of vestibular function

403

3041

1.46

8.75

2.5

2.2

2.66

3.09

mg/l

4.23

354

2564

Contraceptive management

3959

25329

1.12

8.73

2.2

2.69

2.79

mg/l

2.07

3462

21965

Necrobiosis lipoidica, not elsewhere classified

388

2.49

8.73

3.1

2.0

2.79

2.81

mg/l

0.03

333

Melanocytic naevi, other sites/unspecified

731

5918

1.31

8.68

2.5

2.2

2.82

2.77

mg/l

0.26

666

5038

Other and unspecified injuries of forearm

448

2.30

8.67

2.1

1.8

4.05

2.90

mg/l

1.00

376

Other specified and unspecified retinal disorders

355

2630

1.49

8.67

2.6

2.1

3.11

3.04

mg/l

0.14

305

2207

Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

376

2798

1.46

8.67

2.5

2.2

3.06

2.88

mg/l

0.63

326

2353

Other and unspecified pemphigoid

113

668

2.16

8.65

3.0

2.1

3.26

3.36

mg/l

0.16

560

Herpesviral keratitis and keratoconjunctivitis

433

3300

1.43

8.61

2.5

2.1

3.00

3.03

mg/l

0.10

392

2792

Disorders of synovium and tendon in diseases classified elsewhere

207

1386

1.67

8.60

2.7

2.0

3.00

2.99

mg/l

0.02

174

1156

Stenosis and insufficiency of lacrimal passages

969

8099

1.26

8.59

2.4

2.3

2.81

3.02

mg/l

2.55

839

6903

Polyarteritis nodosa and related conditions

155

978

1.84

8.58

3.2

2.0

3.14

3.13

mg/l

0.02

145

840

Hyphaema and other vascular disorders of iris and ciliary body

207

1398

1.69

8.50

3.0

2.1

3.15

3.19

mg/l

0.07

180

1184

Dementia in Alzheimer disease

2033

15376

1.18

8.49

2.3

2.4

3.51

3.24

mg/l

4.53

1528

12897

Sexual dysfunction

145

895

1.84

8.48

2.2

2.0

2.74

2.95

mg/l

0.62

131

786

Lifestyle-related condition

132

805

1.94

8.48

3.6

2.0

3.09

3.08

mg/l

0.01

121

696

Marfan's syndrome

308

2.63

8.45

2.5

2.0

2.92

2.89

mg/l

0.03

271

Malignant neoplasm of bladder

774

6348

1.30

8.45

2.4

2.2

3.21

3.15

mg/l

0.24

667

5322

Other specified/unspecified nutritional deficiencies

476

2.26

8.44

2.8

1.9

2.74

3.03

mg/l

0.68

415

Other disorders of binocular movement

242

1682

1.61

8.44

2.4

2.1

2.41

2.82

mg/l

2.38

216

1443

Vasomotor rhinitis (mode)

731

5952

1.31

8.43

2.4

2.2

3.10

2.93

mg/l

0.90

630

5092

Other menopausal disorders

2732

14082

1.15

8.42

2.1

2.2

2.70

2.94

mg/l

6.20

2331

12107

Acute bronchiolitis

628

4499

1.33

8.41

2.8

2.5

2.84

2.74

mg/l

0.63

555

3901

Tetraplegia

471

2.29

8.40

2.4

2.1

3.22

3.13

mg/l

0.12

410

Dermatopolymyositis, unspecified

347

2.60

8.40

3.1

1.8

3.29

2.99

mg/l

0.55

300

Embedded teeth, including avohilmo

905

7503

1.26

8.39

2.2

2.1

2.50

2.69

mg/l

2.39

808

6431

Other and unspecified injuries of shoulder and upper arm

301

2177

1.52

8.37

2.6

2.1

3.13

2.97

mg/l

0.54

251

1863

Benign neoplasm: Pancreas

280

2020

1.57

8.37

2.8

2.2

3.42

3.09

mg/l

0.92

253

1719

Papillary adenocarcinoma of thyroid gland, excluding all cancers (controls excluding all cancers)

606

4830

1.34

8.35

2.5

2.2

2.88

2.86

mg/l

0.07

518

4113

Benign neoplasm of urinary organs

480

3736

1.40

8.35

2.4

2.2

2.83

3.05

mg/l

1.16

408

3157

Dermatitis herpetiformis

202

1365

1.69

8.33

2.2

2.1

2.66

3.12

mg/l

2.29

169

1176

Maze procedure for atrial fibrillation

324

2.74

8.32

2.8

2.0

2.87

3.27

mg/l

0.72

283

Postpartum haemorrhage

2570

20028

1.15

8.30

2.0

2.1

2.69

2.65

mg/l

0.49

2215

17350

Panniculitis, unspecified

116

686

2.00

8.25

3.2

2.1

3.38

3.14

mg/l

0.38

106

579

Hyperuricaemia without signs of inflammatory arthritis and tophaceous disease

316

2.69

8.24

3.0

2.0

3.96

3.27

mg/l

1.20

277

Pleural plaque

1094

9311

1.25

8.23

2.4

2.3

3.15

3.04

mg/l

0.79

896

7787

Vascular dementia (other)

461

2.40

8.23

2.6

2.2

2.78

3.22

mg/l

1.06

399

Fourth [trochlear] nerve palsy

242

1701

1.61

8.21

2.4

2.1

3.30

3.04

mg/l

0.76

221

1443

Other acquired deformities of ankle and foot

523

2.16

8.20

2.3

2.0

2.83

2.91

mg/l

0.13

428

Other and/or unspecified nontoxic goitre

801

6598

1.28

8.19

2.2

2.87

3.02

mg/l

0.86

676

5635

Other disorders of pigmentation

438

3373

1.41

8.15

2.5

2.2

2.84

3.00

mg/l

0.58

381

2848

Haemorrhagic disorder due to circulating anticoagulants

145

925

1.88

8.07

3.2

2.1

3.52

3.23

mg/l

0.70

122

781

Injury of nerves at lower leg level

109

637

2.02

8.05

2.5

1.9

2.55

3.14

mg/l

1.73

547

Alzheimer’s disease, wide definition

2812

21265

1.14

8.05

2.2

2.4

3.06

3.23

mg/l

3.10

2245

17823

Injury of intra-abdominal organs

240

1675

1.58

8.05

2.3

2.1

3.36

2.92

mg/l

1.47

197

1436

Pulmonary oedema

200

1359

1.68

8.03

3.0

2.2

3.08

3.20

mg/l

0.31

184

1137

Bacterial, viral and other infectious agents

776

6365

1.28

8.01

2.5

2.1

2.92

2.84

mg/l

0.49

686

5467

Impaction of intestines

434

2.29

8.00

2.9

2.1

3.48

3.06

mg/l

0.49

367

Postpartum hemorraghe, parous women as controls

2570

20193

1.14

7.99

2.0

2.1

2.69

2.65

mg/l

0.49

2215

17575

Spermatocele

733

5994

1.29

7.98

2.2

2.91

3.02

mg/l

0.64

634

5116

Malignant neoplasm of floor of mouth, excluding all cancers (controls excluding all cancers)

552

2.12

7.97

2.4

2.0

2.78

3.11

mg/l

0.66

460

Benign neoplasm: Appendix

122

744

1.97

7.96

2.9

2.1

2.78

3.04

mg/l

0.80

110

617

Hyposplenism

5.38

7.96

2.4

1.9

3.42

2.80

mg/l

0.40

Chronic myeloid leukaemia

273

2.81

7.94

2.9

2.0

2.41

3.12

mg/l

2.12

236

Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances

351

2621

1.45

7.94

2.5

2.1

2.59

2.86

mg/l

1.44

307

2258

Mental retardation, wide definition

403

3067

1.41

7.92

2.4

2.6

3.01

2.83

mg/l

0.98

362

2686

Premature rupture of membranes

2270

14860

1.16

7.91

2.0

2.1

2.68

2.67

mg/l

0.12

1961

12790

Complications associated with artificial fertilization

183

1214

1.68

7.90

2.3

1.9

2.73

2.53

mg/l

0.70

166

1067

Endometriosis of intestine

166

1079

1.72

7.87

2.2

2.0

2.78

2.58

mg/l

0.80

141

947

Malignant neoplasm of rectosigmoid junction

179

1200

1.73

7.87

2.2

2.1

3.64

3.22

mg/l

0.68

160

1013

Streptococcus and staphylococcus as the cause of diseases classified to other chapters

367

2.43

7.87

3.0

2.1

2.99

3.00

mg/l

0.01

325

Bitten or struck by other mammals

1067

9049

1.23

7.84

2.3

2.2

3.06

2.80

mg/l

2.22

890

7799

Other and unspecified mononeuropathies of upper limb

289

2096

1.51

7.83

2.3

2.0

2.86

2.94

mg/l

0.24

247

1798

Marginal zone B-cell lymphoma

103

605

2.10

7.83

2.6

2.1

3.23

3.21

mg/l

0.03

524

Use of rasagiline

267

1932

1.56

7.83

2.4

2.1

3.09

3.10

mg/l

0.04

213

1626

Other nonscarring hair loss

111

662

2.01

7.82

2.7

2.0

2.49

2.93

mg/l

1.21

554

Disorders of parathyroid gland, other and/or unspecified

494

2.24

7.80

2.9

2.1

3.83

3.45

mg/l

0.36

421

Use of rivastigmine

1587

13918

1.19

7.79

2.3

2.4

3.10

3.26

mg/l

1.44

1297

11600

Subacute thyroiditis

349

2613

1.45

7.79

2.2

2.1

2.56

2.98

mg/l

3.87

298

2232

Alzheimer’s disease (undefined)

905

0.40

7.74

1.8

2.3

2.81

3.39

mg/l

1.33

758

Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies

429

3297

1.39

7.73

2.4

2.0

2.97

2.86

mg/l

0.54

380

2794

Other congenital malformations of skin

403

3086

1.41

7.73

2.5

2.2

2.75

2.88

mg/l

0.42

349

2647

Scleritis

133

829

1.85

7.72

2.7

2.0

2.72

3.13

mg/l

1.25

123

715

Allergic contact dermatitis due to drugs in contact with skin

238

1685

1.58

7.71

2.3

2.1

2.74

3.01

mg/l

1.10

208

1434

Other disorders of bone density and structure

256

1826

1.54

7.71

2.3

2.1

2.82

2.97

mg/l

0.56

215

1570

Other disorders of breast

1260

10856

1.21

7.71

2.1

2.2

2.70

2.88

mg/l

2.45

1065

9291

Diastasis of muscle

498

2.16

7.70

3.0

2.0

2.99

2.82

mg/l

0.40

435

Other and unspecified disorders of pigmentation

439

2.23

7.68

2.5

2.1

3.05

3.08

mg/l

0.03

383

Ménière disease

984

8330

1.25

7.66

2.4

2.2

2.95

3.04

mg/l

0.67

854

7063

Mental and behabioural disorders of puerperum, not classified elsewhere, excluding more controls

116

696

1.92

7.66

1.7

1.9

2.77

2.59

mg/l

0.47

598

Osteomyelitis of vertebra

211

3.08

7.65

3.3

1.9

3.32

3.07

mg/l

0.25

182

Cardiomyopathies, Secondary/extrinsic

361

2.37

7.65

2.8

1.8

2.67

3.02

mg/l

0.63

309

Polyhydramnios

464

3621

1.37

7.64

2.5

2.1

2.68

2.67

mg/l

0.04

410

3122

Benign neoplasm: Kidney

328

2449

1.47

7.63

2.5

2.2

2.92

2.97

mg/l

0.12

278

2065

Guillain-Barre syndrome

165

1086

1.73

7.61

2.3

2.1

3.07

3.08

mg/l

0.03

128

927

Molar incisor enamel hypoplasia

319

2324

1.48

7.60

3.8

2.8

2.62

2.61

mg/l

0.02

285

2053

Multifocal fibrosclerosis

486

2.25

7.57

2.5

2.1

3.17

3.32

mg/l

0.23

412

Other disorders of choroid

153

994

1.77

7.56

2.5

2.1

2.98

3.24

mg/l

0.52

130

843

Intermittent heterotropia

584

4689

1.32

7.56

2.2

2.4

2.82

2.76

mg/l

0.22

497

4058

Other disorders of iris and ciliary body

270

1958

1.53

7.54

2.8

2.2

3.05

3.10

mg/l

0.11

229

1639

Dislocation, sprain and strain of joints and ligaments of lumbar spine and pelvis

279

2026

1.50

7.54

2.1

2.50

2.87

mg/l

2.51

240

1744

Car occupant injured in noncollision transport accident

351

2641

1.43

7.52

2.4

2.1

2.79

2.83

mg/l

0.16

308

2267

Unspecified human immunodeficiency virus [HIV] disease

532

2.04

7.52

2.2

2.0

2.64

3.12

mg/l

1.20

464

Congenital malformations of trachea and bronchus

109

656

2.00

7.52

2.9

2.2

3.26

3.19

mg/l

0.05

565

Benign neoplasm of ovary

1697

14954

1.18

7.52

2.4

2.3

3.00

2.93

mg/l

0.59

1483

12671

Other primary thrombocytopenia

266

2.78

7.51

3.3

1.8

3.18

3.03

mg/l

0.18

232

Ectopic pregnancy

1679

14765

1.17

7.50

2.2

2.76

2.80

mg/l

0.34

1453

12806

Benign neoplasm of brain and other parts of central nervous system

603

4868

1.32

7.49

2.3

2.2

2.99

2.84

mg/l

0.89

504

4133

Malignant neoplasm of thymus

186

3.13

7.48

1.8

1.9

2.84

2.94

mg/l

0.10

161

Pneumothorax

684

5603

1.29

7.43

2.3

2.2

3.19

2.95

mg/l

1.30

574

4736

Other/unspecified soft tissue disorders related to use, overuse and pressure

272

1968

1.50

7.43

2.1

2.0

2.77

2.93

mg/l

0.66

236

1656

Other bursitis of elbow

536

2.10

7.40

2.5

2.0

2.90

3.17

mg/l

0.32

452

Benign neoplasm: Parathyroid gland

121

751

1.91

7.39

3.7

2.1

2.48

3.11

mg/l

3.15

110

636

Adenocarcinoma and Papillary adenocarcinoma of kidney, excluding all cancers (controls excluding all cancers)

111

672

1.96

7.39

2.5

2.0

3.25

2.97

mg/l

0.55

568

Benign neoplasm of meninges

1009

8593

1.24

7.36

2.4

2.2

2.99

3.05

mg/l

0.36

850

7301

Severe combined immunodeficiency [SCID] with reticular dysgenesis

195

3.11

7.36

3.4

1.9

3.32

3.21

mg/l

0.11

178

Other and unspecified acute skin changes due to ultraviolet radiation

273

1995

1.52

7.35

2.5

2.2

2.96

3.12

mg/l

0.42

231

1672

Biological medicines for asthma

134

846

1.81

7.35

2.4

1.9

2.83

3.02

mg/l

0.49

126

727

Burn and corrosion of trunk

289

2124

1.49

7.35

2.3

2.2

2.87

3.00

mg/l

0.52

248

1823

Disorders of eyelid in diseases classified elsewhere

331

2486

1.45

7.34

2.4

2.1

3.19

3.00

mg/l

0.47

290

2095

Benign neoplasm: Tongue

278

2039

1.51

7.30

2.7

2.1

2.73

3.09

mg/l

1.79

233

1737

Chronic crepitant synovitis/bursitis of hand and wrist/periarthritis of wrist

149

967

1.75

7.29

2.4

2.0

3.02

3.07

mg/l

0.08

134

819

Chronic conjunctivitis

296

2187

1.48

7.29

2.3

2.2

2.70

3.01

mg/l

1.87

267

1871

Maternal care for known or suspected fetal abnormality and damage

1579

12315

1.18

7.28

2.0

2.1

2.53

2.63

mg/l

1.06

1354

10649

Hypertrophic disorders of skin

561

4506

1.32

7.27

2.5

2.1

2.73

2.82

mg/l

0.51

498

3861

Pulmonary eosinophilia, not elsewhere classified

134

855

1.83

7.25

2.7

2.1

3.18

3.19

mg/l

0.02

119

728

Assault by sharp object

140

886

1.74

7.24

2.1

2.0

3.03

2.83

mg/l

0.45

124

772

Other congenital malformations of nervous system

114

697

1.92

7.23

2.4

2.1

2.92

2.76

mg/l

0.33

596

Universal erythroderma, KELA reimbursement

147

954

1.75

7.20

2.6

2.0

3.47

3.10

mg/l

0.82

117

831

Amblyopia ex anopsia

424

3305

1.38

7.18

2.3

2.4

2.89

2.84

mg/l

0.14

354

2842

Malignant neoplasm of other connective and soft tissue, excluding all cancers (controls excluding all cancers)

400

3096

1.40

7.18

2.1

2.2

2.97

2.91

mg/l

0.20

336

2590

Disorders of porphyrin and bilirubin metabolism

117

718

1.87

7.17

2.9

2.1

3.39

3.12

mg/l

0.31

103

631

Biliary cirrhosis, NAS

215

3.17

7.16

3.5

2.2

4.46

3.20

mg/l

1.20

187

Spondylopathies in diseases classified elsewhere

132

843

1.83

7.16

2.3

2.0

3.55

3.14

mg/l

0.63

116

711

Anaphylactic shock due to adverse effect of correct drug or medication properly administered

127

800

1.84

7.16

2.7

2.0

3.06

3.01

mg/l

0.09

108

683

Benign neoplasm: Appendix

122

767

1.89

7.14

2.9

2.1

2.78

3.14

mg/l

1.32

110

652

Traction detachment of retina

571

2.03

7.13

2.6

2.0

3.43

3.13

mg/l

0.49

495

Medicines for HER+ breast cancer

3126

33295

0.89

7.12

2.2

2.3

2.98

3.02

mg/l

0.41

2655

28426

Other deformities of toe(s)

334

2519

1.43

7.11

2.6

2.1

2.94

2.91

mg/l

0.07

268

2110

124

775

1.83

7.10

2.0

3.30

3.03

mg/l

0.62

105

662

Abscess of external ear

143

925

1.75

7.06

2.7

2.0

2.67

3.07

mg/l

1.58

127

790

Carcinoma in situ of skin, other sites/unspecified

150

1003

1.80

7.04

2.5

2.2

3.45

3.23

mg/l

0.50

130

836

Separation of retinal layers (serosa)

363

2772

1.41

7.02

2.7

2.1

2.83

2.96

mg/l

0.43

308

2350

Listeriosis

308

2.55

7.02

3.1

2.1

4.07

3.29

mg/l

1.13

259

Atypical mycobacterium lung infection

132

848

1.82

7.01

2.5

2.1

3.18

3.21

mg/l

0.04

119

710

Other contact dermatitis

798

6667

1.25

6.98

2.4

2.1

2.98

2.87

mg/l

0.72

686

5701

Follicular lymphoma

396

3075

1.39

6.98

2.1

2.2

3.22

2.96

mg/l

1.65

352

2595

Use of ropinirole

363

2799

1.42

6.98

2.3

2.2

2.82

3.06

mg/l

1.55

310

2362

Polyarteritis nodosa

479

2.14

6.97

3.2

2.0

3.24

3.20

mg/l

0.06

411

Atopic conjunctivitis

430

3365

1.37

6.96

2.3

2.1

2.83

2.87

mg/l

0.18

380

2889

Other disorders of peripheral nervous system

399

2.26

6.94

2.6

2.0

2.53

3.39

mg/l

3.23

340

Benign neoplasm of bone and articular cartilage

744

6175

1.26

6.94

2.3

2.2

2.84

2.79

mg/l

0.20

645

5281

Severe visual impairment, binocular

344

2.42

6.93

2.9

2.2

4.27

3.20

mg/l

1.71

308

Benign neoplasm: Bladder

107

654

1.95

6.93

2.3

2.1

2.63

3.06

mg/l

1.32

542

Varicella [chickenpox]

392

3022

1.38

6.91

2.7

2.2

2.81

2.79

mg/l

0.06

346

2633

Other lesions of median nerve

302

2269

1.47

6.90

2.5

2.1

3.08

3.14

mg/l

0.14

262

1897

Premenstrual syndrome

117

724

1.84

6.89

2.4

2.0

2.69

2.61

mg/l

0.07

101

631

Early lumbar disc prolapse operation

885

7448

1.23

6.87

2.1

2.65

2.69

mg/l

0.26

781

6514

Pedestrian injured in transport accident

672

5541

1.28

6.87

2.3

2.2

2.78

2.94

mg/l

1.18

577

4726

Benign neoplasm of middle ear and respiratory system

772

6455

1.26

6.86

2.4

2.2

3.06

2.98

mg/l

0.35

676

5483

Muscle strain

296

2201

1.45

6.85

2.3

2.0

2.81

2.89

mg/l

0.22

256

1839

Other and unspecified vaccines and biological substances

460

2.16

6.85

3.0

2.0

2.89

2.98

mg/l

0.13

405

Injury of nerves and spinal cord at neck level

218

1550

1.56

6.85

2.4

2.1

2.88

3.10

mg/l

0.50

187

1323

Disorders of plasma-protein metabolism, not elsewhere classified

412

2.18

6.85

2.7

1.9

3.52

3.21

mg/l

0.37

358

Pyoderma

195

1357

1.60

6.84

3.2

2.0

3.19

2.99

mg/l

0.50

160

1158

Neuroendocrine tumor and carcinoma of pancreas, excluding all cancers (controls excluding all cancers)

342

2.34

6.83

2.7

2.0

3.03

3.00

mg/l

0.03

281

Other disorders of amino-acid metabolism

309

2.46

6.83

3.3

1.9

4.05

3.17

mg/l

1.40

274

Acute alcohol intoxication ICD-9

334

2535

1.42

6.81

2.4

2.1

3.11

2.99

mg/l

0.36

291

2141

Benign neoplasm of eye and adnexa

929

7898

1.23

6.81

2.5

2.3

2.82

2.90

mg/l

0.41

779

6701

Ductal carcinoma of pancreas, excluding all cancers (controls excluding all cancers)

456

2.19

6.79

2.0

2.1

3.14

3.22

mg/l

0.11

383

Family history of certain disabilities and chronic diseases leading to disablement

426

3335

1.36

6.79

2.5

2.0

2.66

2.72

mg/l

0.22

369

2863

Sequelae of other and unspecified effects of external causes

300

2.42

6.78

2.4

2.0

2.72

2.91

mg/l

0.29

264

Tooth eruption problems

1423

12337

1.18

6.78

2.4

2.2

2.49

2.63

mg/l

2.20

1262

10589

All dysplastic lesions of the vulva

419

3289

1.37

6.77

2.5

2.2

3.13

2.94

mg/l

0.64

371

2803

Normotensive glaucoma

876

7451

1.25

6.74

2.4

2.3

2.81

3.12

mg/l

3.90

714

6276

Superficial injury of neck

192

1332

1.59

6.73

2.0

3.03

2.86

mg/l

0.31

163

1146

Thrombotic microangiopathy

388

2.24

6.72

3.6

2.0

3.14

3.04

mg/l

0.14

341

Deep endometriosis

1009

8658

1.22

6.72

2.3

2.2

2.95

2.88

mg/l

0.50

855

7421

Other disorders of carbohydrate metabolism

288

2.46

6.71

2.1

2.2

2.90

3.11

mg/l

0.25

251

Mixed disorders of conduct and emotions

244

1765

1.50

6.71

2.3

2.90

2.49

mg/l

1.72

217

1529

Benign neoplasm: Parathyroid gland

121

771

1.85

6.71

3.7

2.1

2.48

3.29

mg/l

4.54

110

663

Other specified disorders of muscle

268

1972

1.47

6.67

2.6

2.1

2.69

3.02

mg/l

1.72

238

1666

Dislocation, sprain and strain of joints and ligaments of head

391

3038

1.37

6.67

2.4

2.2

3.14

2.78

mg/l

1.75

333

2622

Lupus erythematosus

243

1770

1.52

6.66

2.6

2.1

3.14

3.04

mg/l

0.24

211

1498

Hypoplasia of dental enamel , including avohilmo

291

2154

1.46

6.64

3.7

2.8

2.61

2.60

mg/l

0.03

260

1904

Benign neoplasm: Skin of trunk

391

3046

1.38

6.64

2.5

2.2

2.82

2.86

mg/l

0.11

332

2578

Other papulosquamous disorders

124

794

1.82

6.63

2.8

2.0

3.00

3.01

mg/l

0.02

109

679

Hypothermia

185

1286

1.61

6.62

2.4

2.1

3.40

3.08

mg/l

0.58

159

1092

Hyperaldosteronism

274

2040

1.48

6.60

2.5

2.1

2.94

3.06

mg/l

0.38

234

1743

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8, excluding more controls

823

6936

1.24

6.60

2.3

2.1

2.56

2.70

mg/l

1.15

727

6004

Nonspecific lymphadenitis

549

4441

1.30

6.60

2.2

2.1

2.68

2.81

mg/l

0.86

476

3831

Benign neoplasm: Skin of lower limb, including hip

266

1967

1.48

6.58

2.5

2.2

2.81

2.88

mg/l

0.21

223

1674

Implicit parasitic Sepsis

307

2.44

6.56

2.9

1.9

2.71

2.98

mg/l

0.48

256

Other and unspecified injuries of thorax

174

1193

1.62

6.55

2.5

2.0

3.37

3.01

mg/l

0.58

149

1022

Fasciculation

121

770

1.81

6.54

2.0

2.40

2.89

mg/l

2.89

104

674

Contusion of toe(s) without damage to nail

241

1754

1.50

6.53

2.5

2.0

2.55

2.81

mg/l

1.25

209

1516

Perforation of oesophagus

337

2.37

6.51

2.8

1.9

3.01

3.16

mg/l

0.19

290

Intrahepatic Cholestasis of Pregnancy (ICP) , excluding more controls

674

5584

1.27

6.50

2.2

2.0

2.50

2.61

mg/l

0.74

595

4869

Pedal cyclist injured in transport accident

2150

19361

1.14

6.49

2.2

2.85

2.86

mg/l

0.04

1815

16669

Other vitreous opacities

388

3042

1.38

6.47

2.3

2.2

3.05

3.02

mg/l

0.08

327

2576

Benign neoplasm: Cerebral meninges

906

7737

1.23

6.47

2.3

2.92

3.04

mg/l

0.84

760

6566

Exposure to unspecified smoke, fire and flames

101

616

1.91

6.46

1.9

2.0

2.70

3.15

mg/l

1.14

525

Hypertrophic scar

515

4157

1.31

6.45

2.5

2.1

2.71

2.82

mg/l

0.64

461

3559

Non-small cell lung cancer

1301

14821

0.85

6.44

2.2

2.3

3.35

3.10

mg/l

2.07

1116

12428

Foreign body in respiratory tract

503

4057

1.32

6.43

2.2

2.83

2.95

mg/l

0.53

423

3465

Diabetes insipidus

595

1.93

6.43

2.2

1.9

2.86

3.12

mg/l

0.48

510

Social disorders starting during childhood or adolecense, excluding more controls

455

2.02

6.37

2.6

3.0

2.84

2.45

mg/l

1.07

394

Perioral dermatitis

214

1536

1.54

6.37

2.5

2.0

2.66

2.77

mg/l

0.45

182

1301

Other disorders of binocular vision

144

958

1.70

6.36

2.4

2.0

2.16

2.78

mg/l

3.36

135

810

Open wound of thorax

143

945

1.68

6.35

2.4

2.0

3.13

3.00

mg/l

0.24

125

818

Idiopathic urticaria

206

1469

1.55

6.35

2.3

2.0

2.49

2.95

mg/l

2.94

180

1250

Carcinoma in situ of oral cavity, oesophagus and stomach

369

2.27

6.33

3.3

2.2

2.95

2.99

mg/l

0.04

305

Monoplegia

159

1085

1.66

6.33

2.5

2.0

2.86

3.14

mg/l

0.81

133

930

Other intracranial haemorrhages

328

2528

1.42

6.33

2.2

3.54

3.11

mg/l

1.52

274

2128

Toxic effect of ethanol

375

2917

1.37

6.32

2.5

2.0

2.75

2.82

mg/l

0.24

319

2487

Torsion of ovary, ovarian pedicle and fallopian tube

220

1582

1.51

6.31

2.2

2.0

2.72

mg/l

0.01

195

1373

Histrionic personality disorder

332

2.32

6.31

1.7

2.0

2.93

3.36

mg/l

0.60

286

Injury of muscle and tendon at wrist and hand level

1231

10736

1.19

6.30

2.3

2.2

2.82

2.90

mg/l

0.62

1073

9278

Personal history of malignant neoplasm

346

2674

1.39

6.28

2.1

3.00

2.93

mg/l

0.21

296

2262

Malignant neoplasm of other and unspecified female genital organs, excluding all cancers (controls excluding all cancers)

265

1982

1.48

6.28

1.8

2.3

2.87

3.03

mg/l

0.44

219

1667

Non-Hodgkin lymphoma, all

413

3282

1.36

6.26

2.1

2.2

3.80

3.13

mg/l

3.73

355

2753

Contact with heat and hot substances

499

4031

1.31

6.23

2.4

2.2

2.69

2.87

mg/l

1.18

420

3440

Foreign body entering into or through eye or natural orifice

737

6183

1.25

6.22

2.2

2.68

2.89

mg/l

1.95

628

5299

Postpartum hemorraghe, all women as controls

2570

23305

1.12

6.22

2.0

2.1

2.69

2.65

mg/l

0.46

2215

20151

Hypothyroidism due to medicaments and other exogenous substances

116

743

1.81

6.21

3.0

2.1

2.76

3.16

mg/l

0.85

100

637

Drug-induced polyneuropathy

606

1.94

6.20

2.3

2.5

3.09

3.11

mg/l

0.02

526

Bicipital tendinitis

423

3350

1.34

6.20

2.3

2.1

2.87

2.95

mg/l

0.31

366

2835

Disorders in reading

153

1032

1.64

6.19

2.2

2.7

2.43

2.61

mg/l

0.54

136

899

Ankylosing hyperostosis [Forestier]

138

918

1.71

6.19

2.8

2.0

3.13

3.14

mg/l

0.01

124

778

Dyshidrosis [pompholyx]

156

1060

1.64

6.18

2.0

2.90

2.85

mg/l

0.08

123

903

Flatulence and related conditions

108

677

1.83

6.18

2.8

2.1

2.75

2.89

mg/l

0.39

574

Other articular cartilage disorders

227

1649

1.50

6.17

2.3

1.9

3.11

2.86

mg/l

0.65

202

1363

Congenital malformations of the respiratory system

174

1214

1.61

6.16

2.7

2.4

3.03

3.01

mg/l

0.03

154

1049

Burn and corrosion of ankle and foot

139

926

1.69

6.13

2.4

2.2

3.30

3.05

mg/l

0.46

115

801

Malignant neoplasm of head and neck

789

6686

1.24

6.12

2.1

2.2

2.77

3.05

mg/l

3.18

651

5664

Malignant neoplasm of renal pelvis, excluding all cancers (controls excluding all cancers)

127

835

1.76

6.12

2.3

2.1

2.99

3.10

mg/l

0.18

113

687

Myasthenia gravis

176

1236

1.61

6.11

2.5

2.1

2.98

3.07

mg/l

0.20

155

1041

Viral encephalitis, not elsewhere classified/unspecified

202

1449

1.54

6.10

2.2

2.1

2.94

3.05

mg/l

0.30

169

1239

Other deformity of hallux (acquired)

543

1.95

6.09

2.4

2.0

2.74

3.04

mg/l

0.76

448

Drug-induced tremor

418

2.14

6.08

2.2

2.0

3.19

3.14

mg/l

0.06

359

Mild mental retardation

238

1748

1.48

6.08

2.4

2.86

mg/l

0.01

218

1510

Findings of drugs and other substances, not normally found in blood

287

2.42

6.07

2.9

2.0

3.19

3.13

mg/l

0.06

251

Benign neoplasm: Skin, unspecified

364

2845

1.37

6.05

2.7

2.1

2.99

2.89

mg/l

0.37

319

2383

Malignant neoplasm of retroperitoneum and peritoneum, excluding all cancers (controls excluding all cancers)

173

1213

1.61

6.04

2.2

2.65

3.07

mg/l

1.87

147

1016

Peritonsillar abscess

2030

18282

1.14

6.04

2.2

2.1

2.77

2.82

mg/l

0.46

1762

15762

Other dermatomyositis

315

2.31

6.03

2.5

2.0

3.92

3.24

mg/l

0.97

268

Acute nephritic syndrome

211

1526

1.52

6.03

2.8

2.2

3.07

3.05

mg/l

0.02

187

1300

Intrahepatic Cholestasis of Pregnancy (ICP)

674

5634

1.25

5.97

2.2

2.1

2.50

2.66

mg/l

1.28

595

4864

Convergence insufficiency and excess

145

980

1.66

5.96

2.2

2.0

2.13

2.76

mg/l

4.08

132

841

Maternal care for known or suspected malpresentation of fetus

1885

12605

1.14

5.96

2.1

2.63

mg/l

0.02

1653

10916

Benign neoplasm: Heart

228

2.67

5.96

3.6

2.0

2.94

2.98

mg/l

0.04

194

Enteritis due to Yersinia enterocolitica

323

2.26

5.93

2.7

1.9

3.20

3.11

mg/l

0.11

278

Other and unspecified injuries of wrist and hand

355

2772

1.37

5.93

2.2

2.1

2.68

2.86

mg/l

0.89

303

2370

Cardiomyopathy due to drugs and other external agents

131

3.45

5.91

2.3

2.0

2.89

3.36

mg/l

0.44

117

Other disorders of amniotic fluid and membranes

1336

11663

1.17

5.90

2.2

2.1

2.70

2.64

mg/l

0.59

1160

10076

Antibody deficiency with near-normal immunoglobulins or with hyperimmunoglobulinaemia

4.80

5.90

4.8

2.2

3.00

2.90

mg/l

0.06

Hypertrophy of tongue papillae

129

857

1.72

5.87

2.2

2.0

3.09

3.13

mg/l

0.06

112

753

Hypoplasia of dental enamel, prenatal

140

3.53

5.86

5.2

4.1

3.16

2.60

mg/l

0.95

131

Mature T/NK-cell lymphomas, hilmo, excluding all cancers

135

906

1.69

5.85

2.6

2.2

3.41

3.04

mg/l

0.77

125

763

Other disorders of optic disc

131

873

1.70

5.84

2.2

2.1

2.73

3.04

mg/l

0.87

115

745

Spontaneous abortion

5013

31923

1.09

5.84

2.2

2.78

2.80

mg/l

0.19

4359

27501

Use of rotigotine

118

772

1.77

5.83

2.8

2.1

3.14

3.31

mg/l

0.22

664

Ulcer of vagina/vulva

255

1917

1.46

5.83

2.3

2.1

2.94

2.92

mg/l

0.05

223

1615

Generalized epilepsy

413

3293

1.33

5.81

2.2

2.73

2.80

mg/l

0.29

349

2841

Conductive hearing loss, unspecified

802

6833

1.23

5.77

2.3

2.91

mg/l

0.01

690

5827

Hypersensitivity angiitis

359

2.22

5.76

2.6

2.0

2.75

3.23

mg/l

1.16

311

Pedal cyclist injured in other and unspecified transport accidents

1050

9128

1.19

5.75

2.2

2.88

2.89

mg/l

0.08

888

7823

Motor disorders, excluding more controls

137

872

1.64

5.74

3.8

3.5

2.76

2.52

mg/l

0.80

125

782

Postpartum haemorrhage due to anatomy

1049

9128

1.19

5.71

2.0

2.81

2.54

mg/l

3.50

894

7897

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

1256

11066

1.18

5.70

2.2

2.86

2.95

mg/l

0.73

1086

9488

Injury of urinary and pelvic organs

195

1404

1.52

5.70

2.4

2.1

3.49

2.92

mg/l

1.40

166

1205

Malignant neoplasm of endocrine gland

682

5747

1.25

5.67

2.4

2.2

2.96

mg/l

0.02

591

4904

Pyogenic granuloma

171

1206

1.57

5.67

2.7

2.2

3.10

2.95

mg/l

0.31

157

1034

Tuberculosis, IBD comorbidity

766

6520

1.23

5.67

2.6

2.3

3.04

3.12

mg/l

0.37

652

5458

Preterm labour and delivery

2438

22254

1.12

5.65

2.2

2.93

2.77

mg/l

2.91

2115

19266

Benign neoplasm: Other and unspecified parts of mouth

333

2607

1.38

5.64

2.7

2.1

2.98

3.03

mg/l

0.15

287

2195

Other congenital malformations of peripheral vascular system

135

911

1.67

5.63

3.7

2.3

3.29

2.89

mg/l

0.55

121

789

102

646

1.80

5.62

2.1

2.84

2.86

mg/l

0.02

550

Injury of nerves and spinal cord at thorax level

292

2.27

5.62

2.5

2.0

3.16

3.13

mg/l

0.02

249

Pedestrian injured in collision with pedal cycle

300

2312

1.40

5.60

2.2

2.1

2.68

3.02

mg/l

1.79

259

1967

Nontoxic single thyroid nodule

676

5693

1.25

5.60

2.2

2.97

2.99

mg/l

0.06

582

4863

Other and unspecified diseases of spleen

267

2.40

5.60

2.7

2.0

4.41

3.12

mg/l

1.93

231

Osteopathy in diseases classified elsewhere

442

2.03

5.60

2.3

1.9

3.54

3.28

mg/l

0.24

373

Benign neoplasm: Short bones of upper limb

143

974

1.63

5.60

2.4

2.1

2.84

2.88

mg/l

0.05

121

827

Vestibular neuronitis

849

7297

1.22

5.58

2.3

2.2

2.97

3.00

mg/l

0.14

714

6230

Localized scleroderma [morphea]

145

996

1.63

5.57

2.5

2.1

3.14

3.13

mg/l

0.02

127

835

Porphyria cutanea tarda

5.43

5.55

2.6

1.9

3.29

3.38

mg/l

0.05

Habitual aborter

198

1431

1.50

5.54

2.2

2.0

2.60

2.56

mg/l

0.09

178

1259

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8

823

7052

1.22

5.51

2.3

2.1

2.56

2.75

mg/l

1.83

727

6052

Melanocytic naevi of lower limb, including hip

394

3149

1.33

5.50

2.5

2.2

2.80

2.81

mg/l

0.04

343

2679

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

746

6351

1.23

5.50

2.4

2.2

3.00

2.96

mg/l

0.17

620

5422

Alzheimer’s disease (undefined), excluding more controls

775

0.46

5.48

1.8

2.2

2.81

3.38

mg/l

1.27

628

Benign neoplasm: Larynx

306

2376

1.39

5.48

2.3

2.1

3.02

3.06

mg/l

0.11

273

2021

Presbyopia

527

4338

1.28

5.48

2.2

2.1

2.76

2.95

mg/l

1.14

442

3739

Other and unspecified noninflammatory disorders of ovary, fallopian tube and broad ligament

258

1949

1.42

5.47

2.0

2.1

3.01

2.81

mg/l

0.52

227

1688

Other and unspecified nonscarring hair loss

492

1.96

5.47

2.7

1.9

2.52

2.92

mg/l

0.83

409

Routine general health check-up of defined subpopulation

178

1259

1.51

5.47

1.9

2.74

2.79

mg/l

0.13

154

1074

Haemangioma and lymphangioma, any site

857

7383

1.21

5.43

2.8

2.2

2.99

2.92

mg/l

0.33

758

6323

Autoimmune thyroiditis

182

1307

1.53

5.43

2.3

2.1

2.44

2.85

mg/l

2.42

154

1123

Myotonic disorders

512

1.90

5.43

2.2

1.9

3.08

3.07

mg/l

0.01

447

Intercostal neuropathy

514

1.91

5.43

2.6

1.9

2.83

3.02

mg/l

0.40

436

Disorders of lacrimal system and orbit in diseases classified elsewhere

236

1769

1.45

5.42

2.6

2.1

2.59

3.06

mg/l

3.22

210

1496

Inflammatory disorders of breast

620

5201

1.25

5.42

2.2

2.1

2.71

2.75

mg/l

0.21

547

4439

Asymptomatic human immunodeficiency virus [HIV] infection status

271

2.22

5.41

2.2

2.0

2.73

3.10

mg/l

0.44

239

Ductal carcinoma of pancreas

490

1.99

5.40

2.0

1.9

3.14

3.23

mg/l

0.12

426

Beta thalassaemia

6.40

5.40

2.8

1.7

3.57

2.82

mg/l

0.46

Thyrotoxicosis factitia

202

2.65

5.38

2.6

2.0

2.92

3.10

mg/l

0.22

169

Acute nasopharyngitis (common cold)

950

8160

1.19

5.38

2.4

2.1

2.79

2.80

mg/l

0.05

829

7043

Serous carcinoma of ovary, excluding all cancers (controls excluding all cancers)

324

2547

1.37

5.36

2.0

2.3

2.94

2.98

mg/l

0.09

280

2152

Single delivery by caesarean section

2004

10481

1.13

5.35

2.1

2.2

2.64

2.69

mg/l

0.53

1745

9008

Benign neoplasm: Conjunctiva

297

2304

1.39

5.34

2.4

2.1

2.98

2.89

mg/l

0.22

247

1956

Maternal infectious and parasitic diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

199

1453

1.49

5.34

2.1

2.0

2.56

2.61

mg/l

0.10

171

1261

Anomalies of pupillary function

202

1483

1.49

5.32

2.1

2.37

2.94

mg/l

4.13

176

1279

Other injuries of lower limb, level unspecified

533

1.88

5.30

2.7

2.0

2.72

3.21

mg/l

0.79

458

Carcinoma in situ of oral cavity, oesophagus and stomach

392

2.11

5.30

3.3

2.1

2.95

3.24

mg/l

0.44

334

Other injuries of spine and trunk, level unspecified

524

1.88

5.29

2.9

2.1

2.98

2.92

mg/l

0.10

461

Benign neoplasm: Parotid gland

754

6453

1.22

5.28

2.2

2.98

2.99

mg/l

0.05

629

5501

All dysplastic lesions of the cervix uteri, vagina or vulva

2931

26895

1.11

5.28

2.2

2.1

2.71

2.74

mg/l

0.26

2513

23266

Poisoning by medicine, drug-induced

128

864

1.65

5.28

2.6

2.0

3.01

3.07

mg/l

0.09

108

741

Benign neoplasm: Bladder

107

704

1.78

5.26

2.3

2.0

2.63

3.22

mg/l

2.08

604

Malignant neoplasm of eye, brain and central nervous system

247

3234

0.72

5.24

1.8

2.2

2.80

2.99

mg/l

0.68

209

2746

Other and unspecified intracranial injuries

289

2240

1.39

5.23

2.5

2.2

2.95

3.00

mg/l

0.16

248

1889

Traumatic ischaemia of muscle

121

808

1.66

5.23

2.7

2.0

3.28

3.05

mg/l

0.51

108

705

Melanoma in situ

372

2984

1.34

5.23

2.3

2.2

2.78

2.97

mg/l

0.86

296

2517

Pemphigus

491

1.94

5.23

2.8

1.9

2.53

3.13

mg/l

2.14

418

Vitiligo

108

705

1.72

5.22

2.4

2.1

3.09

2.90

mg/l

0.31

613

Pathological resorption of teeth

266

2033

1.40

5.21

2.5

2.1

3.13

2.90

mg/l

0.65

239

1720

Other specific arthropathies, wide

195

1423

1.48

5.21

2.5

1.9

3.19

2.97

mg/l

0.68

174

1184

971

8461

1.19

5.21

1.9

2.1

2.33

2.58

mg/l

3.30

777

7356

Exposure to smoke, fire and flames

220

1638

1.45

5.21

2.0

2.1

2.80

2.97

mg/l

0.49

188

1408

Benign neoplasm: Endocrine pancreas

392

2.06

5.21

2.4

2.0

3.43

3.06

mg/l

0.43

325

Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)

610

5136

1.25

5.19

2.0

2.3

3.14

2.98

mg/l

0.64

523

4359

Benign neoplasm: Skin of lower limb, including hip

266

2045

1.41

5.18

2.5

2.1

2.81

3.02

mg/l

0.92

223

1756

Malignant neoplasm of bone and articular cartilage, excluding all cancers (controls excluding all cancers)

177

1279

1.52

5.15

2.2

2.3

3.11

2.94

mg/l

0.34

153

1078

Benign neoplasm: salivary glands, exclude unknown (D119)

835

7218

1.21

5.14

2.2

2.99

mg/l

0.01

700

6157

Enduring personality changes

230

2.37

5.13

2.3

1.9

2.92

2.90

mg/l

0.02

198

Persons encountering health services in circumstances related to reproduction

5639

36034

1.07

5.11

2.2

2.3

2.69

2.82

mg/l

4.44

4916

31215

Family history of malignant neoplasm

942

8195

1.19

5.11

2.2

2.1

2.61

2.78

mg/l

1.58

825

7035

Sequelae of other and unspecified infectious and parasitic diseases

477

3915

1.28

5.10

2.6

2.1

2.90

2.91

mg/l

0.02

418

3372

Other and unspecified mononeuropathies of lower limb

267

2057

1.40

5.10

2.4

2.1

2.87

3.03

mg/l

0.67

219

1741

Crossbite

645

5049

1.24

5.10

3.2

2.5

2.73

mg/l

0.03

569

4412

Malignant neoplasm of adrenal gland, excluding all cancers (controls excluding all cancers)

485

1.91

5.09

2.2

3.06

2.91

mg/l

0.22

417

Personality and behavioural disorders due to brain disease, damage and dysfunction

148

1037

1.58

5.09

2.2

2.1

2.82

3.11

mg/l

0.81

120

895

Haemangioma, any site

795

6850

1.21

5.07

2.8

2.2

3.00

2.93

mg/l

0.26

699

5862

Respiratory tuberculosis, confirmed

195

1437

1.49

5.07

2.9

2.1

3.06

3.15

mg/l

0.18

166

1213

Family history of other specific disorders

128

874

1.64

5.07

2.3

2.2

2.30

2.80

mg/l

3.11

112

754

Eustachian salpingitis and obstruction

685

5814

1.22

5.05

2.2

2.68

2.76

mg/l

0.48

581

5052

Erythema multiforme

224

1687

1.44

5.04

2.3

2.1

2.95

3.08

mg/l

0.33

190

1432

Other superficial mycoses

186

1356

1.49

5.04

2.5

2.1

2.96

2.89

mg/l

0.12

163

1165

Benign neoplasm: Heart

244

2.45

5.04

3.6

2.0

2.94

3.10

mg/l

0.20

211

Hereditary corneal dystrophies

310

2447

1.37

5.04

2.4

2.1

2.91

3.10

mg/l

0.79

263

2064

Tic disorders

123

831

1.64

5.03

3.0

2.7

2.72

2.67

mg/l

0.09

108

703

LSIL lesion of the vulva

275

2130

1.39

5.03

2.3

2.1

3.12

2.93

mg/l

0.45

252

1821

Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)

1373

12270

1.16

5.03

2.2

2.3

3.01

2.94

mg/l

0.40

1176

10395

Benign lipomatous neoplasm of of intra-abdominal organs

186

2.63

5.03

2.3

2.1

3.09

3.00

mg/l

0.08

160

Other disorders of prostate

326

2578

1.35

5.03

2.4

2.1

3.16

3.02

mg/l

0.30

293

2193

Severe visual impairment, monocular

631

1.79

5.00

2.6

2.1

3.60

3.20

mg/l

0.53

548

Abscess of Bartholin gland

266

2056

1.39

4.96

2.8

2.0

2.78

2.80

mg/l

0.04

237

1763

Nystagmus and other irregular eye movements

139

970

1.60

4.96

2.4

2.2

3.30

2.92

mg/l

0.47

121

837

malignant neoplasm of female genital organs

1506

13561

1.15

4.96

2.2

2.3

3.26

3.09

mg/l

1.51

1282

11497

Mantle cell lymphoma

101

669

1.79

4.95

1.9

2.1

3.15

3.13

mg/l

0.03

581

Benign neoplasm of major salivary glands

941

8227

1.19

4.95

2.3

2.2

3.06

3.00

mg/l

0.31

794

6999

Benign neoplasm of male genital organs

181

1319

1.49

4.95

2.2

3.00

2.85

mg/l

0.36

153

1112

Acute myeloid leukaemia, helper endpoint

103

678

1.73

4.95

2.3

2.1

2.69

3.07

mg/l

1.05

568

Acute myeloid leukaemia, excluding all cancers (controls excluding all cancers)

103

678

1.73

4.95

2.3

2.1

2.69

3.07

mg/l

1.05

568

Aphakia

139

961

1.57

4.94

2.3

1.9

2.96

3.14

mg/l

0.41

119

803

Periodontal disease, other/unspecified

228

2.39

4.94

2.6

2.5

2.21

3.18

mg/l

2.60

200

Localized skin eruption due to drugs and medicaments

119

810

1.67

4.91

3.0

2.0

3.08

3.09

mg/l

0.01

695

Major anomalies of jaw size

243

1852

1.41

4.91

2.5

2.1

2.74

2.90

mg/l

0.55

212

1594

Venous complications and haemorrhoids in pregnancy

176

1279

1.50

4.91

2.2

2.1

2.33

2.63

mg/l

1.56

156

1094

Melanoma in situ of trunk

132

919

1.63

4.91

2.4

2.1

2.63

3.01

mg/l

0.82

104

782

Rheumatic fever incl heart disease

328

2609

1.35

4.90

3.0

2.2

3.53

3.15

mg/l

1.95

294

2191

Androgenic alopecia

585

1.80

4.90

2.5

2.0

2.96

2.98

mg/l

0.03

490

Malignant neoplasm of bone and articular cartilage of other and unspecified sites, excluding all cancers (controls excluding all cancers)

119

809

1.66

4.89

2.3

2.2

3.19

3.00

mg/l

0.28

101

684

Malignant neoplasm of other and unspecified parts of biliary tract, excluding all cancers (controls excluding all cancers)

182

1335

1.50

4.89

2.5

2.2

3.43

3.05

mg/l

0.61

161

1109

Tuberculosis of other organs

229

1746

1.44

4.89

2.8

2.2

3.04

3.23

mg/l

0.50

198

1460

Exposure to excessive natural heat

150

2.94

4.87

2.4

2.0

2.90

3.19

mg/l

0.26

129

Other disorders of central nervous system

117

792

1.66

4.86

3.0

2.1

3.13

3.05

mg/l

0.13

680

Exposure to sunlight

170

2.77

4.86

2.9

2.2

3.98

3.07

mg/l

0.80

147

Torticollis

155

1101

1.53

4.86

2.3

2.0

2.64

2.91

mg/l

0.70

132

941

Complications following abortion and ectopic and molar pregnancy

332

2649

1.34

4.83

2.3

2.2

2.90

2.97

mg/l

0.21

269

2271

Disorders of other and unspecified cranial nerves

346

2.06

4.83

2.6

2.0

2.74

3.09

mg/l

0.64

293

Accidental poisoning by and exposure to other gases and vapours

308

2.12

4.83

2.3

1.9

3.34

3.21

mg/l

0.16

273

Spinal enthesopathy

313

2462

1.34

4.83

2.4

2.2

3.24

3.29

mg/l

0.13

275

2007

Polymyositis

546

1.81

4.81

2.7

2.0

2.99

3.20

mg/l

0.39

471

Oral leukoplakia, including avohilmo

252

1945

1.40

4.81

2.2

2.1

2.88

3.12

mg/l

0.59

209

1664

Unspecified chronic bronchitis

360

2894

1.32

4.80

2.6

2.1

2.97

3.00

mg/l

0.07

314

2412

Burns classified according to extent of body surface involved

617

1.74

4.77

2.6

2.0

2.72

3.11

mg/l

0.72

541

Perichondritis of external ear

181

1337

1.50

4.76

2.5

2.2

3.02

3.19

mg/l

0.48

154

1133

Pityriasis rubra pilaris

143

2.85

4.76

2.1

1.8

2.86

2.96

mg/l

0.10

128

Other facial nerve disorders

267

2076

1.38

4.76

2.3

2.1

2.89

2.98

mg/l

0.26

220

1757

Impacted teeth

1827

15434

1.13

4.76

2.1

2.68

2.61

mg/l

0.85

1625

13231

Tuberculosis, wide

784

6789

1.21

4.75

2.6

2.3

3.03

3.12

mg/l

0.42

667

5679

Chalazion

1079

9536

1.17

4.72

2.2

2.90

mg/l

0.02

918

8184

Migraine, unspecified, drug-induced

479

1.86

4.70

2.4

2.0

3.32

2.93

mg/l

0.67

407

Respiratory tuberculosis, bacteriologically and histologically confirmed

199

1490

1.46

4.69

2.9

2.1

3.05

3.18

mg/l

0.30

170

1255

Ulcer of oesophagus, drug-induced

369

2.06

4.67

2.6

2.0

3.17

3.12

mg/l

0.05

317

Gestational [pregnancy-induced] oedema and proteinuria without hypertension

831

7227

1.19

4.67

2.5

2.2

3.00

2.84

mg/l

0.91

755

6153

Other and unspecified corneal deformities and disorders

282

2211

1.36

4.66

2.6

2.1

2.85

3.05

mg/l

0.69

250

1888

Male infertility

276

2133

1.34

4.66

2.4

2.1

3.05

2.80

mg/l

1.19

248

1855

Alzheimer’s disease (Early onset)

309

3868

0.76

4.64

2.1

2.3

3.28

3.26

mg/l

0.03

234

3219

Cryoglobulinemia

101

3.41

4.63

3.0

2.1

3.16

3.27

mg/l

0.09

Disorders of optic nerve, not elsewhere classified

205

1551

1.45

4.62

2.4

2.2

3.20

3.12

mg/l

0.21

186

1324

Calculus of lower urinary tract

519

4363

1.26

4.62

2.2

3.23

3.04

mg/l

0.80

433

3703

Vascular dementia (undefined)

394

3183

1.29

4.62

2.6

2.3

3.30

3.35

mg/l

0.11

306

2652

Mental and behavioural disorders associated with the puerperium

116

793

1.64

4.62

1.7

2.0

2.77

2.78

mg/l

0.03

675

Colorectal neuroendocrine tumor and carcinoma, excluding all cancers (controls excluding all cancers)

131

917

1.59

4.61

2.5

2.1

3.09

2.96

mg/l

0.28

117

763

Benign neoplasm: Other/unspecified site

149

1068

1.54

4.59

2.4

2.2

3.15

2.99

mg/l

0.34

120

912

Benign neoplasm: Lip

202

1521

1.44

4.59

2.4

2.2

2.90

2.98

mg/l

0.19

156

1265

Other operation for atrial fibrillation

396

2.03

4.58

2.7

2.0

3.15

3.16

mg/l

0.01

343

Abnormal findings in cerebrospinal fluid

186

2.52

4.58

3.0

1.9

3.98

2.81

mg/l

0.95

158

Glaucoma-related operations

571

4857

1.25

4.57

2.3

2.93

3.13

mg/l

0.95

480

4098

Melanocytic naevi, other sites/unspecified

731

6311

1.21

4.57

2.5

2.1

2.82

2.87

mg/l

0.30

666

5390

Benign leiomyoma with endometriosis

1577

14289

1.14

4.57

2.3

3.06

3.02

mg/l

0.22

1297

12244

Assault by other specified means

532

1.76

4.57

1.8

2.0

3.12

2.92

mg/l

0.25

452

Injury of nerves at wrist and hand level

321

2559

1.33

4.57

2.3

2.1

2.60

2.91

mg/l

2.47

284

2185

Alpha thalassaemia

4.14

4.55

2.6

2.0

4.46

2.68

mg/l

1.39

Benign neoplasm: Short bones of upper limb

143

1018

1.54

4.54

2.4

2.0

2.84

2.99

mg/l

0.27

121

881

Dacryoadenitis

557

1.79

4.54

2.4

2.1

3.00

3.15

mg/l

0.26

470

Chronic mastoiditis

270

2125

1.38

4.53

2.4

2.1

3.04

3.08

mg/l

0.09

224

1789

Sickle-cell disorders

167

2.65

4.53

3.0

2.0

3.47

3.05

mg/l

0.45

147

Sequelae of malnutrition and other nutritional deficiencies

147

2.80

4.52

3.6

2.1

3.01

2.84

mg/l

0.18

127

Sequelae of infectious and parasitic diseases

717

6181

1.20

4.50

2.6

2.2

2.96

2.97

mg/l

0.05

626

5231

Congenital malformations of uterus and cervix

216

1649

1.42

4.50

2.6

2.0

2.78

2.63

mg/l

0.47

190

1406

Crowding of teeth, including avohilmo

891

6424

1.18

4.50

2.7

2.3

2.65

2.63

mg/l

0.09

779

5568

Contracture of muscle

235

2.25

4.49

2.3

1.8

2.61

2.97

mg/l

0.58

204

Migraine without aura, drug-induced

112

763

1.63

4.49

2.4

1.9

2.76

3.01

mg/l

0.71

103

650

Liposarcoma, excluding all cancers (controls excluding all cancers)

644

1.71

4.49

2.2

2.1

3.15

3.02

mg/l

0.17

545

Personal history of allergy to drugs, medicaments and biological substances

102

681

1.67

4.48

2.3

1.9

2.89

2.86

mg/l

0.04

586

Other congenital malformations, not elsewhere classified

539

1.77

4.48

2.7

2.5

2.87

mg/l

0.01

460

Unspecified threat to breathing

101

677

1.69

4.47

2.3

2.0

2.79

2.96

mg/l

0.46

587

Postdysenteric arthropathy

611

1.71

4.46

2.1

1.9

2.87

3.01

mg/l

0.28

518

Malignant neoplasm of oral cavity

315

2528

1.34

4.45

2.3

2.2

2.71

3.12

mg/l

2.94

269

2130

Adult-onset Still disease

228

2.24

4.44

3.8

1.9

2.86

3.25

mg/l

0.52

190

Other disorders of Eustachian tube

271

2134

1.36

4.43

2.8

2.1

2.61

2.97

mg/l

2.51

240

1811

Atypical virus infections of central nervous system

604

1.71

4.42

2.2

2.0

3.32

3.28

mg/l

0.05

520

Malignant neoplasm of ureter, excluding all cancers (controls excluding all cancers)

587

1.77

4.42

2.4

2.2

2.84

3.11

mg/l

0.59

500

Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)

924

8145

1.18

4.42

2.3

2.4

3.31

3.04

mg/l

2.23

782

6890

Congenital malformations of genital organs

900

7849

1.18

4.42

2.5

2.3

2.74

mg/l

0.03

787

6792

Mature T/NK-cell lymphomas, hilmo

135

963

1.57

4.42

2.6

2.1

3.41

3.18

mg/l

0.39

125

821

Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

376

3077

1.30

4.40

2.5

2.2

3.06

3.03

mg/l

0.08

326

2603

Acute thyroiditis

267

2.17

4.40

2.9

2.0

2.85

2.84

mg/l

0.01

233

Tic and related disorders

128

899

1.56

4.38

3.0

2.5

2.73

2.72

mg/l

0.02

113

774

Acute lymphocytic leukaemia, excluding all cancers (controls excluding all cancers)

426

1.87

4.35

2.1

3.0

2.53

2.72

mg/l

0.34

367

Acute lymphocytic leukaemia, helper endpoint

426

1.87

4.35

2.1

3.0

2.53

2.72

mg/l

0.34

367

Neuroendocrine tumor and carcinoma of pancreas

398

1.94

4.35

2.7

2.0

3.03

3.30

mg/l

0.27

338

Benign neoplasm: Hypopharynx

275

2.13

4.34

1.9

2.81

2.97

mg/l

0.23

230

Effects of heat and light

481

1.81

4.34

2.4

2.1

3.07

2.92

mg/l

0.21

414

Other bacterial agents as the cause of diseases classified to other chapters

107

734

1.66

4.33

3.4

2.0

3.47

3.08

mg/l

0.66

629

Ankle and foot

569

1.74

4.33

2.4

2.0

2.89

3.00

mg/l

0.19

485

Injury of nerves at shoulder and upper arm level

103

697

1.65

4.31

2.1

2.0

2.82

3.08

mg/l

0.38

613

Choroidal haemorrhage and rupture

197

2.39

4.31

2.4

2.1

3.05

3.39

mg/l

0.56

174

Graves ophthalmopathy

230

1781

1.39

4.31

2.6

2.1

2.56

3.03

mg/l

3.25

204

1507

Henoch-Schönlein purpura nephritis (HSPN)

233

2.26

4.30

3.3

2.0

2.56

2.88

mg/l

0.64

195

Benign neoplasm of breast

1153

10305

1.16

4.30

2.3

2.99

2.87

mg/l

0.71

965

8823

Secondary sideroblastic anaemia

169

2.51

4.30

2.7

1.7

3.19

2.99

mg/l

0.21

145

Behçet disease

183

2.44

4.30

2.9

1.9

3.05

2.92

mg/l

0.11

158

Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)

771

6719

1.19

4.30

2.1

2.3

3.12

3.00

mg/l

0.55

680

5645

Other bursitis of knee

125

877

1.56

4.30

2.3

2.0

2.72

2.96

mg/l

0.76

112

755

Benign neoplasm of other and unspecified sites

292

2328

1.34

4.29

2.5

2.2

3.00

2.86

mg/l

0.51

242

1967

Malignant neoplasm of oropharynx, excluding all cancers (controls excluding all cancers)

182

1364

1.45

4.27

2.1

2.61

2.91

mg/l

1.18

156

1155

Hypertensive encephalopathy

274

2.22

4.27

2.7

2.1

3.58

3.32

mg/l

0.31

231

Malignant neoplasm of other and unspecified parts of tongue

139

1003

1.54

4.26

2.3

2.1

2.57

3.12

mg/l

2.89

127

863

Malignant neoplasm of brain

182

2409

0.71

4.25

1.7

2.1

2.78

2.98

mg/l

0.56

147

2060

Other lack of coordination

167

1242

1.48

4.23

2.5

2.2

3.05

3.10

mg/l

0.10

153

1040

Nezelof syndrome

287

2.11

4.20

3.6

2.0

3.16

3.33

mg/l

0.19

255

Burn and corrosion of head and neck

187

1408

1.43

4.18

2.0

2.1

2.78

2.90

mg/l

0.35

161

1214

Pervasive developmental disorders excl. Autism + Asperger

114

787

1.59

4.18

2.1

3.2

2.36

2.73

mg/l

1.39

702

Benign lipomatous neoplasm of other sites/unspecified

868

7647

1.18

4.18

2.3

2.97

3.05

mg/l

0.49

738

6503

Respiratory conditions due to other external agents

198

1515

1.43

4.17

2.8

2.2

3.48

3.13

mg/l

1.06

178

1268

Other bursitis, not elsewhere classified

653

1.66

4.17

1.9

2.0

3.03

3.14

mg/l

0.13

564

Other congenital malformations of urinary system

293

2.04

4.15

2.5

2.97

2.98

mg/l

0.01

263

Benign neoplasm: Skin of trunk

391

3232

1.28

4.15

2.5

2.2

2.82

2.94

mg/l

0.43

332

2734

Benign neoplasm: Kidney

328

2670

1.32

4.15

2.5

2.2

2.92

3.09

mg/l

0.59

278

2262

Mental and behavioural disorders of puerperium, not classified elsewhere

116

812

1.59

4.15

1.7

2.0

2.77

2.78

mg/l

0.02

695

Contracture of joint

114

791

1.58

4.15

2.2

1.9

3.03

2.92

mg/l

0.17

658

Malignant neoplasm of larynx, excluding all cancers (controls excluding all cancers)

187

1413

1.43

4.14

2.1

2.2

2.78

2.94

mg/l

0.50

158

1187

Benign neoplasm: Connective and other soft tissue of upper limb, including shoulder

386

3180

1.28

4.14

2.4

2.2

2.73

2.86

mg/l

0.63

350

2720

Burns and corrosions of multiple and unspecified body regions

202

1543

1.41

4.13

2.4

2.1

2.85

2.93

mg/l

0.17

173

1333

Congenital lactase deficiency

166

2.53

4.12

2.1

1.8

2.88

2.94

mg/l

0.05

135

Pigmented purpuric dermatosis

650

1.67

4.11

2.5

2.1

2.76

3.03

mg/l

0.47

558

Abscess of tendon sheath

362

1.91

4.10

3.0

1.9

2.70

3.00

mg/l

0.63

311

Benign neoplasm: Spinal cord

128

912

1.54

4.10

2.3

2.1

3.09

3.03

mg/l

0.11

107

763

Epiphora

214

1658

1.40

4.10

2.5

2.1

2.88

3.12

mg/l

0.73

181

1402

Congenital malformation syndromes predominantly affecting facial appearance

218

2.35

4.09

2.0

3.2

3.24

2.68

mg/l

1.10

194

Non-small cell lung cancer, squamous, excluding all cancers (controls excluding all cancers)

284

3545

0.77

4.09

2.1

2.2

3.52

3.04

mg/l

1.64

244

2929

Onychogryphosis

167

2.52

4.07

2.5

2.0

3.40

3.30

mg/l

0.08

142

Malignant neoplasm of tongue

182

1380

1.44

4.06

2.3

2.1

2.60

3.13

mg/l

3.09

160

1181

Helminthiases

170

1273

1.45

4.06

2.8

2.1

2.87

3.02

mg/l

0.42

144

1085

Dermatitis due to ingested food

339

2656

1.29

4.06

3.1

2.7

2.44

2.64

mg/l

1.32

294

2345

Foreign body or object entering through skin

536

4555

1.22

4.06

2.3

2.1

2.79

2.85

mg/l

0.23

458

3899

Bitten or stung by nonvenomous insect and other nonvenomous arthropods

301

2427

1.32

4.06

2.1

2.2

2.61

2.90

mg/l

1.88

250

2094

Other inflammation of vagina/vulva

350

2868

1.29

4.03

2.1

2.58

2.75

mg/l

0.87

293

2474

Knuckle pads

101

3.09

4.02

2.9

1.9

2.41

3.25

mg/l

1.14

Congenital deformities of hip

185

1405

1.43

4.01

2.4

2.66

2.75

mg/l

0.31

161

1215

Adenocarcinoma and Papillary adenocarcinoma of kidney

111

783

1.62

4.00

2.5

2.0

3.25

3.11

mg/l

0.25

680

Acquired clawhand, clubhand, clawfoot and clubfoot

296

2.00

3.99

2.6

1.8

2.49

2.94

mg/l

0.76

253

Malignant neoplasm of bronchus and lung, excluding all cancers (controls excluding all cancers)

1827

16593

0.90

3.99

2.2

2.3

3.34

2.97

mg/l

5.70

1560

13932

Nail dystrophy

413

1.84

3.98

2.9

2.0

2.39

3.16

mg/l

2.10

352

All dysplastic lesions of the vagina

242

1908

1.36

3.98

2.6

2.1

2.69

2.96

mg/l

1.33

204

1635

Dissection of cerebral arteries, nonruptured

434

1.79

3.98

2.1

2.0

2.95

3.21

mg/l

0.37

376

Acute lymphocytic leukaemia

437

1.82

3.97

2.1

2.9

2.53

2.85

mg/l

0.64

379

Status post-ami

665

6283

0.84

3.96

2.6

2.2

3.26

3.12

mg/l

0.83

581

5121

Brain glioblastoma and astrocytoma

1127

0.61

3.95

1.7

2.0

2.81

3.12

mg/l

0.47

968

Benign lipomatous neoplasm of of intra-abdominal organs

205

2.33

3.95

2.3

2.1

3.09

3.19

mg/l

0.10

180

Other disorders of male genital organs

285

2277

1.31

3.95

2.2

2.67

2.90

mg/l

1.45

244

1973

L02BG Aromatase inhibitors

2471

26548

0.91

3.92

2.2

2.3

2.99

3.04

mg/l

0.37

2088

22586

Viral agents as the cause of diseases classified to other chapters

203

1568

1.40

3.92

2.3

2.1

2.85

2.94

mg/l

0.20

180

1368

Frostbite

100

686

1.61

3.92

2.2

1.9

3.02

2.94

mg/l

0.11

599

Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck

550

4704

1.22

3.91

2.3

2.2

2.84

2.85

mg/l

0.03

465

4010

Acute hepatitis B

246

2.09

3.90

3.1

2.0

3.03

3.23

mg/l

0.19

211

Malignant neoplasm of oesophagus

238

1884

1.37

3.89

2.1

2.2

3.76

3.11

mg/l

2.10

205

1582

Other and unspecified injuries of neck

566

1.68

3.88

2.3

1.9

2.62

2.82

mg/l

0.48

490

Urticaria due to cold and heat

567

1.69

3.87

2.3

2.0

2.59

2.86

mg/l

0.49

484

Other and unspecified papulosquamous disorders

418

1.84

3.87

3.5

1.9

3.14

3.10

mg/l

0.03

360

Contact with other hot fluids

272

2178

1.33

3.86

2.2

2.60

2.87

mg/l

1.40

223

1893

Malignant neoplasm of thyroid gland

621

5376

1.20

3.86

2.4

2.2

2.97

2.95

mg/l

0.05

534

4580

Palindromic rheumatism

673

1.61

3.84

2.5

1.9

3.30

3.09

mg/l

0.39

565

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

337

2762

1.28

3.83

2.7

2.3

2.74

2.72

mg/l

0.07

297

2402

Third [oculomotor] nerve palsy

175

1333

1.43

3.83

2.6

2.2

3.06

3.16

mg/l

0.19

152

1137

Acute poliomyelitis

130

944

1.52

3.82

2.3

2.1

3.52

3.21

mg/l

0.64

109

805

Benign neoplasm of brain and other parts of central nervous system

603

5214

1.21

3.82

2.3

2.2

2.99

2.97

mg/l

0.05

504

4427

Melanocytic naevi of lower limb, including hip

394

3287

1.26

3.82

2.5

2.1

2.80

2.93

mg/l

0.70

343

2807

Contact with sharp glass

320

2605

1.29

3.82

2.3

2.1

2.59

2.77

mg/l

0.92

266

2259

Motor- or nonmotor-vehicle accident, type of vehicle unspecified

123

880

1.52

3.80

2.2

2.0

2.76

2.85

mg/l

0.18

107

751

Iliotibial band syndrome

101

697

1.59

3.80

2.0

2.45

3.13

mg/l

3.28

589

Chorioretinal inflammation

255

2035

1.33

3.77

2.4

2.1

3.22

3.01

mg/l

0.59

223

1720

Keratoconus

197

1516

1.38

3.76

2.4

2.1

3.07

2.95

mg/l

0.22

165

1311

Onycholysis

428

1.80

3.75

2.5

2.2

2.42

2.99

mg/l

2.66

363

Injury of muscle and tendon at ankle and foot level

211

1644

1.37

3.73

2.1

2.0

2.63

2.86

mg/l

1.03

179

1400

Other benign neoplasms of connective and other soft tissue

929

8275

1.16

3.73

2.5

2.2

2.89

2.94

mg/l

0.24

804

7060

Benign neoplasm: Skin, unspecified

364

3023

1.27

3.72

2.7

2.1

2.99

3.00

mg/l

0.02

319

2545

Brain glioblastoma

879

0.57

3.72

1.4

2.0

3.04

3.19

mg/l

0.15

749

Horner syndrome

117

838

1.54

3.72

2.4

2.0

2.92

3.07

mg/l

0.25

104

719

Colorectal neuroendocrine tumor and carcinoma

131

957

1.50

3.72

2.5

2.1

3.09

3.12

mg/l

0.07

117

827

Foreign body in ear

175

1334

1.42

3.72

2.0

2.1

2.85

2.89

mg/l

0.07

144

1142

Testicular dysfunction, other/unspecified

190

2.17

3.71

2.3

2.1

3.07

3.29

mg/l

0.23

167

Benign neoplasm: Endocrine pancreas

433

1.82

3.70

2.4

2.0

3.43

3.18

mg/l

0.26

374

Use of levodopa decarbox-comt-inhibitor

316

2602

1.30

3.70

2.5

2.2

3.42

3.11

mg/l

0.99

269

2195

Contact with sharp object, undetermined intent

181

1383

1.40

3.68

2.4

2.0

2.61

2.90

mg/l

1.31

156

1193

Optic atrophy

171

1303

1.42

3.68

2.6

2.2

3.31

3.00

mg/l

0.98

143

1121

Benign neoplasm: Other/unspecified site

149

1114

1.46

3.66

2.4

2.1

3.15

3.06

mg/l

0.16

120

955

Other and unspecified primary disorders of muscles

503

1.72

3.66

2.8

2.3

3.04

3.16

mg/l

0.14

428

Benign neoplasm of ovary

1697

15605

1.11

3.66

2.4

2.3

3.00

3.01

mg/l

0.05

1483

13318

Papillary adenocarcinoma of thyroid gland

468

3983

1.23

3.64

2.5

2.1

2.85

2.97

mg/l

0.54

400

3385

Tuberculosis of other organs, strict

252

2025

1.34

3.63

2.7

2.2

3.02

3.18

mg/l

0.46

217

1690

Malignant neoplasm of hypopharynx, excluding all cancers (controls excluding all cancers)

439

1.77

3.63

2.0

2.72

2.81

mg/l

0.14

365

Granuloma annulare

144

1073

1.47

3.63

2.5

2.0

2.89

2.99

mg/l

0.19

133

907

Sixth [abducent] nerve palsy

315

2592

1.29

3.63

2.5

2.2

3.09

3.08

mg/l

0.03

272

2187

Melanocytic naevi of scalp and neck

218

1716

1.36

3.62

2.4

2.1

2.62

2.76

mg/l

0.37

183

1448

Struck by thrown, projected or falling objec

402

3369

1.25

3.62

2.2

2.1

2.68

2.86

mg/l

1.12

348

2873

Abnormal reflex

322

1.91

3.62

2.2

2.0

2.71

2.92

mg/l

0.40

282

Benign neoplasm: Connective and other soft tissue of head, face and neck

153

1147

1.44

3.61

2.4

2.1

2.64

2.93

mg/l

1.08

132

962

Other and unspecified mental retardation

143

1061

1.46

3.61

2.2

3.1

3.05

2.77

mg/l

0.67

122

947

Contact with other hot metals

139

1028

1.47

3.61

2.6

2.2

2.58

3.01

mg/l

1.81

124

877

Unspecified abortion

420

3535

1.24

3.59

2.1

2.2

2.57

2.82

mg/l

1.94

368

3080

Benign neoplasm: Brain, infratentorial

402

1.81

3.59

2.0

2.2

3.26

2.82

mg/l

0.73

352

Other and unspecified disorders of orbit

332

1.91

3.59

2.2

2.1

3.09

3.08

mg/l

0.01

285

Malignant neoplasm of breast, HER2-negative

4695

36276

0.94

3.57

2.2

2.3

3.02

mg/l

0.04

3919

31056

Deep bite

1039

8156

1.15

3.56

2.6

2.4

2.71

2.79

mg/l

0.38

904

7054

Other conjunctival vascular disorders and cysts

217

1716

1.36

3.55

2.4

2.1

3.12

3.03

mg/l

0.18

188

1461

Malignant neoplasm of bone and articular cartilage

631

1.63

3.55

2.2

2.1

2.70

3.00

mg/l

0.88

550

Malignant neoplasm of tonsil, excluding all cancers (controls excluding all cancers)

146

1092

1.45

3.54

2.1

2.60

2.92

mg/l

0.97

123

928

Mental and behavioural disorders due to use of volatile solvents

145

2.37

3.54

1.6

1.8

3.85

2.83

mg/l

0.55

124

Burn and corrosion of hip and lower limb, except ankle and foot

210

1651

1.36

3.53

2.2

2.1

2.83

2.86

mg/l

0.08

177

1417

Serous carcinoma of ovary

324

2684

1.28

3.52

2.0

2.3

2.94

3.09

mg/l

0.55

280

2243

Phlebitis and thrombophlebitis of lower extremities, unspecified, drug-induced

640

1.62

3.52

2.3

2.1

3.16

3.17

mg/l

0.01

552

Acute myeloid leukaemia

103

733

1.57

3.50

2.3

2.1

2.69

3.34

mg/l

2.23

631

Oral leukoplakia

169

1299

1.42

3.49

2.2

2.1

2.88

3.20

mg/l

0.55

142

1114

L02BA Anti-estrogens

1308

14348

0.89

3.48

2.1

2.3

2.85

3.00

mg/l

1.52

1118

12312

Benign neoplasm: Tonsil

108

772

1.54

3.48

2.3

2.1

3.37

3.14

mg/l

0.30

656

Mild or no visual impairment, binocular

319

1.91

3.47

2.5

2.0

3.09

3.23

mg/l

0.17

281

Pilonidal cyst

694

6078

1.17

3.47

2.2

2.1

2.85

2.71

mg/l

1.05

625

5237

Follicular lymphoma, hilmo

396

3346

1.25

3.47

2.1

2.2

3.22

3.08

mg/l

0.68

352

2815

Malignant neoplasm of bone and articular cartilage of other and unspecified sites

345

1.89

3.46

2.2

2.0

2.64

3.02

mg/l

0.81

301

Other degenerative diseases of the basal ganglia

158

1212

1.44

3.46

2.3

2.1

2.89

3.05

mg/l

0.38

132

1035

Retinal breaks without detachment

1431

13092

1.12

3.46

2.3

2.2

2.77

2.96

mg/l

2.39

1195

11185

Intentional self-harm by jumping from a high place

316

1.86

3.45

1.6

1.9

2.80

2.96

mg/l

0.24

273

Benign neoplasm: Spinal meninges

100

709

1.57

3.45

2.7

2.2

3.43

3.08

mg/l

0.67

593

Injury of nerves at forearm level

115

831

1.51

3.43

2.7

1.9

2.58

2.96

mg/l

1.57

714

Exposure to other and unspecified forces of nature

351

1.84

3.41

2.4

2.0

3.28

2.95

mg/l

0.16

312

Generalized pustular psoriasis

253

2.05

3.40

2.8

2.0

3.35

3.09

mg/l

0.20

213

Malignant neoplasm of other and ill-defined digestive organs, excluding all cancers (controls excluding all cancers)

153

1163

1.43

3.40

2.1

2.2

3.19

3.04

mg/l

0.28

133

970

Benign neoplasm: Pelvic bones, sacrum and coccyx

236

2.04

3.39

1.7

2.1

2.77

2.87

mg/l

0.15

194

Malignant cancer of tonsil and base of tongue, excluding all cancers (controls excluding all cancers)

201

1581

1.36

3.39

2.1

2.2

2.70

2.95

mg/l

0.88

168

1337

Other corneal oedema

548

1.67

3.38

2.5

2.1

3.09

3.21

mg/l

0.12

473

Melanoma in situ of trunk

132

988

1.48

3.38

2.4

2.1

2.63

3.21

mg/l

1.50

104

855

Other bursal cyst

141

1058

1.44

3.37

2.2

2.0

2.74

3.08

mg/l

0.96

116

889

Malignant neoplasm of breast

4854

36735

0.94

3.37

2.2

2.3

3.02

3.01

mg/l

0.13

4053

31472

Mandibular retrognathia

589

5110

1.19

3.36

2.1

2.3

2.75

2.76

mg/l

0.04

533

4444

Cerebral arteritis

172

2.30

3.36

2.9

1.9

2.63

3.20

mg/l

0.98

156

Parapsoriasis

174

1346

1.39

3.36

2.4

2.1

2.73

2.99

mg/l

0.80

153

1161

Renal cell carcinoma of kidney, excluding all cancers (controls excluding all cancers)

311

2573

1.28

3.36

2.4

2.2

3.65

3.00

mg/l

3.61

263

2151

Psoas tendinitis

259

1.97

3.35

2.5

1.9

2.45

3.17

mg/l

2.28

222

Other specified and unspecified strabismus

109

786

1.52

3.35

2.9

2.3

2.81

3.10

mg/l

0.67

675

Guttate psoriasis

130

965

1.46

3.34

2.7

2.0

3.39

2.99

mg/l

1.08

116

838

Graves ophthalmopathy, strict

198

1560

1.36

3.34

2.6

2.1

2.63

3.04

mg/l

2.20

174

1320

Lesion of femoral nerve

522

1.66

3.33

1.9

2.73

2.94

mg/l

0.53

445

Injury of cranial nerves

408

1.75

3.32

2.3

1.9

2.96

2.75

mg/l

0.32

351

Rheumatic valve diseases

233

1873

1.33

3.32

2.9

2.2

3.66

3.22

mg/l

1.76

206

1585

Other and unspecified disorders of psychological development

103

722

1.53

3.32

2.6

3.1

3.17

2.61

mg/l

0.74

638

Inflammatory disease of cervix uteri

607

5315

1.19

3.29

2.4

2.3

3.36

3.02

mg/l

2.60

515

4522

Benign neoplasm: Conjunctiva

297

2454

1.28

3.29

2.4

2.1

2.98

3.03

mg/l

0.12

247

2089

Malignant neoplasm of other and unspecified urinary organs, excluding all cancers (controls excluding all cancers)

518

1.67

3.27

2.6

2.1

3.23

2.89

mg/l

0.69

425

Benign neoplasm of soft tissue of retroperitoneum and peritoneum

348

1.83

3.27

2.6

2.0

2.70

2.95

mg/l

0.39

290

Sclerosis of liver

5.14

3.27

4.8

2.4

3.76

2.98

mg/l

0.59

Cholera

381

3219

1.24

3.27

2.5

2.1

3.18

3.11

mg/l

0.14

331

2713

Disorder of thyroid, unspecified

122

902

1.48

3.26

2.0

2.1

2.68

3.08

mg/l

1.38

102

763

Deaf mutism, not elsewhere classified

323

1.84

3.26

3.6

1.9

3.31

3.09

mg/l

0.21

277

Inflammation of lacrimal passages (acute and unspecified)

162

1248

1.40

3.25

2.4

2.2

2.77

3.08

mg/l

1.41

150

1059

Hereditary erythropoietic porphyria

4.10

3.24

2.4

2.0

2.37

3.50

mg/l

1.42

Benign neoplasm of bone and articular cartilage

744

6599

1.16

3.23

2.3

2.1

2.84

2.89

mg/l

0.23

645

5666

231

1.99

3.21

2.8

2.0

2.62

3.04

mg/l

0.75

200

LSIL lesion of the cervix uteri, vagina or vulva

1324

12113

1.12

3.21

2.2

2.1

2.74

2.75

mg/l

0.03

1144

10443

Small kidney of unknown cause

154

2.37

3.20

3.7

2.1

2.55

3.23

mg/l

1.10

136

Defect, injury or illness of neck

358

1.80

3.18

2.0

1.9

2.57

2.93

mg/l

0.71

300

Whooping cough

388

1.74

3.17

2.0

2.1

2.66

2.64

mg/l

0.03

334

Myelofibrosis

4.62

3.15

1.6

1.8

2.89

3.10

mg/l

—

Malignant neoplasm of vulva, excluding all cancers (controls excluding all cancers)

137

1042

1.45

3.15

2.5

2.3

3.15

3.10

mg/l

0.08

107

876

Nontraumatic intracranial haemmorrhage

2056

19168

1.09

3.14

2.3

3.30

3.08

mg/l

2.39

1747

16180

Ovarian hyperstimulation (induction)

169

1317

1.38

3.14

2.3

2.0

2.75

2.60

mg/l

0.46

153

1138

Contusion of toe(s) with damage to nail

102

736

1.52

3.14

2.3

2.1

3.13

2.99

mg/l

0.16

627

Chronic thyroiditis

274

1.93

3.14

2.4

2.1

2.61

2.93

mg/l

0.40

230

Hypertrophy of (infrapatellar) fat pad

633

1.55

3.13

2.5

2.0

3.31

2.87

mg/l

0.97

542

Injury of nerves at ankle and foot level

454

1.67

3.13

2.4

2.0

3.22

2.97

mg/l

0.27

388

Felty syndrome

402

1.75

3.10

2.9

2.0

3.61

3.26

mg/l

0.51

336

Burn and corrosion of wrist and hand

316

2634

1.25

3.10

2.1

2.2

2.60

2.84

mg/l

1.58

269

2265

Acne conglobata

302

1.82

3.10

2.3

2.0

2.87

2.75

mg/l

0.16

253

Disorders of globe

235

1909

1.31

3.09

2.4

2.2

3.16

3.12

mg/l

0.08

206

1615

Chronic suppurative otitis media, including avohilmo

764

6814

1.16

3.09

2.4

2.3

2.80

2.90

mg/l

0.65

637

5799

Social disorders starting during childhood or adolescence

554

1.60

3.09

2.6

2.7

2.84

2.55

mg/l

0.72

479

Prolapse and hernia of ovary and fallopian tube

424

3610

1.22

3.08

2.5

2.4

3.11

3.32

mg/l

1.25

371

2991

Vertical strabismus

304

2533

1.26

3.08

2.3

2.2

2.84

2.96

mg/l

0.44

253

2175

Other noninflammatory disorders of cervix uteri

436

3744

1.21

3.07

2.4

2.3

3.15

3.01

mg/l

0.61

375

3217

Benign neoplasm: Pelvic bones, sacrum and coccyx

244

1.96

3.06

1.7

2.1

2.77

2.97

mg/l

0.33

207

Narcolepsy and cataplexy

456

1.66

3.06

2.6

1.9

2.79

2.78

mg/l

0.01

387

Valgus deformity, not elsewhere classified

489

1.63

3.05

2.5

2.1

2.81

2.88

mg/l

0.12

402

Organ-limited amyloidosis

253

1.96

3.04

2.6

2.2

3.43

3.36

mg/l

0.06

217

Benign neoplasm: Hypopharynx

308

1.85

3.03

1.9

2.81

3.17

mg/l

0.66

271

Adenocarcinoma of pancreas

172

2171

0.75

3.03

2.0

2.2

3.05

3.16

mg/l

0.27

154

1831

Simple and mucopurulent chronic bronchitis

409

3500

1.22

3.02

2.5

2.2

3.21

2.99

mg/l

0.86

357

2916

Chronic suppurative otitis media

657

5815

1.17

3.02

2.4

2.2

2.80

2.91

mg/l

0.63

545

4933

Acanthosis nigricans

207

2.04

3.02

2.3

1.9

3.50

2.90

mg/l

0.88

174

Anuria and oliguria

486

1.66

3.01

2.5

2.0

3.34

3.18

mg/l

0.19

419

Procedures for purposes other than remedying health state

214

1720

1.31

3.01

2.2

2.0

2.49

2.95

mg/l

2.62

181

1446

Malignant neoplasm of testis, excluding all cancers (controls excluding all cancers)

131

982

1.41

3.01

2.6

2.1

3.05

2.84

mg/l

0.52

114

825

Other zoonotic bacterial diseases, not elsewhere classified

3.13

3.01

2.6

2.5

3.22

3.34

mg/l

—

Brain glioblastoma and astrocytoma, excluding all cancers (controls excluding all cancers)

1064

0.65

3.01

1.7

2.1

2.81

2.95

mg/l

0.18

894

Other sexually transmitted chlamydial diseases

570

4988

1.18

2.99

2.0

2.48

2.60

mg/l

0.74

438

4295

Brain meningioma, excluding all cancers (controls excluding all cancers)

448

3867

1.21

2.99

2.3

3.01

2.96

mg/l

0.20

379

3264

Lesion of medial popliteal nerve

246

1.95

2.99

2.6

1.9

2.88

3.20

mg/l

0.39

211

Malignant neoplasm of retroperitoneum and peritoneum

513

1.64

2.98

2.0

2.1

2.39

3.43

mg/l

4.03

441

Calcification and ossification of muscle

142

2.30

2.98

2.0

1.8

2.25

3.20

mg/l

2.06

120

Other acquired deformities of musculoskeletal system and connective tissue

399

3410

1.22

2.98

2.5

2.2

2.93

3.01

mg/l

0.29

342

2899

Single spontaneous delivery

4514

25173

0.94

2.98

2.1

2.3

2.86

2.93

mg/l

1.11

3870

21396

Demyelinating diseases of the central nervous system

763

6814

1.15

2.97

2.2

2.1

2.86

2.81

mg/l

0.25

658

5872

Juvenile osteochondrosis

292

2429

1.26

2.95

2.3

2.1

2.64

2.75

mg/l

0.38

252

2092

Injury of muscle and tendon at lower leg level

1317

12092

1.11

2.94

2.4

2.2

2.95

2.90

mg/l

0.30

1114

10421

Benign neoplasm: Spinal meninges

100

732

1.51

2.94

2.7

2.1

3.43

3.19

mg/l

0.40

619

Benign neoplasm: Scrotum

207

1.98

2.94

2.3

1.9

2.74

2.72

mg/l

0.02

174

Benign neoplasm: Spinal cord

128

970

1.43

2.94

2.3

2.0

3.09

3.14

mg/l

0.10

107

820

Other specified and unspecified disorders of eyelid

126

954

1.44

2.93

2.4

2.1

2.61

3.18

mg/l

2.10

111

817

Pedestrian injured in collision with car, pick-up truck or van

229

1866

1.30

2.92

2.2

2.1

2.75

3.02

mg/l

1.28

189

1587

Combined immunodeficiency, unspecified

3.28

2.92

3.6

2.3

2.67

2.49

mg/l

0.18

Meningitis

432

3723

1.21

2.91

2.3

2.1

2.95

2.93

mg/l

0.06

377

3179

Cerebral amyloid angiopathy

275

1.93

2.90

2.0

2.48

3.15

mg/l

1.67

235

Disorders of hypoglossal nerve

2.99

2.89

1.9

2.2

2.78

2.99

mg/l

0.17

Benign neoplasm: Tonsil

108

800

1.47

2.89

2.3

2.0

3.37

3.24

mg/l

0.16

692

Carcinoma in situ of skin of lip

206

2.09

2.87

3.1

2.1

3.15

2.82

mg/l

0.29

174

Benign neoplasm of other and unspecified sites

292

2443

1.26

2.87

2.5

2.1

3.00

3.01

mg/l

0.02

242

2080

Endometriosis of fallopian tube

479

1.61

2.86

2.3

2.1

2.60

2.82

mg/l

0.50

418

Benign neoplasm: Extrahepatic bile ducts

151

2.20

2.86

3.0

1.9

3.13

2.76

mg/l

0.16

127

Bacterial agents resistant to antibiotics

3.37

2.85

4.9

2.0

3.45

3.08

mg/l

0.24

Benign neoplasm: Skin of upper limb, including shoulder

172

1360

1.35

2.85

2.4

2.1

2.69

2.93

mg/l

0.78

153

1153

Intracerebral haemorrhage

1247

11455

1.12

2.85

2.3

3.26

3.14

mg/l

0.69

1041

9579

Leiomyosarcoma, excluding all cancers (controls excluding all cancers)

616

1.55

2.85

2.0

2.2

2.92

3.09

mg/l

0.30

517

Other and unspecified degenerative diseases of nervous system

223

1825

1.30

2.83

2.1

2.2

2.90

3.19

mg/l

1.00

180

1519

Use of donepezil

2166

19575

1.09

2.82

2.1

2.4

3.17

3.23

mg/l

0.53

1721

16376

Apocrine sweat disorders, other sweat gland disorders

266

1.87

2.81

2.7

1.9

3.02

3.04

mg/l

0.01

225

Exposure to other and unspecified animate mechanical forces

248

2043

1.28

2.81

2.5

2.2

2.81

2.78

mg/l

0.07

206

1760

Other benign neoplasms of uterus

533

4696

1.19

2.81

2.4

3.30

3.08

mg/l

0.84

429

3962

Benign neoplasm: Brain, infratentorial

428

1.68

2.81

2.0

2.2

3.26

2.99

mg/l

0.38

375

Cicatricial alopecia [scarring hair loss]

500

1.60

2.80

2.1

1.9

2.61

3.26

mg/l

1.95

433

Lagophthalmos

122

930

1.44

2.80

3.1

2.1

3.13

3.17

mg/l

0.05

104

795

Epileptic seizures related to alcohol

377

1.70

2.79

2.8

1.9

2.54

3.18

mg/l

1.89

336

Maxillary retrognathism

162

1273

1.35

2.79

2.5

2.3

2.72

2.70

mg/l

0.03

146

1103

Bullous keratopathy

630

1.55

2.78

2.4

2.2

3.54

3.29

mg/l

0.39

533

Unspecified multiple injuries

182

2.04

2.77

2.1

2.0

2.52

2.75

mg/l

0.26

156

Bacterial meningitis

295

2476

1.25

2.76

2.3

2.1

3.01

mg/l

0.01

253

2115

LSIL lesion of the vagina

133

1024

1.40

2.76

2.5

2.1

2.74

2.90

mg/l

0.43

106

878

Other benign neoplasm of uterus: Corpus uteri

537

1.58

2.76

2.5

2.2

2.81

3.15

mg/l

0.73

441

Benign neoplasm: Nasopharynx

568

1.55

2.75

2.3

2.1

2.60

3.16

mg/l

1.19

478

Other and unspecified granulomatous disorders of skin and subcutaneous tissue

230

1.93

2.72

2.4

2.0

2.45

3.04

mg/l

1.21

195

Interstitial cystitis (chronic), drug-induced

231

1.94

2.71

2.0

2.1

2.38

3.18

mg/l

1.33

203

Benign neoplasm of soft tissue of retroperitoneum and peritoneum

366

1.72

2.71

2.6

2.1

2.70

3.17

mg/l

0.91

309

Malignant neoplasm of pyriform sinus, excluding all cancers (controls excluding all cancers)

2.86

2.70

1.8

3.48

2.79

mg/l

0.53

HSIL lesion of the vulva

157

1241

1.36

2.70

2.8

2.1

3.06

3.03

mg/l

0.06

130

1050

Other specified disorders of external ear

336

2867

1.23

2.70

2.3

2.2

2.93

3.03

mg/l

0.38

270

2459

Primary angle-closure glaucoma

428

3723

1.20

2.70

2.2

2.3

3.16

3.13

mg/l

0.07

365

3128

Epidural haemorrhage

524

1.54

2.69

2.5

2.2

2.91

2.93

mg/l

0.02

450

Hepatocellular carcinoma

195

1585

1.32

2.68

2.9

2.2

3.81

3.11

mg/l

2.88

169

1353

Spirochaetal infections, other/unspecified

746

6711

1.15

2.68

2.2

2.71

2.99

mg/l

2.60

589

5741

Melanocytic naevi of scalp and neck

218

1786

1.29

2.67

2.4

2.0

2.62

2.88

mg/l

0.81

183

1521

Puerperal sepsis

1122

10284

1.11

2.66

2.3

2.2

2.86

2.89

mg/l

0.16

957

8843

Desensitization to allergens

464

4044

1.18

2.66

2.2

2.1

2.52

2.70

mg/l

1.28

389

3504

Renal agenesis and other reduction defects of kidney

343

1.74

2.66

2.8

2.6

2.98

2.94

mg/l

0.06

298

Other and unspecified skin changes due to chronic exposure to nonionizing radiation

136

1062

1.40

2.66

2.2

3.36

3.25

mg/l

0.21

118

906

Benign neoplasm: Lip

202

1647

1.31

2.65

2.4

2.2

2.90

3.09

mg/l

0.59

156

1389

Benign neoplasm: Brain, supratentorial

140

1090

1.37

2.64

2.8

2.1

2.77

2.88

mg/l

0.28

117

927

Lower leg

417

1.66

2.64

2.3

2.0

2.11

2.97

mg/l

4.39

362

Injury of blood vessels at hip and thigh level

195

2.03

2.63

2.2

2.0

2.12

3.33

mg/l

3.54

173

Gonococcal infection

253

2100

1.26

2.63

2.1

2.73

3.01

mg/l

1.20

208

1799

Congenital malformations of spine and bony thorax

408

1.65

2.63

3.4

2.7

3.28

2.82

mg/l

0.76

354

Burn and corrosion of shoulder and upper limb, except wrist and hand

174

1391

1.32

2.62

2.2

2.1

2.64

2.98

mg/l

1.83

156

1194

Brain glioblastoma, excluding all cancers (controls excluding all cancers)

811

0.63

2.62

1.4

2.1

3.04

3.02

mg/l

0.01

677

Toxic effect of corrosive substances

293

1.75

2.61

2.3

1.9

2.60

2.96

mg/l

0.50

249

Acute otitis externa, noninfective

148

1164

1.36

2.61

2.6

2.0

3.00

3.04

mg/l

0.09

129

995

Thromboangiitis obliterans

265

1.85

2.61

2.5

2.0

5.75

3.02

mg/l

1.60

218

Donors of organs and tissues

106

792

1.43

2.61

2.1

1.9

2.84

2.88

mg/l

0.07

668

Benign neoplasm: Connective and other soft tissue of thorax

255

1.83

2.60

2.5

1.9

2.46

2.87

mg/l

1.14

216

Contact with blunt object, undetermined intent

367

1.67

2.59

1.7

2.0

2.96

2.97

mg/l

0.01

325

Gender identity disorders

974

0.66

2.58

1.9

2.0

2.87

2.63

mg/l

0.38

834

Generalized epilepsy, mode (most common among epilepsy diagnosis)

283

2382

1.24

2.58

2.3

2.1

2.79

2.81

mg/l

0.06

244

2052

Use of apomorphine

4.42

2.58

2.2

1.6

2.61

4.49

mg/l

—

Certain zoonotic bacterial diseases

168

1345

1.33

2.58

2.4

2.1

2.81

3.06

mg/l

0.68

146

1140

Other acute disseminated demyelination

685

1.47

2.58

2.5

2.0

3.22

2.86

mg/l

0.63

596

Dementia due to Parkinson's disease

236

1970

1.28

2.58

2.2

2.77

3.21

mg/l

2.96

169

1652

Disorders of brain, other and unspecified

661

1.49

2.57

2.7

2.0

3.45

3.21

mg/l

0.29

564

Contact with other and unspecified heat and hot substances

409

1.63

2.57

2.6

2.0

2.98

3.02

mg/l

0.04

350

HSIL lesion of the cervix uteri, vagina or vulva

1907

17873

1.09

2.56

2.2

2.1

2.69

2.72

mg/l

0.17

1628

15468

Digestive system disorders of fetus and newborn

2.82

2.56

7.4

2.3

2.24

2.47

mg/l

0.23

Adult respiratory distress syndrome

119

914

1.41

2.56

2.8

2.2

3.40

3.05

mg/l

0.84

101

786

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS